Index,Bcell_general,Memory_Bcell,Naive_Bcell,Plasma_cell,CD4_Tcell,CD8_Tcell,Memory_Tcell,Naive_Tcell,Tcell_general,Cytotoxic_Tcell,Exhausted_Tcell,Immune_checkpoint,Treg,NKcell,Innate_lymphoid_cell,cDC,pDC,Macrophage,Monocyte,Myeloid,Granulocyte,Mast,Erythrocyte,Platelet,Stem,Stroma,Pericyte,Fibroblast,Endothelial,Epithelial,Mesothelial,Adipocyte,Hepatocyte,Pancreatic,Pneumocyte,Apoptosis_pathway,IFNg_pathway,TGFb_pathway,Cytokine,Cell_proliferation,TLS,Genome_integrity,Reference,time,event,cohort,ICI_target,ICI,cancer_type,response_label,TMB,risk_score,Pred_Risk,best_alpha
UCC_Rose_RS.03238999,-0.8156718040940033,-0.9275239880862339,-0.5047842618518832,-0.5198640544597826,-1.183645894032943,-1.5153037050705815,-0.05436610949512932,-0.6078940960638878,-0.5190020158152543,-1.0320341673494755,0.21732842399314464,-1.0677639502612266,-0.570387517459396,-1.0733701702029672,-0.14774331581686,-1.5115182884004665,-1.2257330674519777,-0.8488961457358825,-0.8676446319241998,-1.5967962951320025,0.6633067679441526,1.2384030922877356,0.8040352691442123,-0.9504483032987203,1.0298228044947717,0.6603852900430847,1.5586879859122813,0.6363967562103822,-0.2638716088170486,1.1323309455384298,1.6974075719213415,-0.21214230556988542,-0.5517671511031597,0.5737158828773087,-0.7402489218552037,1.1962355338335708,-1.290806755776871,1.9923643312539254,-0.25518888350632113,-0.7475522592472348,-0.31749987179318984,-0.7106238366391922,-1.933825205933329,2.2666666666666666,True,Rose,PD-L1,Durvalumab,BLCA,NR,7.0,0.7368021067683154,High-risk,48.80251583654434
UCC_Rose_RS.03239000,0.661742092208591,-0.4451842251365891,0.9410777894315278,0.7258520605459127,1.110298878739623,0.2635181734070545,-0.8625056254287604,1.5462895290598948,0.9195805713246972,0.6266581975933864,0.9620791443331571,0.4796469790022506,1.9646716061760816,1.5059717828940276,1.184896414451595,1.3790367606452338,-0.5882254251211742,1.1637479039535283,1.122729127204393,0.39582654768305203,1.573342532564795,1.5742797376674396,0.6104258072822046,-0.24567014306807822,0.3186001242964773,1.3756341550281568,1.593324903068774,1.6727200237125186,0.5744198752837971,0.9207446246924527,2.0725926613164707,1.993773886419117,-0.4284052343309192,0.29468148821055085,-0.017249999453177234,1.2282840058651305,0.21099680426579712,2.1698752931542393,1.4781314687481444,-1.353173004979153,1.766527116419349,-0.3015062901157953,-1.1527801732480811,10.766666666666667,False,Rose,PD1,Pembrolizumab,BLCA,NR,4.4,0.46973210099750934,High-risk,48.80251583654434
UCC_Rose_RS.03239001,0.9237401009997942,-0.22585378833224667,1.3423328285089573,0.3049471821997225,-0.015567899838015887,-0.6798518158828731,0.3473098240860081,1.3744499658143607,-0.27998784367974217,-0.910864985716028,0.6519882160578123,-0.8505370870532728,0.6646686015164636,0.833390831300759,0.05910547787538674,0.6320500535560651,-0.6543007148216218,0.8446268637427443,0.505071584738062,0.006020438175556254,1.597936658732373,2.2242730136664477,1.2312314465963714,0.09776574010829735,1.6223989150239213,1.2153845372675707,1.0343524567949103,1.3651284670219817,0.003080508071933328,1.81209322073407,1.8225027221647934,0.3495568722795498,-0.7358698090569366,0.5937957228292107,-0.6419113647433927,1.4353700912068732,-0.7677339772839163,2.2420804233411267,1.0873837921596412,-1.0433775757251167,1.0460587226725233,-1.3865899181310346,-1.093646032672491,16.2,False,Rose,PD-L1,Atezolizumab,BLCA,NR,9.8,0.621700282560842,High-risk,48.80251583654434
UCC_Rose_RS.03239002,0.08729856212209322,0.9887697427010068,0.8095071497869045,2.185109085444632,0.6181859205218035,1.0801462476027583,-0.3859973817294029,0.15070866541545586,0.7424607583983548,1.1893119172830975,1.075749885113633,2.27007563107575,1.6167431533584946,1.4962951828543243,1.4063594870421356,-0.06636037173122371,0.06277850118829491,0.7076252463062441,0.9138557145196695,0.6768047839423017,-0.215612875701615,-0.05213859096580476,0.11689702273301686,0.06355228140862187,-0.6210799766376723,0.957354508487378,0.482410417451916,1.2540309854774985,-0.38562777471352994,0.8199333816889708,-0.3952725869436218,-0.32640151252962296,-0.25274614070911466,-1.174647186679983,-0.5603931886191104,1.3901013217285088,1.4425106806576895,2.072835990942034,1.8485206183594312,1.0695566848548268,0.8566234778058428,1.7435336327981903,-0.08957244557253004,19.466666666666665,False,Rose,PD-L1,Atezolizumab,BLCA,R,6.1,0.46005804486133817,High-risk,48.80251583654434
UCC_Rose_RS.03239003,1.942907213792469,1.6418494630407452,2.9220296655216442,0.513732615113297,-0.5275177295041817,-0.9771153310025882,0.32324308315388117,0.6726056851444839,-0.41148119771098307,-1.012621679299539,0.16067368966918683,-0.9535857515652514,0.4067118856217093,-0.6518139001977887,-0.20037905311554888,-1.2185387913281098,-0.8695750547670018,-0.9236514566640744,-1.3795444664758214,-1.65455670479965,-0.8451873757484624,0.2858224729213265,1.7374592757804088,-1.188873212927523,1.2276814881362523,0.34046261358793356,0.4077679930871048,0.7819588535430476,0.7490904223206939,1.1999010823791905,-0.10803335043110125,0.24004137567798955,-0.3528253171405799,0.9684745545566397,-0.637756339743194,1.796143412883824,-1.1823757546504534,1.1436178696401629,0.1267185323333536,-2.298515579590678,0.24763220399032523,-2.067904906747754,-1.7297678745137894,1.5333333333333334,True,Rose,PD1,Nivolumab,BLCA,NR,5.2,0.7718909719497483,High-risk,48.80251583654434
UCC_Rose_RS.03239004,0.2488294069877133,0.8137607685767356,-0.15950892448939252,1.2274079256021293,-0.4721869939610889,-0.8157924998180289,-0.6989020144264347,0.013820714941187088,-0.5012547932665172,-0.8817450851878043,0.05745461567245199,-0.7488038939486988,0.8418200560974296,-0.1016509953020252,-0.17024831059416407,0.5447871495360804,-0.6468788572243424,-1.0683438522672792,0.1584309700273554,-0.7381885595627413,0.4984045718071541,1.2922388284344455,-0.3321609454315706,-0.6046470001296523,0.5607944927018804,0.3824325873994372,0.10148121167906848,-0.10712058195807404,-0.7181256731512607,1.5440089997523203,0.5629867861284603,-0.8546942507649482,-0.5401632332013213,-0.9334711094943483,-0.687374920478431,1.3786735618522274,-0.8969681529212133,0.215997145156053,0.4985926404345883,1.1073153299749572,-0.7012626150368465,1.0850035720952163,-1.3457929023633155,6.5,True,Rose,PD-L1,Atezolizumab,BLCA,NR,7.0,0.6717290029404678,High-risk,48.80251583654434
UCC_Rose_RS.03239005,0.43444943273280073,0.34142753614480104,-0.022709233734929755,0.7323147324357657,0.22031513996873747,-0.01445401570900143,-1.2148633205377435,0.19722225092721987,-0.2161261529719132,-0.22533853219474853,0.6784003412700276,0.0736521461596425,1.223970514325034,0.7678538138876446,0.3536638637263831,0.7914102437500659,-0.2871974125579165,0.370956189161091,0.1693660662106098,-0.5890790238239859,0.2805656649767239,0.5915017548093863,0.5787011022380538,-0.8263420994064684,-0.4548560257605123,0.3827786290165195,1.0171547091097763,0.7469945150766572,-0.12787813000742196,1.3956710605856668,0.46445111735829003,1.1896167053411815,-0.5368226327174763,-0.09047661149866708,0.3430191927927673,1.9169057323083283,-0.3547032994104084,1.6450217161988576,0.7940149285102475,-0.41907692506025895,0.6208618030787586,-0.26641512917870536,-2.214608804265406,13.0,True,Rose,PD1,Pembrolizumab,BLCA,NR,6.1,0.6109144135578048,High-risk,48.80251583654434
UCC_Rose_RS.03239006,-0.42081422462024826,-0.3398082015262098,-1.0921927004852645,-0.9773810001608226,-1.8773442448790056,-1.4525126585853751,-1.035160624430931,-0.79658537987346,-1.5385901008723646,-1.4852799296074728,-1.5487762159092278,-1.6502990269291669,-0.5539967649493802,-0.7722485064186038,-1.0703333554584358,-0.975368581298358,-0.8728720419163115,-0.8463572334036893,-0.7358085224449511,-1.975249497805544,-0.39620275375876424,0.1741465143611196,-0.6521310373774024,-1.41852530398583,1.1550155226009853,-0.3949803502090281,-0.47156655941520165,-1.1592330044807242,-0.18080499758439492,1.784732480009351,-0.45165957161651216,-0.5775924176951313,-0.2937768051193369,-0.577401035429127,-0.7292711698848644,0.7151570435854834,-1.4566322528851006,-0.8871130312607579,-1.1777650810039484,1.0147008655323972,-0.5563497470544445,1.0920443612501138,-0.74245543607246,9.833333333333334,False,Rose,PD1,Pembrolizumab,BLCA,R,13.1,0.6981564788434271,High-risk,48.80251583654434
UCC_Rose_RS.03239007,0.9569278330767717,0.508917452573016,0.5699561008010697,1.4499599269038201,0.5350461070237436,-0.006906026734220123,0.2315735802098308,0.8689682245221886,0.6689932631902247,-0.04781905042933863,0.34878613201529396,-0.3530355672816445,1.13493196323146,0.5183667307658832,1.1081142690248202,0.8669759657024839,-1.2439326314784356,0.7474820670485247,0.9496415741969387,0.36413287993837273,0.8665086720745936,1.6224605955863065,0.4505596763073236,-0.24789671328573262,0.5034244445172237,1.3629412917172214,0.6171231310677702,1.4454902421389035,0.1798379139705526,1.4754903266936423,1.616148410978025,0.3117354840526999,-0.6447824735455379,0.207426479074405,-0.7417422735244584,1.3606412811286654,0.15347726018164345,2.4100805563119634,1.8047138157977802,-1.5922410752205949,0.7472188052662864,-1.7363596353644524,-0.8422881980341022,6.8,True,Rose,PD1,Pembrolizumab,BLCA,NR,2.6,0.5906393988651948,High-risk,48.80251583654434
UCC_Rose_RS.03239008,-0.5929465332016269,1.233960939812797,-0.1112866998180738,0.08615280387519073,0.05044701595854175,0.8532679071838184,-0.24826590191849063,-0.5742414418253268,0.6451607106566886,0.8499640603595525,1.2525653893892137,1.7829544905787398,1.441025696207272,0.4777374030747596,0.9052894799435619,0.5028391791159927,-0.2574542715012123,1.0330677581188217,1.0465684715632935,0.848299908846964,-0.19348135106478567,0.6442363123219943,0.8749328861100328,-0.5320645669556685,1.5910985290187816,0.4268564489967165,-0.162669081830135,0.35845581662789244,0.016386758128664393,1.1688678130286738,0.22015969781261638,-1.0557314156560997,-0.5646483390876551,-0.9235395670689343,-0.8777530630799228,1.6312341957519476,1.3161140776223508,1.2117234958138934,1.9005937575159573,0.7629914883252431,-0.14056751920685903,1.037706930293148,-0.4374620650339979,10.133333333333333,False,Rose,PD1,Pembrolizumab,BLCA,NR,10.4,0.5309028189440409,High-risk,48.80251583654434
UCC_Rose_RS.03239009,-0.12228467546545949,1.378022777422651,-0.03946358303308839,0.8074658484305419,0.37341520854649224,0.9812950918118084,-0.32967901047675807,0.774373202187564,0.44782467260521747,0.9089073039555308,0.6929711987168117,1.3111304292700472,1.2144413181839573,0.843882956099954,1.1987293656490803,1.1737920189935984,5.707502998583897e-05,0.6688284682119011,1.3670782901567635,0.07019977828445806,0.08134094741870064,0.9031950634924125,-0.12301623237321288,-0.6474986024187538,1.1141781535459352,0.031467671842071464,0.02326430550997825,0.09827160969044142,-0.8122877173938827,0.7687823453763004,-1.0424484520881176,0.6879290238761846,-0.5913970648953504,-1.2638873024540083,-0.48767280767189847,1.738709140307316,1.3821119900730732,0.5437929121720435,1.8303334542154852,0.6442373617899326,0.23349852369317964,0.6853632249894744,-0.12155416208105668,8.4,False,Rose,PD1,Pembrolizumab,BLCA,NR,7.8,0.5311847950881349,High-risk,48.80251583654434
UCC_Rose_RS.03239010,-0.7928077058596664,-1.2516177054662503,-0.4786061017972907,-0.07982413603362856,-0.7894768965314521,-1.3266865839679984,-1.6119646773946232,-0.7096751918337658,-0.6982673394803806,-1.0877953164474996,0.10002477069045453,-1.1794395095022803,-0.2447772673094134,-0.3781712947485152,-0.4036866775201056,-0.3067306417133015,-0.2888990945479429,0.0517182867211793,-0.24695107155547327,-0.9944451965266831,-0.2344266128685416,0.9735611609689389,-0.7317094548180358,-1.5364495508787226,-0.0233751778020592,1.0394453798625112,1.553481579584601,1.8928323442783273,0.31382145877106643,1.7096287033070643,1.7678759823383454,0.0032471233097475173,-0.7676193428412889,-0.23420370784339622,0.3416418995054207,1.4609738130866052,-1.3623964639659984,2.723509730766843,0.41794033752358967,-1.483489784786884,-0.2843224715499596,-0.4794576514868722,-1.7416804722143424,3.566666666666667,True,Rose,PD1,Pembrolizumab,BLCA,NR,5.2,0.6835863629002086,High-risk,48.80251583654434
UCC_Rose_RS.03239011,-1.1001435508872728,-1.6363044696681717,-0.8197200184814045,-1.5273375894141972,-1.755804015693867,-2.1278603443599984,-1.0386320239364017,-0.4790251030888524,-1.7586300894039895,-1.5604351245171821,-2.288684310356214,-1.4669777096547334,-0.6629281970299408,-2.4699275577572326,-0.7243608095046955,-1.8210492485152892,-0.9749448120496061,-2.061496283346754,-1.4010274353884105,-2.6043378954860157,-0.9545918708989816,-0.1415474090404218,0.36555684949740846,-1.1596718053230077,1.0536821592098302,-1.3559114206441232,0.03612933776615745,-1.6959865251964996,0.04282510415726272,2.094882426270853,-0.6605849156094423,-0.6823036626484047,0.028910352143943146,-1.0212106775081862,-0.26172039500459354,0.816504602765068,-1.7767469790071304,-1.2361267133686085,-1.1469401166624729,1.009062251817005,-1.449651072316431,0.6830956276790656,-0.5783996426129124,20.166666666666668,False,Rose,PD-L1,Atezolizumab,BLCA,R,12.8,0.7979114668407805,High-risk,48.80251583654434
UCC_Rose_RS.03239012,-0.8516055007310404,0.24956234592135507,-0.8469235881673253,-0.868765060941318,-1.6370587431327681,-1.588199199466248,0.044593075837631384,-0.46921825695141384,-0.883762182290902,-1.1323467909619946,-0.3995093091424997,-1.1776056356988016,-0.2281998920969731,-1.6163833667407144,-0.9053248275958864,-1.0989700527902253,-1.0362807100423537,-1.0572861888541472,-0.2753567682262036,-1.7799255891832573,-1.0253174556003164,-0.22264958832543705,1.5641960223212918,-0.2573780567082137,0.6696336881527133,-0.6688579159601906,-0.4259203711286078,-0.47648904890185706,-0.052677826095678705,1.3893274104625053,0.057714726719685853,0.17262631858583322,-0.34611544942579153,-0.22583436904270252,-0.612954566317992,1.4876135002254074,-1.2398085360698399,0.1820988972776214,-0.11474135646270553,-1.111285987606607,-0.9037022952551024,-1.4482648115136545,-1.2485244371061677,13.4,False,Rose,PD-L1,Atezolizumab,BLCA,NR,7.0,0.7910772117472165,High-risk,48.80251583654434
UCC_Rose_RS.03239013,-0.9668527098958526,-1.3451008018602115,-1.0079465642346872,-1.362376503223302,-1.4046777093518286,-1.971502976719793,-0.9891952529089492,-0.9818719839807727,-2.0739991391683548,-1.5558174046620508,-2.19607825022637,-1.7377639136299525,-1.0914578997100572,-1.0088414052674795,-1.3475194428559747,-1.9972210761941183,-0.8251756686395908,-1.1866020581908463,-0.2290542357680974,-1.9541123856405573,-1.1490960382188722,0.307211164202934,0.7871595468953154,-0.8123617520457374,0.508928981007492,-1.7069242412023238,-1.044896539693242,-2.076635573066528,-0.3466593439361447,2.105442357861651,-0.8012250721868094,0.3090121706520112,2.3350674163582865,0.9917660283123286,-0.3432825747304795,0.412395808094538,-1.7809840030552753,-1.2288537760361673,-1.224168364502674,0.7035497278187612,-1.061439927827778,0.2276320033310226,0.27538973561236835,8.4,False,Rose,PD1,Pembrolizumab,BLCA,R,3.5,0.7435068070901352,High-risk,48.80251583654434
UCC_Rose_RS.03239014,-1.0008450703719058,-0.018595423131822494,-0.82969674541979,-1.0338479984029392,-1.458061816703647,-1.4849627277856803,-0.7976992664383207,-0.1919058786267899,-1.340876275416497,-1.3192302193150338,-1.2284028979273998,-1.3622310926782606,-0.11373203281819198,-1.534980918752837,-0.785621144562969,-1.018392867025188,-0.8606728490768312,-0.9469696405749245,-0.06787103608377873,-1.880308752350796,-0.7155218820319096,0.35055665849161727,0.18328955985064926,-0.7369329347699547,1.1466162503453128,-0.4092171434810488,-0.34173351772522303,-0.5319951892181519,-0.804265139999002,1.2620101636331869,0.164472645298666,0.9416865330166397,-0.41671086682541375,-0.8167379855287,-0.5788116871108022,1.0485146368410307,-1.564786722657898,-0.5514248464184002,-0.8444763891927517,0.8200112651217714,-0.8785861918121444,1.2637311515873924,-0.7110109985504276,0.5666666666666667,True,Rose,PD-L1,Atezolizumab,BLCA,NR,8.8,0.7931183869001549,High-risk,48.80251583654434
UCC_Rose_RS.03239015,-1.0886903796683596,-0.13963463218529445,-0.9756052639899644,-0.995445853243684,-1.8886280866825582,-1.6088416688500213,-0.147547013691685,-0.678665577997921,-1.1271903200596114,-1.5936437353348698,-0.6019909168128845,-1.614230759165042,-0.42282671527493415,-1.1787935360301267,-0.5627676103096685,-1.605556669090366,-1.6183005676397597,-0.9094725185097096,0.5637377805957644,-1.6853674773913048,-1.563831671641556,-0.5557978800883809,-0.5948998861313246,0.10302823127011546,0.6804720373610265,1.3939736961969014,-0.5787718886714447,1.370979679954042,-0.7155291626004185,1.3501463411065908,0.18133646435966022,0.3230712780635655,-0.5960088905260851,0.5264955367262731,-0.9280390124581142,1.2340298738570157,-1.6521869667783795,1.9236529516250047,0.5349988189283936,0.015399829063667351,-1.2064708146923033,-0.7047208835852667,-0.8281867784338349,8.333333333333334,True,Rose,PD-L1,Atezolizumab,BLCA,NR,9.6,0.9999999999999999,High-risk,48.80251583654434
UCC_Rose_RS.03239016,-0.10595389236047123,-0.6397294522049378,-0.253586074212025,-1.0619664435800795,-1.1208169640109251,-1.0513886318474353,-0.276800445555388,0.3316087642344126,-1.0514463377647267,-0.9145127720947418,-1.100766576673679,-1.0396069473810383,-0.6341603526899399,-0.1836956135834507,-0.9336428694830268,-0.45906864932846725,-0.07813723055171815,0.3142955761849987,-0.7896631688924095,-0.6092896354966078,-0.5758203647232881,0.5884269254320735,0.3447958991033018,-0.9583316455434201,2.061690546710108,0.40056627516879184,0.5918934979501644,-0.22251493480805715,1.1477158981905113,1.46007618729771,-0.12814012535933447,0.03970886683410363,-0.46989090469364564,-1.2932748561415108,-0.8353560178387301,0.18924094362386953,-1.0399415360056876,0.5248311233462553,-0.4880933664355726,-0.6241520122434564,-0.3740614444565599,-0.4044208940276928,-0.4765828145044305,5.8,True,Rose,PD-L1,Atezolizumab,BLCA,NR,2.6,0.5867148154960863,High-risk,48.80251583654434
UCC_Rose_RS.03239017,-0.2541922099053871,-0.4160367604674031,-0.3732369612563212,1.438951844865896,-0.8459917465467555,-1.0529709110196155,-1.4562524357708935,-1.1194099853082964,-0.8024478689240627,-1.0935292039035729,-0.6116479665410148,-0.3322049028572007,-0.4970109250527392,-0.901822266239959,-0.3345258688159294,-1.5337034812157653,-1.322961606199955,-0.9145830196287907,0.7028656200423572,-0.8037815273294902,-1.342216262981903,-0.38700088621739004,-1.2164225696786564,-0.32629770957105564,0.8309200240163933,0.43550042031657665,-0.670366898039396,0.6223115728729085,-0.6214330241544653,0.7165089239013565,-0.7064788191585253,-0.3736624555631288,-0.5695119719091243,-0.6082547323262195,-0.4895163976258278,1.2005141488530566,-0.8650122032974054,0.9354448156057772,0.3599227305658474,0.8513472320650206,-0.6128804323420323,1.5117144353675087,0.02120325572370527,9.7,True,Rose,PD-L1,Atezolizumab,BLCA,NR,12.3,0.8222889397563675,High-risk,48.80251583654434
UCC_Rose_RS.03239018,-0.7123970370174084,0.1933023693051301,-0.4517609399126196,0.10068800034698272,-1.4499423810074765,-1.2349497854753826,-0.4526942933010449,-1.2526282852352923,-0.5828187910885693,-0.9677358808391339,0.08013525409078254,-1.0846827794780338,-0.3247922379061635,-0.6621841715743504,-0.03402042668624192,-0.5727613152505928,-0.6798000564114194,-0.6659289644047208,0.37430129765191444,-1.2290586400210612,-0.2104393203977705,0.9886882205406005,1.6617492515632624,-0.584927962593371,0.7679778661789329,1.2796116469310108,0.4947812775280242,1.658289631980136,0.2251223495443518,1.5990273057730795,1.065915928417678,-0.6609879816395878,-0.43760168078440154,0.3005333611288817,-0.8413561072090457,1.4822377232200106,-1.2616269031695115,2.524967805119981,1.2021875278302028,-0.7921329882188395,-0.2074160604901882,-0.3685058847899519,-0.7516448125172578,17.766666666666666,False,Rose,PD1,Nivolumab,BLCA,NR,3.5,0.7363770449404872,High-risk,48.80251583654434
UCC_Rose_RS.03239019,-0.10860897702655724,-0.6657785397558822,0.32414876155702527,-0.5795220313824672,-0.20649432793902142,-0.4287449715056146,-0.5056002208548113,1.6186888358176992,0.08617989576453816,-0.3605460264497918,-0.4247421961227908,0.15874070754375993,0.026440922760660866,-0.15289677258114626,-0.49401749462272193,-0.5718016083324283,0.03676438603079621,-0.5527375119015985,-1.4825619339835383,-0.6925751157439324,-1.1847848718828955,-0.7941247778338173,-0.8253486020666716,-2.0982291716878625,-0.022951986864659615,0.00930777600303252,-0.40166671266262793,-0.2976831795767601,-1.888193395568438,-0.3117491949273207,0.42298232062627006,0.0004085664066350119,-0.49181403261664003,3.0202420827945016,0.38186035384603245,0.4023283438127282,0.10621468120200989,-0.4563310662578288,-0.7192120991382261,1.679488369600276,0.3626404940298219,2.1412241726308805,-0.49834296210554063,2.7666666666666666,True,Rose,PD-L1,Atezolizumab,BLCA,NR,14.8,0.5221973338984266,High-risk,48.80251583654434
UCC_Rose_RS.03239020,-0.6379276874198055,-1.1663829546128264,-0.8215779300927923,-0.3754665022716333,-1.6007521595715142,-1.4144382061450527,-0.5859712850994306,-0.7720392929828309,-0.8933370293566807,-1.1212993081818916,-0.9020540641915394,-1.2661872515666914,-0.620594087592581,-0.9406282985834923,-1.0346894196360923,-1.4531083105952758,-0.38012243880409463,-0.16156720422861787,-0.4277028087737304,-0.9628381617303797,-1.2496626842034975,-0.9503617754338642,1.1067114039669672,-0.9786810296103031,1.2925238881695127,0.9332522946469707,-0.23245486870357066,0.75675872465276,-0.4636388734592925,0.9770023831745984,1.1385302786812066,2.054399085411965,-0.37401184318544856,0.012245029995846373,-0.2773590879525147,1.0255645854529138,-1.3798451975760302,0.772315148623854,-0.4525850264302395,0.3488838530945398,-1.1624170282310429,-0.19058765089693122,-1.1161340522545893,2.3,True,Rose,PD-L1,Atezolizumab,BLCA,NR,4.4,0.8625983309659637,High-risk,48.80251583654434
UCC_Rose_RS.03239021,-0.583626871991034,0.171986149284451,-0.8857722917084249,0.6333214014091506,-0.6425273531684244,-0.7071639789104296,-0.7493746670205089,-0.2931920847919091,-0.70714521827839,-1.1107304523816013,-0.8996616695375167,-0.6095814077205302,0.2739691244889093,-0.24245234059819898,0.3328432702959049,0.15923987396886816,-1.0190527346747957,-0.3666990394124025,1.2754291263019812,-0.12104153506129955,-0.49860849635477883,0.2453660128030668,-0.4296570507979094,-0.4190464202854719,1.4047284091907473,0.31393124932687155,1.144553972248534,0.3961347190795548,-0.3203790167588346,1.2793396436182733,0.43860531457274243,-0.4070694732924944,-0.43636042776264244,-1.2188147738793425,-0.8182367706499825,0.7277578107893918,-0.8410998993861382,1.416939612898399,1.0621904308377836,-0.16625865967338518,-0.3090657632550168,-0.17820450133553425,-0.001814638286180291,6.933333333333334,True,Rose,PD-L1,Durvalumab,BLCA,NR,5.3,0.6788254711574477,High-risk,48.80251583654434
UCC_Rose_RS.03239022,-0.9661963090353743,-1.4678873191261421,-0.6877018921784884,-1.461706948398367,-1.2277208495629697,-1.7286905180763696,-0.37605163850983725,-0.7231198582936877,-0.8399309876754032,-1.172879315594908,-0.6541220956077162,-1.414883124434694,-0.8839081934804868,-1.0644527386194589,-0.5601404796210684,-0.9588634245183499,-0.8435266156349144,-0.33010939348280066,-1.2595755146369128,-1.3554361034003901,-0.682176247467834,0.529047597205478,0.9866095981860995,-1.528629329517722,0.38938152043263946,0.9417292205525296,0.2517425589318342,0.4859571512583306,-1.0369147668442624,0.8123640642435624,0.801423545281839,1.0674568900611598,-0.40615583249329446,1.1909421179510342,-0.5537456555855108,0.6450034479049713,-1.3824994099802994,0.9996806563924248,-0.6602011166550497,-0.9462561010665888,-0.5553760066275494,-1.282539505212486,-1.170660717855627,2.333333333333333,True,Rose,PD1,Pembrolizumab,BLCA,NR,3.5,0.7345925982287429,High-risk,48.80251583654434
UCC_Rose_RS.03239023,-0.6045902234987084,-0.4092676925258586,-0.8300346428683599,-0.7200680335817963,-1.523473492146753,-1.5691813122195941,0.2448849919415193,-0.29230259526433827,-0.8567484104529999,-1.1845426143026139,-1.44690293444951,-1.6797366337173685,0.30068380294615943,-1.2892006838413717,-0.923528387608064,-0.07142280031010992,-0.9027491016540043,-1.1087345481914885,-0.7430359302079012,-1.9583432773485017,-1.2451851720638731,-0.07631903653721082,-0.6274568847939671,-0.22021413970270456,0.678702832862001,0.19701307650461658,-0.3692299595234159,0.08521768449215171,-0.6296358316855509,1.8828418969918643,0.1181732187230732,0.0865760354728608,-0.4279450676643644,0.054610841321145145,-0.5934674610488487,1.3826555407313905,-1.3183536902914774,0.426894562405605,-0.22247397552003034,0.4191036848761809,-1.0691114254623149,0.04581290499434172,-0.21187231179317784,6.233333333333333,True,Rose,PD-L1,Atezolizumab,BLCA,NR,5.2,0.8423829376136343,High-risk,48.80251583654434
UCC_Rose_RS.03239024,-0.9172168849814935,-1.5103742935902027,-0.8595421439806296,-0.4154921900756065,-1.5350700386387903,-1.612534130350329,-0.20994162941079172,-0.05671398394638145,-1.2237930004296775,-1.3777686832410398,-1.4754353331070564,-1.318250351819148,-0.7867817820436526,-0.6630683253385413,-0.9198762304940545,-1.3793812203258873,-0.8125316824644402,-1.2030527211257434,-0.838947342745826,-1.4617183448694397,0.8206635570853675,0.23194471646676126,-0.1658711150461891,-0.9254944642135675,1.6859882690792027,-0.5468017683148895,0.0877544302818032,-1.0154279102417385,0.09333567462581639,1.7001362728289438,-0.06289013867296617,-0.804104349333609,-0.2713258264796797,0.08183876662040367,-0.47359744534589515,0.5766165252863629,-1.506170246611081,-0.1039991422134077,-0.699507744485893,-0.175543652361261,-0.5769371383140932,-0.3125585884165907,-0.7473891366600225,3.633333333333333,False,Rose,PD1,Pembrolizumab,BLCA,NR,7.1,0.6881915202089626,High-risk,48.80251583654434
UCC_Rose_RS.03239025,0.030599433285690997,0.6642346236495579,0.26810266356547174,-0.11983489609480352,-0.12785489145283693,0.6160405691337866,-0.8709225821075294,0.7004679723091702,0.10209180194765913,0.852063058058491,0.7322051082244516,0.6425114751773033,1.066395569769187,1.3988118578247901,0.31123037155207417,0.612936382135776,0.17695663866738506,0.42343372045721017,0.003860889741197968,-0.41280096837249547,-1.0188625490440673,0.33593299178633323,-0.6807442837833397,-0.9421806197597772,-0.11138707008979887,-0.3761590219715348,0.8972671782776637,-0.42473847663669057,-1.0340680024028006,1.1901773752309674,-0.6369885729098894,0.5686901148765524,-0.8123831797699008,-0.8849479739047906,-0.219607546224389,1.6590499765467652,0.5658407910299917,0.38065197013324015,0.6253798619334756,-0.21769932972810968,0.09764957695741343,0.8464190636847007,-0.8053029025845142,28.933333333333334,False,Rose,PD-L1,Atezolizumab,BLCA,R,14.8,0.5277695315285893,High-risk,48.80251583654434
UCC_Rose_RS.03239026,2.006273345280339,0.45144001794840477,2.8177321165526337,1.2338030569331477,1.6486594249149948,0.053472583194537855,1.496925996077275,2.6948734770756904,0.9604609945461419,0.26945197857931463,0.3267058766743348,-0.1510409193929287,1.7771163094308726,0.040043077111476956,0.606554481003035,1.1478616445463175,0.8662298674980012,-0.1638073189922657,0.26260247901489364,-0.3379046334477623,-1.0532813184523597,0.010578640868635438,1.1756482702914293,0.6648582627918652,0.6687472933037415,0.5153606409953739,-0.05313753894989041,-0.4497498010835532,-0.24564354871632563,1.0797847068790345,0.2042046897831973,0.7147123757316796,-0.3926001393699071,-0.27762013907187233,-0.6661556467384384,1.7650605994601973,0.4838014721987677,0.28939118583140583,0.6795323178696707,-0.8649650735737799,2.33400301352255,-1.330701055976573,-1.4106609852787573,5.0,True,Rose,PD1,Pembrolizumab,BLCA,NR,4.4,0.5983374004405279,High-risk,48.80251583654434
UCC_Rose_RS.03239027,-0.31685296137568736,-1.1200564380360443,-0.6053692160645637,-0.2497277025007112,-2.1972121865523175,-1.9826177686263675,-0.005430411588943386,-0.26339732111296527,-1.4717671635585319,-1.4069969651572003,-2.0120761205342506,-1.652577577167301,-0.5856323466023929,-1.0122055186634469,-1.1635215300815065,-1.0241622047035586,-1.4110761689812317,-1.7797015636674465,-0.6953359634866143,-2.0585291863550084,-0.6171880469596142,-0.5613794151453365,0.6025961033567234,-0.5655938013688513,1.341558802232989,-1.3475531946644255,-0.28000121524169114,-1.3281167123532274,0.005922470779220168,1.3624345990731497,-0.6978487563602234,-1.0738397701447682,-0.4306239812871488,-1.446146095941024,-0.8581235496371158,0.706282062790354,-1.7208354600563438,-0.9021906084801101,-1.1798681122807022,-0.025342559756518817,-0.9382701913992881,0.14158604213631973,0.08558839125807814,5.5,True,Rose,PD-L1,Atezolizumab,BLCA,NR,3.5,0.7536279949506242,High-risk,48.80251583654434
UCC_Rose_RS.03239028,-0.8297220971968751,-0.8103094663928474,-0.824809308312105,-0.8412476948379084,-1.2745671445546174,-1.1924960736576191,-0.054677369680263065,0.2574730892722326,-0.3785811743547695,-0.8053457967758164,0.049508135086506165,-1.3400688771612548,-0.3273569309335104,-0.39681306214736084,-0.04466396662539312,-0.44073600829312853,-1.2411508701728629,-0.21509737035147475,0.6932911787601233,-1.2343970414222636,0.47289637959760034,0.48322931658003615,1.7973744006870043,-0.8121301766769091,0.6647086600888074,1.1541614504122357,0.5386984164781161,1.3314526723674422,-0.8537872076464029,1.9005310481857527,1.3226528378013527,-0.4680849537866473,-0.6301091607335273,0.15303598742310623,-0.8775443905717523,1.6083906351688835,-1.3450141476836217,2.094514319318616,1.1553456421489567,0.13887467972235593,-0.2102384528082711,0.1018670568043291,-0.7346200641022138,4.166666666666667,True,Rose,PD1,Pembrolizumab,BLCA,NR,3.5,0.8069211793615487,High-risk,48.80251583654434
UCC_Rose_RS.03239029,-0.2912345820850251,1.1808319079015712,-0.346329112467976,1.0918539633656423,0.027756754941617952,0.3109161939944176,-0.21258772685530508,-0.4630303141641607,0.11620573042503579,0.5524619092308419,0.4793814963790692,0.39809117630792035,0.801079333225841,0.8116082531549654,0.7964778505151653,0.05440495782379553,-0.7419560341136474,0.5751460810643018,0.5951858367394044,-0.11129427462344846,0.2513844699217253,1.6173536247435765,-0.17643952779546573,-0.35761398623193913,1.3123493743203969,1.2055899663645424,0.22148056915026487,1.7152950982130026,-0.6484404697881825,0.8820669582217224,-0.35695205387363094,-0.33120775770834693,-0.4940152987555873,-0.36525271896927713,-0.5839935926636609,1.531180053232523,0.7475542587301879,2.1702199821064325,1.4845674133248776,-0.9605500787973714,-0.1777725250538871,-0.7192918778144155,-0.7440999251245844,1.0333333333333334,True,Rose,PD1,Pembrolizumab,BLCA,NR,4.5,0.634877509707876,High-risk,48.80251583654434
UCC_Rose_RS.03239031,0.05326341299791463,1.7378418095316304,0.2712560022078394,1.4558278969296885,0.17182469142584758,-0.481774436665654,0.03588659937437191,0.2730652260124374,-0.17687642776412935,-0.6192421266710253,0.904505656059734,0.2306884432352534,1.00660143824708,0.04187079411342084,0.7375043206908882,0.7402368468706807,0.019659874524709558,-0.12801038499826023,1.0718045114076988,0.3719857421104493,-1.2484539862949349,-0.5394070657374403,0.957165768464479,0.04217709469593998,1.2299670574624533,0.7552992823892521,0.31128169122255356,0.2402921054485442,0.16791219559214532,1.378761288236695,0.2711688641753658,-0.8987019332651316,-0.21650639414595263,-0.47711597433242325,-0.9250385450980896,1.8395564966948101,-0.04212586079319503,2.0422884051916177,1.334395506308061,-0.3675292597388343,-0.13143385470122654,-0.8974528103476955,-1.554240384596155,4.4,True,Rose,PD-L1,Atezolizumab,BLCA,NR,,0.7080114184802068,High-risk,48.80251583654434
UCC_Rose_RS.03239032,-0.9940890941100882,-1.1346100561965713,-1.02606392401887,-1.2363780128793562,-1.344521612880064,-1.9374307637421742,0.26991778487734386,-1.1561023359938118,-1.338188574199445,-1.665404205577297,-1.5633348344729727,-1.2740848421183668,-0.7580447767295988,-1.3389584677559154,-0.9196994371461507,-0.39003814020146177,-0.936031870810908,-1.2119538768117668,-0.08435931363508137,-1.3347862266984944,-0.15720303397742907,-0.23945688023129674,0.9963805545980987,0.5447378554780238,1.3469812116233415,-0.940950599528163,-0.29802565108144957,-0.7164446475789407,0.4108110804275867,1.4457953645913284,-1.237852522709376,-0.7789367234217515,-0.3850618820457335,-1.5656950328727213,-0.41458721554775635,1.3207959585183724,-1.3480296141105244,-0.6331615583912348,-0.38477355242357725,-0.06791752624383228,-1.4010083821981607,-0.32110203687716776,-0.25577841448493677,6.366666666666666,True,Rose,PD-L1,Atezolizumab,BLCA,NR,4.7,0.8244911811111526,High-risk,48.80251583654434
UCC_Rose_RS.03239033,-0.3348278588705397,-0.34741845954575395,-0.0984609460789307,0.3239057103376673,-1.0147703170052886,-1.0469778661298397,-0.8044453250059698,0.00901689395020519,-0.5977569926484416,-0.8262762228622215,-0.4471287004997067,-0.6308325201991489,0.20108351168971936,-0.20229778226964343,-0.26974436636205196,-0.18499496030685522,0.058291127043211904,0.2591144112112595,0.8428486889949174,-0.6606637056390235,-0.9996895846194872,-0.17375259391038178,-0.03506145392318598,-1.2719763278496916,0.3163166493069492,0.7857252819681083,-0.31829665457218376,1.0884934892878293,-1.214831497532397,1.344319577045551,0.6871836328707731,-0.8628712992024855,-0.5533569213656189,-0.22959598019419736,-0.6559523038784971,0.9786526169536616,-0.9919649015295746,1.1754086467084286,-0.3189349021741664,0.10816488243975365,0.3095740104935334,0.47030388540124113,-0.38802387281805006,5.1,True,Rose,PD-L1,Atezolizumab,BLCA,NR,4.4,0.6490296563281024,High-risk,48.80251583654434
UCC_Rose_RS.03239034,-0.17534520838107112,-0.5376128699305002,0.22832594481288643,-0.16072369977310186,0.04627770526637202,-0.2694614142962901,0.3282624862043872,0.7818584642285453,0.5204167879912542,-0.11756426615855944,1.1025554204369352,-0.09270657784520914,0.40197193700412354,-0.4436796068006764,0.19676657054180377,0.6586367634783724,-0.829602654113119,0.8612743175430342,-0.10835207112444235,-0.1567209703051126,-0.04647133042202523,1.105673669091914,0.2355382776390355,-1.1379938200477977,1.0824955715318076,1.3621930454904538,0.3088477505188462,1.3050398592655206,0.07290774688352412,1.3145050702314518,1.454151307572284,-0.570233856857938,-0.41456780781844016,0.2948695703363419,-0.8695435147360547,1.218611008031034,0.17216440021956889,1.868145555958734,0.8100140821771148,-1.6256181868912516,-0.3486357770694332,-1.3717358482517705,-1.16926961543258,0.4,True,Rose,PD1,Pembrolizumab,BLCA,NR,12.2,0.6325388297203776,High-risk,48.80251583654434
UCC_Rose_RS.03239035,0.053914798094394964,0.47247914641584854,0.24016939568005088,-0.4457328604975048,-0.5777276339555724,-0.16574398988642128,-0.1257321870398602,0.15618560701282594,-0.21720818461918773,-0.4675438046824587,-0.6249151712637331,-0.423505336971232,0.34984498621067184,-0.12374903066033176,-0.6812409018783236,0.9734223957190126,0.28251431644730335,0.3993587036920948,-0.1649052075671837,-0.4126352196899941,-0.22606684950248446,0.6229772037192833,0.024404325036041237,-0.28272688579010835,1.0676485210032363,-0.010894664140380962,-0.25255898057076365,-0.4101976273233081,-0.5903129107580065,1.3692855336113245,-0.2564557283663218,-0.5886129198348783,-0.49208702299864954,-0.7749701839780221,-0.8022077919863849,1.2465684187993806,-0.04730144605716812,-0.6171462755074537,-0.265252446405645,0.8369782847540798,0.43711697896973106,0.6600393264249612,-0.14974885759278564,13.366666666666667,True,Rose,PD1,Pembrolizumab,BLCA,NR,7.0,0.5413249110535998,High-risk,48.80251583654434
UCC_Rose_RS.03239036,0.4329313638109499,-0.36195157658430943,0.6397044806743103,1.2635427713865979,-0.06846595943015249,-0.7763452803453529,1.0051038007005675,1.0301409525793996,-0.11419822821415826,-0.8088201446196136,-0.059464062179721194,-0.5577347782325247,0.24412998765588562,-0.6062517543596063,-0.18473608652285206,0.7965002114042037,0.5043401047534061,0.159883127437089,-0.13576031195507876,-0.11374720213888458,-0.09778000356984949,0.5529988656570732,-0.15681727584201666,-0.7506645793167614,1.8654591634275632,0.4948029377614214,0.779712701050877,-0.23900095844928979,-0.14363257959616538,1.792224902056152,0.1764005356793232,-0.847146861832276,2.917150677518589,0.05382476943368314,-0.6080678432538471,1.4143200472367217,-0.536151739552314,0.8298927475380482,0.2805239705352946,0.09201348495525688,0.7699647040685078,-0.628495086180259,-0.35406530196501057,9.6,True,Rose,PD-L1,Atezolizumab,BLCA,NR,4.4,0.6320352763828434,High-risk,48.80251583654434
UCC_Rose_RS.03239037,0.1792508159524188,0.011704815571671518,0.4555575889527612,1.6572406748587967,0.518607135004442,0.0695674375761757,0.10678980097863755,-0.05438272962282057,0.8052950745256788,0.2985820144626708,-0.07649459789845502,0.6603951454430049,0.7317925153108125,0.0392351399523047,0.1362317513467908,0.2331935439999961,-1.1098248166350224,0.4258062798523623,0.12092185092822563,0.06260048797045081,-0.5998178500731631,-0.40221214529383276,-0.6741647386325036,-0.4946726663845419,1.126324747266503,-0.29654609059655673,-1.2738348163668736,-0.6059305901507043,-0.99907890661962,1.3495782941184011,0.035774818036646026,-0.6799634975099702,-0.4963172481268253,-0.09585481081685286,-0.5085705637609775,1.1604088786887425,0.8133014356218761,-0.16539115739706942,0.38612969082024456,0.7711956230409966,0.44362873509282924,0.4206129803978685,-0.08413960547782103,2.533333333333333,False,Rose,PD1,Pembrolizumab,BLCA,NR,5.3,0.608467913707919,High-risk,48.80251583654434
UCC_Rose_RS.03239038,0.8101572534658638,-0.21896456758391714,1.3649906939092877,0.3636114037523995,0.8573496845136458,-0.30135027349552646,0.20679619718565756,1.4833162409601794,0.7503554943213591,-0.16741158119219932,1.348181965015103,0.43587293029010754,1.648255023930608,0.49588655835068435,0.8252146373607279,2.295093985288187,-0.07089335120485453,1.1701960570882655,1.0791366684318675,1.0432192662602875,0.9612298095954794,1.7021565475888172,0.6376476059665295,-1.1156949189719865,1.36019698919017,1.6522647316575618,0.8462265708570686,1.7268332816365495,0.5408079831249909,0.9470247194633459,1.9221656589699314,0.5890635435404329,-0.38405727764338426,1.253123069216887,-0.619800192270123,1.2102748650074138,-0.36466083914932085,2.5307955121741474,1.4221873358923605,-1.8954213318733528,1.3271394967740744,-1.8672662078118019,-1.3986759055856566,6.166666666666667,False,Rose,PD1,Pembrolizumab,BLCA,NR,2.6,0.5219201636391618,High-risk,48.80251583654434
UCC_Rose_RS.03239039,-0.5984970961801509,0.3627388804062,-0.6040471621171589,0.556639560071652,-0.9237277149808913,-1.0743343010017106,0.9843956319202094,-0.441765760824117,-0.6362020695700917,-0.9719597489539542,-0.6796833886325003,-1.1325864158723475,0.21881221468716916,-0.6709669700970294,-0.2540122124266953,-0.9420251118528432,-0.9742705332624562,-0.7195030167905861,0.28206047988699273,-1.2010816316806974,-0.6768192838760666,0.1051560474784344,0.55700151374816,-0.9581353447825681,1.2970358688928216,0.0801434883947809,0.8315228910951488,0.04796039067213025,0.5712251081990166,1.6280095704877608,0.5029148660052655,0.2858592541015928,-0.4422043775468567,-0.09970551772910523,-0.9779856675883174,1.359605205263941,-1.1890556895257502,0.3397215826558557,0.5360364843616418,-0.343181985726869,-0.6862259414271487,-1.192475739290876,-0.3669446545195547,10.9,False,Rose,PD1,Pembrolizumab,BLCA,NR,12.4,0.7183927162404188,High-risk,48.80251583654434
UCC_Rose_RS.03239040,-0.5407040782748058,0.7197982770694542,-0.6600755655053554,-0.19144711710360762,-0.8460557796938684,-1.2377435131446133,0.12834060750914666,-0.4618453346554519,-0.8785916797456229,-0.9407166463216605,-0.8650409591416065,-1.103495342769839,0.09159418524402248,-0.6293340875633828,-0.9871945099491708,-0.4650112101711441,-1.0781233319184713,-1.2021935022030126,-0.28117603641715827,-1.6190883259047717,-0.946619272643624,-0.3882457148824285,1.2545725871783466,-1.085846215759901,1.4723372006552198,-0.5154310976951618,-0.11564951008496921,-0.788441657999381,0.1575314944359753,1.5567720446399402,-0.08135101573353311,1.1850772425613347,-0.3970436010925698,-1.030276651685596,-0.6835910587223176,1.2869034136094235,-1.0424175122759889,-0.4224508850089236,-0.42637932089514596,0.33952786215833924,-0.7540590438953267,-0.5308447639239559,-0.9453187184911406,6.666666666666667,False,Rose,PD1,Pembrolizumab,BLCA,NR,11.5,0.7664164404888802,High-risk,48.80251583654434
UCC_Rose_RS.03239041,-0.73794282013979,0.774323772344083,-0.9402422563587315,-0.6922729235945907,-1.6990694923796488,-1.1870634406677238,-0.9123587222950366,-1.5245925529070123,-1.248377120240417,-1.2096196688079663,-0.759254336537259,-1.0988037146353997,-0.3997591187994748,-0.8563748592987701,-0.11246061163353947,-0.5453778931645692,-1.0486259636373607,-0.7926265644525157,0.1313747818779986,-1.1250824663713348,-0.9096361859743319,0.232819981093655,-0.3529789961516868,0.12097064289916461,0.291241797457208,-1.268154055167111,-0.3902830359841743,-1.2549473599958758,-1.785976155244988,1.5807013761724258,-0.29692309182497945,-1.3306393303053934,-0.22553520671534666,-0.7705693126669061,-0.8496743601308542,1.7425827813873749,-1.0587843718992165,-0.4746563760228048,0.21700051045105156,0.41755897940491354,-1.3432288128908991,-0.07891312725052163,-0.0644498915718835,1.0333333333333334,True,Rose,PD1,Pembrolizumab,BLCA,NR,5.3,0.7391774700529985,High-risk,48.80251583654434
UCC_Rose_RS.03239042,-0.618324787538593,-0.9989708199271221,-0.7306245975402691,-0.6972514212473149,-1.573083224161734,-1.4021996036942337,-0.734563319336228,-0.7643557234723429,-1.3618299282324422,-1.176684759405046,-1.5557035292039119,-1.5798798214856835,-0.6625395072252774,-1.367079007295289,-0.9633218975586556,-1.34434729537543,-0.6241020511776628,-1.0672647248701237,-1.4989745193283108,-1.711050288215216,-0.752789615112239,0.4592746394438552,0.44071834257475173,-1.0843717881297634,0.9713178244838951,-1.0724125554950048,-0.7070773169380741,-1.7293308608229585,-1.0210299796937865,1.7321385128105244,-0.4459796040688829,-1.0028383712635234,-0.39946141855302414,-1.473485256936831,-0.5577039554977378,0.7258764288401763,-1.3477002970426277,-1.4718990932248341,-1.1304809692848583,1.5218431891927597,-0.4890064831760097,1.8710018274322109,-0.471916291664035,1.2333333333333334,True,Rose,PD1,Pembrolizumab,BLCA,NR,5.2,0.6761855901514553,High-risk,48.80251583654434
UCC_Rose_RS.03239043,-0.5364648710303828,-0.8726119265795408,-0.35491438844915063,-0.4525463502778114,-0.9843883825801372,-1.407685387628973,0.08738154836076736,0.4458684314425499,-0.35754766190785003,-0.8671580555688904,-0.2454301941063481,-0.741108118424133,-0.12602852659510383,-0.41971095842521194,-1.0814016652562901,-0.16538400944036108,-0.7985605901110351,0.1631187081468077,-0.1522778207097805,-0.5610781941363044,-0.8150551598822193,0.19817990657569937,1.4544740996780339,-0.8237499743197851,1.8544437443223898,0.548230072155316,0.3339672301870344,0.2933663978654687,0.6010995877921462,1.4649453693860741,0.26074721073218715,-0.3289925222757543,-0.38569139532314517,0.22538355251836406,-0.49573769152946723,1.107843582621229,-0.9545199415247937,0.49336712879964834,-0.22694209472945692,-0.44134201861870465,-0.7355445067446296,-0.6433399932054592,-0.6538468752617472,1.7666666666666666,True,Rose,PD1,Pembrolizumab,BLCA,NR,4.4,0.7172558514662404,High-risk,48.80251583654434
UCC_Rose_RS.03238953,-0.10467796315963113,-0.565033981066345,0.3953415266661853,-0.24182475756099409,-0.09963926571777221,-0.80684630294491,-0.6751785407042424,-0.599561308421577,-0.0842738696586795,-0.6196353305973085,0.37817263696593484,-0.7398745529436296,0.7786837436101036,-0.035842159440699094,0.09407083259518775,0.3079130527737046,-0.16706053234790447,0.22237771166124423,1.0656948204104226,-1.0278489579210235,-0.7459750005551716,0.33527029384809803,0.9234756362591993,-1.1510616136643037,0.34262454552941524,0.40212227859466987,0.8012665168953442,1.3241992692444773,-0.028491767585674302,1.659319125398043,1.446093955072969,-0.12971823210143488,-0.33569699909166556,-0.22904732732701755,0.19962083844526246,2.2585466977421986,-0.678513976001045,2.1932091052022633,1.1143933281076406,-1.095065895121042,0.44168236014265855,-0.9674820491072039,-1.8712902524397066,2.1666666666666665,True,Rose,PD-L1,Atezolizumab,BLCA,NR,7.0,0.7514002293361007,High-risk,48.80251583654434
UCC_Rose_RS.03238954,0.18435035584059398,0.009139845688097017,-0.38588451300844245,1.025441096096632,0.813180402215794,0.6042146590625352,-0.12124047317830534,0.2909891805279953,0.18831872341044623,0.44802238084632695,0.6513389420897755,0.8724082077423101,0.6285112662965682,0.9535334584284196,0.9510144468393358,-0.2331526908815612,-0.6144713563955871,0.5601381137179139,-0.7875029238418356,-0.5997631276939152,-0.7956411683339015,0.6451748147652371,0.472729811894672,-0.46624290065986873,1.0018270783963714,0.03242423957793332,-1.1330328549694764,-0.47527615011675534,-1.3559488983638495,1.69044874706838,-0.987616282464051,-1.187097384240987,0.37934725379046436,-1.1861875953396608,0.3222744955887457,2.5425438391081103,1.2132050077462693,0.6651905896462101,1.0659305322936465,0.34016105247784506,0.35108910640975627,0.49587163449272226,-0.49451346824575176,13.566666666666666,False,Rose,PD1,Pembrolizumab,BLCA,NR,8.8,0.599097685148068,High-risk,48.80251583654434
UCC_Rose_RS.03238955,-0.2837033664350118,-0.4838972291327906,-0.4758024668984112,-0.12178605520742784,-1.1578496677936625,-1.2571690724045215,-0.909675495615036,-0.46247721893001764,-1.0959728030483233,-0.7429651385281265,-0.8117720844121487,-0.957316880156849,0.3747542046306982,-0.2862171592197568,-0.688820969033304,-0.20886052999895866,-0.16345320013823172,-0.6314053131396339,0.4184524565474582,-1.184427130000287,-0.7796549755558179,-0.32619248787612215,-1.1198091306843176,-0.6787054003878723,-0.10453871504445501,-0.7753467990824547,-0.6256072032870841,-0.1927972455877226,-0.6763054878815352,1.303438745984556,0.30642021609786735,-0.8450930495688462,-0.57239909120191,-1.0055359113804212,-0.005338422667898497,2.0319168528210874,-0.7349062131324161,-0.0016194407642109616,0.2313657012271281,0.3974340145370974,-0.786128582615001,1.7118227374404642,-1.066327679985475,4.2,True,Rose,PD1,Pembrolizumab,BLCA,R,16.6,0.7431225112349225,High-risk,48.80251583654434
UCC_Rose_RS.03238956,-0.43614574659515354,-0.84114911733614,-0.9657535938827014,0.23018493904022533,-1.8715325366534508,-2.098615518479634,-1.6242578681017616,-0.3080877966993144,-1.97989566639618,-1.8133988816072262,-3.1889618976201826,-1.0449069766671828,-1.2827745169763278,-1.7513321202349308,-2.999910209795147,-2.3536519988943634,0.32812641929112274,-3.6665731025476584,-2.2137520109702393,-2.6978389353978427,-1.220173788965927,-1.325324163090078,-0.8389023778755069,-1.4540101336698492,-0.3927025238081412,-2.0665278976230064,-1.1908741282242905,-1.697936400232484,-1.506266389040989,-0.5938342312776601,-1.8917595400838816,-0.9662324843474721,-0.06354795166025702,2.2007662353334414,0.42818573918027236,1.1850371477369885,-1.9967391708909177,-2.769705384325132,-2.2244856665801667,2.8660654904026006,-1.6935949551630938,3.3448928454814246,-0.7849949178935937,3.2333333333333334,True,Rose,PD-L1,Atezolizumab,BLCA,NR,1.7,0.7282155062853151,High-risk,48.80251583654434
UCC_Rose_RS.03238957,-0.36578797314096895,1.090662018730462,-0.5320837777707199,1.6657226591173135,-0.4730521771154077,-0.30478133469691976,0.020654212324814587,-0.9290128923945166,-0.5050779053105958,-0.3486262134826273,0.6542037509518801,0.8595447649625865,0.6180745175818578,0.1577209261447873,0.7796062645700979,-0.23854098061563006,-0.6894620732031372,0.011161514866669392,0.8353805416742645,-0.24708213208470145,-1.0997877560303018,-0.6641303876904321,-0.3148366772703969,-0.3360370923171936,-0.9760222545439503,-0.5991715633379651,-0.3120155881700842,-0.8389416673396658,-0.6776100806373391,1.702826269121113,-1.8364726946910026,-1.25581287463507,-0.7155417572919488,-1.439786429460897,-0.6966482673355956,1.7885228274864233,0.5523185787392297,0.2586381746624428,1.8086126051263502,-0.0489064833132292,-0.14000969182742087,-0.17363161975098781,-0.05594056150555563,13.866666666666667,True,Rose,PD-L1,Avelumab,BLCA,NR,10.5,0.5686491127380408,High-risk,48.80251583654434
UCC_Rose_RS.03238958,-0.7646045655992525,1.0326948775253397,-0.34753814300578456,0.9080396876208902,-0.8698903766379149,-0.4347656370710332,-0.12282475629120151,-0.960401690786877,-0.11365934011887677,-0.3827911768770635,0.6174319226534568,-0.0530144257434138,0.1984739519197096,-0.09850264922598524,0.43805908220143774,-0.0543517505197532,-0.6284710819943317,-0.037072368194394516,0.9495937770563669,-0.34868227939665175,-0.4057757147892578,0.48528895971815417,0.10140362657436941,-0.37483885954005913,0.7895976023386784,1.2482793157115102,0.10590920996150306,1.540516950927081,-0.3363222497022774,1.0590987973074382,0.8127199290311331,-0.7778737967129474,-0.4622131915460883,0.07285537402053048,-1.0153699116282688,1.3785967148712284,-0.05556153817284409,2.116641917714834,0.9908856180348339,-0.05277169126563779,-0.42000255833408445,0.29141575885317916,-0.7221096672984582,7.866666666666666,False,Rose,PD1,Pembrolizumab,BLCA,R,11.4,0.69438231954339,High-risk,48.80251583654434
UCC_Rose_RS.03238959,-0.3678580941843082,-0.41450983139287517,0.7786848084097611,0.9627189436604825,0.050644217357508556,-0.10115902628179782,-0.7070544390138291,-0.3890373857963353,0.2003535276704465,-0.20872731672750483,0.9843407487670949,1.3020750776357162,0.3180419437143066,0.039800940545814595,0.3353123934859932,-0.2081960867783746,-0.31325143909835085,0.15579460092359174,-0.013473976789564033,0.26235436385837174,-0.038133035462516285,0.5461441268374677,0.6973930578426714,-1.1355503017098225,0.7921417777772676,0.5452901320405197,0.34285393302141115,0.5427240293549168,0.0489514810813275,1.1378994347638869,1.7584748185317984,-0.7393281771733758,-0.1825358746049583,-0.01236777070554275,-0.5289488011041875,1.5873097574103177,0.2290153532598826,1.6265188478782315,0.698502426319826,-0.8393367467090679,0.38068591325489276,-0.45871504915626626,-1.007426176363175,9.466666666666669,False,Rose,PD1,Pembrolizumab,BLCA,R,37.8,0.5027218169300758,High-risk,48.80251583654434
UCC_Rose_RS.03238960,-0.8130070498684148,-1.1853821629040502,-0.533653694272538,-1.0287839439935023,-1.639957949273229,-1.3069053034435638,-0.39541955474014656,-0.3092773083210556,-0.5892755738616621,-0.9851693598300437,-0.4987913458419903,-0.9624375650893914,-0.2594863137528973,-0.9571078374932183,-0.9298334301682006,-1.4160576939717937,-0.6512421833014638,0.05128120530173454,0.13938207142897235,-0.4558047442026378,-0.576732502394572,0.14801406310915127,-0.4459846279004876,-0.1478644361584583,1.4943290993411837,0.06992708642732275,-0.32349561539624333,-0.34775617177167795,-0.34237860917235513,1.50751739048776,-0.4550855130135726,-0.3661178846585246,-0.4275491930924845,-0.8039449980246766,-0.5277154204403596,0.800687187031644,-0.9685349960439393,0.04550691264340804,-0.3060532229206333,-0.5551924123549244,-0.9151923143437796,-0.7099399544336086,-1.3159758448688212,23.3,False,Rose,PD-L1,Atezolizumab,BLCA,R,26.9,0.8103335941605392,High-risk,48.80251583654434
UCC_Rose_RS.03238961,-0.48922084213991085,-1.2295323622089078,-0.7211418795278459,-0.3853037772631616,-1.7982839517571496,-1.583561847344723,0.45241158711471263,-1.3931027045803412,-1.1975867284822206,-1.312908224452104,-0.3810577559247108,-1.4328287614280697,-0.5131984735459929,-1.7130063351449647,-0.9332807921425366,-1.2833634319543277,-1.1717368649153632,-1.4415884978012488,-1.1730848617783491,-1.9775304093387227,-1.2139489869949471,-0.48216869753673575,1.4966503615478979,-0.7409158294681225,0.43934335831576093,0.1144820566682985,-1.1133070481549932,-0.7096062634467781,-0.5486310335592924,1.746504087493762,0.5041199624550059,0.5190867915658728,-0.4351440453804192,0.2922553319829198,-0.8390148146434743,1.2759359448493706,-1.4574316636127294,0.07384265951831061,-0.3012452665327205,-0.3153999397912926,-1.2874506257962999,-0.41284931073281056,-0.4790627017228363,1.7,True,Rose,PD1,Pembrolizumab,BLCA,NR,3.5,0.8475189053189371,High-risk,48.80251583654434
UCC_Rose_RS.03238962,-0.0974553198856119,-0.18275345222667927,-0.33056040104131096,2.1657257963694776,-0.6658577615392722,-0.9210566923941739,-0.17983627690263088,-0.04280934778947913,-0.18157862416068413,-0.8138371097220175,1.18374252208659,-0.45157948844073964,0.2356846068635085,-0.44792824858443825,0.7956647060068788,-0.9008205314123924,-1.2872845984777244,0.29313321883586324,0.8824054077644524,-0.5717141484700666,-0.8270400669492234,0.7565595719398838,0.4405472816914972,-0.7785166506898386,0.9654527225865309,0.971457992002994,0.45402324880594663,0.46232327055874967,0.09829487846237044,1.3458052117306016,0.7116547384156795,-0.18541381098661378,-0.02012512439668335,0.8328522307661576,-1.0329617635694914,1.3027208130873373,-0.6265159029627932,0.9968237585475692,1.1117370459230362,0.35692592308054194,0.04090134256819293,0.00011369042260218453,-1.1058713225084502,4.2,False,Rose,PD1,Pembrolizumab,BLCA,R,8.8,0.7006679260987283,High-risk,48.80251583654434
UCC_Rose_RS.03238963,-0.3386028595825499,-0.17365441238914842,-0.3125954144228012,0.9402585300916328,0.22103944363736,-0.08656723173227572,-0.1486737711751661,-0.08475803875310006,0.25433356826545356,-0.2167101016341027,0.38410863231412673,0.3866316297808611,1.2082545208417241,0.11344389800080157,0.4382576760939334,0.22074787755832442,-0.7357521890257291,0.6314832325707559,-0.14950601261754792,0.4469127445835285,-0.13767810775489783,1.1771055404379707,0.23317157854374795,-0.8185596681886907,0.9792437412738076,1.6054881760916881,-0.16385353951484213,1.8066051556928484,-0.11733129696614744,1.1411880451232455,0.5239090876703454,-0.8597294257548839,-0.47846518808498417,0.3902640571641081,-0.7842262716160538,1.4090541818755675,0.06869584955050612,2.2600997080677883,1.058576802483655,-0.4505734979248507,-0.04264846699963884,-1.0288715760773346,-0.8542848134430561,1.1,False,Rose,PD1,Pembrolizumab,BLCA,NR,7.0,0.611316008913655,High-risk,48.80251583654434
UCC_Rose_RS.03238964,-0.7361424883041655,-1.154508357161385,-0.60596989588172,-1.3155436024265368,-0.7872318538039296,-1.0398274387300754,-0.12964058261693764,1.3104197698516113,-0.7165311251476476,-1.2054982737121815,-0.06604443093771258,-1.1499436792245814,0.12188280856372004,-0.14454048498635272,-0.5723503825883904,-0.36051306033679714,-1.1515552542595797,0.2863028962879596,-0.11964041921120813,-0.5333111362076451,-0.7793971774857783,0.00576506681207744,1.7083807131259643,-0.49788954048430833,0.8565023849829212,1.2005232017741416,-1.2778729454534965,0.7690193675692738,-1.327433423757201,1.8897785596075523,1.4496911730642725,0.36783072795663474,-0.5701419765352788,0.1786184747472154,-0.9281421232016299,1.2834680522928816,-1.3086474401854522,0.9217490968888441,0.4168386996231481,-0.4424588797498896,-0.4374737509585198,-0.81551270063116,-1.2186884719175468,16.2,False,Rose,PD-L1,Atezolizumab,BLCA,NR,9.8,0.7999582595027744,High-risk,48.80251583654434
UCC_Rose_RS.03238965,-0.44011401562543856,-0.7989967249161052,-0.04925425511633158,-0.5901238492776629,-0.02048337600324443,-0.7806434616141216,-2.0284046436575256,-0.04229569739551595,-0.2798808439756426,-0.4413469047099556,-0.002955078406966906,-0.43609555584338305,0.8548809419439327,0.5643024480191908,-0.044538595748323084,-0.4929915895077047,-0.5349664988776441,0.263167267565635,0.47200396377752424,-0.43068187466893015,0.7047013927375354,1.0856131247090655,0.309916443807391,-0.9873170890835032,-0.449531680883153,1.3869800137095372,1.3042494722585296,1.8925218189971307,0.21828226169860634,1.1787249630108791,1.5820635891327948,0.866660305718648,-0.5442437909047132,0.44650462109488387,-0.04427208431052109,1.9591260363314547,-0.729625782401303,2.536977232938413,1.0338910496382379,-0.31123760599359557,0.8036630131094601,0.8523158141022603,-1.887050334081693,4.566666666666666,True,Rose,PD1,Pembrolizumab,BLCA,NR,3.5,0.6519929925083501,High-risk,48.80251583654434
UCC_Rose_RS.03238966,0.009486320803124657,-0.20238913368863115,0.20233776157220246,0.5998106001760453,-0.2706098302953947,-0.19670839713183647,-0.5609852361824958,-0.0591631551014725,0.14003724461483902,-0.07137355370774891,-0.43518635482757323,1.181164418976704,0.5193100687739671,0.3367718276549355,0.6283083564329508,-0.4213501052033059,-0.5892859788905532,0.23586211342496058,0.22116871196600738,0.28267726308376184,0.2958928961467195,1.7698379521119838,-0.5516650404714919,-1.17815557724781,1.2970027373738713,1.4633762541509885,0.0231765005876736,2.07394993043742,-0.007335255250115426,0.8298743980711972,0.6829610271213514,-0.24104569100512527,-0.3960737829363765,-0.4604994791923074,-1.0316132306514818,1.412171381502362,0.24794442058191968,1.9968040435069847,1.6766990021594435,0.8222376080047672,0.01944637460814697,0.8029839849436872,-0.49568007413001414,15.1,False,Rose,PD-L1,Atezolizumab,BLCA,R,5.3,0.5729364587503016,High-risk,48.80251583654434
UCC_Rose_RS.03238967,0.3981469755430409,-0.04801996979233001,0.22447769780637816,0.18066200959338094,0.17397765613104357,-0.5729912186296258,0.37386513212717454,0.07670437158195377,-0.18090147193211809,-0.4538584106635945,-1.1423434306664118,-0.16857606358596955,0.5745632126648532,0.05506692198837028,0.25244114890383407,-0.18383418649916067,-0.3539682779448433,-0.4001239509497045,-0.4987768447215207,-0.9022240863301163,-0.11619968571301828,1.0017574766686543,0.8552729183802082,-1.0116336009346594,0.6120566536862453,-0.7090772175655634,-0.4971463634545433,-0.928668529549943,-1.4435843240764001,1.5133063039866925,0.7951995554510061,-0.6657580010349305,-0.47155033548220193,-0.9660315388599546,-0.801862852705321,1.8055058964273163,0.08244821553836028,-0.20717126059690497,0.05781911274517915,1.2044246285573235,0.8792089387095128,1.5743120837167477,-1.1626177304288887,24.23333333333333,True,Rose,PD-L1,Atezolizumab,BLCA,R,13.2,0.5769765005372224,High-risk,48.80251583654434
UCC_Rose_RS.03238968,0.10553933010299765,-0.7513330648197764,0.8406475560038705,0.5768258119822137,0.6674546057281562,-0.3872722528838013,0.3432039119065008,1.2808941659537083,0.5061233529937541,-0.20938734670687065,1.616110674890315,0.23802447355664735,1.7953398908201166,0.5316218078652708,0.6993178440454191,1.5369833035512075,-0.5692060531732754,1.0010284950082993,1.433363742776958,0.9401050122182846,0.1638106689060546,1.1827711722938274,0.7085665257127405,-0.9112892562340936,1.3273096863162648,1.3495177574997552,1.0916362746732555,1.7071836707668908,0.3409242070746617,1.0967913152825741,1.7819077023502867,0.11413824787922015,-0.5287447620489671,0.18078757347968302,-0.4192656454871038,1.5145874454270525,-0.26085383365393455,2.5868889764097265,1.6290676794045718,-1.4579426028607483,1.444897878092185,-1.3367155248086249,-1.5624572231872862,28.866666666666667,False,Rose,PD-L1,Atezolizumab,BLCA,NR,0.9,0.6057685885833863,High-risk,48.80251583654434
UCC_Rose_RS.03238969,-0.867859039725139,-1.5678895308112866,-1.1405740824841903,-0.8160209612047762,-1.8894016859021978,-1.9397625983054518,-0.7067786595477894,-0.9718631756933023,-1.6203837124716511,-1.60476151395393,-2.0105269364497427,-1.4055541833838336,-0.7835486244745792,-1.5868191251704844,-1.1698333195724362,-1.2731593999808988,-0.9294457535508864,-1.9884507022737665,-0.45320819719908,-1.9630742684968816,-1.0631536110440662,0.4716180210219434,1.2651430114000985,-1.3966297158605956,1.3661359689158334,-1.180863597737476,-0.7995308785175786,-1.499557911369666,-1.1264497884574738,1.5349874399787133,-1.0332390460209542,0.060847059731921095,-0.08788555315144009,-0.568255832105115,-0.7443742229127412,1.0363333179434373,-1.6256995860387746,-1.6227299598595553,-1.682913287375709,1.3708831659997072,-1.701120547060637,2.23049268946789,-0.19986054091182906,0.4666666666666667,True,Rose,PD-L1,Atezolizumab,BLCA,NR,4.4,0.8602623382133383,High-risk,48.80251583654434
UCC_Rose_RS.03238970,-0.4484572563115273,-0.815878289568074,-0.48777135759384715,-0.8234377766938363,-1.4374575572393393,-1.0528487809433125,0.09601584045605026,-0.40207499222918724,-0.756298828192187,-1.143154300843172,-1.152703498116963,-0.7875687777303753,-0.13275566338966188,-0.718462299002631,-0.07163706420450612,-1.2309612134979053,-0.16828059091496386,0.013207098069741081,0.22978392959872257,-0.44085873551909205,-0.19100865906180348,0.726064538396979,-0.24489379928610527,-1.0870120722587313,0.518922298615845,0.5904738123769655,-1.07018380586237,0.46512025205534924,-0.7736064366470384,1.5246885841033382,0.1442533124746816,-0.5746834352558059,-0.5495844445358856,-0.9714045611588832,-0.7615302745282333,1.2942419423494855,-0.9033999429383088,0.7849384256468511,0.5144600229340487,0.19914741464256525,-0.12229095333903077,0.45813140986793527,0.08478166380266121,25.166666666666668,False,Rose,PD-L1,Atezolizumab,BLCA,R,10.6,0.6691794948433869,High-risk,48.80251583654434
UCC_Rose_RS.03238971,1.187414843341232,1.1499414978186386,1.3898881065122055,1.3967119862019586,1.1909744994603186,0.16662742528207983,0.7200373043202625,1.4311448778351628,1.0356239265180927,0.2080106050474303,1.7047265475892854,0.7982483025731798,2.1063073030987827,0.3316905021541716,1.2968110320127377,1.499360418899555,1.7031418561914797,0.8699199622763083,0.5922535587150701,-0.08480158557146324,0.3006969531580747,1.2860898778723975,0.7562817236075066,-0.868943837975153,0.528393353541313,0.07517125163126542,0.7648761762790712,0.3214966303142533,-0.5521846675063184,1.276578525294841,1.1166999881814579,1.6064873943747133,-0.7233020977322083,-0.057003385592948166,-0.49099603320673413,2.272769468709593,0.4473169587437136,1.4717078484645671,1.189850971268581,-0.6900816795876503,1.1425194217195724,0.22211133129181226,-1.3108121485376436,24.23333333333333,False,Rose,PD-L1,Atezolizumab,BLCA,R,5.3,0.478841464592346,High-risk,48.80251583654434
UCC_Rose_RS.03238972,-0.8310454692108696,0.12778614567622018,-0.45723049503302415,-1.0757731367681835,-0.6326054406038784,-0.8459626164642582,-0.09438648620179699,-0.36576703912747477,-0.6369185454907765,-1.2706861646758711,-0.5191520659699163,0.13190456794164312,0.10209282419507117,-0.4672544637034447,0.06016341593421608,-0.43860764812219305,-0.6139078842957463,-0.2650382278395824,1.4125888186205882,-0.2774352476374357,-1.1012614458360948,-0.23813349181600624,-0.14888040620105497,0.08942548227779684,1.2837671553568057,0.7313718416249757,-0.4105645094601379,0.4174941402497158,-0.5438998336098602,0.9853398099698765,-0.35393643653435514,-0.8667250727433352,-0.4716255182104539,-0.9998700288047948,-0.8289471056806902,1.8010267878810242,-1.0565956925108573,2.0995152435371045,1.2793230552538912,-0.7383769750847828,-1.0114111680292774,-0.8867998753802809,-0.7462947362217096,3.933333333333333,True,Rose,PD-L1,Atezolizumab,BLCA,NR,1.7,0.8441552461890021,High-risk,48.80251583654434
UCC_Rose_RS.03238973,0.7848072145890244,-0.5363421238938564,1.1666240394277256,2.151712347470232,0.16801583444831347,-0.26291500406008994,-1.1712941466517253,0.6543553625744609,0.445452243163857,-0.4112498630134968,1.2640375042208067,-0.046257436531783824,0.47054104391534557,0.6643752995542427,0.5872305109273056,0.3830384836765614,-1.4105283411962313,0.655941441874609,1.8354700533885167,0.33907757985335046,1.0721847972555356,1.5556985510018886,0.48928836185317154,-0.43390541354362316,0.7539887230643642,1.0227625040394552,2.0990398580419174,1.9227744868245271,1.0843034424867288,0.5875848287169259,1.5732075276410946,1.7764326382264375,-0.383022673960477,1.1534803454360028,-0.3320937992453498,1.281678895579202,-0.3541299796975333,2.766159470777462,1.688999203538811,-2.308519463962841,1.5749079914008586,-1.4624358110478535,-1.6811251864261467,23.466666666666665,True,Rose,PD-L1,Atezolizumab,BLCA,NR,2.6,0.6206212544473632,High-risk,48.80251583654434
UCC_Rose_RS.03238974,-0.39971565991770525,-0.41677249209658046,0.8076927451569162,1.1836517646968259,0.3571810074777136,0.6087517771551935,-1.043314751165573,-0.41200567201419663,0.3099487813265325,0.8940973090149318,1.3172612920958948,1.4491441859232033,1.2367154981054227,0.9938641840674679,1.0118844198741554,0.5239634060298469,-0.4364408646779143,1.244207561003199,0.909508985810506,0.06924122483848548,-0.48778247561131516,0.5354259717427026,-1.036175076957857,-0.5884511145287775,-0.6177295228943709,-0.13720166946035126,1.1752735133909442,1.1657880365938276,-1.0525935184009185,1.2054581853215134,-0.08676608263784102,-0.1125923694778244,-0.33615134484728004,-0.5094104303949958,-0.042825850330816755,2.27556909073554,0.6321473067928568,1.370580385892802,1.9695172863191215,0.13283148733430714,-0.3167064316350475,1.0829688702310394,-0.6924463721706615,2.7666666666666666,True,Rose,PD1,Pembrolizumab,BLCA,NR,9.9,0.6211195331027142,High-risk,48.80251583654434
UCC_Rose_RS.03238975,2.821898494351034,1.7923292887865392,3.933979682681837,1.644265962577534,1.5906827490269053,0.8243671721758649,0.6385174363438523,2.0693524156113625,0.7148961915805347,0.38403008649478626,0.6056148865099639,0.44301045424181046,2.10746715814119,1.2062961200390176,1.085758968260559,1.7168275409820686,0.7941265617944088,0.30598649261391586,1.408412269286981,0.28822113744777633,-0.22843033098423055,0.6445485333066697,0.40278793813049624,0.37272670936236046,1.0560060719286852,-0.01547458744390782,-0.172959648553151,0.3583720411016219,0.3554577177946679,0.30425423363748433,-0.6588453318324433,0.7450637668422482,-0.3891588284169541,-1.3489477070965583,-0.26225850145420915,1.4890144079650076,0.8451106320837374,0.7679543235977909,1.8421424914258626,-0.7184479281185805,2.5188754314623965,0.2211702016201438,-0.976386171962161,6.6,True,Rose,PD1,Pembrolizumab,BLCA,NR,4.4,0.5435811386037634,High-risk,48.80251583654434
UCC_Rose_RS.03238976,-0.6643052624507503,-1.3576944113391678,-0.5219495821269716,-1.0751686135312846,-1.0341815158757766,-1.4668659849477972,-0.10766578062485854,-0.36479076739436067,-1.272422135031739,-1.3034285033356126,-1.6966227182821272,-1.1758572076031888,-0.8446718590359621,-0.24521780507559454,-1.0178067658013643,-0.8479799378589398,-1.1845657064865944,-0.49308207516962016,-0.012281142649985893,-1.5339694254168692,-1.2706771220238602,-1.059493283790189,0.04750751255502178,-0.9630389932231166,0.6833940581581434,-0.02970495731514793,-1.448204280792168,-0.4994171974568192,-1.7582143542309352,1.3103158198577645,0.5002742164133188,0.8685109882086011,-0.5715050195672782,-0.19688111117266976,-0.268544238695041,0.7265481648355934,-1.1847060392076993,-0.7770804940909223,-0.9010994826395549,-0.5925668487184534,-0.22508400027404085,-0.5066661696321388,-1.1030708411118286,2.7333333333333334,True,Rose,PD-L1,Atezolizumab,BLCA,NR,8.8,0.8057166924184993,High-risk,48.80251583654434
UCC_Rose_RS.03238977,2.7729675776066105,2.1620086737579873,3.935879838405327,1.8824371365335786,1.0183289011030603,-0.06148962490347006,1.481972708835681,1.5422163200978172,0.7322557437168599,-0.25235180337972635,1.1303876745295862,0.09578325608629353,1.3065058007893557,0.10485007144136829,0.6200420226961051,0.9837652511234861,-0.041557103745947004,0.43295270988676604,0.06389284496609006,0.11206445487235868,-0.46745376083196216,0.9554998938999375,0.8321368798001733,-1.5970414031605953,1.7545724620527092,0.7820270992580436,0.599292650566364,0.3318340779992835,-0.2992146316030879,1.5062745747297877,1.3812496134057075,2.8400046396113066,-0.41489563469725743,0.7343817824988146,-0.2611187977379198,1.3097050611150158,0.27658462772356995,1.222251611530517,1.0980512402514737,-0.6387160407594396,1.8949059319161086,-0.34302596797877916,-1.3482235057686043,11.3,True,Rose,PD1,Pembrolizumab,BLCA,NR,2.6,0.6476755699954955,High-risk,48.80251583654434
UCC_Rose_RS.03238978,-0.26148819775501525,-0.9060589932065646,-0.4582367318106706,0.8809080111483286,-0.56341046931333,-1.2478331949968298,-0.3206554264640249,0.2072179755037387,-0.5509844811031345,-0.6968550533004545,-1.1217340164129759,-0.5740288665769482,0.28462266245627466,-0.07989397108318075,-0.40304401458486816,-1.009560501396529,-0.33655062766211935,-0.32124050825122924,-0.08836077394787353,-0.90119223141889,-0.45166516264391365,-0.22915878674659673,-0.7072084821558166,-1.036427261459867,1.1690935371591584,0.4267205386188396,-0.12655054757655473,0.01370040982897647,-1.0569613062606493,1.419785843546367,0.01171888744664204,-0.4786438458147804,-0.5872812766145961,-1.773294262988385,-0.06909984289308939,0.49093485874525117,-0.5081883688646344,-0.10023109298087983,-0.35856513405978363,1.1278491412328948,0.2688756812295412,1.0367197816224147,-0.5019518041451905,3.2666666666666666,True,Rose,PD-L1,Atezolizumab,BLCA,NR,16.7,0.6413401144183112,High-risk,48.80251583654434
UCC_Rose_RS.03238979,-0.10537661945009012,0.8536388487567153,-0.11540841779998523,0.8308732810316061,-0.6104211081675983,-0.8572395132811896,0.86155657074758,0.5537035150352663,-0.2470927738910308,-0.5422345026900914,-0.2207750934706723,-0.7537348590995621,-0.006055201848000082,0.02398683455855821,-0.34152396842751764,0.07280284431604218,-1.1710039023687404,0.20528773759915375,0.39444961510247756,-0.8902823832353478,-0.34297877265032944,0.5882027375330635,0.23033833036565665,-1.0712173475476094,1.670945102628572,0.2719977321014683,2.1490918557371916,-0.10869179704292711,0.8147874561714835,1.4653186032152887,1.1065600183365787,0.6161542524668574,1.5265132075516084,-0.44375571947824427,-0.6466323100436296,1.199835453527697,-0.630426284457072,0.7674424353222705,0.31148171672898234,0.09847089278207612,0.6865379721258428,-0.19755722214842952,0.29332722718276355,15.166666666666666,False,Rose,PD1,Pembrolizumab,BLCA,NR,3.5,0.5689922399208596,High-risk,48.80251583654434
UCC_Rose_RS.03238980,-0.6498746817364234,-0.39397776489286057,-0.5692455347487385,-0.8707216474580212,-0.8871831736904675,-1.3077311874718967,0.0844966859561803,0.6467309880127613,-0.27404517731063877,-0.9337386753951783,-0.3519567974639902,-0.8418227603009908,0.1307019883147098,-0.73864064658506,-0.38004570967527634,-0.4021681867418157,-0.43524895303838324,-0.7727388156735757,-0.5586386908574593,-1.7585705067815418,-0.4469248033942759,0.7871087309446589,0.5503276024617949,-1.1324715026836936,1.3647756655367778,1.293981607060456,0.3026330829157735,1.055480351360201,-1.2028794976331851,1.0872179455640478,1.5712294825309274,-0.5716146859887681,-0.6432143864193863,0.70690070561795,-0.6947610999139082,0.9345747140123968,-0.8888480667829893,1.3861522874525443,0.06661537840467452,-0.44385292329109016,-0.3715506856453785,0.3873329136165078,-0.86973634955915,6.333333333333333,False,Rose,PD1,Pembrolizumab,BLCA,NR,4.4,0.6935581184765551,High-risk,48.80251583654434
UCC_Rose_RS.03238981,-0.25575776777027154,-0.8154132039353029,-0.37822647245464214,0.8227840536265171,-1.6537516440356408,-0.9762557170581109,-1.603215591217954,-1.1436783130377837,-0.9150153545561752,-0.9570022117973268,-0.6130204279438767,-0.3545859794444697,-0.6622164440636722,-0.634190101037008,-1.9279565976186392,-1.047527902941876,0.4108516880026718,-0.49771585253218475,-1.3288122240345148,-1.5291429652506223,-1.2740259019446198,0.2587065652259925,-2.4367677909631418,-2.1511680713995553,-0.7972680108654014,-0.24488417443252297,-0.7280301976363889,-0.3896633292563998,-1.7236590009168102,-0.18230159216776587,1.2880140652688514,-1.1048240715138007,1.9004631183267695,3.6164885938528935,-0.030848086089474994,0.3743708458724789,-0.5168730447039092,-0.6567035216617749,-0.5840120346830799,1.005569703850702,-0.3985587043221888,1.5241289308149766,0.4129763372230614,15.766666666666667,False,Rose,PD-L1,Atezolizumab,BLCA,R,11.3,0.41505211544934134,High-risk,48.80251583654434
UCC_Rose_RS.03238982,-0.8168394775487021,-0.3308991830885175,-0.6096944943648908,-0.7858273660747023,-1.3318671496991048,-1.3445116761581695,-1.8957067326752266,-0.5412043426957777,-1.2505443363051696,-1.4660371861198975,-1.2413068536323162,-1.1590931273986724,-0.46542537863345285,-0.6864228424537039,-0.3893581906550664,-0.42519592301469467,-0.6263918627090604,-0.5332937699593482,0.08815112521154986,-1.3959150904009379,-1.4376414082121327,-0.01595808873877998,0.4376157487779681,-0.9671987342781456,-0.007672914783291232,0.6750558366114014,0.7313847734551322,0.46340689287132397,-1.1053944219250615,2.0014200775096973,0.13214103540313138,-1.1455028038901627,-0.3403556332850396,-0.9072750921056786,-0.46171974027744506,0.5283684288082117,-1.099127123722388,1.02842320286372,-0.06904820088449656,0.3073012412045641,-0.7182996710773949,0.5712029981706795,-0.3016505255618002,1.4666666666666666,True,Rose,PD1,Pembrolizumab,BLCA,NR,5.2,0.7107189319432329,High-risk,48.80251583654434
UCC_Rose_RS.03238983,-0.9543553481535912,-0.5407632677077922,-1.1007031612228364,-1.1999047095481337,-1.0398557259994068,-1.2957899454612394,-0.9494225253361411,0.2916034390290671,-1.1312587959504516,-1.5347366008230685,-1.021922254208345,-1.4013273559779327,-1.5066442876624817,-0.5600429128371502,-0.29292184768411933,-1.9340658910696162,-1.1601223443086814,-0.6431314207239328,1.1422338193023895,-0.5923768071003701,-1.0772278071844021,-0.9041893481237575,0.48754294310779,-0.2918249887009725,0.9379622634304161,1.5906572884631918,0.1785040787434724,0.3511257931404649,0.923615156584834,-0.45686488400001685,-0.9375870775330083,-1.2118053825207165,-0.2846086834645091,-0.015683452126813643,-0.995898092570072,1.021462678905226,-1.302727499612636,0.99081721101313,-0.0740622564638543,0.5884454211619716,-0.7444599958571934,0.554320601388433,-0.31006120871088366,3.6666666666666665,True,Rose,PD1,Nivolumab,BLCA,NR,4.4,0.7963457584216418,High-risk,48.80251583654434
UCC_Rose_RS.03238984,-0.22176125653305437,0.032056407782239574,0.15996490507445177,0.6393445613903864,0.09159838891982522,0.08327964099538811,-0.4278448443218228,-0.8281633252319804,-0.14242142283264034,0.2447109659549928,0.557021283301915,0.7539820413949072,1.08385831461066,0.19600266724037044,0.40670351982384356,0.5170683172776623,-0.12579164373628438,0.08069610771698263,0.7716409066295989,-0.13368189997028626,-0.49699612038779073,0.09970141170731928,-1.7372724356883698,-0.6051245083860262,-0.06461390153732002,-0.8806599926595443,0.33224161941797464,-0.4836450984872998,-0.7368470485698293,1.2176695131314914,-0.0444327056377536,-0.05457844650409689,-0.5879731120254204,-0.8848433894496732,-0.5561235852971894,1.4296639997342013,0.4725898156223348,0.025917432641375797,1.0482509363985422,0.68008947742107,0.1086344018210653,1.2179305938439637,0.06322231433392785,7.133333333333334,True,Rose,PD1,Pembrolizumab,BLCA,R,4.3,0.5332237116473089,High-risk,48.80251583654434
UCC_Rose_RS.03238985,-0.5193526986848124,-0.8324461292995122,-0.5211598518310426,0.15452496372042265,-1.3359944791647527,-0.8046681986799941,0.40256427119236404,-0.006630654462851043,-0.4626254526039091,-0.5747883456573796,-0.21706673869197712,-0.29624707092664293,0.08899400742096437,-0.31946135648340057,-0.5035978065386812,-0.4446977546815265,-1.1343827513833302,0.1919520625066396,-0.4111720444787396,-0.936222765625591,-1.132616778091539,-0.2649713043769537,1.097470633066259,-0.9703106008158925,0.2603528578462767,0.9437116600496845,-0.5397956735513612,0.838761000438242,-0.8883856490029279,1.128633855733762,1.0255595557255777,-0.5643572642779211,-0.5241819873490807,0.14621481451933055,-0.6605541522843096,0.90603401498978,0.03707204664484463,1.0276175925352982,0.41456481506570775,-0.2080590450510976,-0.18033182682469787,-0.6826732638054374,-1.050143681392758,6.766666666666667,False,Rose,PD1,Pembrolizumab,BLCA,NR,17.5,0.6726985554322799,High-risk,48.80251583654434
UCC_Rose_RS.03238986,0.8968393189762539,-0.03642686652916885,0.9162454853648981,0.9811445131399346,-0.22336474468119238,-1.201136508677813,-0.03570109514420468,-0.4795835850601166,-0.2288378723161104,-0.8234944263198987,0.13473032151313685,-0.37826764976195565,0.6315085641423538,-0.5599655123908941,0.0461419794679499,0.10595878331589899,-0.7812539841945504,0.04655876122302056,-0.17933963982508164,-0.9984231550742153,-0.3561214306336647,0.9391201930494276,0.6906343323488748,-1.2829803016362127,1.2266630894601336,-0.07601710936550236,0.621528585607111,0.032430717772695,-0.9202117651294173,1.4578038275098764,0.6411912954983442,0.15437400910843987,-0.3623310378232798,-0.5149586188127256,-0.40067022046495737,1.5289494116814668,-0.8079517060362994,0.9836375518200261,-0.07343955614302287,0.11603694442457077,0.8742442716707461,0.16988184390444555,-1.0287869956003348,4.166666666666667,True,Rose,PD1,Pembrolizumab,BLCA,NR,6.2,0.6774796671313805,High-risk,48.80251583654434
UCC_Rose_RS.03238987,1.397527852450308,0.49917349637141084,1.9960554412138252,-0.885525754528194,2.378486031107287,1.7735304324424503,0.7866101066030237,2.8038359076563117,2.1160031885659576,1.8355273075094118,2.169645016667199,2.0430837153034176,1.4015299250035822,2.3668263035330117,1.725981093452409,0.5089409421897927,-0.3403173438689915,1.0646306986473102,-0.22820586925428246,0.9999010930719253,-1.2678851268175242,-0.5153655448433502,-0.8364193676796107,0.06605043599203522,1.303260746564721,-0.9266158099737436,-1.2673005712186947,-1.1584612989040246,-0.7537315372893778,-0.05235363569482333,-1.032730883862649,-0.10477854896709721,-0.38593152107644935,-0.5971227955414405,-0.28377528953507575,1.8071307739257105,2.032208730558411,0.8333494652928377,1.0501954780297211,-1.4231119598664528,1.6599928967410849,-0.9479102756805415,-0.9100823007173194,4.833333333333333,True,Rose,PD1,Pembrolizumab,BLCA,NR,0.0,0.4805177418778646,High-risk,48.80251583654434
UCC_Rose_RS.03238988,-0.8791202557725716,0.26155508148491696,-0.7000851991424809,0.372614977472939,-1.2288541191312286,-1.2085597523595184,0.038707566938647756,-0.8382376174387199,-0.4932056644225588,-1.2511221988758552,0.2999063586539985,-1.060153195320501,-0.5961854227238389,-0.6332366684028016,-0.0004078958063636068,-1.5068609948989926,-0.8644532467575472,-0.2023400447646328,0.10225841391386707,-1.036712247523167,-0.13418309866159833,1.3262067196591465,-0.08604857116291247,-1.3923178416844397,0.490446850220965,1.6726738128777352,1.1965848539537691,1.9456358125764899,-0.5745910880578521,0.9591866769419863,1.8310000579797867,-0.4921868287182275,-0.5276931343781758,0.807147922592445,-0.7116820598298504,0.7170523150293222,-1.4200174741712437,2.5046630446930154,0.5822119617902901,-1.0539290147259806,-0.5100012157338002,-0.9322374032276627,-1.206824691874269,3.4,True,Rose,PD1,Pembrolizumab,BLCA,NR,4.4,0.673750515829431,High-risk,48.80251583654434
UCC_Rose_RS.03238989,-0.4857179617488506,-0.8826194835583782,-0.6983085159799545,-0.84004075706692,-1.8529760827251647,-1.4391880258920788,0.39333979329688384,-1.047075770678585,-1.1703148147747224,-1.2300266563364857,-1.2276077233013007,-1.3630738782503633,-0.4909980128888239,-1.1047177459729582,-0.8295318583220491,-1.421619610318041,-1.622131689321245,-1.044225034443467,-0.30608262199736175,-1.7571418606392992,-0.5908530430846535,-0.14532296697974306,0.6805110685973736,-1.0990611894866946,1.709650969539787,-0.6124170780286946,1.1161534086519,-0.30467335960677316,1.2314053907650964,1.335792451552437,0.36258309457464616,-0.1314913941285818,-0.5049366154831395,-0.3147002474584168,-0.5866004758513976,0.6486513027415264,-1.5503759762454774,0.27568116784433266,-0.6822553098028692,0.07898276168364295,-1.0542394390322734,-0.219126848136902,-0.23190866546846461,5.4,True,Rose,PD1,Pembrolizumab,BLCA,NR,4.4,0.7618053297287529,High-risk,48.80251583654434
UCC_Rose_RS.03238990,-0.6701153804819346,-0.301235673096047,-0.8184428007384141,-0.9087745764483662,-1.9812418244309074,-1.6689374644187986,-0.6270641344402375,-1.4525382009044696,-1.3616535760675232,-1.181489850837817,-1.0082172536484015,-1.2603776707314853,-0.3774511580568836,-1.3035582014654188,-0.5140841369457453,-1.6344107770008276,-0.6503750785504009,-1.7353523468612495,-0.6379147853374282,-1.8375978047914183,-1.1588250948556125,-0.27101494472895515,-0.6720009671900221,-0.968445591839557,0.1166149664713944,-0.31480732072809564,-0.5210715617469776,-0.8472371775654175,-0.8493554809092001,1.849968417969413,-0.617249049116955,-1.0902442894096096,-0.5652901753387924,-0.2569831871753116,-0.35727206042603715,1.3958177814471264,-1.2529941222441696,-0.03300238244916557,-0.5078328285815442,1.3524159699534144,-1.1376886893272558,0.8537449795428107,0.18676265484337679,4.566666666666666,True,Rose,PD1,Pembrolizumab,BLCA,NR,5.2,0.7716810234912148,High-risk,48.80251583654434
UCC_Rose_RS.03238991,-0.9748312237622129,0.5649817543926032,-0.6755362450007878,-0.7652689692686041,-1.2282540281138903,-1.1172719849954047,-0.9608972706091483,-1.1564742004073938,-1.0036383135465716,-1.3075838428638602,-1.3901732243707667,-0.9335652323313482,-0.7214195401222244,-0.6810625492604263,-0.807835866251716,-0.0491208615746656,-1.3326896210243722,-1.1723945121663715,0.9844001347189347,-1.2641613973475603,-1.3703562668621605,-0.40952355181892613,0.05367224164149442,-0.7354193844716154,0.7057180230537922,0.6978805452538508,-0.6445531535163562,0.8688298637289206,-0.88999454151459,1.261056509787434,0.2535491989955173,-1.3322179756419927,-0.5777826677785529,-1.1637293285029446,-0.712179340422879,1.5980957868124495,-0.9908684959097513,0.8532503789053644,0.1436671581151787,0.2520559181678616,-0.7420031382909997,0.530569197326871,-0.2334639627810186,2.3666666666666667,True,Rose,PD-L1,Atezolizumab,BLCA,NR,4.4,0.822254904542919,High-risk,48.80251583654434
UCC_Rose_RS.03238992,-0.6534235709213179,-0.9750824700413565,-1.0223760478345356,-0.8895218391319705,-2.031036827476153,-1.8455536032844917,0.005685171392378665,-1.4571097492976477,-1.3835689135854823,-1.5659763579666515,-1.5878034585781404,-1.4515708071758076,-1.0072552448954646,-1.288173073839989,-0.9994013922505448,-1.2426589211544283,-0.4503410621484687,-1.2270485173046028,-0.7177004734012246,-1.588080499009259,-0.9580194465070406,-0.9750855484721676,-0.09118770986358317,-0.9980375862061208,0.09575984397273368,-1.476243738940255,-0.2460958501704314,-1.4632369455065992,-1.3450988533366053,1.5141726673259996,-0.5120205685142035,-0.7446176850155989,0.16860491363753705,-0.05790700086912598,0.04704203983406795,0.6322738284723998,-1.531226448996692,-1.584513107208255,-1.0307390013206286,0.4442498316852611,-0.7248932299883379,0.7610378946298235,-0.04437149913013481,15.733333333333333,False,Rose,PD1,Nivolumab,BLCA,NR,6.1,0.7044163865652766,High-risk,48.80251583654434
UCC_Rose_RS.03238993,-0.844225762094825,-0.34406500416089875,-0.8838743818589109,-0.4546314916095916,-0.9308606163716031,-0.8803750630740579,-0.018999119894985945,-0.9369229227281887,-0.7092561362322878,-0.9295456734252664,-0.27102545729283906,-0.6052421920876256,-0.17697462387722554,0.1691052315595593,-0.1762011915204473,-0.9255353325447176,-1.0045652732594799,0.11199659674567934,1.171538810441428,-0.9047458477889131,-0.057891209007972816,0.3181147463499271,0.942020741719353,-0.13724492233803143,0.4591765145497752,0.32350071558940924,-0.9345479270398278,0.23348887592627204,-1.024047482611002,1.4346620751618007,-0.25550840992039986,-0.3780061251731574,-0.45934850370052266,-0.9006598677826299,-0.5439112620852352,1.3843283057572986,-0.5064942950079371,0.4669193993977424,0.5206354769910552,0.09139417225888706,0.24547416118168497,0.2917870411234035,0.058460011911117965,0.5666666666666667,True,Rose,PD1,Pembrolizumab,BLCA,NR,7.9,0.6919852350370764,High-risk,48.80251583654434
UCC_Rose_RS.03238994,-0.19806128199799825,-0.9901559517102261,-0.29394384988360184,-0.21127056730332652,-0.4297627006687386,-1.0378066270735054,-1.4372616791338784,-0.8607783739632081,-0.46199802872036866,-0.967770864937848,0.00906865137572001,-0.5812436694566875,0.22091204476224682,-0.9659358959695813,0.20043544447929784,0.5258474548699089,-0.6073822752909853,0.05646953948315875,0.7456427908817786,-0.6591375068444473,-0.8476836315736821,0.6296957589140674,-0.35279356328783684,-0.3548106308233764,1.7346811832684568,1.4627211967020062,-0.0013832387992846085,1.1466327019652058,0.2915860949252779,1.2869534923770887,1.2762487778276859,-0.4014547708001616,-0.4883123101574314,0.46640345634228814,-0.6617119661572977,1.5492028284204398,-0.8098159982055539,1.4309627815742818,0.3589580515867668,-0.5212885764266327,-0.6108415516083229,-0.774438516199872,-0.5309724384597234,0.0333333333333333,True,Rose,PD-L1,Atezolizumab,BLCA,NR,9.6,0.7509159186581603,High-risk,48.80251583654434
UCC_Rose_RS.03238995,0.06371883860516861,0.26812007536964716,-0.5399477567862914,1.8221785169060165,-0.8728646666595641,-0.7561196168850968,0.7209577014538651,0.3744841180230785,-0.529537397839198,-0.739202051620259,-0.14689771154337253,-0.6917410404580253,0.15905873323400982,-0.07120608422997965,-0.022352183836647343,0.2621000008078268,0.6005365268449486,-0.0584770214776058,0.7435436411295729,-1.0335329058726868,-0.3351807852621775,0.6869366045057562,1.1743944409031732,-0.7156426291746286,0.9955037422895064,0.46704551359531943,0.15707153792476997,-0.01978341328612287,-0.26542056006437015,1.8230160588718927,0.5211964277110928,-0.7691864423302168,-0.507406514033489,-0.8728201940116301,-0.7892033454971695,1.4116011142252576,-0.4764692143509301,0.3181850847873631,0.7487343274394377,-0.04692017652858831,-0.32647057181436834,-1.1488201387796222,-0.4531034646163132,6.633333333333334,True,Rose,PD1,Pembrolizumab,BLCA,NR,14.2,0.5651303576676939,High-risk,48.80251583654434
UCC_Rose_RS.03238996,-0.7308450796935868,-1.3484382772407337,-0.8191061754161003,0.1271539070486468,-1.7276136913445823,-0.8362847915586915,-2.4465072953940306,-0.851980659915916,-1.7158305805034195,-0.8915986529958079,-2.3131604613801167,-1.2786433323436597,-0.9343914169824125,-0.06606108044353501,-1.0696781303940408,-2.0201904598614884,-0.5733042052613836,-1.6625451924125723,-0.6824872821116525,-1.7615255163875996,-0.9913753687738117,-1.2173309896116753,0.4763456605753523,-1.0418350908453518,0.0525390403420795,-0.3011493160988682,-0.46274144844004783,-1.3319273895999748,-0.8180340973809904,1.0011461377453166,-1.555588810565101,-1.3458552894000588,0.12836303137348398,-0.03664400588424086,-1.0511425893886126,1.0488689158532423,-1.5156222553166283,-0.8241428951627181,-1.3440479826292608,1.707956092859503,-0.6976203404249357,1.0828158120096292,-0.22232070382654176,1.8333333333333333,True,Rose,PD1,Nivolumab,BLCA,NR,3.5,0.7216845593364618,High-risk,48.80251583654434
UCC_Rose_RS.03238997,-0.886995941822907,0.3953854481871522,-0.6396430019460823,-1.6247370490893471,-1.3944978394356518,-1.2760169931795213,-0.5911610628191417,0.1345328605395312,-0.7668596240346578,-1.1578156945603957,-0.023757395226717788,-0.9850345559589441,-0.41871174405211586,-0.2864534519517955,-0.466736137248174,-0.053278512328689624,-0.9689366414706793,0.48845387544379043,0.7299461021992869,-0.06866101223288329,0.6854990576116011,1.3098167396213125,0.6400668334490921,-0.7756614767102762,1.8589858093402354,1.0335448737552222,0.6702297858075429,0.9280634886269195,0.1412635295200251,1.2684157858432261,1.2655325367327181,-0.043598132172078134,-0.41267671004709333,0.4928667106212738,-0.7600157671662797,1.2739879727162764,-1.1824115999730758,1.2816331087001152,0.5460772416387715,-0.6192469452157565,0.04371849572917268,-1.268290641670252,-0.8675930914413942,3.3666666666666667,True,Rose,PD1,Pembrolizumab,BLCA,NR,4.4,0.6511561336271807,High-risk,48.80251583654434
UCC_Snyder_471,-0.3437155474792547,-0.9259148665415382,-1.0759117789845953,0.41499310595970595,-1.1799377947015248,-1.615372171869685,-0.4070494633688692,0.2001407611393711,-0.6162416413620788,-0.7317915902438201,0.535256136186469,-0.16060813252376563,-0.9464638163977195,-0.44277100491834015,-0.4016103911636141,-0.12654432526729567,1.7457027456254919,-0.3822885989977359,-0.5455991080919512,-1.4704540226788516,0.5600368661101054,1.0197034932505278,1.4813873107241984,0.18174650532942294,-2.1989899458067836,0.3160689498056779,2.1682069250425755,1.1024171498162816,0.5211050454408744,1.078408220882847,1.294528222568181,0.5391516228753315,-0.08572308546119418,1.5337224105955687,0.4509942842758679,1.4971853245779079,-1.7724921353966288,2.1139839350549345,0.6823381597438032,-1.7873276957939899,0.0027475351299738647,-0.34115210316900213,-3.5384291778700607,10.966666666666669,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.5134696038011465,High-risk,48.80251583654434
UCC_Snyder_522,2.9760105927033593,2.0548634633911234,3.4260589453504626,1.9349368456444775,1.672181359927985,-0.17112953911281403,0.708225306411608,3.185078490097082,1.1785978825956709,0.22658181606988864,0.9132162854694407,0.9017009892659676,1.4521673723524195,0.6869727502237395,1.0352949025176237,0.0562596477987159,2.5788194416709826,-0.3370887027506455,-1.2337277522207954,-0.44280504201919674,-0.8405483893414576,-0.2043800412829963,0.8856138509824042,-0.38442847783617357,-1.065820300413807,0.32006532087446166,-0.4822226153718288,0.1505300446880595,0.3340082207595488,0.8341349205618283,0.11214290551860892,0.860859897494726,-0.35016777955849987,-0.23715212044553163,-0.38063753537728684,0.8703964430417866,-0.1438944739140448,0.6313592728322308,0.4809127887473763,-0.47650563755433273,1.980240785815274,0.7711853918464405,-1.793626998172959,2.533333333333333,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.3391821189388342,Low-risk,48.80251583654434
UCC_Snyder_1233,0.7767381191887635,0.229263698290194,0.44038949589622567,1.7120518129390385,0.4021826911719642,-0.2675299262845245,0.04214807015988533,0.15584743778411694,0.41100382148459896,0.46790130160775306,1.2211301516751976,0.6603688140628476,-0.2423107823851625,-0.13548536507855236,1.161181522383666,0.3905851550068087,3.396555753548421,0.4799902503424503,-1.5933585628756262,0.06740536240257161,1.5905626257741188,1.6027111750891923,0.8368273447915001,-1.1399268433847969,-1.3330749596195548,0.5499293985952416,1.9810298127494974,1.2980158460423905,0.3138712915342587,0.6527501031535592,1.0208475675535966,1.4300462017072628,0.1199464764238866,1.1420643049747456,0.34532621120330503,1.0550635932440504,-0.502650732395906,2.1684909134425525,1.3524737476105761,-2.048925295343712,1.1343551467748196,-0.17008315354517278,-4.184586958936975,24.133333333333333,False,Snyder,PD-L1,Atezolizumab,BLCA,R,,0.33553260127706797,Low-risk,48.80251583654434
UCC_Snyder_1849,0.03104809135518883,-1.0739623583216387,-0.5136306839414272,0.27900691761654456,-0.3699204536852952,-0.18854894586045048,-0.05537307278103164,-0.6090910265215808,0.309534644368905,0.4648297247558646,0.398389212001718,0.8551730928641433,0.5267019469144332,0.3512055903999866,0.37712337902500376,0.5215062078279296,3.16978366413834,-0.16919373754831452,-0.34122735905813273,-0.5947717050099295,-0.8729734620318497,-0.42461637724456,2.090510854695946,0.1879947056323016,-2.3435576767467907,-0.1837775335436868,0.504136265765676,1.1917734316568,-0.3665411806832695,1.2583501451072132,0.8411478047689134,0.33151960731082253,-0.3897619760550991,-0.09099422996262664,0.9455148166493973,1.9522904657855396,-0.6476190435744571,1.419589326570126,1.3552749457043083,-0.053104487785995975,0.06874890730053604,1.4824518797523045,-3.793077371996572,15.6,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.5665274614850998,High-risk,48.80251583654434
UCC_Snyder_1994,0.1410981331573698,-0.35637431936895947,-0.46565514540043523,1.3500906654054259,0.17329624715478928,-0.8265204568563541,0.2940872575896982,0.22966332415403307,-0.05624482085027951,-0.8274508789878654,0.7320751789420088,0.08848786532332117,-0.2530830602034644,0.10515189875831138,0.5369544812729398,-0.34589591243474976,2.6146981901752646,0.4870090990661237,-0.45580173063706125,0.04229248653407446,1.4824880006273797,2.0140119798152702,0.5856479936880542,-0.5518398185333361,-0.29288968780281455,1.4346186525781086,1.7905870597454474,1.667622292335093,0.6540394869324928,0.6765945006270166,1.442194403402987,0.9535044374036752,0.5529124876934569,1.3120593354095802,-0.04118394136919851,0.9106125665166119,-1.019810928420862,1.9803090427237615,0.4150195754659022,-2.556877089707202,0.5732120672483328,-1.907471091127646,-3.4966885341358243,13.433333333333334,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.39752653550712125,High-risk,48.80251583654434
UCC_Snyder_2131,-0.3076825256901449,0.48603604413184853,0.4364140568435992,0.6861691882480738,0.27544202596950135,-0.24584593897123846,0.49470006782878256,0.28059847280436456,-0.5083158465011234,0.06620134220690688,-0.42921192801651653,1.1749667795264094,0.7124615298078185,0.465948193856782,0.6462778497027846,-0.7690783077643925,2.5673912532985357,0.5100854788423742,0.3246438244332839,-0.0975524071033728,0.17046472687152558,0.2851141364129706,0.08656025495945772,0.2076848238096271,-1.6869849668369907,-0.9377242047934469,0.2329913594269846,0.00891404423327148,-0.19939427710289265,1.31520634322646,-0.28191693413871594,-0.29074096214291945,0.2537368369053434,-0.9941302570465149,-0.18132224610688563,1.072679382784993,-0.33480790683209594,-0.1488580929197736,0.3834920401561126,-0.401025119512534,-0.041884676048547655,1.4530861845768674,-1.5640194896211477,21.0,False,Snyder,PD-L1,Atezolizumab,BLCA,R,,0.38214138981512535,High-risk,48.80251583654434
UCC_Snyder_2278,0.19693209431481512,0.10642037489055103,-0.7647451086919322,-0.14057232722223476,0.4857498344365937,-0.7521156416726482,0.19146383719974758,0.668760673597501,0.17392430078925897,-0.6426011511077179,0.8852676660538703,0.5727965371498333,-0.27564702972315624,0.8261088074164807,1.4579025861697652,-0.5896061022660978,2.118782707643291,0.10899009204199435,0.7573988165884932,0.13140555224537698,1.4394785547297713,1.958256976379731,0.07462320899168651,-1.032713558412731,-0.09008116257370279,0.8142353694382469,1.8920256572067415,1.5020114367531754,0.6539444346879503,0.5353892840421518,1.4287040741200365,1.7877055365530317,-0.12049802891437641,1.508650277423489,-0.07703064540620957,0.5130984736751957,-1.260580419673952,2.1689550235831074,1.6742644771340167,-2.1082489836559195,0.9263934988154103,-0.8111048028808352,-3.0331155763143753,23.4,False,Snyder,PD-L1,Atezolizumab,BLCA,R,,0.37847991932665326,High-risk,48.80251583654434
UCC_Snyder_2389,1.7305068385356785,0.5373747428830928,1.1012225304108232,1.6388974983867957,1.4109541964921162,-0.023542889751531723,1.0145166502166187,2.7329125991092784,1.035763973354944,0.42129779454662597,0.5182020864526388,0.8313037139177455,0.6348451486923583,1.5524167296098428,1.214610352119965,0.24966253098775765,2.815863913135317,0.2235935478805146,-0.812802136464846,-0.02319989841223284,0.040261771380774636,-0.34380121630412674,1.6222121732972918,1.0274935459323122,-1.4044610196241378,-0.05538051284106251,-0.21662845385774224,0.5055715707278008,0.7363420285750347,1.253120399516081,0.9250680160479255,1.3669167576886954,1.1967528714841709,0.08813477663840799,0.5651585286245737,0.9430212163479135,-0.33724672783062615,1.0531327680349511,0.924866572870596,-1.9506716799538175,1.9094710570071427,-0.7580232849593022,-3.735706871731443,21.7,False,Snyder,PD-L1,Atezolizumab,BLCA,R,,0.36916999939184514,Low-risk,48.80251583654434
UCC_Snyder_2849,0.14209288980871668,0.4176387080579278,-0.5317098806205469,1.1969331158806258,0.10207011069027326,-0.3353195409812911,-0.45808418176924354,-0.0008390539121535847,-0.07689708745606409,-0.4948999590331472,1.1576760593325333,1.0627794858159632,0.8064973746710866,1.7129105361656005,0.9198260515330812,-0.6859101526651268,1.2350209906692915,-0.20413286546132078,1.63326725219298,1.1579655793147543,-0.10857125534243711,-0.5650462903234184,0.36115997644896203,1.5477789708274459,-1.9040469125172903,1.0249758721532325,-0.01065264370312324,1.516374706456549,-1.1912083766634571,0.7683592679522024,-0.8926169711072882,-0.9970497246934272,0.3883262753361348,0.13304000083397713,-0.08792434850310939,1.1679199607931978,-0.3182681128109674,1.4225234126215942,2.336260088459935,-0.40064900381036833,0.6103206541789056,0.6182095030642073,-2.762331019707223,19.53333333333333,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.6057629052627564,High-risk,48.80251583654434
UCC_Snyder_2937,0.7575917765785776,1.1417983060234145,0.2661809658150343,-0.31479522582982605,0.6764830798256206,-0.3368785092662071,0.6849426004944259,1.4616073847191642,-0.08205040980501803,0.1779504378567688,-0.4709316241363209,0.18221143604297904,-0.12182157679755294,1.3142212219810667,1.0237613040883866,0.2512293663422473,0.7735058726350795,-0.6258714402142601,0.7679569389011791,-0.6463683638855334,0.39256290974657765,0.2297619935258822,1.8714231095718066,0.7119643142797931,1.0688113961491914,-0.2657743071788738,-1.1348201552809554,0.48903608811458776,-0.1156878126106092,0.8494183534924296,1.260712344289868,0.7732808473599655,1.752768953073812,0.3992607015894693,0.7321050962168664,-0.11719166117232492,-0.6084717269569816,0.13645142028012944,0.9193223775541057,-0.3821340771102894,0.8025684596616055,0.21532363851203512,-4.003410327806225,1.4666666666666666,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.6215860662305759,High-risk,48.80251583654434
UCC_Snyder_3529,0.018918362640413734,0.9316581702600093,-0.5317729348431461,0.3573569785950763,-0.1127698938937184,-1.0618547132567213,1.132760124757592,0.5336932712146175,0.36019280469861725,-0.582733402232623,1.3961636263520225,0.40279537333169735,-0.4434258787654917,0.234131541926244,0.9010749771480745,-0.8147499135065146,1.4715384482634741,-0.3516691375063954,0.23824988532321756,-0.47296373282995674,0.5321373718659703,1.4051640608113716,0.6826094411783493,0.10172163868393995,0.7175897025045603,0.39871379330129614,1.3436331784501099,0.9433206568519209,0.42634094153175106,1.3044503599543682,1.070256782385,0.9745611754175729,0.812059260605702,1.608441824516173,-0.2208809262740048,1.4237396581598676,-1.5032903013642076,2.1601809682677424,1.5270877794177862,-1.9091829383531622,0.20583137090367137,-0.9899664831693299,-2.698741496882097,6.066666666666666,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.5689775447639761,High-risk,48.80251583654434
UCC_Snyder_5037,0.0186028489711853,-0.4969516601591663,0.09524097738583007,-0.2800377564413111,-0.3045966588628922,-1.2735347038935285,0.8391972402190535,0.9202941245859872,-0.5110407000222903,-0.8702910789194681,-0.49520814618781034,-0.748817053084636,-0.05584616031578462,0.19413671331705523,0.13056193125484317,-1.9653764852573887,4.326420786895925,0.024323187518447007,-1.8659678709091,-1.188892564367583,-0.6997921438085635,-0.13573907284469666,1.2166550292080727,-0.6515027466941392,-0.5310871361171656,-0.718030953001196,0.9368040861505061,0.5484396333877036,0.17801349904911018,1.0763643966362753,-0.12470071255235804,1.8042752801117603,2.0162936688064264,1.1253522704571428,0.6769334570207792,0.8411134611799882,-1.4989568764188819,0.5177633420825336,-0.2519924437300356,-1.1935791936264497,0.0645324139582288,0.04645197351832014,-3.791836263408999,20.33333333333333,False,Snyder,PD-L1,Atezolizumab,BLCA,R,,0.5444360714629047,High-risk,48.80251583654434
UCC_Snyder_5122,0.3355064188767659,-1.208647395102743,-0.952923035231727,0.7135668076028452,-0.8850614719435768,-1.9153451579480127,-0.8577480858198022,1.175005804723389,-1.6229332367160625,-1.169337851824889,-1.8853686877004296,-1.054587964887007,-0.8979763011582876,0.6125024986992366,-0.9257192754212449,-2.530014587902658,1.150924176242396,-2.399051320700765,-1.3373418084472206,-2.2560915487513578,-1.152675861113493,0.07688823506455722,1.1139751143482655,-1.948224600868859,-1.4846772663033445,-0.5720424244950483,-0.6041413988106181,-0.6395822072143322,-1.3858530796179915,0.6762698104286249,-0.8194624195447072,-0.22228152629238618,0.564351392254036,1.5832942789335158,-0.5241056680715226,0.15469536515939838,-2.1236721312539486,-0.9500257225744143,-0.6719766705078958,0.6925733816784525,-0.6726764020133904,1.1940432586145073,-2.368631714829046,23.33333333333333,False,Snyder,PD-L1,Atezolizumab,BLCA,R,,0.5697956871838479,High-risk,48.80251583654434
UCC_Snyder_5338,-0.45207906532214226,-1.0653621730218328,-0.9499102070617895,-0.3568393328877084,-0.8380621425184569,-1.2732507184367994,-0.09943968748007,0.5738137536233537,-0.36222306708298335,-0.8696488285544907,0.5519779340158331,-0.5858027054229108,-0.7879807439192075,0.41869138075368756,0.3466624168288262,-1.1064230852435808,2.500796700650405,-0.0652524007405159,0.45541418551686963,-0.5224231545808898,-0.11357759067302899,0.25217269188426744,0.8208237442724168,0.7485166061873589,-0.743854359365897,1.6136033985614031,0.9123615584754815,1.855010376336433,-0.3227432466711591,0.5795750400938836,1.2205012267925586,0.723713981539168,0.17337637552669696,0.9843481946062604,-0.1182214682868394,0.39301550381999584,-1.4895436466178305,1.6824905809838537,0.33709092541085,-1.296419384144205,-0.12896332570156413,-0.6575455852758856,-3.934414229095818,8.866666666666667,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.6328485277768917,High-risk,48.80251583654434
UCC_Snyder_6229,-0.21835667491557567,1.1039008302592304,-0.7184975835925752,0.4694070066653925,0.33926590675674817,-1.059640827320044,0.2537363301714433,0.9161851187274108,-0.28884478626066334,-0.2793810819350713,-0.5636691290059053,-1.5012109551446369,-0.031034059009160956,0.22025772134997226,0.6811835044157735,-0.25724592969016186,0.7390190595892331,0.29961885408764133,-0.5905583710308727,-0.040573236341542994,2.3235340634378474,1.7679349162828675,1.4915394055331601,-0.059235195658499946,0.7536802216951669,1.0342264081233559,1.5987707785670133,1.0211082877926023,1.4536661726800104,1.264784731853654,1.1186742044240134,1.2306091292310128,0.9729316327953489,0.9901032934396794,0.49116041541971023,-0.1074479551181432,-1.363486586939798,1.5913088171361893,0.14278341793375376,-1.3357633301947545,0.4675956884255918,-0.12411401279708856,-2.7483812692892604,21.73333333333333,False,Snyder,PD-L1,Atezolizumab,BLCA,R,,0.5166321946698038,High-risk,48.80251583654434
UCC_Snyder_6428,0.6345900782307661,0.3814244740401204,-0.048932618037896114,0.9663047902680485,0.13518430523014446,-0.8732751136222466,0.4488344686437431,1.5384939209230295,0.41151874603669997,-0.18720541054896123,0.8459137497429838,0.17684468853292226,-0.6686012041207842,0.834521294117995,0.48693214796073375,-0.2980196638172065,2.0451572873360835,0.3884607603170144,0.546229316390316,-0.26128473109589523,1.3022187533699627,1.725776830114283,-0.16883548296545023,0.31160168416574496,-1.7572551404958012,1.3340105834120939,1.9474350453154252,2.3451911335945477,0.8031108517697192,0.5902917623789876,1.7978569600195657,2.121104059361951,1.7512917947056454,1.4665728877268198,-0.19265335098517308,1.9968262514898,-1.139567748812273,2.4964142005590118,1.9432485526607624,-1.4925509232712564,0.27102864368577667,-1.4500042222686185,-4.540704374362627,5.433333333333334,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.5539181914651073,High-risk,48.80251583654434
UCC_Snyder_6800,0.09550059279211516,-0.46400184530216343,-0.33718723300009595,0.29621728047116214,-0.32139173125712445,-1.261064990026395,-1.1459856154052055,0.9835778801283925,-0.5399405865683333,-0.7559604088294729,-0.18691736903020328,-0.8207719532073433,-0.7589988322802041,0.7840036528487967,-0.23627220060622497,-0.8999913322521272,0.404873831140481,-0.7164103616767692,-0.4998757469252039,-1.1247589404236806,1.5335254358010042,1.5185599025226435,1.2785943449587422,0.06503328107101548,0.24684362261560877,-0.11738824645385784,-0.001235247289455081,-0.3248021335475281,-0.001919862418718506,1.766812598042001,0.35314812062926043,-0.5409120201411082,0.04628781897960502,0.3358585563352919,-0.46806430466940596,0.9305844705827881,-1.2913505446664775,0.43169207181344765,-0.3261614798822687,-0.539373046836291,0.7193551167850654,0.9957319431665812,-2.325715757578366,21.7,False,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.527506926356041,High-risk,48.80251583654434
UCC_Snyder_7577,0.36295533444933287,0.6680148375597479,-0.43702183315007703,0.7276116404952093,0.8982453600236474,0.025887595092949772,1.0204592756768158,1.3417536935708172,0.8714855237129893,0.5609653953590401,1.719427401275536,1.4779474599367028,0.764109612422368,0.2995671636903363,1.5497148769594884,0.05360212814915965,3.0432482040380155,0.918125609333983,0.04486202541873581,0.3803186117327253,2.024001325957231,2.1397874484663864,1.394137315938332,-0.0171699664924997,-1.2143965807069228,0.9315265735564172,1.9139447340312432,1.7256638120701264,0.5075433602713867,1.0041755762243456,1.4304699183629428,1.7782773584330367,-0.29940013374638247,2.0723246301647853,-0.2159315356642319,1.519868418709016,-0.1439608662180124,2.387404689643564,1.1942567403600557,-1.8543962929937963,1.0315031130044858,-0.3335582984132089,-2.4946346661228183,3.9,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.2766793725817165,Low-risk,48.80251583654434
UCC_Snyder_7729,2.3821571921467424,2.305609434841965,0.8570601726171161,1.5831791141385934,1.1887564329873463,-0.8354226811586084,-0.32889233426865544,0.8805274929412881,0.7563874058839317,0.7677962536043071,-1.093975320294412,-1.5768251238313522,0.5225320723070167,1.096215237260673,0.6213806737768954,0.8442226424452611,5.219807752829026,0.41804087009175434,-0.6711964546960687,-0.24575294933372185,2.6773807150418087,2.0291623765202487,1.6019849004313247,-1.2398035626483965,0.9229999476170156,-0.5756666205816712,0.6611915660823777,0.6447680589839382,0.08407470565990503,0.7176686188471322,0.93452806690267,1.4875628117085928,2.6606494422626006,2.5126324429871842,0.32961797337018983,0.8418349023109476,-1.0380934615187958,0.8515767042034524,1.8579373890819244,-0.5026499450086801,0.5475543931055509,-1.258530428410618,-10.47827308405071,11.8,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.6837109232382331,High-risk,48.80251583654434
UCC_Snyder_8728,-0.48765561538316843,-0.8841015510386772,-0.4643518044693629,0.007181894299159459,0.035800478682839275,-1.1686529305468374,0.7492369821691381,0.560391186329442,0.1764231085772926,-0.7546898388633773,1.1219416954769912,0.9378698927841133,0.1288121062199152,-0.2338924059559583,1.1645736452569784,-0.5354078208359272,0.7159568450587841,0.22769702659698743,-0.008616425556906872,-0.0294608145021224,0.5993787861426156,1.5657712130296095,0.6386008706681974,-0.3905783066964252,-1.091445458593393,1.1792990888135573,1.6984609526903012,1.2376764674198788,0.29609004537572337,1.2149343106254187,0.7470620059864538,1.6226398267535347,0.0561376504413706,2.0816528582744085,0.20520800506112616,0.9224945799602299,-1.2451033667274474,2.484468308989149,1.5539362422654743,-1.607931656402032,0.4810946035617958,-0.17280008373493833,-2.5109824709055073,18.2,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.546229659125292,High-risk,48.80251583654434
UCC_Snyder_9517,-0.4479108812521376,-0.4979148283211533,-0.911894108553118,-0.8665124468428079,-1.587736489212408,-1.8049949131774152,0.25237086242769863,-0.4911020865638392,-1.6127268981021559,-1.3678468111376303,-2.1272822959028046,-1.5944498143547514,-1.3515016413798424,-0.4115533408135221,-1.319011015451576,-1.445025398738221,0.8116144383372599,-2.4990748984589533,-1.9939536732470884,-2.7694984363774933,-0.6389747940737811,0.2218822476850532,0.5620235603770617,0.03625299369252871,-0.466912191474552,-1.7038360364395775,0.9936081250094528,-0.5562909004610149,0.27536692676696006,1.3771762989578682,-0.15144841798882672,-0.6699639977927213,0.5158044637647203,-0.2739626311793606,-0.03839303032275053,1.2843329225162585,-2.265536239246624,-0.6012483928010772,-1.4694631131677058,-0.8014940072827317,-0.6931645222810975,-0.3993806923248098,-1.708208366318538,11.033333333333331,True,Snyder,PD-L1,Atezolizumab,BLCA,NR,,0.6030581948839793,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO10-T1,0.08023234062086193,-1.405434016359578,-0.0944753781649814,-1.0966191236538365,0.6295637113678252,-0.4466267924637912,0.24839110933570485,-1.985146803552821,-0.2771608491771506,-0.23616385912953047,0.07863234658600345,-1.0391079137606822,-0.7970727806878227,-0.6016757931733016,-0.043821203937068134,-0.2148363483978811,-0.4712482611271076,0.9010185651705411,1.0076781284084193,1.1984156392523564,0.8232343286274698,-0.25062310606997096,0.0973504652314598,0.8655874909377398,-0.19155237016268692,1.5036924248646222,-0.49418140130589255,1.7365244514444365,1.6781794376294172,0.9679541369354865,-0.044859698323252095,-0.45453309374323536,0.8995910934040675,-0.05021718005755479,0.7327428589069949,-0.44571440593275846,-0.2169840914184647,0.478213050929753,0.8191068416418481,-0.8283022474395837,-0.32711369071033136,-1.3806981002718575,-0.36514978705722506,2.8666666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.6666716764159938,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO18-T1,0.6623616013761833,-0.5926600799219676,-0.046761127456565015,0.8786607511126169,0.06871618986877052,0.4557347801617915,0.0026781222064983182,0.043719919599330984,0.9111429880549115,0.32673512112228076,0.7564558345604593,0.5417409899270338,1.4013019311768893,-0.06980528681860194,1.3526723323178989,0.15969895271983942,-0.5162473228691488,0.7987157394398743,0.467691781404268,0.9154723553138794,0.24389976247205947,0.2825711295372738,-0.20898611683856444,-1.439411661314035,0.17012902275777983,0.7669351707493566,-1.2842057689123727,0.4202828980241352,-0.17118196115453224,1.0313038022113086,-0.1718620738482599,-1.1030806676209,0.15804586426564118,1.5164204726956156,1.6431265553927836,-0.27022425381791987,0.7570060021306088,0.08746703890708124,1.1819091247427205,0.41875294063062757,0.6028958169277533,0.050315377749907464,0.9738028349086675,5.366666666666666,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,149.0,0.4331561316057905,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO19-T1,0.7333176485095446,-0.16882889476123147,-0.16927504649338407,0.4532147165704846,-0.0098560924776101,0.42711042356454093,0.22725877729632285,-1.2610483726157853,0.32964271738818807,0.3968937995665481,0.7493181871849701,0.7037330325350566,1.0765347168338533,-0.11385630309450344,0.8150800403893719,0.888078351046651,0.17931032123407475,0.20281308133703113,0.1858320301253759,0.24738316680530792,-0.021727654318513142,-0.004913474768513314,0.19585563618882196,-0.9008469637065127,0.35335370645075936,0.7971904153330819,-1.1081225715555802,0.27137373501079304,1.2738247146005157,1.070693177835579,-1.2760926008405697,-0.6966368610499745,-0.27622635070800255,-0.1968450313789351,1.4515912934486053,-0.07208657357582791,0.8366512421935699,1.0236890102442737,1.3776741101762113,0.5051428277002994,0.566756623192913,0.35211356148721257,0.769668259193323,9.9,True,SU2CLC1,PD1,Nivolumab,LUAD,R,602.0,0.4582760516061178,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO20-T1,1.2022884617183112,1.4236068037486411,1.1831597453010576,0.550144564668823,1.1238815664042192,2.2095044240372776,0.9036791795760152,-0.06480104962923476,2.2668762460439886,2.447952917732502,1.9303798404486472,2.937847114628849,1.4477005609706068,1.1993377013699682,2.7286296782437827,0.22985753706829537,-0.0940365273022837,0.8749276569982142,0.44192130721068,0.7026155572983844,-0.7667309980522519,-1.1088152838379555,0.6079667805525731,3.0132717272936995,-1.4936258394096753,-2.068088479031602,-3.2118113890461806,-1.4899978733459753,-1.8116950636459312,0.4685382256892284,-2.138805574315013,-0.15445584235757714,-0.2235516773284108,-0.7977407751219503,1.0098980607617234,0.4937752209280455,2.1652600650775105,-0.82338946376629,1.256512505066284,0.7150092822885411,0.7269165499302975,1.2484117020324397,1.0072686168202092,9.1,True,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.42269658838715474,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO2-T1,-0.14455214849685089,-0.194217049445467,-0.5050380108057412,0.3236961920931003,-0.20098827360803223,0.37445468572150203,-0.2211988175939501,0.6122403947670892,0.6980079218459189,0.4869296538503024,0.9526671781754398,-0.3234407462777897,-0.4657183934789421,-0.7452853521658732,-0.46687797866922937,-0.2665032062278609,-1.5132968435649417,0.14964717498511004,-0.25292977407570466,0.02873363685966801,-0.8610953819882893,-1.6915156939614147,-0.1250474911514284,2.086028064200242,-0.11374541651893771,-0.6706061595683906,-0.301050711729007,-0.5523055858678181,0.3681104116763791,-0.6560754562711115,-1.1892134693608074,-0.9301104079774712,-0.14359309317808522,0.3947866654559826,0.8887957045765719,-1.4460934110997397,1.0302799382469243,-1.047383837576635,-1.1669055146968752,-0.024600753703434838,-0.2839670880517889,-0.16152658643998286,0.9704777995483076,4.1,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.5021524454697719,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO3-T1,-0.4576837127127062,-1.3039903823125008,-0.6898838899827592,-0.4242822251677211,-1.7444571318264168,-0.9068447607834699,-2.3390530767963806,-1.1881514073655637,-1.2145416722515363,-0.2992988518120309,-1.8932544516656116,-0.9878004627026596,-0.8650787823196882,-0.18214843789502944,-0.6306814673212959,-1.3575816380823829,-0.07835052898721154,-2.115294433477874,-1.8599399475202663,-2.1754707486614158,-1.3534631558029862,-1.0545968727251205,-1.1688519707076817,-1.1810328671664914,-0.5465841105980392,-1.1366983015299739,-2.2816490273035357,-1.5556737340070521,-1.533730275833727,0.5707434591161883,-0.706969243957475,0.48774731241471864,-0.18284562679776292,1.9470290293440322,1.7813514174348652,-1.2638160687896083,-0.7523335142175365,-1.5093033657930448,-1.638395159824646,2.2041273226866402,-1.1716407468533856,2.7537440123377914,1.251195111703324,21.2,True,SU2CLC1,PD1,Nivolumab,LUAD,R,84.0,0.5599364455843001,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO52-T1,0.22499301241744318,-0.728215992314814,-0.8739143900231422,-0.8791646238110522,0.5911331879326851,0.01820892651982973,0.2901493532111076,0.19916243520957866,0.8334963448985954,0.40037974343676835,0.1989687462745428,-1.898755089833506,-0.1262101918544073,0.37343319572143724,0.7543617035271426,-0.068359086419396,1.8945688788752966,0.3940285390697283,0.5112282311206018,0.7878954704522716,0.6141609239415591,1.5997871265756654,0.15554857194234945,0.6984176013772405,0.99132254898095,0.6046171406614694,-0.8475658514009441,0.27242177695151937,2.9151171345573768,0.8561931746683304,1.2283950773892556,2.240671190083926,-0.402794789447277,1.1440957445991888,2.7135898097023436,-0.658739008374652,-0.8297693586772626,0.4195010605625554,0.17647165736588083,-1.7212965387338521,0.35351661589654965,-2.770571079077465,-1.0710104349593417,30.366666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.4265353951000365,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO5-T1,1.5948087258642785,0.10870245211891791,0.7361141291644023,0.38072642497846093,0.5052406136297097,0.5948696943741923,0.394352089933543,-0.33655011330462287,0.9840937803427857,1.0514804013504773,0.5369356620900289,0.009338930061238947,0.8271499847770757,-0.02602745247219169,0.6941382816953293,0.18949373640636238,0.23323632774691197,0.7731928795964291,-0.5943460730827961,0.03212464109991871,-0.5491627794601719,-0.932812028411884,-0.14873381818240453,0.4034723700062195,-0.3535476923552851,-0.009433009966487355,-1.6881581892520807,0.11871450242957428,0.19282467719093394,1.4157455821341407,0.1246969251762187,0.8895590197947153,-0.30839398962241316,0.1777864279092617,0.1801655139730389,-0.27281119452228914,1.1343322075104254,0.7097874365881807,0.06836365187764964,0.11601774717009906,0.9067609388899859,-0.5382334363892871,0.7836124400349407,18.23333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,R,623.0,0.4703284003055598,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO9-T1,-0.6540445026944683,-0.913394043540736,-0.582763614641874,-0.5719242553590104,-0.7218415953599403,-0.4421187156732029,-0.8218940326714982,-1.2883071555985859,-0.282005676264016,-0.4198895111536585,0.14415753843012158,-0.9206806777769416,-0.31551829492051253,-0.698356000542223,-0.35461137697772566,-0.22474912547178894,-1.0137303523096723,0.3637427480897467,0.1355155093497222,0.5887491808158473,1.8198324693566277,1.7992816083028014,0.18360787627825428,-0.33412422344263376,0.908357212041353,1.677935822765349,-0.6200364169212828,1.7241947675890983,0.5423460191867007,1.6871300846971111,1.5813518705690373,-0.554341808527338,0.2599711614880094,0.46820102985328166,0.4543790686029596,-0.85197678227948,-0.5130064544596714,1.468270902769161,0.33255936618436016,-1.7950110520914082,-0.21853322729355193,-1.4394749045725055,0.31587309602001223,13.466666666666669,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,296.0,0.527833981139302,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1008-T1,3.386826235139283,2.127865596052627,3.6727587437427833,1.599206388536194,1.8542897491613182,1.2945017973593835,0.5547507596615062,1.7145397060037681,1.5005922561626082,1.6487739507371744,0.4938239710699974,-0.15313334895897032,1.9233088069916853,1.4769780398818138,1.7595677114695485,0.5357436418567176,1.3413429595164958,-0.837150771236628,0.5081967583652653,0.2303378507531874,0.46944531642813436,-0.10543363078627013,2.920807007469606,1.0981823913644335,-0.4680216496411635,-2.21276686770329,-1.8674688914174515,-1.7649523319557,-1.3059189036428944,1.2245418888279798,-1.8178871286487517,0.3968645205345314,-0.14957175428386812,-0.06720908467593911,2.272173819036264,0.23682287223137377,1.102737712174033,-0.8175502805262432,0.34504236892166623,0.7545723877824596,1.2660903189910895,0.6484355145162726,0.7134281611924554,7.9,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.5050028368056703,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1017-T1,1.3384815222446076,0.9240858720127086,0.8244479850620587,0.6751720975428418,-0.053695161931939905,-0.04090685612604771,0.2790422927804892,-0.3204721466170338,0.15927757765595163,0.4260404015841694,-0.7012632363763303,0.1355298814893413,0.8273053776154056,0.5763098182781782,0.12396181241746847,-0.169878784422863,-0.9158150922078933,0.402349785666758,-0.347357352414515,0.019098437838925748,0.5451287552083528,0.15151734246686632,0.6484914936530118,-0.8398800863001585,-1.3674070198909376,-3.123905666099523,-2.49553183387145,-3.209998669975243,-1.7957206965661192,1.4869371914134273,-1.6241675664409407,0.012744168870123298,1.391646562205136,0.09140083140998771,1.774104952641031,-0.28926123503781725,0.16502668452976105,-1.0493805059147059,-0.155858416710733,1.5739352532254798,0.10822643861346086,1.4430702444625245,1.1894576338969283,7.5,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,,0.4620826815525021,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1020-T1,0.45014946371070014,1.3645632938646555,-0.4926236607478552,1.2327564157247224,0.8613951072844314,0.6683543665531964,1.4384872220882514,0.05805394192591512,1.2497004342520106,0.8784385271734788,0.21683008946390697,0.11118290783811557,-0.5505443794565298,-0.07518117857904864,1.2010730167195183,0.8501489821150557,-0.23172412348734908,1.2069232150716278,1.220727212208778,0.7363824794048582,0.5317029707353574,-0.06097255780593723,0.11296443245078672,0.06524692215029251,0.2477678714100647,1.0652569736143713,0.7965067419058652,0.8104172501604797,0.6032183478649029,1.9972538793402341,-0.1498457488991274,1.5362642325170164,-0.14010521450888713,0.4401015554563873,1.532093966731777,-0.8114720180733891,1.0676728878631447,0.9585176233243252,0.6561939462121469,-0.8314140830851262,0.7175805140529996,-1.712862336372614,0.06392701418998954,12.133333333333333,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.4999448067632224,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1021-T1,-0.7883488112640761,0.03496264035691379,-0.4496870490820048,-0.28493092840758744,-0.07077122988808576,0.5857031350154034,-0.2195251867540052,-0.8791100165675755,0.4858355847192661,0.6889068672877381,0.24211724768117152,0.5533210281221445,0.9095636378685564,0.16874013268517093,0.9687403970638915,0.6740097905210913,-0.6833609401282268,1.3801035199234135,1.0870727899290011,1.6533915739994323,0.9465173837087779,-0.2766926186426016,0.6889204652715786,-0.09978839480523874,1.4621028934813107,1.626393349515898,-1.22476380443829,1.922917237010621,1.3473319868732436,0.7974046529125739,1.4341777454102125,1.2778099153156945,2.507685640134494,0.14944573603820002,-0.26870699802813386,-0.518568122515557,0.8431976719822718,1.3473127778949745,0.9853205236212426,-1.1072088495551446,-0.17597261106545514,-1.0510668474355573,0.20026303672661205,6.033333333333333,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.5570852195013754,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1022-T1,-0.691101714408849,-1.2933143521315447,-0.753405731885536,-0.1796340459433045,-0.4487590300961254,-0.4807929490798499,0.0869635287941992,-1.507359372998738,-0.3167818356339522,-0.3812919615657106,0.4673798902990785,-1.2361222636863125,0.118651438690124,-0.7985739239650861,-0.6917250406353506,-0.2226165308648053,-0.06326745575334138,0.7927383513596087,-0.32658376166851616,0.3376142478268335,0.2922865596547669,1.2198249638489636,0.5816369790806522,0.31401607750035915,0.4200055772997239,1.7116570274674414,2.224396923802257,2.1450814167797754,2.4532222064069003,1.0068388017355585,0.04658158532443691,-0.04562158244231487,-0.15524072702268701,0.7972176635843446,1.3695085663967492,-1.1306478983540944,-0.7250409044184222,1.5756453663529968,0.5317129569735863,-2.1481207757330636,-0.6676832760725452,-1.7273484247960007,0.064993715907234,2.6,True,SU2CLC1,PD1 + other,Pembrolizumab + Carboplatin + Pemetrexed,LUAD,NR,,0.5223787555062259,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1023-T1,2.3006551726570885,1.4496761282949668,1.3245376368355017,1.540492181751382,1.010947991185456,1.7584624278903251,0.45477355316392826,-0.29309191034921817,1.8738567228382546,1.8106512519065439,0.9496621550927347,0.7448529631992111,1.720041540544804,1.070946020946634,1.2163550758819115,1.1302952533556418,1.2124904860141796,0.8593613734910194,-0.5288832279213388,1.2096568093945739,0.19240812690176418,-0.23993415913507127,-0.5962686590598277,-0.4430765332058721,0.384504268711379,1.4196869883015417,0.8458525672110095,1.3620632598100881,2.127675202058647,0.7941997955016793,0.4756200349345384,0.659246173676776,-0.40398789690806125,-0.28499154884941885,2.1235387322383823,-0.3514736840673258,1.5621390437244647,1.3928950503366857,1.0578305544324462,-0.5060071368847517,2.0733325974956798,-0.3314932207541002,0.8329316154957199,6.566666666666666,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.2351032498384041,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1026-T1,-0.710122152863908,-0.548174978594178,-1.0055877502072885,0.11703126852239798,-0.4191872433126428,-0.13840270796162094,-0.10102208816301973,-1.1378890073580479,-0.21469833278832373,-0.20808878725647506,0.5663572433846165,-0.29984316006665074,1.3347862329089266,-0.5432458729694145,0.4635176133743925,0.1675708640436441,-0.7629983979175868,1.415391237910556,1.3868245852610304,1.4754086519829153,1.955023430292115,1.6056484529914872,0.28099628010485384,1.855595885705973,0.25003943621839825,0.5195023296284186,-0.3732282160672115,0.8220679233973843,0.6873867611564534,1.1531566983612143,-0.6042617253494995,-0.4334627857680699,0.49898947174098585,1.3422864684257714,2.330633207371012,-0.6862386972434603,-0.20172248189897443,0.6931673755446217,0.837147134033724,-1.105516334960068,-0.35305783774158617,-1.1959864833916973,0.7634145615738395,9.5,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.5406612259069754,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1029-T1,0.29819673985271705,1.6185339191544759,-0.1810979528254233,0.752609477605127,0.25949708468731114,1.0679680474293585,0.023177292766467208,-0.6902774332804276,1.1473117417730017,1.4419248373861349,1.2770035936785997,1.7257350769220738,1.3006738970931537,0.8736142120497893,0.9735435227732366,1.0207057979992011,-0.36566291098558174,1.5075368674582723,0.10434000827190537,1.0213581414142874,0.7617010054270231,0.15221111211498622,0.5226022716443129,0.3333290990208607,0.41884931786569357,0.6986086570611773,-0.4196217923342963,0.24822922487947466,0.5068452459403956,0.8042369749786862,0.09622631364095315,0.7492826933281619,-0.39661349501153703,1.2748304587559878,1.751360544581453,-0.01251378881049884,1.4710510178594918,0.44275151412902386,1.5076856697775447,1.3363577383435357,0.7729946149956883,1.3435820546603732,1.0596296948364086,17.0,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,398.0,0.3270365029833425,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1031-T1,2.487319171963376,1.934877735923838,1.9668880375070221,1.5666814883634839,2.0910506274007945,0.9361225888602376,1.4579262450212431,1.654498568324929,1.3397000623955853,0.694744538236017,1.3834896724178107,1.4143702971400034,2.6567493504603354,1.2457727539607297,1.7690982365638916,2.104013871244889,0.5791317464651444,1.7543380282938996,1.2747452696840487,1.6804340162857103,1.1587632492171631,1.187414058689417,0.9111770046386778,0.9356346240154505,0.8840071164388089,0.763580160672311,-1.1509825516971381,-0.05921167802414244,0.6847707652223529,0.8437027082001198,-0.07912852848811207,0.807467492110081,0.5540202644858623,0.09902642852934794,1.5549479369204116,-0.19246226262514918,1.2792047186013142,0.5956719256271887,2.0982621408345365,0.11087187987758734,1.5732497236512342,-0.9265524021588089,0.6321013086024441,6.333333333333333,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,240.0,0.3140041324654409,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1032-T1,-0.26251404589816296,1.7445110451750658,-0.8199037831544453,0.10368794004390616,-0.939401152224141,-0.6123283294367418,-1.0713599539869483,-0.8726253384276607,-0.9173959583233106,-0.38547690289889774,-0.9557893774749373,-0.40545671343287193,-0.229875889795068,-0.808942547121706,-0.8518351793672614,-1.1086092636766383,-0.582149558854502,-0.46697857718320435,-0.789027533014576,-0.3889988599644449,-0.41297252539640744,0.05487361008507811,0.3846727241370243,0.0012005800179760683,1.0499497236930948,1.0253014037668196,-1.2537435501164351,0.7280089022063988,0.10526828696244783,1.1547063754004265,-0.671525884859026,-1.1069029777172006,0.007311529144277754,-0.3732273060803226,1.8669726751609224,-0.889874832478285,-0.8537991173868552,0.7327256223918399,-0.5494458704653924,0.15190914363834523,-1.1230750232215339,0.47328887202001013,0.6498896392013777,12.933333333333334,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.582626666987381,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1033-T1,0.37287541104960614,-0.10386649751544216,-0.788702052301146,0.3188725075193681,-0.15896167452550616,0.09033269078668399,0.8298912691384527,-1.065814352313595,0.3360170875295769,0.2976802035846968,-0.2832746073335086,-0.6064510273527366,0.8608050209007257,-0.7810192178401624,0.5384755133492436,0.8509651647989316,-0.08588481088286516,0.6517209557810523,0.2843746199065717,0.7872852545501765,1.3641866314527908,2.250873679044374,-0.20061042810079885,-1.1139093684007346,1.4058397067090929,0.8988709122025728,0.08056835888051311,0.8267015696160314,1.4681083695895252,0.8868773867376093,0.781279338254355,0.661332548604976,0.4586934436299439,1.160450324828113,2.697230572857541,-0.884129685624942,0.16924921916430513,0.48435713455527496,0.44629309779922666,-1.781370285385356,0.750666270193411,-1.8474938384744652,0.8611790696218794,11.233333333333333,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,NR,175.0,0.3613172809070043,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1034-T1,-0.7563751687259289,-0.22199822194561958,-0.8584660606484608,-0.2874949754976304,-0.9677998710632653,-0.5134946763258544,-1.934190994993088,-2.0872596498730496,-0.6394524836906859,-0.470269479306205,-0.6811975814898541,-0.3833672601412204,0.4292449047846113,-0.5616451087036395,-0.08549798881301814,-0.08648892612923632,-0.4118009320196219,0.5141000809374653,0.015132685968202268,-0.024143027129731865,0.5016657388085556,-0.05309801101518083,0.36789168119787846,0.6327896478775115,-0.5169544543189297,-0.23059170830892353,-0.8212751323034106,-0.8590106180694972,-0.29169639466821085,1.1874217581294888,-1.4514927054481819,-1.1119937929869825,1.2200813227618614,-0.708071281143582,1.304872229769383,-0.9510844713816777,-0.5853123296427019,-0.19724601896762006,-0.0035942482063528168,1.4307901808946728,-1.2816426747897662,0.6161100511907017,1.3097242747053646,7.733333333333333,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,769.0,0.5345440280925372,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1035-T1,1.6604523997481482,0.6533585542346712,1.0023086328177784,0.550043680849436,1.280547727082078,0.7992802924547263,1.2816828604556352,1.1229870000109783,1.944634139575902,1.2507768324824144,-0.10994984532863422,-0.24513197184057123,0.5289042032545059,0.9536774574708528,1.4109012358444384,1.0691868430947677,1.275276575791613,-0.5181138131189587,0.17930177230847452,0.08853758563563212,-0.9052652733941897,-0.7562829966193354,0.8052187201664166,0.19680150842731103,1.4742409453159935,0.6810318438374859,-0.05084676302404636,0.9464232818855788,2.9922033298555646,0.14787001118411333,1.9207432292903135,1.450267631326904,-0.22144216751603432,0.38051387808811593,0.18105008217146118,-0.8315332423890388,0.7809261681790038,0.6436789336637617,0.24646904431020303,-0.7952093999405755,1.9726002442400985,-0.9192417231002042,0.06560569237213162,12.233333333333333,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,NR,74.0,0.3089269633557118,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1036-T1,0.08404003813956704,-0.39176500000679776,-0.6967391329848106,0.8990222947803248,-0.013971321540665573,0.7824709166159096,0.44794491571998785,-1.2619819414240037,0.7941307317968903,0.9489430688525965,0.11467192218712005,0.17129361974160418,0.9057322673758766,-0.17697256172730613,0.40333019911000123,1.1945092514264002,-0.9758700467847846,1.2430409778095777,0.22312370525054243,0.7783963333707475,0.843648599936761,1.408089450774572,0.10393469872004389,1.1050282058334155,0.7910816747807086,0.6294773785474633,0.558945626816769,0.7562226233199931,1.95424940038009,1.336841430400875,0.22073574935373902,0.157438837628821,-0.47814112305578726,0.6096864576711712,1.8440436727257892,-0.29419507664183786,1.2449806158594587,1.0869653957867673,1.0170324368250627,-0.8048321355388212,1.0599003907838924,-0.6421921544320429,0.7089856222260545,12.8,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,,0.41260686720589507,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1037-T1,2.1881884325307266,1.094623676824054,1.8823290674053472,1.4891384843787772,1.770141839018957,1.8029354568453633,1.0072008633140712,0.9299559918065169,2.1236094457376167,1.6629507287232774,1.1893721270255118,1.940507011327606,2.168715446048897,1.2359528956571741,2.2927700730322798,1.1753727878090086,-0.13483743752872235,0.4905993915358891,0.07906654289819495,0.7582669058555469,-0.568944039060549,-0.8403852365883856,0.4808402651969268,-0.273044838361466,0.3385650103090978,0.20099803308299702,-1.5594253629465777,0.2730142371091861,0.8491728551302016,0.688516677383013,-1.0673768925277172,0.4272949950571563,-0.3640152335566155,0.45549444138150713,-0.22751930842762255,-0.13184326537764596,2.081058965355643,0.4153682745945419,1.326718298706014,0.9986735213496822,2.2055134421871636,0.554009682133295,1.2853581324862813,15.933333333333334,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,257.0,0.3288943104333913,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1038-T1,0.2722226419232113,-0.8996704635438134,0.00902151151394763,0.2751657105553451,0.48643202164512994,0.44068842758303717,0.9127321687788337,0.010236947639689561,0.9215295753096914,1.1306058844963787,0.8210100963366378,-0.20112410645530396,0.5934375083743224,-0.16681279583882858,1.3338660436465875,0.7359180703521175,-1.171139889457575,0.9934496987100473,0.6456058116274729,0.807631284499872,1.2135097031759312,2.0720655532961563,0.9792058686051093,0.7090078433444932,0.2382429389820902,-0.16739657445928477,0.14042555847525667,0.44076563353992193,2.863704238559291,0.6956401110787452,-0.2480887419491519,1.6667360507336395,-0.36880330422376706,1.1354620565473965,2.6230991997618958,-1.0168302096240993,0.4648737266216088,0.3064946509104723,0.2943748034261064,-2.1493180292311007,0.4235142722288486,-2.074446040486732,-0.19104552463011232,16.433333333333334,True,SU2CLC1,PD-L1 + CTLA4,Durvalumab + Tremelimumab,LUAD,NR,,0.43819978170309776,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1041-T1,-0.47108485920017473,-1.0276174259478745,-0.536356765175763,-0.09429105991360803,0.21148686445577414,-0.683721364487391,0.4251409276826282,-1.2944045077249695,0.005990228635912601,-0.20394719206834455,-1.172273115250949,-0.7172687191717351,0.001614464850837737,-1.1823061910052588,0.34368522579261823,-0.3917872633824327,-1.0838423798638788,-0.3303894941007923,-1.0314762651666851,-0.7180901440016076,1.0192378267863529,0.9835852373252051,1.037572161017537,-0.8203382608177734,0.8238105938252881,-0.3098228029862066,-0.18621596529499845,-0.10045828128588169,0.5692388453201521,2.1711594964402146,-0.48220427688346473,0.09661029815457915,0.39559644582792325,0.10246717187710332,2.7293111716884284,-0.7702212450460312,-0.05490859735916231,-0.1888197852597453,-0.21249139785501506,-1.3497469084252742,0.16868060974636442,-1.5668651806881133,0.13955897559765396,19.166666666666668,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.5525055151053614,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1043-T2,0.7274164128712837,1.4408928670192016,0.49071438187681404,0.4826125666498823,2.1155801729790094,1.7686161953676727,1.9313840764696717,0.6433542186626142,2.43991282069665,1.5867412544863038,1.117252218878833,2.038422443884089,3.0225326307640707,0.7837292345274077,2.028126319802264,1.886425666633023,1.6828417299188037,1.2949963198974526,0.6047091021755263,1.7009561615177238,0.9279850286220706,1.5122417838873132,1.264074675308446,0.6660008926540233,1.0817505652516652,1.0279257856638395,0.17096604148846697,1.0004888097541045,1.3310409040701907,1.4085482778074752,1.5945754270449228,0.24629017991090008,0.7046973900880298,1.0807656907677565,1.6409824826748312,-0.2596007969058915,1.6477858864680153,0.5663600799036229,1.101505796997748,-0.6647904352008143,1.5068713682565993,-1.1113998820696294,0.7731416787405744,23.366666666666667,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.1556213563228424,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1044-T1,1.000117181573867,1.2158450670438836,0.7227222746272756,1.4456855030285296,1.5168996904022405,2.707869137113654,1.6522878236910332,-0.036346207163579745,2.688031770792274,2.628483656195326,1.837843495729233,2.8664271421313323,2.7002735893681287,2.4976399575770416,2.7450792864917886,1.796720923090548,0.3320110830374907,1.6306795477407494,1.643816176225123,1.9860036825612946,0.46956109121369916,-0.37309090917895466,-0.490851478012558,-0.35585170129234867,-0.45185116097203565,0.80983855830427,-1.0447043755060874,0.886688014168013,0.6632481133034192,0.4282240805888225,0.19602790690431585,-0.06031022316835137,-0.3247977666767458,-0.3485981817791978,-0.19937784639656514,0.3513290903714289,2.6566418838092605,0.3124256219943597,1.9834521531821976,0.93936266160302,1.6279780765822078,0.9295513966827835,1.3520238922051389,4.6,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.19648752639952738,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1001-T1,0.987367458318689,-0.01097443779504782,-0.15391465295319684,0.5518322946574677,0.7399795871519202,0.6518398842958832,1.1054648413450578,0.2129887542951677,1.082794194830541,0.9428113040212178,1.4767838109724045,-0.13803247215689396,0.8580722185457819,0.18389675352403373,0.8591832884486569,1.2464164906142274,-0.22426761602114284,1.6879734618060558,1.5024861030963992,1.6193998256358237,1.7096110986717452,1.8531075181732102,0.8349524810066181,0.5579007162265409,1.8012802404662462,1.4158428426103988,1.3801738530058092,1.5933248755403449,2.2012480570134234,1.0452610519135377,1.4652396838348367,1.5301493730509808,-0.07810996912105417,2.2162441701416835,2.4775258467494874,-1.1261123577006125,0.8047612797445644,1.277619229471865,1.6008697177030071,-1.3895311044922056,1.560090734464392,-1.7464168442142696,0.796894826439716,7.866666666666666,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.3524577671037643,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1002-T1,-0.7426773020987522,-0.16479359082933212,-0.6287855585553285,-0.15363482940707748,-0.3438880781921556,0.2024228895347695,0.33778709178426275,-0.6659739993439758,0.20414124946576395,0.2128138977940883,0.683659897226007,-0.569782392955246,0.589057748059678,-1.2495784853185654,0.6316433144236144,0.14159456360218117,-0.8409145070765027,0.5490838826530132,0.4555813252396047,-0.0452456493162816,-0.626946830979409,0.01704836640361448,0.2541336494568729,0.010333380150268539,0.444073320082461,0.19453407043704998,1.587352054270259,0.021650223199347673,2.661842215136816,1.1932569945738267,0.4073832982514814,1.8544191362531928,0.09024203549276592,1.5843484282290854,3.305333559590302,-1.335037781359902,0.16230452256292013,0.688612838141715,0.019807017688418627,-0.6141689520570588,0.4364722998258594,-0.7617313148370027,0.5308356476895328,36.93333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,76.0,0.4982947332826901,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1004-T1,-0.27374902684105024,-0.06409786307663985,-0.36885985932790244,-0.3196553053362658,0.08865002527431705,0.5497505690223177,0.5349963399642498,-0.49159314112245234,0.4219084978948799,0.7471748347572396,0.200698822404822,-0.2579836844758586,0.6105433550582254,-0.006308901050132513,0.7565286435817585,0.4836211632538903,-0.11925729237687668,1.298368183656006,1.1630716771362126,0.9709892442211531,0.9345970044276827,1.4068735815410287,0.6613318522970901,-0.810051859265324,0.671970562632202,0.4606277705249996,0.4729160525748934,0.5087441793987754,1.6975459968791264,0.9539844652889239,1.097686160481792,1.1289529814067976,-0.2950796440714596,0.6122477422211942,2.486767399989333,-0.855645907923941,0.5232555694864051,0.7688497053513798,0.5614848527790582,0.25797737035848345,1.1985216329285824,-0.16920112945518223,1.3246858446460288,12.1,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,155.0,0.32351432086054166,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1007-T1,-0.7931722668113275,-1.3101815033845257,-0.7753389199985693,-0.2419548876562596,-1.0049572983247834,-0.3214350270045259,-0.8293807579906998,-1.8422536462872845,-0.4916925629914123,-0.5929464760035176,-0.46434638560683017,-0.8079686800251406,-0.32618266114347017,-0.9699875487250217,-0.46688146284340165,0.4686508515214998,-0.6942170852620698,1.0999688478536631,0.16699896805560782,0.5927789489002621,0.11651973398138377,-0.05375571386285562,0.2724939970799019,0.5492727985956862,1.261176064683494,1.545222257173662,1.3545493973660674,1.58558595374527,2.1677529072968564,1.043547968713145,1.094731878538691,1.5518722316362943,-0.06976787949523437,1.2331227991967681,1.435173954759852,-1.3515285975899238,-0.08844952365246649,1.4341660292112304,0.47512701310741906,0.47605729676666514,-0.16200002492475293,0.5359357219555249,1.1453441840005623,0.4,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,104.0,0.5684454603378688,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1013-T1,-1.0984793820378762,-1.0461428216826771,-0.7813226524537575,-0.3178792935293359,-0.5959888772016018,-0.04562405929127582,-0.25505552898902834,-0.6490699549345461,-0.26651986193556676,0.07770953822491952,1.0889204088846915,-0.4399605531971007,0.37449873572658626,-0.778207036707604,0.5101200858494976,0.4373936005417994,-0.18846050492608762,-0.5368684834029628,1.9182317842177439,0.10991311355778965,0.6490343059037362,1.4405895609380301,0.4888172667541499,2.5901234891208103,-0.7977662741647997,-0.4310074453224244,-2.0657375773228455,-0.35072647537974183,-0.34351876082317717,1.536939499099715,-1.1425010591464142,-1.28302657172001,0.3446513449987588,1.6151096798819315,-0.36493349194607744,-0.004942229155267345,0.14509277519579833,0.4426967927084175,0.7982655382340846,-0.7646301371231288,-0.7877827907922194,-0.5131961700473341,0.3673405774757174,1.0666666666666669,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,134.0,0.6523265992513814,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1015-T2,0.23584372558205005,-0.46641972430335304,-0.4036598970820263,0.6770491903316382,0.26679141176981414,0.5396217859234288,0.5685841742804146,-0.46265003087569506,0.8023716702836814,0.9119691598880064,0.7950267339355764,-0.5666033756405037,0.5561220544057366,-0.5358359426163919,0.3216647264955803,1.1917447290460896,-0.0497676632543278,1.884685928399977,1.1171971032163501,1.3866391343005224,1.8663574867691912,2.881416215553913,0.577297120141363,0.07379278639921377,0.6270115389607667,0.7252175936486913,1.499538935186953,1.0990641392417142,2.032341769009731,1.0177926729882887,1.795320604627787,2.4980474486542366,-0.08956104461582587,1.5749322583992889,2.870117978963532,-0.6100426602750523,0.4968438032529007,0.9599610045075991,0.9310798539284131,-2.00214423443925,1.0935050497215832,-2.052435972252279,0.5526144240049764,6.433333333333334,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.3249720676650778,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1017-T2,-0.004764443051401086,-0.3610936896037901,-0.2528924353951381,0.6377877896416094,-0.8733632621969243,-0.33293218649021533,-0.7272177305246431,-2.185693958245276,-0.5144599189586996,-0.4564504711075854,-0.09072835973849937,-0.1029532763203126,-0.36907660453579616,-0.4991596267647319,-0.5815620984334028,-0.33994139883749,-0.48190417762180027,0.5312869834988175,0.2616496514913144,0.592224449353986,-0.24814716145509652,-0.3661504974454564,0.3822130065364946,-0.046806908120269324,-2.0789425959219314,-1.1957459318646069,-1.8681714832342686,-1.2324164160195514,-0.7287779741298156,1.3241726576737913,0.040454615207411275,-1.53791622403793,1.0765236521460926,1.1850696195155677,-0.4292997174485759,-0.5023369959091604,0.08291130060427224,-0.11974160454435276,0.041423239675912674,1.3392960031373107,-0.3702422198612063,1.4660113355284596,1.2872199704442289,24.7,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.43845026235772283,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1018-T1,-0.8792780221641991,-1.3593223595739152,-0.8439542905807778,-0.24660415226611934,-1.2399785597373982,-1.043652480489642,-1.5069818704193507,-1.475934484724606,-0.8821013717589451,-1.1025739711411726,-0.44086714748345884,-0.7220360451819317,-0.3386098115483355,-1.2845084005045633,-0.4367497779894581,-1.2082487783615936,0.4084855525285019,0.24861669519249946,-0.1698718564387091,0.11085807488433388,-0.4860927650043139,-0.8986331630808979,1.0986111604190216,0.7044257685385903,-1.0439812244488489,0.8418294979260741,-0.7488648856580696,0.9408770986420395,0.42021128951930276,1.3276727349984572,-0.5792973227327184,0.6898316535667413,-0.47181085793008154,1.8424088159025032,2.48498866012649,-1.3220899820705811,-0.9992939510773222,1.1162820416952586,-0.2795860886086544,0.3500692949300253,-1.38659792981335,0.15640615261265522,0.8298428407879401,3.2,True,SU2CLC1,PD1 + KIR,Nivolumab + Lirilumab,LUAD,NR,126.0,0.6373868636513884,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1019-T1,-0.47336087417231887,-0.15445049576324482,-0.2447538786940729,-0.29710503894801293,0.3021561529325447,0.20760457695742607,0.6279122244945576,-0.5778682526123702,0.6169792322485442,0.8836066952302785,0.5652427902205145,-0.5487815725839467,0.45489575482029354,-0.8486402994901923,0.8459537086465533,0.7536851055625522,-0.05313964885948441,0.9090613454626785,0.964446358187016,0.80740154968268,1.3320625226888256,2.237430831775697,0.5661827598960842,0.0447151673396419,1.165459993154839,0.1239831111905068,0.5051909129398976,0.14973180793240634,1.9736488751878989,0.6426239317836948,0.465212333873256,1.7946882516489189,-0.12551458640570548,1.1465928919867363,3.00497523046198,-1.0231434573865694,0.3704660753200196,0.39517044756910236,0.4427134560333546,-2.317761513676482,0.4092684817477595,-2.089755633416196,-0.00028801722173784456,9.933333333333334,True,SU2CLC1,PD1 + KIR,Nivolumab + Lirilumab,LUAD,NR,,0.4267779950862613,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1020-T1,0.9392499124500642,1.2623904555954693,0.001229690735447432,1.7797616858324992,0.4329492061047087,1.3715431905573507,0.44785511274482603,-0.4293389668188814,1.4067455453959132,1.2591148364923281,1.5631888412061479,1.3735702927758981,1.3333121298044486,0.662784780020966,0.843547395544628,1.3219216300494046,0.6083421852700682,1.5920705633135335,1.1288584567511002,0.9702443144586064,0.9995389847543994,0.6917213424824659,0.7734583647425622,0.17414496676448785,-1.3985586272045587,0.6051839171151887,1.1722466506350502,1.5339116795060168,1.5590744788216582,0.9373228332777939,0.02406137473195002,1.1104296250574177,-0.7356560884802987,1.5723853463784965,2.892995778008266,0.17178736032587272,1.2635840163022969,0.8356768026740841,0.9250058300382143,-0.8076773950252845,0.6855077414109385,0.12045446015546135,0.17141782199138175,38.73333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,R,120.0,0.30011544365851683,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1534-T1,-0.8628525522570532,-0.4380001930563032,0.024664427156190827,-0.1958976479783941,-0.7176282572621641,0.42331081535493015,-0.7907861149799655,-1.9163461906379626,0.09658505065464734,0.1844916204018077,0.6343413791143694,0.06722899293220592,0.09383099945164519,0.010343033473935209,-0.15163199096017838,0.2506447487041793,0.1738739960485629,1.2421694875255396,0.24570184283223487,1.6015906398457775,0.7595553751952183,-0.4414438350754282,0.3293279977023251,1.7816318471330252,1.7992213842551195,1.6991240354265171,1.9830994337842354,1.6327833561856007,2.890316437340532,-0.2881255563187122,1.8065688908639932,1.310674460989854,0.3172580966417311,0.4625170772968326,-0.44820080258162914,-0.3911483717342892,-0.060354538400912726,1.586882520800422,-0.34269775332060876,-0.1520611462748363,-0.21356845289291235,0.016342988804767367,0.4999775924653952,0.3333333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.4892841255907795,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1536-T1,0.4526941558083356,0.5214684536138382,-0.3876747598749746,1.1376259439237701,0.2668423442965916,0.6339423649848991,0.35931187413922666,-0.5708732990664689,0.8095109569236957,0.775834639909563,0.6253724986638722,0.6836945729979881,1.1361679304013548,0.35037436421735857,0.9801220951555005,0.2883907673828059,-0.4956163164083913,0.6889102710574796,0.7836840190767134,0.7983196689503002,1.5098390847215448,1.1861766922165087,0.31718198954305593,0.7976325778959777,-0.008092626346371156,1.3273765696623374,-0.004420490956204018,1.9620615375003134,0.9735359499289529,0.9984093492427343,-0.85781007643004,-0.8038360273558601,-0.32740116514666673,0.18035438601877313,1.4144161126320705,-0.6687936070577872,1.1377591862630136,0.8926894883156394,1.4194980469261975,-0.9318345029094276,0.4920358903527942,-0.9113143623457599,0.4047256251755642,13.066666666666666,True,SU2CLC1,PD1,Pembrolizumab,LUAD,R,428.0,0.4095324337503176,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1537-T1,-0.7837321803081212,-1.010434390236827,-0.7054759795681327,-0.4147102349722334,0.29393475249663104,0.1791945360808008,0.7806544361058226,-0.2810035436476488,0.4058441091185749,0.5697332031413986,0.8982054471550447,-0.39270814995994285,0.39504876857046356,-0.4675183161500269,0.5975943718489446,0.6062711292606637,-0.6714687990143531,1.1847642937184362,1.1596926049536393,0.9083422797919385,1.3058560547510196,2.0917710186758227,0.39503165842466503,0.9145937938166235,0.9336690751045443,0.3559848555199323,1.680347890697567,0.6337876763213862,2.854041773325775,0.6599658521240765,1.0010972304343686,2.142281130608104,0.7083228537686894,2.542442722222254,2.80324543204546,-1.001949837761864,0.1908281897905528,0.8690396782531773,0.7396255515410785,-2.5188399488748403,0.4529206279803736,-2.5467446737661263,0.1685464491739919,16.1,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,,0.42288814039113054,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1538-T1,-0.4714864998982514,-0.8546028460017998,-0.6271600562988312,0.49958499694933456,-0.21669916670435177,0.3649437863894468,0.19613043832690863,-0.8296444183348122,0.5633425419278448,0.7167785914031781,1.1854729642129938,-0.23986945431428952,0.05122832296501184,-0.6337852523949,0.19219988334462326,0.2660600123880109,-0.08949551331772551,1.593620057672147,1.5326114529099066,1.2650084230912304,1.396321781122924,1.4321109268656573,0.6365670657181507,-0.254964111681993,0.7153769061773221,1.4228725557034858,1.4091698192042317,1.7683427956502713,1.812902384486491,0.7956273096343149,1.703620884598586,1.5909305825050077,0.1668926626260618,2.166389616662555,2.7664275417901947,-0.8592088988800776,0.24946390740329288,1.2221819078314058,1.1164931705321952,-1.9959567305291968,0.5688689124947648,-1.8553494432870015,0.36216595437475246,2.2333333333333334,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.41997240036706857,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1539-T1,-0.47678588740450034,-0.939098476223874,-0.730729358208268,-0.457697245112517,-1.9504765191569355,-0.44374574168098174,-1.8647117410993308,-0.583257347345729,-1.1896916864420886,-0.9919369963973266,-0.8153319277632287,-1.0459915061638465,-0.817645039477849,-1.7392253408118148,-0.947401372004942,-1.4155717404199653,-0.018932588221928497,-0.5221272217114514,-0.3365792990179236,-0.3885340913431518,-0.3134725686765911,-0.5350496367209714,0.17663747820846842,1.3339096132245654,0.0023453281390664925,0.39335687885416304,-0.5529578068762874,-0.06196509340171919,0.2942420131559722,0.5887122512585155,-1.0328541813090026,-0.7400334248730054,-0.7035380606611439,-0.6743037003287242,-0.050396640186226783,-1.652465334283212,-0.7902393820346999,-0.3037107452788724,-0.9890396213609378,2.068922799460962,-0.4835523231124867,2.151058688832921,1.2819559439654933,12.866666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,409.0,0.5489494437313897,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0033-T1,0.8130798246074141,-0.36842664384345797,-0.11956717372668384,0.9703015501042924,0.4442695138384797,0.6068606451467944,0.8715190906192364,-0.4477342886719958,1.0313467606629236,0.9276832990692412,0.8224299079395575,0.3232030017402806,0.7093121939465639,-0.4722931910924345,0.6668108695408628,0.7373349977162809,0.15971574394472104,1.3021424135371602,0.10473434678873784,0.8981788502409002,0.3733577895042193,0.6812776629883999,0.06346788816349683,-0.5340945052222001,-0.48080905753388903,0.18828992424387037,0.6469953403890971,0.36323744329040064,1.3002450432199555,1.4730383804560392,-0.22603055520973994,0.8223067842478173,-0.35942752292778085,1.3092548039828509,2.6913825612005082,-0.8616950133686184,0.8812184489240065,0.6623523065625905,0.8142631242432009,-1.7602956612257263,1.0647994428645267,-1.5486477172182336,0.4162770593309331,18.666666666666668,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,188.0,0.3432616622850155,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0107-T1,-0.3918978074278008,-1.0672430777906357,-0.7751849403514521,-0.6891682568370066,-1.1730333704702727,-1.0080233548783493,-1.497383585432996,-1.8334943790811795,-0.9748747638993842,-0.8408828285987838,-0.897865150196129,-0.9763168417869358,-0.5575914666485465,-0.4206923361651929,-0.6157140194932484,-1.1148679490224171,-1.1065042524493933,-0.776083582078502,-0.04701892850043519,-0.8212612695669328,-0.4184812077409725,0.13419405051118813,0.9953018759664517,-0.3661459622308117,0.3000924257281436,1.0526788592206058,-0.7491992985569231,1.2586810845327565,0.4299772924401033,1.1868686424346255,0.9679136578258326,-0.6395606278175485,-0.25297891725223903,-0.046566298499861415,1.1660522073278008,-0.7493235351845386,-0.9119481611858752,1.0342456374008688,-0.08545853850214725,-0.1899652346718328,-0.45700763948782247,-0.4999221315252448,-0.22016776644528643,16.466666666666665,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.6318119762265689,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0108-T1,4.03730346150171,2.493042578176408,4.378802219497131,2.379679438159025,2.551601372000591,1.8164632034066488,1.4484278599975735,2.4474437720818534,2.160066746642664,1.4173689489449712,1.0938001007748905,1.8352663991987506,3.534423065419014,1.238153550274259,2.626750377723087,3.0072709052543103,3.453639555642158,0.13635617421723228,-0.47293340005509255,0.6342843754506604,0.5829486011415024,-0.218769754724507,0.8672499192947679,0.6040606788372633,0.26296412387767754,-0.46931780017328,-0.5803347033759106,-0.28253075766480307,1.5058536403481009,-0.25055931874524207,-1.2052982296691221,1.762169363530087,0.5539486232891787,-0.947222658738038,1.4524962571039304,0.156798521649388,1.298216342575518,0.21931375453732524,1.2278086152494796,-0.1207266316898969,3.5933126876841612,-0.23660724397153762,0.4199168561328611,36.266666666666666,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.1257082435621788,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0109-T1,-0.5331939510556079,-1.7898563920305746,-0.9185621276828672,-0.19324560146255504,-1.3093521520572045,-1.1257891716366908,-2.021783595175454,-0.9289806781555316,-0.8051881771009163,-1.034794250028624,-1.4814537539902302,-1.4502618110550636,-0.5619927127250957,-1.1482971056301758,-0.8070819153419023,-1.18701454011466,0.01290350754122682,-0.5527749451497854,-0.3881924376792677,-1.0361223562243922,-0.44482991570716957,-0.08733184091864407,-0.17447144263222586,1.6160266922592064,0.9992836745963518,-0.37225596469243905,-0.16595458967067442,0.1160777128236952,0.008317102583149879,1.2291318040849983,-0.9554765025175032,-0.29043080030386703,1.978223607986664,0.19167544752483817,0.8769687540505199,-1.4981163167331821,-1.017208132359305,0.30501486877489564,-0.7404440265517055,-0.8706504668407177,-0.6351595753885282,-0.6634800094831007,1.074272523144065,3.966666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,333.0,0.6369247553624244,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0112-T1,-0.363079065752137,-1.488203552928256,-0.9324003115219,0.4002780546585844,-1.6032075475911254,-0.6136835810504022,-1.9104601085510637,-2.2668213147675758,-0.5026551495959581,-0.24714164760756396,-0.01881678233262818,-0.9554744575395294,-0.7311039667409704,-1.2055765768499787,-0.5528902147751523,-1.060745510378773,-0.3078531666770062,-0.30002478207871963,-0.7464699814279077,-1.236412666278023,-0.8884930777786954,-0.059105606753442015,0.27189450401545373,2.1705647886461916,-1.6508796050796737,0.8191222018760549,0.8397881249176055,0.7348807593191656,0.3764301309623204,1.1612807435100594,-0.7467547060279978,-0.5347059612097063,-0.4927646959216463,3.192640669167941,0.6732678025215981,-1.0820782104572098,-0.7242256026440973,0.9700441187809097,-0.6034331762521918,0.8592952149622943,-0.3796241461261153,1.26840162765227,0.506636232289815,20.33333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.5995366251405436,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0241-T1,1.9718291989191736,0.8672105397435037,1.5299197542981826,0.7210053462986127,2.8218069814310307,1.772642030133299,2.9190161683515674,3.373712250302315,2.70245990826256,1.9076776242463973,1.3636464393284138,2.0136806940484715,3.5351521719402177,2.676327937203902,2.6997392460989493,1.3280270187246594,1.5491536304145073,0.9281121340011037,2.2487799358574243,2.0499114021990428,1.1581533568222053,-0.7150061731925687,-0.14592205106265135,-0.2712571053996524,-1.3851239065731409,-3.16087546113437,-2.592853138171299,-3.2242684628008624,-1.593631829266961,0.6357118135456248,-0.7196681000446582,-0.0023078043134195252,0.09757646711037282,-1.1997305277660453,1.7365824413741329,0.6078064900628704,1.0100556242590033,-1.4534644757111632,0.5388264708205248,-0.22758554325526678,1.57457511696883,0.20909995633455425,0.7505276574748813,31.23333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.22202501956225928,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0499-T1,-0.18989075126882038,0.5236196087024676,-0.17199440400054095,0.27764561576002045,-0.0021789411537919364,1.1635497349893684,-1.2599398971124043,-1.0908839101870929,0.8020817473527075,1.4248293406881392,0.6565887804506766,1.512301455875577,1.080761927508763,0.7155854651124584,0.5726357618337944,0.991300241277001,-0.17942249838611557,0.16971703571473873,1.7291336005982973,0.7472005875413392,1.1779100321440747,-0.053471569953429283,0.14749375826201644,0.6576676249169223,-1.2536519677707136,-0.5786515219336208,-0.24213896499280887,-0.2997756757520602,0.5404832797902737,0.6039045763613636,0.01228871740989019,-0.016078645093458598,3.784984380562229,-0.3566355209905262,0.8085084698548709,0.808745859257655,1.3649335040144108,0.6751544920397891,0.8948060381773065,1.2412748068156216,0.3410052876203911,1.8630079649165001,0.4363210877324093,10.033333333333331,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,123.0,0.45883051779176903,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0510-T1,-0.6901054068517722,-0.563823055526719,-0.642963349503662,-0.08582792589102023,-0.48694646426253074,0.13525244898161345,0.0999696351688006,-2.005950922197111,-0.6774033471423069,-0.6264737351469312,0.30960103877274037,0.11971014193261302,0.5342187533852707,-0.45750705974621975,0.38139697903027564,0.6998688781329593,0.8199869092893098,1.6719772346415163,3.32326942973007,2.8195719040766534,2.3197542730461085,-0.604010126654392,-0.41800589653655096,-0.4219300156973051,-1.1590749800229962,-1.899023044458171,-2.188130713461155,-2.217805411024165,-1.708644481289038,0.728857003907871,1.6621275546993681,-1.0084154290778455,0.5974126798704301,0.16622012569887695,2.108286485362358,0.24257433859310742,-0.9362957046028132,-0.937605651586519,0.15954441263604618,-0.19550905152198134,-0.8285968394329437,-0.18853623153556756,0.7854069871381617,14.966666666666669,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,150.0,0.45319465428246486,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0512-T1,0.20735553246674351,0.8424537624249978,-0.2960548884445378,0.43985097559578384,0.23163451043289596,0.5223929270300577,0.5599285296579293,-0.4501060012605924,0.8025499857741418,0.5990038952075463,1.8115348441144408,1.0752676206314338,1.4863380083164814,-0.22308145128998605,1.3409775749526074,1.326080912928778,-0.13290772829397474,1.6946997572571005,2.1177676831167727,1.5338029521812597,1.6299981194416018,1.6323001772651844,0.8382514737206764,1.1069478346109145,-0.07950880672078076,0.9627392067177641,0.18087098175348143,1.1368453108545418,0.986100982760273,1.152662404212119,0.6729762469562702,0.7768565460890425,0.3006405168584419,1.6801725844567748,2.768281511254293,-0.19957622008857195,0.5846734359760345,1.310903004032732,1.951243993757656,-0.52115984006854,0.9251367315789127,-0.521410634861928,0.8169529285526017,15.466666666666669,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.38635928231905026,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0561-T1,-0.2054559205009015,-0.034187224796815394,0.2189906204016703,0.12485696623836048,-0.08335534996433001,-0.04382284867797833,-0.3297182021023348,-1.170677129197386,-0.042672489189257395,0.5444645864138348,0.9969536335545118,-0.556119489261945,-0.24702177433443157,1.6639682688520325,0.7524101055603757,-0.23664811845449044,0.6861907305481789,0.09054704395219397,4.004924429076489,1.4606548325433208,1.6130609101100384,-0.46350968312863217,3.0515924673650745,2.8306244729004035,-2.2667479416645557,-2.977979600926908,-1.426363883548916,-2.2925505315249928,-2.0482711722417353,1.02176192064575,-2.1862645593330288,-0.3369001572494941,0.35691603179849046,-0.4474242929512299,2.0127314154992293,0.2773776562892847,-0.06254842664611684,-1.1024437293817568,0.6029251340097446,-1.356998103740746,-0.2969501145470391,-0.8822670193699179,0.01759008553129634,3.4,True,SU2CLC1,PD-L1,Atezolizumab,LUAD,NR,192.0,0.6318714550526549,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0668-T1,-0.38750120798719234,-0.7482881373425273,-0.5046082358081142,-0.03637879006077446,-0.77493048208919,0.10789204335613034,-1.8299427927889895,-0.5304731525750768,0.1808192384289469,0.5541330864968305,-1.142703398052256,-0.8279741452567467,-0.5643769636866208,1.797094090927915,0.1135493407450996,-0.9526061573370243,3.329420944893407,-1.538715778546781,2.404662677581491,0.290916675203867,0.6909150926190064,-1.1474182907484587,3.9122290171096936,4.41595200928777,-0.6807061327976934,-1.2929667256792055,-2.3168270983769426,-1.013318687791876,-0.9480313924725391,0.9147951522356652,-1.2061154231426485,-1.3651940960147413,4.228896600144025,1.692451470845319,0.5690573386562402,-0.410919091386883,-0.45310353896146893,-0.3934809306045722,-1.2742241988659997,1.6301127738544487,-0.34853859387537195,2.3869391474816277,1.2376315311752983,4.133333333333334,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,2238.0,0.5863341956282413,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0790-T1,1.9511624662805982,1.0184463982269212,2.15482944967312,0.7661831720146365,1.6224200139082148,2.275375407739595,0.41247430480745434,0.5832905945449263,1.8798921234413775,2.1791661565976264,2.603979179042476,2.4324416941652807,2.100597452772957,2.905589058106442,2.4632661061288363,2.3490937084255004,1.1996812651558373,1.7493276349761224,3.512274821782341,2.893867255951556,2.714882508019379,1.4319314455512961,3.759105923048396,4.711924181566005,-0.7691604715964344,-1.1546249287823294,-0.7504772963240539,-1.0454064102089309,-0.2885858846729346,1.2272171258923363,-0.6244795558342434,-0.17950796182382095,1.2144893452430916,-0.6056321934138743,0.9942625217084523,0.8589534495813739,2.119371041435353,-0.3098131348479442,1.3729731122458504,0.13623019979485287,1.2720858109884534,0.47612073427671336,1.0794191844059038,11.033333333333331,False,SU2CLC1,PD1,Nivolumab,LUAD,R,2949.0,0.3127023216452632,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0840-T1,1.116947619514868,0.7141811422924189,-0.030819353589020573,1.0546743704599997,0.3743389517127336,1.179368795304302,0.5460677553660664,0.5113423781370674,1.4592549458978024,1.5163336198560728,1.5430574064154576,1.1765884823105293,1.8969599294027317,0.7763453758335053,1.4452586774334202,1.1610276956774956,0.5360031712717821,1.2831517712626304,0.6718648478136389,0.8706882657950588,0.5635885604036593,0.7903225574184414,0.8364975514390102,0.16813089834647318,-0.3533411160408033,1.4173138670891077,-0.0715129469292522,1.6090666972340206,0.6931140207690235,1.1974716304294057,-0.17510788111934786,-0.29028020869152266,-0.25701326034553085,1.7532684978886035,2.508578734253291,-0.2366460050621146,1.40225456407523,1.3232718622962576,2.2188392932812366,0.035990490549450256,1.2387720178112185,0.21744303831209322,0.6777697728095984,9.033333333333331,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,526.0,0.32809015312434064,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MDA-1441-T1,-0.990048734400648,-0.515160120490993,-0.7878459157413472,-0.404816070765431,-0.2605852731011027,0.17424163268638357,-0.4249482082235681,-0.803640718954892,-0.194748549277503,-0.6046579454094068,-0.14569736833358843,0.06239944037189439,0.6204932299001812,-0.9481149477546692,0.1820746123909639,0.6278178665925344,-0.6756295925074038,1.1828148482231786,0.678251073347545,0.8285637328971218,0.7501574451768096,1.2306210033162375,0.9050540920783589,-0.1793815289897334,0.45078136525133694,1.555776493705429,-0.04301271516087395,1.9153066520848747,1.473554663390639,1.304983958257488,0.42988426123170065,0.2168137736464342,-0.5431333452760799,0.0018557346198973992,1.0057329571791425,-1.1828420511598208,0.08685750338165511,1.599622964428165,1.2618043240585304,-0.5565505103941191,0.2273042472865605,-0.7411503994647387,0.6568834586083663,7.833333333333333,True,SU2CLC1,PD1 + CD137,Nivolumab + Urelumab,LUAD,NR,,0.44738153749810877,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MDA-1442-T1,-0.24376291205251313,0.030081480429088314,-0.562643255129817,-0.35767760322969117,-0.7484875580116174,-0.7084144483892487,0.16033970179375517,-1.7435736855174921,-0.4450287264211786,-0.8088257556282152,-0.6743482467144684,0.34574920027299433,0.6621959412130105,-0.4209194989627257,0.334544131396987,-0.5247739446283181,-0.036519783161682785,0.42194770690199673,0.5066150367810117,0.5562798021616118,0.8568595533753939,-0.8709269539802587,-0.01719352739093182,-0.9404838075522717,-0.46788499387324156,-0.70644935188145,-0.2336429393458605,-0.4360094039045525,0.18907453189745246,0.9026166372415263,-0.17689361895502506,0.33017752651129567,-0.5689529773664607,0.5320037896535026,2.400814838094044,-0.41964153814750765,0.08434883085280845,0.07766796255163932,0.9151093052737431,-1.1291593031765352,-1.192617297965525,-0.8579224658309794,0.7985163390028733,16.633333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.4898896472241458,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MDA-1443-T1,0.37624386689907363,-0.8655239688899979,-0.6086590370987913,0.20229319221367456,-1.155638612673393,-0.08540247172987346,-1.688868991225314,-1.0694520695219893,-0.10461999004522037,0.004742040713356514,-0.16209257390319057,-0.8936118788620763,-0.3303421535861439,0.0834046260252447,0.17551991669749928,-0.1526276603985839,-0.7895406910556817,-0.34202047777125927,-0.4399962824659192,-0.19102220620109336,-1.1266654316025462,-1.1269684273746963,-0.35994047808609303,1.2240768815379475,-0.7519443435818448,0.7417368061853419,0.5833072737625451,0.18763929883806507,-0.08009966986342056,1.000760777446447,0.10330834549369303,-0.9409230568253002,0.18646932650244885,2.7574746937901145,0.9918173140286897,-1.4830394075418398,0.2739427456724835,0.47667670863952877,0.18213242658006867,1.2531868070321373,0.25629727434030414,0.8169859687287004,1.0463487588859997,2.2666666666666666,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.5168168786278026,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MDA-1561-T1,-0.8451955549025703,-0.8277364202603124,-0.5015602500863326,-0.17541467426510718,-0.6506533479987738,-0.2571371269919399,0.39556416655957516,-1.554873838167316,-0.3940470706043294,-0.5072944098415708,-0.1491235006420063,-0.19452851914850838,-0.2604006143784699,-1.104318982891271,-0.31449045878514514,-0.31870107543217296,-0.309208488157159,0.9507531295310637,0.24735780864226195,1.6173555183489403,0.35457306534357735,0.3475282341275056,0.0725366720930557,0.6591149134211917,1.8877520451213665,1.6448013385395825,0.9602301749629222,1.6822797436631323,2.862798947348778,0.47865653613410225,-0.10577236511028218,-0.8591985724279888,0.19316459032654293,1.1194781146471484,1.95080913499255,-1.154228230366578,-0.45493438406044456,1.4367021692189055,0.21046132591024072,-1.57940517165354,-0.785898166141095,-1.4171439965419974,0.6682775969955467,1.7,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.5489404438472731,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MDA-1562-T1,-0.8322386618549488,-0.7127117766585613,-0.6089647711621189,-0.5205652387860392,-0.7509438559795388,-0.5954472734582618,-0.6933108426503349,-1.4936294231316034,-0.2790712359533031,-0.3485075200734205,-0.7256347497941479,-0.7798867111571189,-0.8926332893434904,-0.8917307539874322,0.10523725585932565,0.05595135517691802,-0.32416733153237154,1.18903990702098,-0.08733461686840285,0.12922215735223935,-0.3043370175788697,-0.7950153105483406,0.13864826809491182,0.2080035963217642,1.949147322419279,0.22298746647736378,-1.93427769374867,0.48469135365348076,0.12207760606106835,1.1713886575882506,0.44609329453912405,-0.8340989792290623,6.815713918107487,3.4482983904516544,-0.0037922213884214223,-1.245435713975916,-0.43667905331277573,0.2911737990011091,-0.2711034759085864,-0.9613840557120976,0.6982061409254716,-0.6711656770080066,0.28379636298897454,7.833333333333333,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.6210027513278639,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MDA-1631-T1,-0.352090447292434,-1.3471810971938976,-0.6125105805562805,0.13608050636924535,-1.009564284654124,-0.8337222560528796,-1.1424816316433666,-1.9131241211632644,-0.7332926176003591,-0.6666768969724187,-0.5207468501899656,-1.060690198606983,-0.11532423659874942,-0.9502657404581524,-0.7789301687754954,-1.460778612238301,0.8030287400497712,-1.2149698577159673,-0.6481038884404325,-1.4459036447847815,-0.901469057720268,-1.2919342622926298,0.30050617256696366,-0.3657413475909957,-0.8274464525539864,-1.3516960131273388,-1.468785942341911,-1.2433564004418722,-1.1413555582609387,1.2360960607869917,-1.6018375783605812,-1.1043136615180502,0.3377985739909762,1.6565756926145223,1.0330795708897196,-1.5274646674451002,-0.3902347776093077,-1.3808811958387883,-0.6047217801880622,1.9767235085776753,-0.8742443442631125,2.127023407029393,1.6706566595568788,19.73333333333333,True,SU2CLC1,PD1,Nivolumab,LUAD,R,755.0,0.5391148430756817,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1054-T2,-0.7647804036691302,-1.005647203429643,-0.715370892690793,-0.34211491460579696,-1.2070888083038647,-0.8535934006261766,-1.2053022120427874,-2.179946214793164,-0.5393833209896554,-0.38385344928774634,-1.432742403352429,-1.07644196639208,-1.05459384717476,-1.0600663556272485,-0.7694866457810133,0.09905194395410867,-0.34904579354546894,0.12324221325797644,0.12014204006307186,-0.7048304949238143,-0.8796615940138791,-1.0766618181167344,-0.4350984873478717,-0.28860983598305484,0.0024899284964541944,-0.1781404725845534,-1.5968322510272481,-0.5921002931402507,-0.3077132683074503,1.1372058244322338,0.21677207276796767,-0.4164030224762201,-0.3272399895804489,0.9876435266568404,0.2305004625486512,-0.9254417304556098,0.06243975438741598,-0.47303313537712877,-0.8750973282761887,0.9195324247704976,-0.5799596224227198,0.46424751257165975,0.8607008805500511,34.63333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,R,1650.0,0.5870138550399737,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1135-T2,-0.26836959102705665,-0.7002078590986035,-0.4283875402654855,0.10918664057707345,-0.19126173518055994,0.2129878095341049,0.1750535407167946,-0.5328575843222562,0.06275848193636932,0.2724546334171714,0.011616855659374545,-0.5611010063491823,0.007429360418914462,-0.7320628464669438,-0.08079536480183332,0.030732263187072284,-1.1781695955412792,0.4423890006199886,0.11072402645684766,0.41630635729213533,0.06173114774809031,0.37687111553145713,0.889407510997752,2.8471887959644535,1.0489626624048942,1.1751464316695917,1.0003643008235266,0.8686689734442731,2.7095806274783443,0.7174788386314677,-0.8572647534513897,-0.8084645285701376,-0.3830516360932369,1.0058466910721837,1.2574665176214972,-0.8495144985309703,0.11013526071277834,0.7285199165918521,0.5502473129377068,-0.4729462770979714,-0.445419040082293,-0.48137639006581995,1.317018172814358,13.2,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,74.0,0.5674376031252923,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1149-T1,0.5524125771434892,-0.573795502098838,-0.16963724580222828,0.3855389465153008,0.4308509358385707,0.6654907957183537,0.5471606214236123,-0.37288791574252267,1.045175284415535,0.9479899584118734,1.493103807333664,-0.3002102321604188,0.24812030596148735,-0.25898358150728473,0.7806060535637751,0.7957098928213653,-0.4239814765864252,1.7113497603411965,1.2433844898932036,1.3146360159041597,1.7497881016897323,1.9422794808238646,0.11625322703307159,0.008777436123086905,1.0014072968148846,1.1630992955456938,1.868098590631605,1.4101017393835749,2.528837652970332,1.6956189539461026,1.5666069935090834,2.1731947179421485,-0.012780424219808293,1.9730960077653708,2.7294834524878278,-0.7801236256116207,0.6908408878457144,1.6443134578532552,1.0416683745267041,-1.3098518855232992,1.3343626089889227,-1.3993282202660617,0.8753438978562305,3.1666666666666665,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,342.0,0.38820187402174494,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1161-T2,1.4747696609671659,1.5175026169820012,0.3951861464171191,2.125170726392546,1.3331702735097462,2.260350440215027,1.511813867338458,-0.043852323211371745,2.2301052857640986,2.383531977210363,1.812290353666085,1.8532991074758205,1.9743544294294382,2.612207822955255,2.1802521049364407,1.2985984673052853,-0.30867195557285615,0.9548930942170688,1.23699120265046,1.2778317941144328,1.3975739853863052,1.0967754167588364,0.11573015409682408,-0.5310472781696168,0.5102837974440793,1.086091615205526,-0.5205705499367312,0.9192768593147329,0.6852798307457446,0.6157004895641218,-0.46986614591238485,-0.4366740278982642,-0.4388737497306653,1.0833887463202332,0.34578791059770075,0.05876542125759911,2.264863947437765,0.5657929051516503,1.7956134437067142,0.4599286608977901,1.8606977030614436,0.07129145175088966,0.8157627896514866,12.033333333333331,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,191.0,0.24158491504383628,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1163-T1,-0.9887838779396415,-1.0820484868490892,-0.5127938565772728,-0.4044168120882104,-0.33633166470649734,-0.130103668885649,0.49516741411642956,-0.820971404339815,-0.6140605985681578,-0.4604740276008992,0.18224297859664634,-0.17828322570128116,0.6557465555904272,-0.6510578423722571,-0.09533044890383936,1.1897807006518593,-0.3151191763071964,1.2626772712245224,-0.696579116683373,1.0666779669846274,-1.164961141484695,-0.23749473409527486,0.6855121467194353,1.4118752088538418,0.701832466348269,1.3997544798725414,0.5038811184949213,1.1528076695706508,1.7115666670112357,0.7109984779215176,-0.3233005540516719,-1.2702910843360053,0.12671008326700137,1.1533132022920969,0.7371556288892975,-0.8287857012437527,-0.6550337979639204,1.2457957630398329,0.5327230743670632,-0.9446498462412068,-0.4412656344529577,-0.9293022826107855,0.5266954881033534,31.2,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.5278183340367565,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1169-T1,-0.9288224257571225,-0.5868106818933932,-0.6420422640012554,-0.411722538203326,-0.6136214657634802,0.4161762663063877,-1.2634985469546272,-0.8770882708417473,-0.15394533684231465,0.3517589170636438,0.5581199251005011,0.23329416600451577,-0.007736489529172843,-0.11721582645236879,-0.18808569165639757,-0.5056871130176467,-0.030697116769508478,1.7452543526727016,0.47692016203975435,1.5325444219442017,0.31756936867206337,-0.5996080209990959,-0.26321602350742057,0.23409513547254424,0.1928477939049694,-0.90472480542267,-0.5213200792695889,-0.30869354608328037,0.5288130184305475,1.3069245011376274,-1.8397312792263283,-0.9055399033147742,-0.1978819850534664,-0.03399733451950068,0.7928583177770772,-0.9787150297927771,0.37777745254607265,0.24916008558796335,-0.3278551533267727,0.5996403499705488,-0.31886176513232994,0.44382545211184765,1.2527039955908221,25.266666666666666,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,1019.0,0.45432123909700195,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1387-T1,0.028354753722926982,1.1895036764517999,0.02043634150470866,0.02150380659302596,0.0471649398267462,0.6433688964197821,0.2042415907537726,-1.1670852702048573,0.9149736176868828,0.7543046319224519,1.305061279451903,1.011399261487854,1.2246844502244245,-0.7356725178996647,0.6790427613018813,1.0155855380698882,0.0375248156541721,1.3706106788750103,0.2131692489631502,0.9932925313293969,1.2213262747564992,1.1276593585495989,0.9727481119490583,-0.08542550518331589,-1.0805832782619236,0.050294851634236123,0.6278209420763611,0.3441009284113897,0.33831456980766506,1.005476532001686,0.31192731415347397,0.4933044932963203,0.22880080621739518,0.3863477063377359,2.7329478865001517,-0.08915316574929211,0.8489444744646402,0.3531255598091604,1.0148607466872641,0.29003456257784327,0.9198954089211309,-0.1605137994069145,1.0578085819942042,41.96666666666667,False,SU2CLC1,PD-L1,Atezolizumab,LUAD,R,261.0,0.27929183264372637,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1411-T1,-0.8530354914965653,0.27179082676395505,-0.6107390114653195,-0.360880790988214,-0.4564954944337447,0.2023647242414189,-0.0693708186025267,-0.8697921496659414,0.4105988538046145,0.27514101969370774,0.9670552056803493,-0.3398369385406062,0.0480362731179557,-0.15947467550757188,0.32873133961459167,-0.04719842736828176,-0.477387013423537,0.8414985985122335,1.6239037088552637,0.8316636449733327,0.8248725236044391,0.2993587240603649,0.20734994644653473,-0.18072164966573973,1.2826282966327294,1.6356436077872751,-0.6145281472604788,2.174183039956395,-0.12105407903049183,0.6267918473251444,1.0678922576667582,-0.2657991854423609,-0.5112309424836248,0.9372377333045153,-0.4068521698905298,-0.6519356875531066,0.3295838130340424,1.4798729956047147,1.6784631175707545,0.40111091146715827,-0.25402718278056086,0.05169405873539201,0.9883201705980731,35.1,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.5703754765724931,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1412-T1,0.4161600899266313,1.6217570478988865,-0.12908569095226705,0.4954725215107789,0.8933658263281682,1.6415606438684558,0.4859226002342612,0.01415313736920231,2.0211974200537983,1.663498475382818,1.2083762065131562,1.2641122159566942,1.983933463284475,0.3521770536946575,1.5477646468733368,1.3015075956564452,-0.6677627796640125,1.7023889332166504,0.633240377696856,1.3557229004877678,1.1599956262926892,0.11977949125859656,0.1249388682521721,0.5680975851073761,0.3059222719299366,0.5207978153131562,-1.4934944333012454,0.5057904576857433,-0.278314755575012,0.8041028036543566,-0.5424067613338216,-0.5667948641395019,-0.4423740477797797,-0.6452653439178873,0.3637394306483549,0.33205276349837703,1.8970587095523206,0.041881559833805905,0.82743721994135,-0.36798632083534805,0.6386583952586854,-0.7871914310335794,1.0947088368724593,9.933333333333334,True,SU2CLC1,PD1,Pembrolizumab,LUAD,R,1282.0,0.37901810009713716,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1413-T1,0.2158899208438284,-0.9701196807263213,-0.15662679469008037,0.10652289181715985,-0.3612460316769649,0.10037224667731565,-0.5448693037673057,-1.0892946105087928,0.29587448904222197,0.26174531432463877,0.8653342879618855,-0.4562143338680987,-0.32914833164679175,-0.34795369148235494,-0.1506795162713921,0.7150690293624724,-0.5076108783176669,1.0219389367709728,0.08492295106076404,0.7430717526517338,1.574019912770166,1.158800371767876,0.37122554922077977,2.002099313368835,2.5519415222803206,1.5814447967925558,2.233893372725013,1.0476928383036703,3.46284155162776,-0.9878438300610666,0.2136589168927355,1.6423229458420705,-0.035568284848439866,0.8630723420331442,-0.144893567365936,-1.063337468505228,-0.07427597056769498,1.180169159686724,-0.1454291213862264,-1.7619858191328404,1.0932426594634554,-1.8508868586934377,0.42833629521274635,19.83333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.40570939889598434,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1414-T1,1.4372148326480083,0.14910509391432356,0.3368667395792058,1.2283614710254158,0.4579072603713034,0.7194411502167847,0.555222086148413,0.009623412214594626,1.1496033032537003,0.8643542400422748,1.5316781372784531,0.29822397892938396,0.3173469249451428,-0.11406824752984208,0.4477610588650698,1.6411488179286344,0.9920512881580889,1.1709163265104117,-0.01124919713061548,0.6616706922041298,1.429640282797491,1.2280752047854777,1.0940382224674732,-0.7306714091576642,0.2835667862474776,0.6953659048591034,0.4897013556729711,1.093571295710929,0.8302402175350263,1.522184914021542,1.2901072071192952,1.7689891542063751,0.08188259667421484,1.8233262646506405,-0.2012978840943635,-1.0643332101532361,0.9951738909743288,0.8613834242180608,1.3512094727044301,-0.5751216378001164,1.4542159470464673,-0.9191039044342538,0.630577679222244,18.4,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.24230800056418172,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1415-T1,-0.2027203176398109,1.232031762185893,0.2173991505195728,0.018166141712647008,1.8906511380251219,2.0197008876227005,1.992648971929893,0.9652806600597359,2.6906866301293455,2.125537653136195,1.5482990265559613,2.1560035596883944,3.0069971069164865,1.7582761861986027,2.6308695947262812,1.9500908711382074,-0.07062999051095958,2.096201293239896,1.450138758005465,1.760715271340281,1.24966107597526,0.2743846910579614,-0.40523497080624504,-0.6112504832600303,-0.12271396043190565,0.2617290090548186,-1.2341855234325292,0.1105336432840696,-0.24773767394195567,0.7335827087073158,-0.7004426203496292,-0.59642665509825,-0.20206318846915125,-0.11204443040205803,0.9403888056325529,0.07233301236001005,2.087850302732188,0.05091145125980103,1.7227834073732642,1.2133355115039661,1.2352199021433754,0.7011557298987392,1.3759377105633834,9.533333333333331,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,672.0,0.26397475981524887,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1416-T1,0.18749049234237927,0.7627539973413736,-0.22349358641340802,0.4386142101967255,0.3767124849080475,0.7514701210269938,1.0396531562035327,-0.5784901027047192,0.947866542485061,0.9376582969881023,1.1173264803352199,0.47318400527137755,0.9424377689965148,0.03039872293516313,1.092448430967101,1.0687735864773515,-0.3838579658275805,2.0517500744924804,1.3399860119731626,1.5827686479800864,1.595514787175346,1.6634530634041906,0.6184387383412896,-0.5158063178211455,0.4728752394544602,0.874434274300429,-0.20128545785328994,0.9706665738413572,1.1970390959402062,1.113616062584862,1.0579198883733147,1.4169479090842547,0.4695554611490299,1.4842658630105312,3.3562088412376747,-0.8485986794037345,0.981860847288465,0.6095165254991839,1.4906839286638107,-0.5434343696579208,1.1836778407938393,-1.140536279608084,0.9574727136968973,19.566666666666663,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,469.0,0.3173365246479733,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1417-T1,-0.07353913940189956,-1.0584667830485597,-0.8116473910020158,-0.18173262806861087,-0.28798040876673964,-0.6545958396263779,-0.20892572548164112,-0.9386610618452954,-0.1694982071515947,-0.33561920545053675,-0.003741412254415371,-1.0333740727091985,0.2599791068247807,-1.757358826058214,-0.2188249812540152,-0.4128186535849578,-0.8461159402390384,0.18352218377366017,-0.2968449913264772,-0.47094150403338814,-0.5141480397013126,0.2928582364197309,0.5341088305127185,-0.060207133543371615,-0.40963212924605563,-0.06922660950564387,1.187502142144485,0.1384995734592687,1.4597048921330806,1.1920340589594354,-0.4554460176515447,1.2590770724167395,0.8639949260271337,1.9310755569628477,3.2194214433835,-1.5856280850992506,-0.4537247750804679,0.5074054088288248,-0.4176118863510524,-1.236530215387809,0.39740837339859353,-1.7241477211437846,0.7901716327363923,20.566666666666663,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,393.0,0.5091700713593269,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1487-T1,0.34059479989443725,1.5761302879930676,-0.4221268828910537,0.4458195521069215,0.006050876688702882,0.8474415223725213,-1.6423264674585532,-0.8081952525309959,0.4459097701346258,0.6655415734756033,-0.38864312049954225,0.24347896626917595,1.5640228562749294,0.999773452746775,0.9129528781558255,-0.5895525075945302,1.485747547592439,0.10220438380512502,0.0655970792897446,0.17535956639098008,-0.43522142954123955,-0.7551302879133408,1.7334094643929796,2.302244517481034,-0.17253003849414136,-1.6768849849409992,-2.703433760326387,-1.9390556412207909,-0.9494170079021782,0.6528615230256625,-1.3252038213536381,0.04717007319388761,2.5499490638141027,-1.4964613344265556,2.0809187440959866,-0.430189318592432,0.8536701667775222,-1.2297602385249595,-0.005933866766332042,0.8138858144154713,0.17493501510475723,0.8752383572135576,-0.6326290536066013,32.733333333333334,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.4625621285734522,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1488-T1,-0.43511162636152123,-0.5064260012298146,-0.6244527080426118,-0.6573119929336186,0.0197395455773135,0.054859449896871096,-0.09869502880531167,-0.7173187140880609,-0.08811702425715802,0.11543828867521436,-0.06512941614271564,-0.3059482721286091,0.058695019223146294,-0.03358586107828471,0.04948885854133699,0.32711571083712754,-0.8779232230541703,0.5025407849332026,0.49260528405166004,1.0100560028065273,0.7482992601978417,0.23429807945006237,0.969111445748225,3.2721895244764747,1.6921531293387864,1.558620548060979,1.166427500353123,1.28579274108069,1.9969138881010216,0.7968114118480665,0.3732761045811417,-0.195044845205427,-0.18607770142383415,1.9461923425391554,0.10045881317068249,-1.24470418347101,0.19211429238448768,0.9204307851084121,-0.019082357242207373,-0.8936716459565718,0.4161926503382429,-1.0526553418276425,0.6736815693524194,30.8,False,SU2CLC1,PD1,Nivolumab,LUAD,R,902.0,0.520978341716121,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1489-T1,-0.4221509142017456,0.19897833897766143,-0.4657415394675132,0.31062558838910825,-0.10792275093467275,-0.09829105895512906,-0.7320593117168858,-1.093660748438514,0.03649066112113468,-0.2955394449219498,0.27082877183957443,0.0518229706234147,0.5127725050758258,-0.0853111937484542,0.8213827712304486,0.05088063216692474,0.6699477830463928,0.3058514695845032,0.0058099029739938175,0.798388949688432,0.2449586503336472,-1.0284227809227326,1.7268205941862698,1.416127484466909,-0.2240526755022262,0.9322465958688039,-1.3885057194190351,1.3870020926056772,-0.038469024551371425,0.7711289856396959,-0.5665157322522008,0.056634579057238996,0.2999024364780091,1.2139514621659873,1.7769007954717475,-0.8286671575760691,0.09996680566553223,1.0848192995752246,0.44015651565784475,0.28454642720174883,-0.2742501522950915,0.07237663456928617,0.024721813540982126,27.766666666666666,False,SU2CLC1,PD1,Nivolumab,LUAD,R,,0.5743893773363932,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1490-T1,0.32808248318992017,0.2852596081515562,-0.19638130400507492,-0.11391063175512856,0.6223138310817231,1.1703907055128038,0.23254369900198466,0.5442827735619337,1.0402352558844554,1.1939025939497356,0.1925968289808734,0.6097905494219203,0.5300664269101075,-0.3762614952966813,1.2401849366087767,1.3292223565088641,3.3422636921977937,0.9641458835580382,-0.42624942659860965,0.5821858573042936,-0.2344884798717298,-0.3651041358855846,0.6390706085737348,0.4307276495598132,1.7721628394592615,0.1551818052753336,-1.818351186042567,0.10845081418442631,0.22065902022861167,1.3118579699876225,-1.6020941271541518,0.28360755595497883,3.420843797859509,-0.23221960689021467,2.0216742349856256,-0.41483793527058366,1.4415269415037977,0.43741887870016477,0.601104705484363,0.5036871581457124,1.1006385845257571,-0.01345378367139582,1.3992163043157373,9.0,True,SU2CLC1,PD1,Pembrolizumab,LUAD,R,426.0,0.36896192688305457,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1493-T1,3.958839665711255,2.4772975728065787,4.102205965417617,2.4245859670133045,2.508076303706797,2.2502710620247535,1.3654651344182716,1.561640076018938,2.4467204480384006,2.345368098924678,1.614339943578272,1.4292930561029837,2.3193013917472785,2.539090469141309,2.7737875456353294,1.1240510351650985,0.7357373339783437,1.283436023212243,1.9155249593853525,1.9910592097810018,2.0663956968731183,0.6460183366860827,2.2176917196156336,4.082616367907274,-0.5881564059634834,0.10389807060299508,-2.021237592735902,-0.04025416925528437,-0.4542776110173466,0.809498754827954,-1.215639161472829,0.7321639185468949,0.7966912380491048,0.28352840903069315,1.5638746139108446,0.29227254628905314,1.8645425641371394,-0.14580091693215955,1.547994796070183,0.6096367956474043,2.4801325498783164,0.4801524329471869,0.7881529483400903,4.633333333333334,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,,0.4255906016848679,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1495-T1,1.9233486875153627,0.482129144721126,0.967899474052,1.1813269189077398,0.25305209841271814,0.06507440179670305,0.38460947910851745,0.4086845572507252,0.7113433750039259,0.29909477946478286,-0.47765162470369643,-0.876197184758376,0.016050674246846794,-0.8804602677183276,0.24260961827288025,0.49501108628563584,-0.190325271169303,-0.16020643945036087,-0.7807756117839088,-0.2034185893784681,-0.9933281744415486,-0.46868002157360444,0.4698058031987248,-0.35427852056629416,1.249981851494593,1.0851983237691945,-0.5585045024116625,0.988697400264153,1.6164621322532815,0.49421460339657775,2.2975042699837296,3.443183760980243,0.4506583873914888,1.368602366097341,2.1604089703381595,-0.913164092434779,0.20638858345728564,0.6838245159292841,0.14225614573728812,-1.3433879436064915,1.037326080961501,-1.625534498033001,0.5241597233774902,14.766666666666667,True,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.4986021125077648,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1501-T1,-0.07579175765656082,-0.37268259247645863,-0.31299801569298746,0.20206375430967113,-0.12708817619725898,0.585409805200661,-0.8225185653010681,-1.3102641478336834,0.32717381832522324,0.4752282627314407,0.7383718101131406,0.7305525700457682,1.0434482609870186,-0.03714632021193805,0.5995238379171847,0.24992807586665863,0.14123259191163898,0.6809794090484692,1.3699595916224359,0.7395065710727315,0.35753920375880405,0.6027116674536562,0.21808591944662598,-0.3266700865583437,-0.569662471768581,0.5611601028909678,-0.75986778119894,0.5787065833768431,0.217725559528138,1.21370517963424,-1.0846249743776408,-0.7139997913672084,-0.592392240663521,1.1035403067778642,-0.8454609441556845,-0.09661619954657272,0.9174932649441117,0.7632257231636354,0.8230918144481315,1.0360651829580687,0.6956748433805756,0.3686193201382269,1.1824354015725358,20.133333333333333,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,245.0,0.4169733720234294,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1568-T1,1.6698637538565142,0.8363727604958296,0.9814783119036614,0.5225629659873978,-0.004000407639246628,0.3511602146552465,-1.0359754987858951,-0.7875284829040121,0.4668473654325039,0.1307188757473975,0.040500500458033585,0.27881298968138024,1.3580661541573704,-0.10741251733898961,0.4246561596031591,0.936902405545116,0.800588982365878,0.8138472593798489,0.4868610822539019,0.7259502101166007,0.30383228621761293,-0.2575436347734569,0.8455220862663152,0.046798060949729936,0.043817802588654545,1.1597594187547111,-0.6732574102931411,0.5765463881208216,1.0446690358967514,0.9440371922411598,1.2471825421543694,0.9630003096480512,-0.3328274576519397,-0.3093376194388632,1.412760529631056,-0.6120439503912487,0.412982130633644,1.0496104325446305,0.8486546281078747,0.862696219386754,0.989394383566628,0.7903804271280646,1.1760326799372025,6.266666666666667,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,218.0,0.36822393737567394,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1572-T1,-0.6279394280513652,-0.7975226959239315,-0.44366839907441863,-0.16243696585294154,0.02344233088077946,0.17817256717569765,-0.795905216342498,-1.0562368055682065,0.11480571694140945,0.2811378218297545,0.3982734790926279,0.13671285820134493,0.6654071889989508,-0.29133064790441315,0.06381073363778725,-0.34609762228414037,-0.5354444764002769,0.33818124248793585,-0.5247836092830278,0.5743343179691369,-0.6758494886457043,-0.7651736347287106,-0.5288276362885169,0.1439216079160902,-0.7798563307136221,1.2540724640171772,-0.7747102349959448,0.6097270944024158,0.3806325570182468,1.0371712743502168,0.09435604558904567,-0.7642264110869624,-0.24616249546509467,1.412407544531438,-0.5958240456818441,-1.0205071998688946,0.20021679868517467,0.80184677478094,0.0030814988469374523,-0.3583046919496149,-0.1649506312703359,-0.6687037579619978,0.8001334083742371,5.333333333333333,False,SU2CLC1,PD-L1,Atezolizumab,LUAD,NR,362.0,0.45593548113612786,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1574-T1,3.9818769523903397,3.1604813685407374,4.033225620064519,2.7870146586304547,2.8420229267369597,2.0080902833807444,1.562204767235176,2.4652609744519722,2.229256929185217,1.6878189045469834,1.0615079927501112,1.5861953371211182,3.0228394572377804,1.9832846032197018,2.473997466897579,2.2415137468510182,2.425896982860359,0.07797244431695535,-0.901925446351353,0.5929636096061166,0.03291836821143578,-0.09860989931962243,-0.30187602122870644,-0.3359156064866116,0.07523594682751943,-1.7370126338540905,-1.1544479180179303,-1.296566625735443,1.1889135697027116,-0.46984526329893594,-1.4864631801149457,0.987743931823607,-0.22035530747568957,-1.691711339724906,0.33829147602612175,0.23941087386190588,1.4706479662370733,-0.6850609144985158,0.933677193588424,0.24655211310198977,3.4543599589735012,0.23235350155964168,0.7918442865112786,20.3,False,SU2CLC1,PD1,Pembrolizumab,LUAD,R,,0.03480101568223559,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1575-T1,-0.4372302489598429,0.738617037948712,-0.6685530188376386,-0.018574517139629956,-0.6297487204685465,0.06786078051281784,0.38657889417635466,-1.0472265725113703,0.1441900306559384,0.031880415908569916,-0.33459011885785944,-0.31884418455939556,0.0034670819759667648,-0.19494701184924032,-0.009367162085158861,-0.20503591978287983,-0.6433995478642323,0.8006169114795816,0.5719445040947596,0.5861754051363467,0.7656983538296837,0.8683611240498688,0.4703096260779695,1.445032494891807,0.5566701663309315,1.1512613251154682,0.21304444509423454,1.1888601941145718,1.4301848696107315,0.9244657534013698,-0.7212893531042813,-0.18363194916400769,1.5388872647789438,0.7820060243995062,-0.5614517247970169,-1.134823325655768,0.30010630744991473,0.7649568033334723,0.8592137899092247,0.4028856438426867,-0.4456231151900687,0.0409620233117904,0.9390624571811031,3.3,True,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,344.0,0.5215195898726992,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MSK-1364-T1,-0.1758691572227403,-1.9114701981398146,-0.3950253193405123,-0.13068367630235123,-1.1844319990578145,-0.8316917235755649,-2.1787658266592445,-1.7196438799426597,-0.7227767062376275,-0.6660486327064811,-0.7294454404068773,-0.7015689357528531,0.27280061681136564,-1.5231162005343584,-0.602878855964949,-0.3366049866502083,-0.013457768541635851,-0.541011305514294,-1.124082192780907,-0.43848733422112274,-0.1440137707390163,-0.33722907242983735,0.8629679604039521,1.072265423654246,-0.5649876925004796,1.1494284235251664,-0.921932330555753,1.4061961640881502,0.3916242016411521,0.6895561085646078,0.19134668614108272,-1.3075182217411352,0.07113336062107706,0.12203626584631386,1.8221292119711727,0.39750976955885264,-0.6500951428522062,0.6793745238791452,0.23117735809290543,0.3750446895101445,-0.09572005714436858,0.5015609334835486,-0.01037075237313007,14.466666666666669,False,SU2CLC1,PD-L1,Atezolizumab,LUAD,R,789.0,0.6197978301163929,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MSK-1365-T1,-0.7518732893598916,-0.698935822849937,-0.1070289320579743,-0.1393586000945116,0.18731200671518985,-0.4794507314245708,0.7467977400087631,-0.24351781597627978,-0.23591738707940857,-0.4490015453056649,-0.6047818089745418,-0.5045020678218929,0.5718030405318809,-0.23178725192191335,0.1869123470756273,1.6144492353345663,0.6838190657172231,1.0971233489423748,-0.08826546281168543,1.041897603094698,0.5430448731956984,-0.050724585061380195,0.9164917024532219,2.8214688074146106,1.3104481921810218,1.3006817032154272,0.31845585895193523,0.4952918753681716,1.25993312617106,0.6567275798815523,0.25729687219723124,-1.1225848690553486,1.4360727622000955,1.505325271203742,1.8269746210837619,-0.6373728898802603,-0.2703234412793753,0.8235916707190074,0.14890999147719755,-0.2825333588110028,-0.6795039879460124,-0.8342214610901828,0.06671652715105356,14.533333333333331,False,SU2CLC1,PD1,Pembrolizumab,LUAD,NR,67.0,0.5755382852520589,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MSK-A2013-T1,1.561129789672333,0.03895170338648245,-0.265723235564069,1.6308745494030374,0.4401675494189881,0.4998142568062188,0.9193200974103207,-0.13536907103548398,1.145678047789155,0.7735690422854449,0.16757899570615342,-0.5407615632166484,0.6779716638332521,0.04812480392565115,0.7344205100208709,0.8657817739555701,-0.5525997128418545,0.593503473125947,-0.9322472283536059,0.3105766190491903,1.1274043663179965,1.9760485383375839,0.8347291975038289,0.030926484442368816,0.6640400403478758,1.2899487087929855,0.7676503256731663,1.4331842192684991,1.7377578599495842,1.4721895888655712,0.8478383591049397,0.358943653414786,1.6756941183456247,1.494070567223444,2.031867096235357,-0.7319804803097488,0.7082904047390594,1.316464938137912,0.9559899440520108,-1.2050257929941348,1.5112814163358437,-1.2528634406765216,1.1092658037763137,10.033333333333331,True,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,153.0,0.3251416769886859,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MSK-A2014-T1,0.24259441408565174,-0.7430351838252263,-0.15893367246242057,0.2747147144683758,-0.031214494905706627,0.5934823543925982,0.36786001550263325,-0.9170208822182552,0.5960068288769563,0.639849038631105,0.27877058265051863,-0.45146045519951356,0.170820567860163,0.33930573210898085,1.035453351585545,1.0764934099161991,0.06454543751792645,1.8284528442003731,0.39599104585126765,0.6973519951737098,0.39170477154833566,0.4489740255949987,-0.4133128822154643,0.34953073246231176,-0.18369899282434957,-0.08414837673725756,0.7195758713087391,0.252482417448484,2.236399807574325,1.9580210473157218,0.5199525892743089,1.0812353684369715,0.7509780072929553,1.9095138022844542,2.698917100401845,-0.9493750506148546,0.6960798310961602,0.8575308472507787,1.0167871224363476,-0.4519180472861951,1.218086744000344,-0.29793603871582003,0.8476855145926849,13.0,True,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,71.0,0.3700635646013293,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MSK-A2060-T1,1.1798905798810635,1.3881165150068573,0.7471822827762262,0.747609328902185,1.4699065718359137,2.3870395712382,1.9264833903293768,-0.03768919144433902,2.476430567388902,2.252977491595065,1.9059601560006991,2.292315665014458,1.9182144030292434,1.9051586380072478,2.2726972005140103,2.0273883438993443,0.3694830357110598,2.0772814205364316,1.9075537432381493,1.8738477369721391,3.4965687952609255,2.975216019678662,1.6315249877603641,3.5521559278061416,-1.1395564628040498,-0.10551323568250341,-0.08835552278142264,0.2860113113988641,1.1611887880772467,1.120820111915638,-0.4412405090136889,0.6776827855228889,0.22636343288026972,0.4867602924794549,2.65634226777813,0.08013361143627344,2.3556242014856945,0.057758809684077615,2.017707784224651,-0.6209945668962413,2.175850400663117,-0.5871281510267894,0.8200688436354234,19.83333333333333,False,SU2CLC1,PD1 + CTLA4,Nivolumab + Ipilimumab,LUAD,R,807.0,0.14093575565096178,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MSK-A2075-T1,-0.5653556628275297,0.9716930614422699,-0.8150954086864899,0.24095060873470317,-0.6673905195281549,0.18502722139235733,-1.1395490749390829,-1.3249947186452067,0.051642482395333804,0.482299317965372,0.5362345074030169,0.4087476090715655,0.2544133516909869,-0.0529890074289824,0.20765957686429837,-0.967778444611859,-0.307204599203141,1.4058883892359881,-0.21263170053502178,0.6081791439730566,-0.03329007942384067,-0.3839033906709702,0.39040926702901463,0.43089879929207014,0.7195545475107283,-1.0312227218724714,-0.936412615358868,-0.7405534566075195,0.18185029874974523,1.1171411433086154,-1.2572375775988829,-1.1231578717684205,1.2985346252313679,-0.13256386365788914,1.4951244139933129,-0.48878831821428476,0.4959919820399121,-0.11538507869578112,-0.2093993460917901,0.8002120997505161,-0.3690175874600901,0.45399727801988266,1.2187355239590878,31.266666666666666,False,SU2CLC1,PD1 + Other,Nivolumab + LAG-3,LUAD,R,,0.43068651497069105,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-UCD-1124-T1,0.22504806656364854,0.3956990729445199,0.5864493892019654,0.38150420550655895,0.05238904064599015,0.25550238925851915,0.07230699002686755,-1.0096280840806335,0.14086636710937628,0.28717822044615693,1.299447280123288,0.30157958451823774,1.4917391333940841,-0.17899379021513562,0.24787020361441214,0.6497082563834974,0.44559375471461965,1.3802933916105171,0.4771921350056147,0.7203031595479392,0.7556895544351867,1.1499839501420672,1.2533596864589542,1.4301019259118948,-0.25235010503115785,1.071151093514714,0.8052670825985172,1.607408697242164,1.1198408677858074,1.1788356619128892,-0.0823590312494982,0.715892286984666,0.46479304442884967,1.3833223911945656,2.6147473663517413,0.026776626354368567,-0.21176924239882225,1.3498000890330053,1.4548639472706937,-0.892409298168381,0.3253954098699331,-1.0522967725411194,-0.4466061937013945,35.43333333333333,False,SU2CLC1,PD-L1,Avelumab,LUAD,R,157.0,0.5220350742228912,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-UCD-1142-T1,-0.31116146406610595,0.524180298584771,-0.15179874979658656,0.605702648207777,-0.03521424060254817,1.1903738908088062,0.1582124066201146,-1.033226981394587,1.0503195558807503,1.3230837927689663,0.5806142500288188,1.8033300859448023,0.9492422638868614,0.3216265085450561,0.7683623373665108,0.8223297813137903,0.38644980279285424,1.7535765917785708,1.0403601351461997,1.5368107387903434,-0.24870474064017092,-0.68074207605086,0.24598126526240646,0.32274703449698894,-0.4925890374134765,0.15624387123273129,-0.7272410272348958,0.33489779372090617,0.4069429062347244,0.9320378026446499,-0.4439796248310905,-0.4553441552172128,-0.3428682846797389,-0.10176403313057554,0.9521230973314493,-0.03376868112458652,1.5308646220174615,0.6521198651288131,1.5496778600129355,1.390658490577937,0.1506759173659841,1.1993876686834348,1.487782886861916,26.1,False,SU2CLC1,PD1,Nivolumab,LUAD,R,642.0,0.36811848672313136,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-UCD-1143-T1,-0.7302259056560527,-0.9666018186423996,-0.5913153120830625,-0.0850020922418245,0.609056513586797,0.9106398269421171,1.0609499284568749,-0.2836186943892689,1.3238254386197374,1.402027391865656,1.5774025822396642,0.25165686921650865,0.6027066313492072,0.13261811678676724,1.4473143846711913,1.4926636854230455,-0.8943255205878189,2.0575310294183766,2.0302884139997883,1.6008183888653185,1.221651241720007,1.7302349453497126,0.10698504065123238,-0.24858029885604338,1.061591218129095,0.4585572904595688,1.2863139856756556,0.8187035157068608,2.591478566264424,0.9540741145236336,0.728291338824868,1.8910078628459701,0.07941187180230189,1.6790666239464815,2.7882263204870914,-0.8847663137353057,0.90517080871756,1.021269260087492,1.703222728934037,-1.341246500416196,0.6830433645830022,-1.8183665937288087,0.9516378378019461,21.866666666666667,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.3947589674086721,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-UCD-1557-T1,0.551170104284906,-0.10096167288741992,0.06028831497658318,0.09127214386494861,-0.19347843298352357,-0.5474378691010082,-0.03566991344997017,-1.201590761817617,-0.25895084648121347,-0.31327461762633185,0.46781910951284045,-0.3213804149278337,0.7061050483525524,-0.6925970051491039,0.05956526554704295,0.2006335832123869,0.14101344525795656,0.6404420418208493,0.6845215888735982,0.5959164644222007,-0.6375233365031644,-0.7138727068817079,0.9232618716935966,0.14147852253326268,-1.9290835656801575,-1.1473785129132676,0.7565886870311226,-0.5612037556963748,1.2439277607463308,1.0687474115757443,-1.2943356971324653,1.6132271609711784,0.4684679023201983,0.4490150518357416,3.30291280511628,-0.8489645827846302,-0.29350624555381155,0.15932842208905165,-0.08686601977032801,-2.155262454371172,0.1318996370755859,-1.5098092035677153,-0.3411100075246442,27.3,False,SU2CLC1,PD1,Nivolumab,LUAD,NR,,0.5149901284349909,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-UCD-1560-T1,3.721244458977843,2.5662511304323763,3.8712984564164747,1.9672708015595795,3.841277689455643,2.583094569361333,3.47015925864158,3.4626120548059314,3.0042543441473173,2.9713822068507394,1.8401300441630986,1.1662439614321065,3.635891883743569,4.865423159268908,3.8997214407839005,2.212106408109625,1.602023310102957,-0.9550170530183151,-1.0654585457988845,0.02716002581353601,-0.8836880952851386,-0.6345223301674123,0.10674524189657711,1.2464865222539832,-2.1759558656913547,-2.9872211988815347,-3.4688452715367073,-2.465734421530377,-0.7380077132598829,-0.0013397325335913885,-1.641685993831831,0.44808173689199954,-0.07645603896576943,-1.5534107695912578,1.2920322581544663,0.6639703092583005,2.2246621947416956,-1.5134587797906984,1.2192484984846736,-1.3011049170528641,3.007768716624112,-0.9520435659632177,0.1649282010306447,3.466666666666667,False,SU2CLC1,PD-L1,Atezolizumab,LUAD,NR,,0.11374519365261299,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO24-T1,1.3625331988698897,-0.9629196549410259,0.849760572928807,0.25441601238748585,1.1132533312209194,1.2679062819254914,0.01625883309899741,1.401103850953093,1.2724455999332573,1.6586749137750052,0.012797169259463358,1.1517987204692408,0.5001783469245041,3.419204075697508,2.0263368082160795,0.6070437251664318,2.18553719025272,1.65388830428459,2.014750205867478,1.940445310686572,1.297318253739714,0.5068493553024089,3.3889827688892042,4.533422366153483,-0.017761650407389237,-0.6729564675120366,-1.2400099559307218,-0.33677948784364997,-0.749857312094492,0.3474525623726997,-0.11813812371601416,1.7145719870383545,-0.6192356663734092,0.934596076557282,1.913995265204816,0.4043841312744539,0.6182964351186548,-1.1274758189277048,0.993066293170241,0.2669290655168635,-0.059512526568920025,-0.6777839702954508,0.48733228812068136,5.733333333333333,True,SU2CLC2,PD1,Nivolumab,LUSC,NR,,0.3977876608701516,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-CLE-NIVO31-T1,0.7903034828824768,-0.7878925573272272,2.304517322738249,1.2410947129869003,1.7399123807863646,1.0944190576342208,0.619779428327675,0.7494087005073742,1.0535843311377528,1.218435357161302,-1.3218894372805996,-0.14529823938757755,0.7972246108974173,2.259981707160971,1.3170671479172211,-0.7513316158973716,0.9514548595088266,-0.5220486568992072,0.44664479085651143,-0.06035206377221768,1.6062931250357055,-0.7104180357127544,-1.184521355013501,1.7826715412452239,-1.930714219730173,-0.37907988316513863,-0.42346688373004804,-0.2247702029423373,-0.7270891794751227,0.74463725767855,-1.1523714321721565,1.8243177227563756,0.629915063783353,2.2162077933322784,1.705364095005028,-1.2275830279346818,0.26386817188033357,-0.7132435819222065,0.4381113923980222,-0.13088693084039807,0.3411741159807283,-1.0971307813333973,-2.3132905031526008,3.2666666666666666,True,SU2CLC2,PD1,Nivolumab,LUSC,NR,,0.627467306987495,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1007-T1,-0.08593094311836005,-0.5456860451377727,-0.2413362543848512,0.4656470138903588,-0.8184570489136607,0.15459300113688867,0.08553209723932956,-0.009462116153238187,0.4886674936545544,0.4669823687687427,0.11083112593055894,-0.7001668399295077,-0.06296572320106578,-0.4328921640962708,0.127965024603927,-0.5006627385781574,-0.8961357926238663,-0.05339032257732838,0.7578790064528957,-0.16569873848690694,0.4807107375325299,0.4254680421611409,0.0796671750084701,0.08730025009639662,0.7404549987417077,0.6684321203727798,0.04629807693155464,0.585942772822657,-0.16506182052935295,0.927180840710698,0.39295597801867543,-0.10891831237916055,0.11144781481387353,-0.20999615064810376,2.2501590983344926,-0.8987955678123575,0.46798111974068857,-0.20800317321918863,0.5684276111319898,0.41859899397071154,0.7786411172902096,0.09809548673760345,0.800803958800744,7.133333333333334,True,SU2CLC2,PD1,Nivolumab,LUSC,NR,338.0,0.5317869073271735,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1010-T1,0.35162654048674286,-0.4392002860385731,-0.9391122134735685,0.7091635636720928,-0.8666352765470796,-0.06268042235790847,-0.990900694440348,-1.741992635344894,-0.4349191002988558,-0.19709029744104994,-0.9178299852515885,-0.8653037683246461,0.03807783162938262,-0.15063108231058353,-0.18814174509438647,-0.5108680646487618,-0.49139778629078734,-0.4040884183876874,0.24789946065887875,-0.6175885466159351,0.7992180915302859,0.640216308651856,-0.07511637086814359,0.8693235187947543,-0.6061515487121004,0.9528965000777632,0.3601698034875259,0.969827396152194,0.6939985707465646,1.2773205828621486,-0.05415844002732617,-0.815840864058777,-0.3456536503712229,0.6664010440140016,-0.48835100147807625,-1.01418404638852,0.057069104841687535,0.545411352027278,0.26547992043365076,1.9738130483354341,0.1794079267531377,1.931255189594122,1.1775789335574656,2.066666666666667,False,SU2CLC2,PD1,Pembrolizumab,LUSC,NR,,0.4706457083562534,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1016-T1,-0.9384309309981815,0.9670151441455643,-0.9070571617884793,-0.3892551177508973,-1.4316461806459513,-0.2579978435703442,-0.5621986907809288,-1.7073032908143073,-0.6060634773860617,-0.32978638746970435,-0.25892495405230026,-0.6860173563330109,-0.31699950319307574,-0.9796512296258973,0.14569801135139357,0.20411239902917222,-0.8261801029022343,0.04602451319174794,0.24022594266319028,-0.7397503892548649,-0.774510016704714,-0.9430541875748817,0.4404697024851758,0.1982495609326133,-0.18343310022775924,0.24622436243154697,-0.4560519968331405,0.4562985062162492,-0.9883970761682958,1.2001644226282124,-0.9584048019848966,-1.0804060671150801,-0.4808560928330877,-0.24299528798717532,-0.5930792428260578,-0.4689205565041998,0.13193620142200482,0.4779177669216081,1.3531854239478633,1.57537677635628,-0.9234550435077491,1.3169516207347784,1.3088272045901574,8.033333333333333,True,SU2CLC2,PD1,Pembrolizumab,LUSC,NR,,0.63946893804097,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1018-T1,0.11142898112118323,-0.6651400435599086,0.23128999792352478,0.5309733875938555,1.5442641395968053,1.0071743658795291,1.631696980844338,1.0794025854538134,1.1644647183584103,1.1562262532970804,-0.5320955684441268,0.6908314831073011,1.7645927469745657,0.07880664358932986,0.6758751718393807,1.1362354658870082,1.6700795591748794,1.6653343461138388,0.3952900378678137,1.1584388184130419,2.9583580213853033,1.7308206175834533,1.236108393902249,2.252721775177222,1.180881103902734,0.5001118176055321,0.34931873139489594,0.771212586480291,2.0347063569370816,0.031001282821280247,0.5732774261632013,2.3935199741155646,0.577332183792774,0.8104565753740879,2.790597667467084,-0.4384669038681463,0.45111261430981026,0.5089538552606839,1.107871999664641,-1.8089178859477668,0.6511580748323954,-3.0565629130343037,-1.1813337256234064,8.4,False,SU2CLC2,PD1,Pembrolizumab,LUSC,R,,0.36528696158444673,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1025-T1,-0.783884306123311,-1.1932673749570872,-1.0384367091063338,-0.45187659915644,-1.691555905428835,-1.1006622191624436,-1.2707508861040153,-0.8713011533672834,-1.5187833058066447,-1.0056341959039752,-1.6970241816696998,-1.000257297596989,-1.1586306334985417,-1.0948369346404683,-1.4977061498158593,-1.1151449933775135,-0.4587983576808351,-0.817795635334713,0.47912010230031693,-1.2878820682545304,0.19210401487986611,0.2472933394845745,-1.3245858986299957,0.2505181392571067,-1.2639989901887152,0.19547801245433932,-0.46913081892268504,-0.03559996876666208,-0.5082793103863338,0.7829553570332378,-1.0005062311417907,-0.4111446382796319,-0.38524773677427226,-0.6186176217811432,-0.22167243278323456,-1.1341795214373163,-1.310609067311355,-0.7068120801118262,-0.12159113056029756,1.6833412880279446,-1.246597296775462,1.8041737739410022,1.7566769171384786,5.166666666666667,False,SU2CLC2,PD1,Pembrolizumab,LUSC,R,906.0,0.5476471115486022,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1027-T1,2.1401910993677156,1.0108655764194627,2.099049393400013,1.2942601977945034,2.4752452247457133,2.2232045225076047,1.7477041457182745,1.6737712878625561,2.810946949438304,2.339698850776772,2.037279316744295,1.6988664138810727,2.164353590803627,2.1888114172691298,2.441743814203475,3.4120416387407673,3.2677416996197253,1.8914842225976678,1.0606711037208019,2.445897230551869,2.7332299324300373,1.6476330958053094,0.11926719138564029,0.4210853403540082,0.7746498312688889,0.3340214319795048,-0.29614140370990216,0.2466234574613118,1.204215121482214,-0.8946141108411214,-0.6395032119757966,0.9744226094886141,-0.14690797092870292,0.547296225740609,-0.22877696080912502,0.15699333650549138,1.8233337017208422,0.46839190694212673,1.3285360413246636,-1.2118203276019273,3.0062136960755517,-1.2520675770635195,0.9717173488662083,9.866666666666667,False,SU2CLC2,PD1,Pembrolizumab,LUSC,NR,,0.0,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-COL-1039-T2,-0.9007032306525442,0.12442063002288714,-0.1768798118312362,-0.27585268900304755,0.37328872254470497,1.3208633028383385,-1.070260258308052,-0.8096418811233977,0.9033650423862505,1.6403331217308712,-0.00012477045776408436,0.8750519143187208,0.27404396201917175,0.6403389235900521,1.009948881246362,0.0001317948648959742,-0.8290446456117018,0.634450902434161,0.9092364987817141,0.8363683019691471,0.38954779291365227,-0.9941006721381238,0.24670242265070988,1.1997174769630576,-0.9881627923456645,-2.1215885665846823,-1.8671451273501265,-1.7586569881305032,-2.2072853598268423,0.8915848564781439,-1.0608626539629726,-0.699375701124362,0.16940634861663356,-0.9460867098949421,0.5356572063405373,-0.3009295731349221,1.585856645758832,-1.097777576403018,0.6933406025410845,1.5769918120330457,0.024958647102093983,1.0213247640460006,1.2580456703405878,16.1,False,SU2CLC2,PD1,Pembrolizumab,LUSC,R,,0.4701508215083205,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1016-T1,0.25192185652880195,0.2292806954294327,-0.19965468798696404,0.814795894853361,0.1477802282035888,1.226378401957286,-0.014574132767666392,-1.086953482964136,0.9418590669298826,1.166230768552038,1.3033404100810633,1.7435702906696136,1.9396927112279219,0.766694734335316,1.5296203545733418,0.5791270522585715,-0.17241965872482048,1.244866066574891,0.01507623909525915,1.0198476471300257,1.010571729541268,0.7516558481389397,-0.6875518327327755,0.053721661689438455,0.44172116446259985,1.272526087440215,0.03781487455524863,1.1286145449265377,1.322680022437879,1.1438387849897655,-0.20029346836492323,-0.4710822928878661,-0.3908849108324945,-0.6150470389051159,-0.6860963887917805,-0.3967979268982513,1.7918316334154667,1.1384558542262677,1.1072122286372776,0.19875848086994813,0.4327320814826841,0.008409790848383098,0.6955415021318482,23.766666666666666,True,SU2CLC2,PD1,Nivolumab,LUSC,NR,251.0,0.3037965545129572,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-1535-T1,-0.9692583245794594,-0.8382450479870345,-0.9532519293124994,-0.25570915395117366,-1.3487905214081952,-0.35215918185106493,-1.132314976111566,-1.7195657861001534,-0.6233068292774463,-0.18147224318244048,-0.8389342818188752,-0.7602483919622252,-1.056049845079727,0.5899855838987502,0.7244850041574024,0.03042194482640544,-0.39302847770837035,-0.38808677103466166,1.4047984081139633,-0.7277443210385978,-0.5136188536067491,-0.9016906372870775,0.10141788328984215,2.0648829847494548,-0.8477613165384892,0.6862755313694927,0.23147022257952665,0.9716213020583959,0.9185862583174669,1.016460395405801,-1.1392387773547223,-0.6055373535088829,1.2299694031319235,1.302337850507766,-0.4699870603768557,-0.2999497729517462,-0.3938600612244144,0.7389065601379408,0.8435446085551018,2.1490250827690836,-0.40354115655695766,2.376945848238433,1.1701935750594399,4.0,True,SU2CLC2,PD1,Pembrolizumab,LUSC,R,541.0,0.6687906467818583,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-DFC-DF0047-T1,3.5899437629973376,2.182030129810658,3.9915336724245796,1.8417620153678897,3.3610987052320382,1.7935103064464284,2.308205151903431,3.496294709927132,2.6422405879185162,1.6832830674068913,1.477508882605861,1.36436006090468,3.239284601275652,1.9075263701721146,2.4259743079085956,2.535088988644043,3.434475432526535,0.5902758259223663,-0.1936776740498133,0.8335997905503211,-0.35570509590842486,-0.5487186674619592,0.5344350737828231,0.9281394851876156,-0.4547610255399013,-1.0654105170626635,-0.8144924498175738,-0.4084130985442706,1.2075186346538704,0.011858670042290891,-0.4432065369364432,2.184354447185164,0.3624813230298734,-0.6346729696172951,0.8767094484384974,-0.13116651559373163,1.2535515901357492,-0.28781998749624726,0.7613789812106887,-1.3183844106645495,3.3066094647849633,-1.0604163305925742,0.809140658875897,30.3,False,SU2CLC2,PD1,Nivolumab,LUSC,NR,25.0,0.07373468587955656,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MDA-1444-T1,-1.0392959453405242,-1.011878129643601,-0.8159765078619218,-0.36884059357013294,-0.955553214526066,-1.1443733773993843,-1.7015593313467734,-0.7194169556952866,-1.1944669214374324,-1.3487973225462648,-1.5658217745858392,-1.4211742766976463,-0.6915203014389608,-0.9381704266537272,-1.1420428501448832,-0.9852891153571515,-0.4784694619979099,-0.38326055184910945,0.2281919838954507,-0.5546360587854213,-0.8115073066795689,-0.5401906811943115,0.0455130063602835,0.38104208163301606,-0.40564343391154795,1.295592375288094,-0.44398667728816554,1.5556387428398346,0.040380126229977636,0.8646459326284893,-0.18730430111498106,-0.42475165242354596,-0.5233445427387409,-0.8069069428698701,-0.5310749380856609,-1.7833601067203386,-1.1970085751465143,0.5419958827734332,-0.8868667846731759,1.3966453818697326,-1.3266647405340857,1.157343397280931,0.8554438371766647,5.433333333333334,False,SU2CLC2,PD1,Nivolumab,LUSC,NR,,0.6411647640892209,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MDA-1563-T1,-0.930663383679431,-1.3098988439302932,-0.7313496845706348,-0.37383105573886577,-1.3807645911090474,-0.3163876058230849,-1.5080634105775133,-1.7724037570708555,-0.8440999593324437,-0.535358115417485,-1.113440239848797,-0.929892189157017,-0.7157053893918709,-1.013014771954652,-0.4470589730249468,-0.3679889979969064,-0.22057498590405367,0.27635249485393193,0.25248859550987673,-0.3538390758759905,-0.19268239313116287,-0.2776390639504373,-0.8298531994149841,-0.3863729203632477,-0.1927242452297487,1.2016391597222564,-0.37180971361930254,1.3502758267378097,-0.07188050574899213,0.4158735079151813,1.517634660454779,0.5926979394519086,1.8005973487593572,0.13336540053905444,-0.48419455260437017,-1.0274008833219366,-0.34948163848723135,0.4951558287482168,0.11917988598830295,2.1185309440855473,-0.8080559391482869,2.1837680979303506,1.1430442342069378,7.066666666666666,True,SU2CLC2,PD1,Nivolumab,LUSC,NR,145.0,0.5820905030959813,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MDA-1564-T1,1.4941972465669116,-0.6659869407595487,2.5532162323613403,0.29791022539654294,2.344743436209263,0.7009443094811673,-1.7733741528630107,-1.2732240241568946,0.9994678550525762,1.6887159800262297,0.21352430371982226,0.193148720484393,2.477515935498001,2.600210208596942,0.7746151899549484,-0.3988092450429237,1.2547306687637307,0.2802079853007261,2.2891948507953717,1.8384759401709145,1.0905514762624378,-0.5421282960477126,2.621201410283925,4.557309262341957,-1.812827856692393,-0.9432119133350159,-0.6358963178015322,-0.9699103757322577,-0.9951360003338136,-0.5824786037671607,-1.2723829085005363,2.6784153318906236,1.9195066461575985,1.6585813057505208,2.619631473290834,-2.8123661046837443,0.3526864373041589,-1.675677183112029,0.14759289061184963,-2.4123614823930004,-0.5910182044865887,-2.5831981162319293,-2.5347166559088907,13.466666666666669,True,SU2CLC2,PD1,Nivolumab,LUSC,NR,,0.6285386629433397,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1044-T1,-1.1053281794938052,-1.3017695325979641,-0.8690877223653763,-0.5520721060032643,-0.3663689879133684,-0.9140483385707695,-1.7621468908521447,-1.9027175044468474,-0.8203610877031677,-0.9549224014960014,-0.5539570758775288,-0.7060176267849682,-0.30601548469716644,-0.21676944217367267,-0.599081432366423,-0.9844114432820547,-0.6385826594425047,-0.7015120894787832,-0.0402099671881375,-0.5674690320359147,0.5655010038150802,0.6044226576050454,0.2020212792067407,1.8351706217420294,-1.019297409214692,0.9491955836552773,0.9170412324266125,1.2206082025646285,-1.0003319702969962,0.9126220654651463,-0.3106083769271914,-1.347090012115557,-0.2378762016262779,1.3043315624939305,1.1062391718990108,-1.1489158435197784,-0.7257108301241829,0.3869132478785024,-0.20576683618896113,-0.36171942809195773,-0.6459406581829629,-0.6058697289602427,0.8164092299467386,35.96666666666667,True,SU2CLC2,PD1,Nivolumab,LUSC,R,,0.5386458249951375,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1055-T1,1.3682289259927887,-0.9248019420878505,0.7992714509098101,1.3409240054658706,0.35316924484957907,0.6493595512025765,-1.4235493308509481,-0.6910350006063035,0.06426086547733377,1.6275471525619436,0.8232783768420369,1.1612229433889276,0.5356199276282554,1.2620704218109537,0.5448539347183088,0.29487565263063376,2.1959174783711632,0.6057026047990056,0.13980238178810914,0.3466188645460599,0.2541991221209643,-0.41510283539941567,0.25239820821526543,1.9489448408106582,-0.36395182230809586,-0.9215661678122148,-0.18532341522135506,-0.8482711871760973,-0.041535966201703176,1.1358508469251791,-1.4126865550167493,1.505326789545134,1.3311896064025688,-0.695431751183711,1.0772240934770958,-1.352605180493328,0.5247763579912493,-0.07755396909330395,0.4719127599178259,-3.1306139259192918,-1.3419019178145477,-2.739712064354651,-1.939732957384003,32.233333333333334,False,SU2CLC2,PD1,Nivolumab,LUSC,R,,0.49409435444462063,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1148-T1,-0.6734022396687042,-0.6073684735795072,-0.9061039947444831,-0.032757635301924964,-0.1508628307560698,-0.1465995913038748,-0.6358211459891628,-1.0464940424565616,-0.21371200202293533,0.17997749855008915,-0.41059319150464985,-1.0880224592140793,-0.3266076423864139,0.8895024237865502,0.3154995292676983,-0.5957163433854751,-0.5482517347896452,-0.938477993585167,3.3693599822640463,-0.001464989771591712,0.2233004536291194,-0.49414766698079865,2.090849764088346,4.645345312018232,0.8104371227044549,-0.758865507738432,-1.758174306581121,-0.9978446256121033,-1.229872077439054,0.6349606442265878,-1.3528454927155293,-0.8614455830578115,-0.4572449339328892,0.08918970754035728,-0.15997228128416693,-0.7956920337379686,-0.08634511574334007,-1.234272660661631,0.5784650690180843,0.7004678580484209,-0.6727017670109188,0.744095916461068,1.0788073295105505,4.6,True,SU2CLC2,PD1,Nivolumab,LUSC,NR,599.0,0.7618544058996852,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1150-T1,-0.402702176580475,-0.9904806483445865,-0.13245607754807973,-0.06297068232246411,-1.0863488727261743,-0.46061336693903016,-1.2327847257737397,-1.7250018463826,-0.5174724277311593,-0.4469467396069599,-0.37279988440516254,0.5884144758866633,-0.6286764566564649,1.1732487023323632,-0.4618563587256198,0.03438505160245292,0.5871696299782921,0.16978994909288142,-0.10324902690208432,-0.14011444676644652,-0.25751318535135687,-1.402716379843757,0.35853903452750796,1.5996567946596787,0.05893579215255022,-0.23172690640272361,-0.30751007697175053,-0.5068327259259899,0.8166048973787597,1.3643101615902729,0.2399657564303771,-1.4109551875645472,6.430706807956323,2.6697956408990726,0.6352596464420245,-0.510264649710901,-0.21590487155384216,-0.5139916664366659,0.28471191677500773,1.5738387286862028,-0.325300691307125,1.298240338246083,0.19034441159307525,4.033333333333333,True,SU2CLC2,PD1,Nivolumab,LUSC,NR,,0.5111544631292035,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1389-T1,-0.22729867675337412,0.4023220032185671,-0.5813206356937318,0.33163062634753304,-0.6188356863650125,-0.608897386465348,-0.05790255722384581,-1.2162316559156299,-0.32868129512705263,-0.2900503713848115,0.7138658797979482,-0.5528822440634629,0.08573667315527315,-0.5496163993357372,-0.26285424804016344,-0.16966487142264364,-0.4748318544598735,-1.2208344892261607,-0.20396204267188034,-0.8618306821644971,1.311603819200958,1.4149261098147654,0.30947642137581377,0.6175225001023114,-0.2346572250276308,-0.0014252256654057425,-0.9861815044308064,0.19964375124328476,0.5848598877514379,1.3247423865291832,-0.7685446487332062,-0.8851788832434963,-0.17973509744998944,0.2246640683419992,0.44189315166872334,-0.8935451656017337,-0.2829963878926591,0.14476553483481058,0.10657942605317566,0.07599345094199049,0.15483427358528534,0.47727393347798347,0.37465328016549504,21.0,False,SU2CLC2,PD1,Nivolumab,LUSC,NR,516.0,0.4578656709765132,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1409-T1,1.442752109313218,-0.2457709149037183,0.29248195741107685,0.6246503304653923,0.45156325372297895,0.5441632324282732,0.7949135942175575,0.22166942877261459,0.8754366582629688,0.6617841720152744,1.3689182291604722,-0.2808999012179927,0.4512483058268824,-0.1512636970894758,0.7048947701036403,1.3478531223182646,-0.1983375182779797,1.7056205919144711,1.7964108790830429,1.9257704203470891,1.9390529655443567,2.752816138223607,0.35880304208629826,0.7710686202820808,0.6517345141255232,0.5432939180621976,1.052279008983677,0.7789172165051116,1.7279472116603507,0.9841461314462706,1.552512597371779,1.9732268460681004,0.040384542606972926,2.294027727090135,2.8806811423329934,-1.1642793878274482,0.423182448377693,0.7413889016882451,1.2769966692095975,-2.1644601078915153,1.6111674057238299,-2.5040896731953395,0.5227178787219348,7.733333333333333,True,SU2CLC2,PD-L1,Atezolizumab,LUSC,NR,,0.3116626163636179,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1492-T1,-0.5975512108216253,-0.7642696802322871,-0.4114303721590467,-0.10313647750789089,0.7192053118433961,1.0081967722485272,1.5189782352414278,-0.0015603743300078808,1.318673510183485,1.127919105930103,1.5592947942442124,1.0399014712882577,1.1546245416360579,0.9889404414628804,1.9686804219653908,1.3350294641938867,0.0633621707009314,2.183807758399599,3.0234433131829483,2.219250525045249,1.7623681180795627,1.457041004299191,0.4269534496049563,1.3769588980903114,0.7413939219957182,0.47495123625826824,0.9329317813921959,0.5324233433281541,2.3182151412092282,1.010348084121968,1.0890868399140108,3.0637720732075824,-0.01312240444394104,1.2763260759426365,2.976173777114048,-0.9661499147272701,0.839906302820098,1.3646692940040657,1.6709473891270694,0.24924176775989745,0.8469177226317722,0.1627978208503584,0.816765997302825,4.2,False,SU2CLC2,PD1,Pembrolizumab,LUSC,NR,323.0,0.40967118876297826,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1500-T1,1.6103428912498376,0.4331090703538821,0.2788507446926823,0.9535484070727653,2.158912179724259,1.983096355298236,0.8380349070480015,1.1451272115155828,1.6353007980000325,2.03297651402381,0.8670792344562958,2.1585150316342885,2.12482475167327,3.7846601913626237,2.3997126941751645,0.11764170148366601,0.6632954298369924,0.5899571298446031,1.2487500360967465,0.9564442895748922,1.210222212612525,-1.225115793226246,1.5638012964683652,3.23397224633238,-1.8141802833855756,-2.414777508360963,-3.296856898475032,-1.4865110064309424,-2.2413449514706576,0.22605889712382962,-1.2326528758208772,-0.36472900371980427,0.9524959282271209,-0.3799723996610357,0.9524088146003002,0.9652584214744334,1.7745333094736242,-1.3845745812008519,0.25607967465056203,-0.5911993318833555,0.9717254711455207,0.6752394750883636,0.07266535299961542,11.033333333333331,False,SU2CLC2,PD1,Pembrolizumab,LUSC,NR,,0.3504827138070372,Low-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-MGH-1565-T1,-0.7709911220288955,-1.3396164081483617,-1.0204690585782603,-0.2087646234102245,-1.20463154298229,-0.8729167754315317,-1.5122333387376157,-1.3762442084522803,-1.213703820372912,-0.5788874471370251,-1.27469271883754,-1.3182604972366456,-0.39736546236587983,-0.4970223398990258,-0.5397917984982045,-0.6325537793847531,-0.3517584009331096,-1.1756442298160201,0.5694538596111285,-1.369519777062206,0.1310060790490755,0.36715626638083465,-0.27699796984258535,0.3268976801395614,-1.6560304276318711,-1.1499855393877565,-1.0343391847957994,-1.6356294839406949,-0.9984419857330175,0.9325046365264419,-0.5879269210755341,-1.0055053506362304,-0.4152110620115671,0.16247597851309395,-0.4092061282968358,-0.2675474370725193,-1.1151647116318606,-1.171776066750907,0.060456571587194086,0.9485835097266666,-0.6644056242485226,0.6126139118330104,1.2016332186273253,6.633333333333334,False,SU2CLC2,PD1,Pembrolizumab,LUSC,R,630.0,0.4983608899726811,High-risk,48.80251583654434
NSCLC_Ravi_SU2CLC-UCD-1137-T1,3.2888289662040124,2.54846496597416,2.092998674514331,2.377080887451943,1.8490775933298518,1.9424587888378153,1.8691532978156034,1.7274244626073285,2.3626307998147,2.014879197677252,1.6263936497714169,0.7604832029140881,1.8000051268008892,2.21653920671523,2.158740334627141,1.034610152739186,0.97345065821481,0.6881780561155135,1.3755534252274515,1.2608197628152193,0.7337541982908139,0.739923950062675,0.4333116003113019,0.49913157252431395,0.3275612030229701,1.0888537769159123,-0.6625817650565152,1.1639277591394914,0.7462409381811149,0.3670066584051381,0.157584331741101,0.5431004464911541,-0.36628666373480956,0.3797662347267703,-0.29574246967319734,-0.28052623532745624,1.6563573510323581,0.5996164912286772,1.2312004783550439,-0.36782751947398945,2.6905123207430166,-0.4756919879500126,1.2245269252147073,24.73333333333333,False,SU2CLC2,PD1,Nivolumab,LUSC,R,,0.21454107476759882,Low-risk,48.80251583654434
Pt1-baseline,-0.11899440291680781,0.11589453823747116,0.060098249386296126,1.1107214781427621,0.16607673440169107,0.3827711317986591,-0.060403912243375074,-0.5944197976107213,0.021307714145208555,0.4782159625188831,0.39034093419296045,-0.3073140553128345,-0.25383827850766055,0.7181170603258425,-0.21975053995527316,0.9854043024380067,-0.20462174131622957,0.7910429878803749,0.12575325186984226,0.3715350387184665,1.0383666845077215,1.0795100679411735,0.697029725844676,-0.05002640495187832,0.9042029865433852,0.7559625377124836,1.8128214865390664,1.1872032120919005,1.2346148512020905,-0.7490544246163703,0.5989188252012624,0.38119403907540705,-0.359408349022119,-0.08918819795738836,-0.4196796948296314,1.2441594450031297,0.3674358417377658,0.5231424931690604,0.9900561392004985,-0.3623448236928337,0.4282422064382934,-0.7271191639837598,0.22874757003248508,20.23333333333333,True,Hugo,PD1,Pembrolizumab,SKCM,NR,1889.9999999999984,0.3994024091995849,High-risk,48.80251583654434
Pt2-baseline,-0.7573380303419134,-0.20427067688632755,-0.0656987540168974,-1.1036471207806267,-0.14005287305069614,0.10448570960790278,0.0547099156235279,-1.3730197504219135,-0.26329901259805144,0.12330231756893396,1.1708273029713459,0.007172787773608452,-1.2277115006872328,0.39369412166119894,-0.8371549321026341,0.3053024869313641,0.5592872158149473,0.4410896778869013,0.1719093091093178,0.4077743902247957,0.9385250977631455,-0.5626199382471231,0.4473620264272558,-0.8654509512475737,0.847492831668189,-1.8422858573014156,0.8996784172622192,-0.6837863922460621,-0.34768340191952557,0.2546769046975683,-0.3565133359662852,-1.2264896849328115,6.627230774631519,2.5140515578268734,-0.6506840382396226,1.5215999257965014,0.4477808218309624,-1.0624864284886462,1.060838141898212,-1.3642799639485315,1.0077341875598884,-1.606547945746969,-0.5883561341302421,30.9,False,Hugo,PD1,Pembrolizumab,SKCM,R,2050.999999999989,0.4754507882372555,High-risk,48.80251583654434
Pt4-baseline,-0.36036170318759797,-0.4189978268249031,0.062396261799614425,-0.46878414609483554,-0.4655083635208473,0.04422553878664383,-1.458087132513673,-0.9078322764294078,-0.7174811432397324,0.02788847180831472,-0.6680966017024595,-0.29891493702919086,-0.9049406653209556,0.08783004208291573,-2.0549944098207975,0.28401202508190704,0.004896904594263517,-0.3588447992426265,0.529406985542995,0.3704255164660002,0.34964984113595954,-1.193478911874151,-0.8918573664939337,0.4047090071621237,0.8518055953318462,-1.1130632537425509,0.8548565944502293,-0.6848788450428716,0.5731393787819898,-0.700244953033248,-1.276339229848119,-1.0220626231618701,-0.590180765706441,-0.3869299304414577,-0.2586253980150317,1.2132654784770505,0.11374961228181053,-1.0527819215176764,-0.8540649410233956,0.7633151199525434,0.2756037281990654,0.8365665098449054,-0.020606354454131733,31.6,False,Hugo,PD1,Pembrolizumab,SKCM,R,4104.99999999999,0.5498615877622494,High-risk,48.80251583654434
Pt5-baseline,-1.0832971309647543,-0.7517409440347068,-0.6676031919565404,-1.1201010404877239,-0.6602264194735381,-0.8319469329232241,-1.5788172665599025,-1.2109655377646282,-1.4709807380472304,-1.186510323633153,-0.8639463462874329,-0.9913163089310888,-1.5243112028259351,-1.0043602922828851,-1.6951904904288118,-1.3136876774130877,-0.06643899051299094,-1.3168298997263577,-1.5685106188192146,-1.2884003725190332,-0.6755569462981688,-0.4690694873874319,0.022716114808701938,-0.45086431737933114,-0.09406435536736145,-1.4911532520283965,0.22125447500643355,-1.1859644238580906,-0.1796054078968094,-1.073087706418504,-1.3739667335947954,-1.2668263439694705,-0.5252782569419845,-0.8804804099008322,-0.5507089283194309,1.5859504368687838,-1.3316933906587007,-1.437507069432756,-1.2602499206587685,0.3834225741319995,-0.9223038602242805,0.04580058156716766,0.11435083640245935,14.633333333333333,False,Hugo,PD1,Pembrolizumab,SKCM,R,339.9999999999981,0.5293043795886553,High-risk,48.80251583654434
Pt6-baseline,-0.7703165906622949,0.004471576506937543,-0.7771364337505561,-1.108074128812798,-0.7028918240740442,-0.34172669100658865,-1.7565646557506462,0.14569237732367582,-0.9923816135755308,-0.7480240032130654,0.0810703380420051,0.08649591241296338,-0.2450482726536405,0.748613896497022,-0.8390904870772686,-1.2006090541704904,-0.6276668912583051,0.40456680912047904,0.44180123074088723,0.6671532058051511,0.2984321089802241,-0.47137367305037003,0.7727999318107689,0.39215354434428124,0.1359732141579318,-0.144101454841157,0.41332381787978356,0.12717639638645092,0.012678706749541075,-0.8102811830744037,-1.082959973402232,-1.3923130726252146,-0.33840488548817327,-1.3006111423575584,-0.5431733463824829,1.6329921688044153,-1.1568800085317272,-0.3306976228024654,-0.8881289767643831,-0.29698362338141987,-0.2770018002938391,-0.15808727403970801,0.47651214542653697,29.4,False,Hugo,PD1,Pembrolizumab,SKCM,R,247.99999999999972,0.4813222757344958,High-risk,48.80251583654434
Pt7-baseline,-0.8731520497000597,-0.5288748631595761,-0.4540027629995946,-0.8419821517463967,-0.735479362742101,-0.068970676727398,-2.0894338712754466,-0.7911352473074396,-0.6468123774001023,-0.22398244216892732,-0.26579888241645644,-0.4154172412221331,-0.9234464542543486,0.39930008846022147,-0.6670705229331588,-1.0580006198334482,-0.35035893535004314,-1.0649148433443216,-0.8204969182653304,-1.3571116336295406,-1.2801146879698673,-1.3274466953850195,0.16226792991065592,-1.596670427428149,-0.9451459295469319,-0.9299884256658438,0.3362132586276532,-0.7994561144147545,-0.37531850755501295,-1.0373636498051682,-1.1723927634931997,-0.951567437151765,0.006530031438865704,-0.5575850945244133,-0.1979611987319376,2.0393973816537354,-0.444682623251633,-0.9990370694051968,-0.29724950195213334,0.941217264342311,-0.7927476009483003,1.3379488590643105,-0.17024017020230298,22.066666666666663,True,Hugo,PD1,Pembrolizumab,SKCM,NR,1250.9999999999948,0.5604946191558234,High-risk,48.80251583654434
Pt9-baseline,-0.06205915137836153,0.7311194075349849,0.3613255891443262,0.8071284035483621,-0.363031471609576,0.44307416600740146,-0.4987678910700275,-0.2580757553804355,-0.18255139258337125,0.9925761035367417,-0.05470106330221965,-0.48090548533270583,-0.5068291628479173,1.312311905850987,-0.7150573597146279,0.2775181846530474,0.00022280510297944753,0.2208692444814172,-0.0668766933754547,-0.17583437531791923,-0.32722547404794594,0.1854291206574568,0.8092407701060788,0.09587677043478066,0.2371435934418194,-0.2253523781008439,2.110397662328835,0.45442247022241705,-0.13390047103709382,0.4336393281426917,0.265417549441271,1.2881031972706005,1.0468394392736355,-0.35119378116770694,-0.669418237256109,1.3573912312022252,0.5960716465197002,-0.45970090596169777,0.5113265925135907,0.18605741134670697,0.747917668343017,-0.07741278498865112,0.05687525687040873,35.13333333333333,False,Hugo,PD1,Pembrolizumab,SKCM,R,582.0,0.46880973848291624,High-risk,48.80251583654434
Pt10-baseline,-0.9505867263257386,2.034507703535866,-1.0653922686691357,-1.1655932755172513,-0.8981505572431162,-0.2576127039611519,-0.9141551249738447,-0.2815009339994515,-0.8980191242466732,-1.0215275531636565,-0.06606817963899116,-0.30424492047300317,-0.47629792243907865,0.47542543706569973,-1.2771168542234772,-1.6636704481775537,-1.1519772920771587,-0.7283795314661188,0.3390069004222959,-1.1338567559902621,-0.3887819409006416,-0.6147337556402553,0.0916325821900762,0.27497972299726775,0.2521825094698617,0.49012789123099315,1.9821127770322655,0.994052374606303,0.7401585019868901,-1.0728992562006965,-1.2108854904764959,0.01795771863137729,-0.3369150997708714,-0.34937873847584955,-0.7118802018779372,1.322854133945602,-1.3699683389443904,0.6375641053993526,0.7372171838236726,0.8031212653759656,0.3021717928381321,0.5724458408425928,0.4538509726386512,12.9,False,Hugo,PD1,Pembrolizumab,SKCM,NR,247.99999999999972,0.541101820330756,High-risk,48.80251583654434
Pt12-baseline,-1.0204561138467263,1.2819118231395015,-0.5235432231162841,-1.052931461624943,-0.2585652619106202,0.046562107914405904,-0.4960895044437129,0.31227123715585575,-0.9854491895724476,-0.5844995829621202,-0.5082920470336292,-0.6873597265462517,-0.28883889492443354,0.15688008992642244,-1.151175442218116,-0.8862822780591291,-0.626526899668966,-0.6170349063355272,0.3240072988487448,-0.36544374038746835,1.4482113124099047,0.18153822347373294,0.4421309032763695,-0.06104541273233612,-0.25665580661906373,0.6235113326155346,1.8581008422243173,1.4428533177834348,0.28820186721060376,-0.6800765807233211,-0.9600803920560346,0.22321786151134856,-0.012455585969939188,-1.1197789340467013,-1.030816795447913,0.8811981013425123,-1.2101854959704041,0.16144784822848215,0.3142462473767952,0.8527047405130583,-0.4776532785566622,0.35781357369318495,-0.27337625269131005,10.9,True,Hugo,PD1,Pembrolizumab,SKCM,NR,134.99999999999935,0.5714979564534164,High-risk,48.80251583654434
Pt13-baseline,-0.47579622459016435,0.6193278659190142,0.3653313558996989,-0.8183009824689775,0.277236324207611,1.134991171611609,0.8937109753816751,-0.3762512618924167,0.4960607532976892,1.2213137132137126,1.6062849871123746,0.8221603443375303,0.45656859797888405,1.2661574652556398,-0.2413260928923724,0.5471917611648938,0.12251109446459975,0.5891819523599612,1.3702507527410375,1.3788854809120625,1.5202089545500919,0.057867416160541134,0.32265474632321495,-0.3213211598013615,-0.033607779476305305,0.6450545633787877,2.0566068257399244,1.0761488778558845,0.9050131899962058,-1.243554262798594,0.11682537809198631,-1.0308218689425184,-0.4081182331645547,-0.2181008960758344,-0.9813074560511573,1.4847891423326522,1.3275202751252335,0.29765071026633466,1.5732991150389957,-0.7460915020091475,0.05296186061373293,-1.2104065511224453,0.05197147756825011,30.566666666666663,False,Hugo,PD1,Pembrolizumab,SKCM,R,495.9999999999995,0.37317504534123036,High-risk,48.80251583654434
Pt14-baseline,-0.7266433867727333,0.9247184259737629,-0.23352898189270904,-1.3746634391747579,-1.0122236081381424,0.011047209931404857,-0.9962597402506915,-1.7750932103371349,-0.5298255842917762,-0.15375816906859993,0.03423997570866699,0.9092502116454955,0.1615238831270192,-0.37358004490493246,-0.9396886282109778,-0.6577476302962576,-0.4978708466555807,0.9353419159759474,0.7167956110691268,0.312841360745556,0.5888237221228342,0.820835160138665,-0.33181717283202045,-0.901361336882262,0.48538184137037327,0.5400958171962987,-0.16510164406154595,0.6920142330793154,1.997615915286183,-0.3740093383650821,-0.36461795200393987,1.5892446469582284,-0.08047069017087076,0.3394941526556475,-0.7105610062667709,1.762464675460687,-0.015001392720231155,0.40256974750371144,1.5315936233159917,1.3471527148061497,-0.5427477471771037,1.4293394839074347,-0.029314889670225937,1.8,False,Hugo,PD1,Pembrolizumab,SKCM,NR,1226.9999999999989,0.543587004092209,High-risk,48.80251583654434
Pt15-baseline,0.3089506870670705,1.141344398258459,0.7566412530007228,0.7650267179880036,-0.4378371074671226,0.39340670138492106,-1.485770433594174,0.4411393827542641,-0.4487255005636913,0.22774774566036543,0.07421462589749077,0.31003053038764405,-0.22746133494665854,0.13591819878869016,-0.9473436326257432,0.23936936011573595,0.8624131773016696,0.3040588228917337,-1.1157119728423617,0.31398192892459087,-0.7240036411389215,-1.1989188907134327,-2.090687383818862,-1.6975854794949978,-0.16208614876528676,-1.0747406414994902,-0.4754115232667558,-1.0403112240100243,-0.0941100139698788,-0.8036642207064318,-1.5550090769396014,-0.14278630554857474,-0.5255793308814807,-1.441863362716835,-0.5957379585423626,1.265013100962284,0.48249292064155747,-1.0598375370357438,0.05551637232031771,0.7825844851714466,0.84681772618289,0.996200790113783,-0.8237948135024418,32.666666666666664,True,Hugo,PD1,Pembrolizumab,SKCM,R,802.9999999999998,0.3743796854754629,High-risk,48.80251583654434
Pt19-baseline,0.1511981540320332,-0.09473201956386149,0.3812304112280278,1.268096387491176,-0.5207022546322345,0.378919856847017,-1.6380431601667422,-0.049109117959977064,-0.2797512596213189,0.7923589466069746,-0.10429405548788875,0.4227303412093532,-0.03121023790255,0.7086514315321878,-1.0362956733426958,-0.11330039561742135,1.7292990046189771,-0.26669317377925916,-0.3915142393570905,-0.14497405579123074,-0.4998427230617466,-0.8869164753206625,-1.690955456559099,-1.2792916170945066,-0.8697748225003268,-0.12660315701259023,1.3683735707977018,0.5672111194742904,-0.2468648825637236,-0.9603297326638569,-0.33360149164393843,-0.2705324826713835,-0.5521083505830409,-1.3162789568329454,0.020230627929811024,0.9997318997499098,0.11819423110674702,-0.6323506802166231,0.09876402113227346,0.6608613798067516,0.6887329905558741,1.2792212312807392,-0.36463854604283624,35.333333333333336,False,Hugo,PD1,Pembrolizumab,SKCM,R,675.9999999999995,0.31702138883875514,Low-risk,48.80251583654434
Pt20-baseline,1.6563660820863384,1.6430529660159967,1.6158563682354836,2.90916286288368,1.3245036728608004,2.591602309701943,0.49087938837340755,0.2145834315711916,2.0504228281784322,2.7579590487977095,2.5078419481814045,2.6956181323594617,1.0429049243441575,2.7424041735607116,1.1583042115416078,1.3329685051958462,0.5291268740013201,1.1992693835109487,0.32606946691855904,1.0118639858573129,-0.69177126002317,-1.2606810864229065,-0.6028127147902127,-1.4711726376551604,-0.617572955040879,-0.9003521341747817,0.6293742190760622,-0.3627873205063558,-0.4447197706857649,-0.8182695790707676,-0.9540014652558947,0.3319957906738692,0.10964618593291438,-1.659051276520599,-0.4967485213731306,2.0460984374562488,2.5230636418687085,-1.4046778703157718,1.4036245703635528,-0.4977083601201273,1.4994164753222785,-0.6616845730232914,-0.5956909353051256,11.233333333333333,True,Hugo,PD1,Pembrolizumab,SKCM,NR,681.9999999999957,0.22700186812240528,Low-risk,48.80251583654434
Pt22-baseline,0.35445305114509595,0.44703978379795434,0.5585871625440079,2.3063144056468206,0.4247391402171835,1.06939357753873,-0.05326405647343259,-0.44567718766120373,0.4331208609876355,0.775869471808951,1.3003564920946071,0.274646825277962,-0.1742953126630487,0.6022388749829187,-0.736857668297831,1.2291867694725105,0.33420211803695926,1.5569561139698622,0.776750237347762,1.4675430802739935,2.1546641142714105,1.2068031849745495,-0.07180096086097609,-0.13022758334416662,1.9587681465483882,1.252717066290715,2.460938408418762,1.4053228670388593,2.4559772297477727,-1.0485744041876153,0.5294956508339462,2.0523287199710056,0.6486776049136785,0.19600490735511544,-1.0564525097309787,1.4744335639704313,1.0289174575846685,0.6764634080221453,1.3237519158018696,0.39374257061494056,1.37570527804172,0.12567680483266455,-0.14437917376256545,6.066666666666666,True,Hugo,PD1,Pembrolizumab,SKCM,NR,248.99999999999883,0.38056366448166373,High-risk,48.80251583654434
Pt23-baseline,-0.869786894449402,1.458724348260095,0.17385097050541823,-0.7873222582414547,0.1454154409886633,0.7754117278247428,-1.1074137739537329,-0.21745957353710535,-0.019638183033271753,0.5438457427988831,0.754631387335105,0.8247477291272478,-0.3924592354545568,0.4704024617191826,-0.2746664027372819,-0.09171318910280021,0.561932015823748,1.5873308500114345,1.239871155455759,1.270890618987673,1.0600969642411784,-0.22518418340745613,-0.10744308988580223,-0.3283032497572603,1.1325371392631782,0.4185921862077085,1.5909924841776575,0.8473570475957003,2.0339269143105194,-1.13559961996773,-1.4555669571112135,0.09691040830910731,-0.6521774017615162,-0.09144280894119303,-1.039184985587892,1.47442799821531,0.9789955940178313,-0.1605721762724439,1.0151509397925689,1.354695670157317,0.37607257625620555,1.738238389866202,-0.30085236210833227,3.433333333333333,True,Hugo,PD1,Pembrolizumab,SKCM,NR,311.99999999999903,0.42551809736878343,High-risk,48.80251583654434
Pt25-baseline,0.13033196176189013,0.16512278628959948,0.8329389000740205,0.6496182558281067,0.1819500886437143,1.2504209369384132,-0.7981572567320466,-0.42203127287420866,0.6041829317744659,1.6714143944954096,0.22848122251450884,1.3656677403192004,0.03801778495657127,1.317716209262791,-0.9370497373944481,0.6339276118694791,0.314433817089138,0.44698096971481827,-0.7475881598583288,0.24686484153547636,-0.8013773227609859,-1.0732823223725483,-2.5727043455678875,-1.4462777327444987,0.0711971435667724,-1.1663829243602541,0.3253420575129458,-0.22815073132858749,0.468899094975652,-1.1637805219861566,-0.7627406057499991,0.9705726194568085,-0.40611818025938,-0.8212324757117976,-0.6465470702099334,1.0893045385618698,1.2792242987935343,-1.1192242011889606,0.26520109731649466,1.0021389154303058,0.9621665248387449,1.5494910372333413,-0.6413008151539155,8.733333333333333,True,Hugo,PD1,Pembrolizumab,SKCM,NR,152.99999999999915,0.3512411288706011,Low-risk,48.80251583654434
Pt27-baseline,-0.02824593983131599,0.2896184326332783,0.525324778666927,0.19976697181346367,0.1521453830251106,0.6658443998166055,-0.7467954815434554,-0.6005672407741481,-0.02915072940527583,0.7745861935997447,0.8557694385714031,0.7028687642656389,-0.32164833826101646,0.23086420429203683,-0.19461420051385458,0.6786544695783574,0.2480307295134534,0.5213029348819883,0.1264769056710973,0.7280624281893154,-0.0835772685142964,-0.7582623250133494,0.5332629107286074,-0.6126280626980724,-0.7326375900718151,-0.05645460655369978,-0.8942420519737638,-0.2662510413969658,-0.6006902566636014,-0.7159047635262513,0.19867924840949197,1.8887379548497973,0.03892450547355268,-0.21376461048604084,-0.47119628287255716,1.5859738531297858,1.2325582598086509,-0.24844427950220588,0.4687737534329723,0.6651421184449736,-0.042731603990580964,0.9724521535851813,-0.15677219500781833,18.266666666666666,False,Hugo,PD1,Pembrolizumab,SKCM,R,1135.9999999999934,0.5083769082246488,High-risk,48.80251583654434
Pt28-baseline,-0.8414757837103397,-0.6965759783578565,-0.7130544215919136,-0.8570680382793726,0.042853424267655114,-0.4153960480432524,0.3059078030342365,-0.4094464022812159,-0.5241840243518071,-0.5823854443271201,-0.12640968283992898,-0.10596063130927885,0.7016466719548753,0.12998914502780895,0.047053033306340177,2.0168731680613723,-0.9049585333820724,-0.8630434049135601,0.9806686531737606,-1.103790035748773,0.3695722037707937,0.9074958419350447,-0.4369870927173625,1.392484810559095,0.8132479762139031,-0.5296996712573974,1.2914831084720526,0.5417747416005275,0.5570433086092995,0.8875032886144458,-1.0296384174928204,-0.11972309316506788,4.006208797009536,1.6405090952967005,-0.8598714215128174,1.34586091735988,-0.4176454727306754,-0.7252283608013564,2.2015655321825824,0.13145001642813656,1.0639989815478577,0.29933351456914187,-0.48402934434319095,14.633333333333333,True,Hugo,PD1,Pembrolizumab,SKCM,R,900.9999999999968,0.6472835036676073,High-risk,48.80251583654434
Pt29-baseline,-0.2226603247182348,0.039212927954485076,0.4882710126326859,0.6396237750072811,-0.22069645134557483,0.8018510214750074,-0.3859857839660258,-0.8911793163696979,0.22345012352394278,0.6136836717513126,0.37336920647928307,0.5451674976528552,-0.12830184237392428,0.24021414105073016,-0.4814598489406533,1.0801881760597232,-0.35222916375175567,0.8869272747536797,-0.5094097205885998,0.9236054999502169,-0.43622343492552007,-1.017863113034584,-0.608523944110236,-1.1818258945224214,-0.05390955460136897,-0.4761651747864147,0.4340939463225045,-0.21675834356322865,-0.3661272047478185,0.20037476926794376,-1.9552706109615272,-0.6264104405093914,0.01467828177238876,-1.0950485027801917,1.8070391178088625,1.4594222078268426,0.9748389023436468,-0.2027052357692532,0.8334578450108356,0.7816566823970942,1.1073215074484977,0.8935880266482145,-0.5716998725100048,8.966666666666667,True,Hugo,PD1,Pembrolizumab,SKCM,NR,299.9999999999985,0.5513578380921256,High-risk,48.80251583654434
Pt31-baseline,-0.5353508448590211,-0.6860336636448939,-0.4049405483997334,0.5459690071052352,-0.6400140882344885,0.3491708717470644,-0.7296331106931507,0.32087035774619865,-0.3401039423811939,0.45581240949104984,0.1887068374542541,0.03010013183908391,-0.3090347555083292,0.008845046876169521,-0.7721589842773542,-0.3613200554968391,0.750002909236794,0.0673075081554228,0.34414713710646727,-0.5602929769413375,-1.279279033702557,-1.4527142963116988,-0.9124790185544377,-1.140936896601554,-0.31208314371791485,-0.014422632959074802,1.549816080440698,0.7982431127577344,1.0268633146187516,-0.9749517153076663,-0.9932648228821018,-0.4188277840462971,-0.4491442868337914,-0.22841182461289364,-1.1712077786256352,0.47556271929852334,-0.010469039065790699,-0.04074640265480987,0.47173616657606565,0.9239258451496791,0.20238639122833188,1.3183039011538966,0.0022548582625788083,23.466666666666665,False,Hugo,PD1,Pembrolizumab,SKCM,NR,572.9999999999997,0.44441579490286154,High-risk,48.80251583654434
Pt32-baseline,-0.0753255204502875,-0.22947794455701687,-0.4448592952482071,-0.8830645741037709,-0.9852961611998425,0.05808162329482133,-0.692764799349202,-0.6288015090725383,-0.4178127098212345,0.1283608717843392,-0.14990554249687732,-0.9454264715090257,-0.2845163234605942,0.25831142661601275,-1.5566780874918864,-0.3187040253449498,-1.12472187715191,-0.6464008761747838,0.1328949560635796,-0.664809431897794,-1.165908905589,-0.8362252382445261,0.3385782515871619,-0.422336709663032,0.3865954137310369,1.0865246244134614,2.0628534310484765,1.6533554131297483,0.36687452568037665,-0.7757720281005384,0.26975790188642934,1.0717688175217126,0.09408050508745698,2.4572028176653857,-0.6807425173691858,1.162578188161324,-0.5480202750733786,0.05893721404371629,0.18572361001548365,0.18227435850209586,-0.9055939908535384,-0.49461660861151857,-0.21159911227007633,5.7,True,Hugo,PD1,Pembrolizumab,SKCM,NR,173.9999999999995,0.7268566861304525,High-risk,48.80251583654434
Pt35-baseline,-0.6746516920187215,-0.33579535216179235,-0.07702689380564522,-1.1848170625869419,-0.8200930934869466,0.15480489049780255,-1.5352901596126203,0.008496580777896954,-0.6027570109743722,0.08707420725420836,-0.5841588547891621,-0.18455432056205404,-0.8950194555443519,-0.19783705007319302,-1.4421701029823792,-0.058444167743158054,0.2826612815750506,-0.46746961719366453,-1.187316373220612,-0.6364638218843162,-1.0428908769154301,-1.4813705859805804,-2.0932251891071294,-0.5859602381822682,-0.2070401287896545,-0.655818701996721,0.9123090708801415,-0.8071200634773721,0.5222672722138821,-0.8746326276203865,-1.3210247690842625,-0.9735633826255515,-0.5704439162338675,-1.5786025203407452,-0.9599540548555745,1.2674506045422134,0.0802512764386849,-1.051005538002473,-0.18188639255403888,1.4813527882919464,-0.6512404022992154,1.4847396351889186,0.22818837969212433,14.233333333333333,False,Hugo,PD1,Pembrolizumab,SKCM,R,240.99999999999875,0.48104977113861525,High-risk,48.80251583654434
Pt37-baseline,0.10887037617216568,-0.18663098757573598,-0.20480249022592062,1.5393504591484686,-0.6412147812353418,0.2964236739450555,-0.6753577886529404,-0.8334376333544016,-0.0030048883011628475,0.6904897664477916,-0.2871766667805161,0.18541869775020245,-0.40345528284500815,-0.38193648988387496,-1.3139284182373305,0.3926678968101037,1.528275457986256,-0.8743897443784935,-1.3095024443793963,-0.7179695948402754,-0.9260802339951719,-0.453250125492806,-1.1801713761042152,-0.5676600490292387,-1.395161479411381,-2.3890734853728866,-1.1509907994328663,-1.6633629697998207,-1.208718612023878,-1.2413216796203912,-1.52477967547853,-1.0100611061812297,-0.38429075503990284,-1.408919015411172,-0.21890104763780813,0.8102817660937406,0.36123287096241424,-2.337556263988347,-0.37598342899682946,0.3169124241103087,-0.3480872704827026,0.8838600162250734,0.16151608325862216,12.133333333333333,False,Hugo,PD1,Pembrolizumab,SKCM,R,470.999999999997,0.30360772656790036,Low-risk,48.80251583654434
Pt38-baseline,4.786453272824522,3.791219053135689,5.296062440564742,2.840880964877937,2.1639204970182746,2.516492003553379,1.6185526375306563,1.8492669888855604,1.558324371768789,2.2316051052766075,2.3222316991990146,1.8812375190821857,2.692959113488167,2.2479223319412354,1.6899236932163677,2.4263781186778326,4.10440629734426,-0.24987427972800988,-0.6040060578595366,0.47995859350928927,-0.6838829832044807,-0.8125909344200528,-0.5710466011187675,0.06561443950936384,-0.5732824904943689,-1.569731338897099,1.0623041292851019,-0.505960685211915,0.057450920083033916,-0.9876041967383538,-1.598230035652094,0.525685530601753,-0.5863811005443748,-1.0839754612534576,-0.5085551555276783,1.8575655661809383,2.0293974892946123,-0.9610743141980823,2.1143487359865896,0.5658801772626583,3.3062962175340944,0.778179235549568,0.29719633534352324,14.933333333333334,False,Hugo,PD1,Pembrolizumab,SKCM,R,139.99999999999974,0.08844393975777987,Low-risk,48.80251583654434
1_ipiPD1_PRE,-0.430858937935185,-1.1100684947348196,-0.8544197482005395,-1.245636729687835,-0.9929538898961912,-1.005065515210317,-1.6621083286809797,-0.19761406008588275,-1.262829112755185,-1.1823861237957354,-1.0201991135288595,-1.0553176486292042,-1.5365485792756086,-1.459334120608551,-1.089134580789728,-1.3401764845693769,-0.2696418706519003,-0.9680751481290345,-0.6811607733700596,-1.0588857600590278,-0.9028859261657062,-0.880846707057711,-0.43008141899079494,0.09097044838039635,-0.8807531620506257,0.03036884420960751,-0.30566296257545106,-0.5111421482632214,0.23271653596057337,-0.9682160469998015,0.8802585345746721,0.9312748054491737,-0.03222314712092581,-0.32467067563157553,-0.43136404666081274,-0.9565357964711405,-1.2432508698456048,-0.6474011238432343,-1.5217407475373341,0.9358700375523561,-1.0137260817954976,0.9152797114759907,0.8704892349017316,22.966666666666665,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,NR,,0.4780485344136727,High-risk,48.80251583654434
2_ipiPD1_PRE,-0.10831660097406433,1.596647199840893,-0.16532428148866912,0.03564720700989343,-0.21000544637505766,-0.3515742119005826,-0.16887959341331663,1.0575907637224116,-0.391591359128178,-0.7666215165132348,0.5729316609543967,-0.815754030230299,-0.2143111984187665,-0.23450917752813377,-0.9366901012086859,-1.2082875034973548,0.16379308614477012,-0.19895418200473294,0.26529833896629856,0.26642449314573313,-0.8363759355670791,-0.47978381770886985,-0.2567700380420993,0.2846249457560585,-0.9752842680497309,0.38565347061485766,0.8259756732908389,0.7921350484234129,-0.8231277316496591,-1.1100680064139985,0.3041443063208331,-0.5120321920165695,-0.24056404417388091,0.03128253437379031,-0.016859370504943294,-0.3504877471587976,-0.7201170519629059,0.5182573170537536,-0.18722952802791296,0.7004237571098899,-0.9508578308796846,0.748877884354122,0.2680885473145917,17.666666666666668,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,NR,,0.4980728483525526,High-risk,48.80251583654434
6_ipiPD1_PRE,1.0437026844258468,-0.0039656003396260735,0.4391337031461919,0.4267881522721094,0.5073977642294751,-0.0015879986325242667,0.037853611744844085,1.2995587017166195,0.11853716386374905,-0.23029304229874287,-0.1422875944753481,-0.7900928466465205,-0.3910936743553332,0.1758297500506195,-0.3825010617490393,0.2672315359665989,-0.11132835592869991,-0.4948176253328001,-0.7170935218431422,-0.3795739577127765,-0.775537829190845,-0.5502325267531152,-0.49970005612064383,-0.009427481631337383,-0.6186016117031141,-0.4890250742849509,0.9570432623726336,-0.19452446092077966,0.020057825195428532,-0.8601876265669024,0.8679667053376016,0.23903960775962596,-0.46589715994330055,-0.9666004811299017,-0.4869946830400176,-0.19408454244141987,0.028216483027230916,-0.255439128626733,-0.6487360310075606,0.3203060215659344,0.6198688670058536,0.38041962429644394,0.6156678112701419,3.6,True,Gide,CTLA4+PD1,Ipilimumab + Nivolumab,SKCM,NR,,0.3564744969768143,Low-risk,48.80251583654434
7_ipiPD1_PRE,-0.11658985635987777,0.23351005716241166,-0.29178126348399513,0.14449625517403494,0.4311608952983021,0.5200187829117969,0.666374485320458,0.8713846429342609,0.444899823199793,0.44290355898209655,0.5276216809009893,0.21076875546666363,0.014085793768830047,-0.12022287576932679,0.26329519243388316,0.1565063128176934,-0.35056193286123793,-0.01571935588883349,0.094497686993009,0.0705191337878212,-0.27935179817068384,-0.62003217896449,-0.02361553523988567,-0.47594515160257533,-0.33838349927330386,-0.3534818868425359,-0.6085560521906901,-0.7503041910662647,-0.9889820406368937,-1.0175477065039455,1.2048350428541401,0.9604454374079745,-0.32611625382004744,-0.5778516819865551,-0.510262186912308,-0.31433625869906634,0.921626742606035,-0.7464435893660125,-0.19919680673720414,0.3036416064477457,-0.2764620262745785,0.05496784332872802,0.29564399927693225,5.633333333333334,False,Gide,CTLA4+PD1,Ipilimumab + Nivolumab,SKCM,R,,0.39988988166122474,High-risk,48.80251583654434
8_ipiPD1_PRE,0.8424797941863694,-0.06200404361047977,0.5583802087260029,0.03956982044157382,0.3379913896927076,-0.4266633092836259,0.11049841297408837,0.8064584281833336,0.13218177792086414,-0.49651209572602145,-0.5426449403648576,-0.757907008542302,-0.7486838395059436,0.02417615450731839,-0.633994872059879,-0.6636971511562758,0.4273223242597668,-1.2179649247100053,-1.3853031804744529,-0.896784110871356,-0.8947901532283457,-1.1096942958615472,-0.643298858966571,-0.3571868817700683,-0.38116591459132726,-1.058887929773953,-0.8471682264932936,-1.0859869991582862,-0.9781920880881241,-0.5493123478983328,-0.6044856913825285,-0.5192322197703807,-0.3433341649446653,-0.18479660788697413,-0.4711593780482918,-1.1795813395298702,-0.39627846459218885,-0.9200511385477643,-1.3874006737662508,1.2555431902770522,-0.2936726304951433,0.6146734507928868,0.1022934200397425,21.23333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,NR,,0.4552261016237592,High-risk,48.80251583654434
10_ipiPD1_PRE,-0.23556399029797606,-0.9931438092140694,0.1396125765515376,-0.9193717654047306,-0.7688657216484375,-0.7604455482320295,-0.7650242980383898,0.4238184396188244,-0.9353556371857961,-0.9734223875218222,-1.1752310608605694,-0.6481079195901873,-1.1348324115500381,-0.9946168440509638,-1.649939206789203,-0.5274287630005179,-1.4097538469163147,-1.3561412786828355,-1.1317802003706916,-1.0960027278824476,-1.6825394850730253,-1.2987476050475826,0.16455299448267208,0.14237023233300097,0.44339242108797416,1.089905161759399,-1.8333831984116737,0.17546052053903213,-0.7559041251241471,-0.9878508871785674,0.26850752713795073,-0.14669831141340983,-0.14231418994774567,1.2595703668187028,-0.3350027929033483,-0.9697559144441843,-0.8221811772045243,-0.34213671301903603,-1.1214736611853986,1.0219854454211257,-0.4769934016140203,0.15906042009933877,-0.6502658012077157,5.866666666666666,True,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,NR,,0.69682093705396,High-risk,48.80251583654434
12_ipiPD1_PRE,0.938891661477479,0.22221961242452806,0.1483950072828749,1.404856286840307,1.2246361936491232,0.8920547346298309,1.9169117906976156,0.8851093091202016,1.0841116854651596,1.2830927354786261,1.429756829607909,0.5027287193457008,0.37326204174152655,0.6679312898656614,1.0176782059235174,0.7473556506214837,-0.08107241184752655,1.0510307963500525,0.591950215410981,0.7474056072468427,0.52017325639306,1.472236460349652,0.45574816215082503,-0.6987203821219515,0.6298776211658705,0.5108482482690024,0.3055612625692305,0.3196765479951725,2.451692388422377,0.7880859210812958,1.042747351580306,1.706788229579019,-0.43705756650172645,2.105400272659103,2.866315915935039,-0.5740432465582613,0.9365037776613818,0.5374443526528673,0.26960556507437095,-2.367865348118658,0.6302066092385055,-2.365661291436665,-0.05817741171018143,9.766666666666667,False,Gide,CTLA4+PD1,Ipilimumab + Nivolumab,SKCM,NR,,0.3029635901546828,Low-risk,48.80251583654434
13_ipiPD1_PRE,0.31406843964593933,0.6710310386761837,1.2614516696344955,0.6417403962662903,1.6169259642151657,1.9792976758149041,1.544970851150398,0.6202640307037551,1.656254876310357,1.6188459760948708,1.5108547909847243,2.4065897262091127,1.0708657721738242,1.4176040138783963,1.5050295664024838,1.1586171549964723,1.2875397357836664,1.1769494988948581,0.6644828029004017,1.132527845662147,-0.24463508631605838,-0.9844122961274896,-0.962341696683762,-0.6617625824050983,-0.6131882351472745,-1.1732535480969675,-1.6714177601251305,-1.099314105865167,-1.1389257215647717,-1.0428050334829992,-0.29289601749721184,0.1465037308180349,0.2520473070723119,-0.8605150640258756,-0.783232157569499,-0.24147154154933873,1.8774791819003025,-0.5698842157425762,0.2131107260701841,0.5363186353874617,0.3826831460362125,0.09415017044055865,0.3075177990405969,11.9,True,Gide,CTLA4+PD1,Ipilimumab + Nivolumab,SKCM,R,,0.24617494588117886,Low-risk,48.80251583654434
14_ipiPD1_PRE,-0.45993479411317695,-0.5903668801082498,-0.23146797467163133,-1.2509267493407914,-0.8172768371888729,-0.8772352098095223,-0.1205706636665042,-1.0046400157978355,-0.8551064110100671,-0.9588670558691011,-1.452234487369392,-0.935114674353176,-0.7812563846205018,-0.8042842247166004,-1.4874747416710785,-0.9502806035958681,-0.44289983980795594,-0.5511407344845755,-0.8695735483465099,-0.2762425189479406,-0.2743315943213961,-0.4403833233239575,0.26739397262210096,-0.22953943069521932,-0.6240996330850501,0.26055629857863416,0.1531756487934738,-0.34449448824294376,0.2128404906170825,-1.1904649688182547,1.532497655211069,0.7270647329360006,0.25527436340071513,0.8777442605920207,-0.4281139692560284,-0.9794642127291008,-0.8961580627063945,-0.5998447817885592,-1.379703705758905,1.0129937764178956,-1.103348624350074,1.056548270086678,-0.2951029593937876,23.03333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,NR,,0.5184253904361213,High-risk,48.80251583654434
15_ipiPD1_PRE,-0.31534240197779884,-0.09638100341269135,-0.2639558408748414,-0.6088774135329692,-0.3554302603608139,-0.788291978707044,0.2033195829500448,-0.20060609738224805,-0.6999277917513202,-0.686966262151111,-1.495134665933158,-0.7376372533662358,-0.5159871247400261,-0.25537483032359537,-0.4323840543313913,-0.23669297145795226,-0.45267086483213925,-0.8453496809157882,-1.0474445680575732,-0.4429096868847881,-0.4877678368879752,-0.0902587773685611,-1.1893619905613324,-0.10508072010184845,0.49743553426278014,-0.04739569602853496,-0.9308820141849804,-0.15709344646551612,-0.26328158168081045,-0.6675317358235205,0.45317284175117584,-0.5358590927665668,-0.3852766287254169,-0.9447877766033869,-0.6728989877827178,-0.9803950256816976,-0.5329222840646584,-0.36528066308812107,-1.1614661530597636,1.7288929442246728,-0.5241891100555399,1.7113859165123384,0.2523880147329215,22.0,True,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,NR,,0.4946839688841636,High-risk,48.80251583654434
17_ipiPD1_PRE,-0.44592327712262303,-0.24571660667949688,-0.7513333661971191,-0.18250822995998953,-0.4649575215914744,-0.5369668249871181,-0.42320007056196746,0.7112387239835852,-0.521857462154535,-0.7181223625353836,-0.16588078075226254,-1.054569113147989,-1.0742069445736353,-0.5777204225502699,-1.370611542555396,-0.6925367187033531,-0.7909677685076976,-0.2595826928303251,-0.8057570597745998,-0.29221171365171145,-1.0087644505652444,-0.6074164965412762,0.7439617662125694,0.2793864519393719,-0.10717527235586166,0.6982716168093689,1.0490762621998848,0.8392327453797161,-0.1931235892817339,-1.0537680551434978,1.6885412008609892,0.7136558291163186,0.5974308572178502,0.467840121814354,-0.6199979885652148,-0.42200487424049593,-0.5367604005701362,0.2465406647483399,-1.0567089266820284,-0.013383228738803949,-1.0250293850198051,0.1424636946018298,0.542589491502137,6.533333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Nivolumab,SKCM,R,,0.5167865137123413,High-risk,48.80251583654434
19_ipiPD1_PRE,1.7825965633655034,0.8385291077447478,1.4699373132073563,0.9844034284282974,1.038100968968504,0.20063007644832115,0.7070367155594423,1.3733852309880292,0.5348215062659806,0.06806763437963809,-0.47393626599429983,-0.24800166388276076,0.05000143170134042,0.6644329024490029,-0.10729496828544297,0.8664929732643383,0.6543380150512212,-0.5802886003045095,-1.2842081680422637,-0.32134730482949975,-0.594213504683749,-1.049005562350543,-0.8511236651103246,-0.5697046580580214,0.48445590853217607,-0.3252673125458863,-0.011272538955658069,-0.9142851499791229,0.29230640491542703,-0.6207401992483443,0.5268389591966957,-0.3525123455369765,-0.464190069962064,-1.0275372883896638,-0.31545640134528774,-1.1222546448367712,0.38212131626478074,-0.15601676492216865,-0.6657812444845279,-0.28957752529834396,1.2446113318695748,-0.035051053234034374,0.27452454315044167,21.166666666666668,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,NR,,0.2733009081632146,Low-risk,48.80251583654434
20_ipiPD1_PRE,2.954324896284751,2.8092343186644144,3.557599636567681,1.844280981336242,3.9099888111024597,1.5072373550546383,3.0826623727254576,3.9711670199950095,2.296885181339023,1.5117650309887218,0.8174934221389498,1.3922071698363645,2.695394079204274,1.5948824012028766,2.0320057349206646,2.400581190040754,3.1308343642971908,0.06704596451863018,-0.9216375442981202,0.4156479015988369,0.228162302756445,0.06981843128226409,0.748964224791339,-0.35316263278957977,-0.19176198364169836,-1.1473254929782526,-1.2384507925092316,-1.3077743408820282,0.841572811352366,-1.019215598204627,-0.44099695903599234,0.677873078643182,-0.0615023735800622,-0.5708897859099586,0.20893089788517094,0.31424437863101157,1.147982831730837,-0.5016954505425218,0.3839233744327952,-1.2487546068782076,2.998527578356492,-1.6002975926967096,0.06913204696383904,17.933333333333334,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,NR,,0.0012740612436424326,Low-risk,48.80251583654434
21_ipiPD1_PRE,2.1101028860752065,2.7450484541503646,1.8401987842737488,1.3568938035899705,1.2835273309580597,1.3043815897891868,0.7016432022467327,1.4815851963574485,1.2649264184284867,1.0994443384495856,1.3688173940450574,1.1818583253538772,0.44608599305085256,0.9371431863773367,0.6143643665386417,0.8490506349051536,1.1019399862438886,0.16733911367765525,0.17053529286036082,0.8148436182242862,-0.13512923185122072,-0.17156370645624977,0.318526930441323,0.5999355998798429,0.748437721676256,0.5913421756386704,-0.0013260541588449796,0.2998923281455332,0.27397373693342325,-0.9992996299697953,0.519152715533214,1.4458178703523876,-0.1992996803880933,0.37573486000465095,-0.5244780216386272,-0.6950562879706759,1.285033616576821,0.4551852147579963,0.06401128676537286,0.834696338269894,0.9718575177278929,0.594677724335276,0.5731750100818762,13.666666666666666,False,Gide,CTLA4+PD1,Ipilimumab + Nivolumab,SKCM,R,,0.2868378059282606,Low-risk,48.80251583654434
23_ipiPD1_PRE,-0.7171588172658031,-1.1546905178108522,-0.8526092088081888,-0.7918226974464113,-0.3594945583513831,-0.9700031020287339,-0.39552057886324143,-0.6067555517872227,-1.128928132559514,-0.974717181315507,-0.874532823069945,-0.6796811623453005,-1.5020635526540602,-0.9953364464320134,-1.4108708445569262,-0.46426914611256925,-0.1585833295854043,-0.9700364535629774,-0.9645029153384781,-0.5141502651584511,-0.03257569712156175,-0.7799888712215935,0.6819795574305015,1.065681944077931,-0.18618651705327308,-1.1301800002095324,0.75963584051401,-1.2734056177382944,0.09434223509315076,-0.7389522609781024,-1.4186195824986743,-1.107993913371581,-0.44817228486886557,0.09836450785258727,0.17423149076550815,-0.6201217260516988,-0.7635274125507732,-0.758778277884935,-1.5741040962908073,0.5607405661289487,-1.345007520640059,0.3691112201128434,0.7845999816738448,16.866666666666667,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.512840117384006,High-risk,48.80251583654434
24_ipiPD1_PRE,0.017928637631908096,-0.38994781796603806,0.33835350889722016,-0.2039610539514652,0.5190913119786522,0.11654118479634339,-0.014482283176940875,-0.18355024913330786,0.1483579614812006,-0.09764335220704852,-0.15737833222575756,0.13008324607840557,-0.13898864547015782,0.25515981266642795,0.3298515551949655,-0.10683770256506557,-0.39052237939034595,0.42791418012405247,-0.7137859394756829,0.04646903482221914,-0.6257130032606413,-0.7724088203124608,0.8184186869613503,0.32974535347705236,0.2841217435972626,0.2686457438891986,0.11301648630933851,-0.4929498607859465,0.1844714350291714,-0.7177052438285313,1.0323676607081809,-0.038741681887154766,-0.44276630733099764,-0.17946091421841007,-0.09419271019748837,-1.1435199555461952,0.21204063941028126,0.03593343831318114,-0.6763283174424795,0.155762533367079,-0.3257803603162892,0.20144195125638387,0.31016906019227397,40.1,False,Gide,CTLA4+PD1,Ipilimumab + Nivolumab,SKCM,R,,0.4054486941282406,High-risk,48.80251583654434
25_ipiPD1_PRE,-0.6863178919055186,-0.4033479280591226,-0.5357916999571105,-0.9835557561531414,-0.6562710359426426,-0.46685920900309874,-0.3487875723272658,0.007390228894204719,-0.2768093987545158,-0.6374904992521284,-0.5896169838242536,-0.40720457257172454,-0.7605467536165831,-0.3029197011945086,-1.2763713155645904,-1.1234378923260826,-0.7637900377458346,-1.4876423406160053,-0.6692809137963749,-0.6497249228147994,-0.47634870271657564,-0.5248292102488588,0.18389189961321845,0.26335896839385325,-0.7199104010452854,0.7510225866743829,-0.10784898808851524,0.825700703908761,-1.229811482105747,-0.9658769219473666,1.4451628038543545,0.02596386449032512,-0.09639964681123918,0.11365710118211074,-0.4992641955859032,-1.0335750505848067,-0.7167717447948168,0.12692187034796987,-0.9708189168629083,-0.3309093644142639,-1.629693692558631,-0.2553209247710456,0.31936831873784893,17.266666666666666,True,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,NR,,0.5432632978605432,High-risk,48.80251583654434
26_ipiPD1_PRE,1.0787803252826267,0.5708055305444856,1.3800129227560287,1.4179951178665666,1.2039187777540536,1.370457313041275,0.6609976511521536,1.0727780830075009,1.315480090336275,1.338611467966666,0.8129264648532778,1.2027112920163445,0.5021762428611145,1.7657130310450915,0.5431547038763305,0.6322095899726405,0.4276997532909222,-0.13505813935109717,-0.4671938852380917,0.05905244539056328,-0.7230659143053088,-0.7741936616436997,-0.5938151425377638,0.10622185043486743,0.18925767213246408,-0.5094131653843604,-0.011014955247709022,-0.6851344014801896,-0.18963767750978475,-0.8887848039653171,0.4931356768586276,1.2675274893935697,0.03230466528925221,-0.20717000040196076,-0.24024098331989838,0.07653587111522604,1.178628943444323,-0.0409310451610583,-0.4484532074881827,1.2171533764760138,0.7676778750837062,0.7250025365357303,0.7656802978219301,18.133333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.32395977379430474,Low-risk,48.80251583654434
27_ipiPD1_PRE,0.9780349206095347,0.8910020064148695,0.7644408747363144,0.8115887026717911,1.1749189609176263,1.32409124742054,0.8588272366973451,0.6957480325073787,1.3383352614496178,1.1478449627300176,0.9697642399902884,1.4053633663655902,0.8439737634390112,1.185352877738816,1.0768971250616326,1.148864789081655,0.9433308046024046,0.11764651551348443,-0.3827597461733472,0.5068418347370449,-0.19889515609934397,-0.4178573402678182,-0.7293776450827453,0.001916997235495767,0.02517170210523677,0.38244378730513534,-0.8539487062174316,-0.05353503518129482,-0.11464520472369108,-0.8588848564222372,0.4494792283763333,-0.5114831727942215,-0.27366384802024346,-0.6095869941198888,-0.25877471366004523,-0.40856572090506416,1.4772314520600731,-0.3578306248706034,0.009324551420577252,0.7898282696390913,0.9934526834662989,0.8004974966575749,0.522882823210049,18.2,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.2159383993524343,Low-risk,48.80251583654434
32_ipiPD1_PRE,0.6879849560061937,1.1600467819270985,0.7058165781546935,1.6250980102910964,1.1461573437419235,1.2242498080056576,0.6864665485850587,1.0393792360701959,1.042172607232797,1.5751718182532226,0.48453750929761863,0.9426353358319718,1.0088409116383046,2.373836932040673,1.5395989989172714,0.4479472497715192,1.0755386828911135,-0.39417459668494464,0.08694081759637087,0.2718669741798954,-0.031797287119231604,-1.134121883441594,-0.26681897701661555,0.07898011103903765,-0.47094080562795604,-0.8089279320243749,-0.6235647830768423,-1.3380005576134768,-0.6370048979832069,-1.015550764119238,-0.08454165780086069,-0.4099947389680921,-0.6001254994333125,-0.8744138834357655,-0.23254186791159343,0.23008329583678966,1.5033956478921366,-0.6793928127804986,0.1136303337600255,0.7585897708135746,0.13197435150702383,0.48536357795010604,0.3682950710004982,19.9,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.2700799501429173,Low-risk,48.80251583654434
33_ipiPD1_PRE,-0.7141133052536683,-0.7009149413237303,-0.5799004384753185,-1.1425312206365685,0.10327510125689655,-0.3547674874493605,-0.0775588600413787,-0.043774778441445186,-0.2626671562009047,-0.6126141294671644,-0.21340759267299048,-0.2839976314807984,-0.19685158023489285,-0.34916667916359356,-0.14069382951185985,0.08541632666316644,-0.01708491401172931,0.26296691262734384,0.20924330274710531,0.24079117054737412,-0.3116479781768958,-0.04196459582356084,-0.3860799626220943,-0.7691931634964762,-0.03424563547657176,0.4871973228373109,-1.2107163330719497,0.18485575512713498,0.07312949390089128,-0.9100249517377553,1.4520575893647862,0.54480157856062,0.040133664771844144,-0.7284060687433533,-0.7431007211640902,-0.8257309673935946,-0.16357163645017833,-0.2687585952898855,-0.7638917975864863,0.7683184799064741,-0.6526204371885962,0.734834358655702,0.8766550628973788,20.3,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.3991061531147348,High-risk,48.80251583654434
34_ipiPD1_PRE,0.021577644894219216,0.34544448662202276,-0.13714249904856363,0.7836713438298126,0.22532154887613368,-0.13564184963719844,0.5698231487618889,0.5894182622773096,0.018313560402778387,-0.0847059469242592,0.5808451653282692,-0.4372505456085628,-0.7198040325854281,-0.34878887739545905,-0.08136772002840373,-0.2991070868511286,-0.3718446068603863,-0.19077094835106573,0.28950188678288596,0.09213559542929899,-0.5125501414106353,0.07149688645162172,1.382055568097622,0.7560213661969112,-1.1259314943629302,-0.020983936500731784,1.4202991187343514,0.15810744422711623,1.1361560149792869,0.3315257004685826,1.4455971918927133,0.3273512836033367,-0.501213920393155,0.7852654819856505,2.338731230528806,-0.1787960356317681,-0.0707727475355608,0.589407784186806,-0.49265412166833333,-0.8985383560874842,0.09538986580851301,-0.36497362843531195,0.3999030538114809,20.766666666666666,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.4041147581639361,High-risk,48.80251583654434
35_ipiPD1_PRE,0.6096246628388363,0.05847196481528362,0.04050398585877881,0.07726742448965786,1.0765563333935215,-0.21571166475001308,0.8545092375319032,1.1552581988337607,0.34080054372558216,-0.20509069720984457,-0.8318254024363081,-0.2830046480327277,-0.06009157592930616,-0.5969614522995316,0.03549972314479375,1.5134679393239525,0.05976729907964348,-0.7732698489163087,-0.9076411770289345,-0.40633950718233247,0.4362002594128759,1.042812420978592,0.4734497825511551,-1.527383114603031,0.1302014026590506,-0.4961623067501539,-1.6512528143623948,-0.9092359133644095,-0.7024636656437634,-0.5610884113566165,0.08614198817732178,-0.09752763187823166,-0.35914438198801835,0.4351580931612951,0.05745343345455138,-1.2919304923510564,0.42374171926833754,-0.7893866785651674,-1.004126948139271,-0.08000402711134261,0.5210806030349772,-0.004973420274134403,-0.0799346195094736,20.9,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.3199265072168893,Low-risk,48.80251583654434
36_ipiPD1_PRE,1.1351346496585928,1.0157021787298943,1.2198179012566641,0.6024960399563025,1.6182910255436724,1.2414051240419894,1.4478143272688289,1.7028844162502155,1.3733249602847895,0.982750238390066,1.1530008674379493,1.3391083772098713,0.9835617851436096,1.1990895251091838,1.1895139673356274,1.0896538849642912,1.22285451660904,0.330667948079922,-0.12536980578297868,0.32466226184439156,0.06318741225607775,-0.17206161663968275,-0.5664648723034266,0.2475008752851061,0.11679940313208872,-0.10553969654565735,-0.10646678993335493,-0.5079743273050935,0.1336369049051085,-0.9269117759129561,0.5123553645237005,-0.39933237002122735,-0.49648534229373503,-0.802111211306648,-0.5952662445399243,-0.7831686754698111,1.3250782951407043,-0.2167674148038701,0.45033646175901004,0.5484926446865286,0.8681925532754448,0.4906712649217385,0.02632764383099746,21.23333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.1970130917072107,Low-risk,48.80251583654434
37_ipiPD1_PRE,0.5928167337489316,1.9182960110788743,0.8647890986135466,1.3211317904740645,1.2616610675437219,1.6635098826550456,1.5789877114643878,1.0233475043915217,1.7455142105105248,1.4481458677713093,1.474082263635437,2.0723279609533414,1.147381098238183,1.905123360120927,1.23560434019849,1.040319770271374,0.8347216224229556,0.8892422420552447,0.4159724736434288,1.1341421062437347,0.01814349780085181,-0.5715942317657282,-0.07692865038868496,-0.34808200256598915,-0.5684163808132192,0.20217434257663858,-1.7455829724719696,0.28212044906458045,-0.45468574800076805,-0.8830040971234326,-0.6012929261925012,-0.8269071011114851,0.18371514115854304,-0.4354328453466901,-0.29140854796346577,-0.6005691693204567,1.8404183669971796,0.09856830233329153,0.3895431209388469,0.8222665357182182,0.7102189625896713,0.543052131851469,0.13643431271361967,21.23333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.23116223019009138,Low-risk,48.80251583654434
38_ipiPD1_PRE,-0.6523783927771356,-0.7627968500867415,-0.5902118641675089,-1.4394558891590277,0.13940346252844937,-0.5480519794768098,0.40633066645973975,-0.29884428603048346,-0.3867541490492556,-0.7980547245805745,-0.7789889345029202,-1.0426193902873182,-0.7707925364337698,-0.39789938515983925,-0.523107100361812,0.4602741272019242,-0.5663796531561429,0.4194398995946435,-0.8176549001141394,0.3115250525625474,1.2357034161030944,2.202022166082418,-0.6551829235131328,-0.2777524801526065,1.5632538416684465,1.4186472579760805,0.6609079266366417,0.9240481458063565,1.318958635408673,-0.5691235561200532,1.4904737785649023,0.6714801383018224,-0.08733334179469623,1.3228359326420636,-0.5829477721825648,-1.058779811230757,-0.6726230273670113,0.7850084530745814,-1.1528833547666697,-0.812020459854921,-0.6802583732223549,-1.2280698062904487,-0.18619470191222912,21.666666666666668,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.44360570837851304,High-risk,48.80251583654434
44_ipiPD1_PRE,1.2194010660520145,1.73048838825819,0.9501869811279193,0.5389837917081037,1.0154883017400993,1.2189241894942573,1.6142477383380824,0.8102659135931015,1.256134246668518,1.1545758836632545,0.9291220085284224,1.3247359771008758,0.3700440179671337,0.7236410297842883,0.5291874327114203,1.016061680832382,-0.12410053163504232,0.18024446212076098,-0.35058472921699846,0.3455565264527688,0.19392721094979973,0.7082326705595475,0.48985095283111735,0.9668565336730308,0.4506864978301855,1.449857791536361,-1.7635773303580948,1.1910493137979021,0.4071253094306615,-0.8747477984562317,1.6625427282521426,-0.6718020526053635,-0.7075107222521343,-0.3112620036930216,-0.2507336399511904,-0.4019926340784879,1.135625122191416,1.4127878175196729,-0.042999835609641227,-0.2112804436305014,0.4110500880469616,-0.44751207337289517,-0.14948719592912854,23.166666666666668,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.3300524649051181,Low-risk,48.80251583654434
45_ipiPD1_PRE,-0.3529595558151527,-0.7193080951944855,-0.34313912633850807,-0.12501880355662526,-0.09957542982103239,-0.6745176506791452,-0.879112733772953,0.3459954223248002,-0.44734739895251174,-0.8810236636510302,-0.839863888375822,-0.9835240892671823,-1.2964636845394466,-0.29343160655230227,-0.3876580943799108,-0.9118435056772567,0.1805091108787303,-0.6530049114443132,0.19627629194496737,-0.25723332166288343,0.23365511027483915,0.24233235903861688,-0.7182187093685564,-1.1782248049204345,-0.38771253558644425,1.2089096109811324,0.3904530247228086,1.3396112287647823,0.6783841051770212,-0.5000715400143003,1.0730215495142255,0.22144436213175872,-0.7144799308067712,0.6194744697763462,-0.7425954683243067,-0.6529956896906586,-0.8463551833965152,1.2964249487529302,-0.7725885988753287,0.48419351249033105,-0.5422205248440188,0.022136725189800324,0.28691063858450544,24.03333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.4667873783577965,High-risk,48.80251583654434
46_ipiPD1_PRE,1.6943143085818644,1.6289982602518958,1.5663755466659706,1.42102659739901,1.6714399598169891,1.1008641121580809,1.8626070989027768,1.722998441575786,1.5632662281701455,1.0003942644939454,1.2755333142381822,0.8605240862315896,0.6513981071947392,1.0905310227307792,1.002359433395706,0.9489156227691384,1.1212836161471849,0.2875546539732186,0.598757359257391,0.6722345145081231,0.961909135636032,1.0889891000165388,0.5270736227025811,0.0008129773848110738,-0.7603002791350633,0.4576210835073461,-0.040317669895219954,0.6229042201184282,0.24849218548944688,0.17778158296385707,1.029051075251766,0.26321999313818717,-0.5909527443698431,0.7693149165468277,0.9102027685920545,-0.27073324054432696,1.1917021457794192,0.5749426681271977,0.689816682443044,0.018496094426598386,1.4086244339989826,-0.4556578346270065,0.10505544017977703,24.03333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.22416765725035864,Low-risk,48.80251583654434
47_ipiPD1_PRE,0.4460932462759034,0.14219721281084532,0.3580469236633293,0.8995155802261261,1.0992406990734909,1.1246273841595733,1.4150369834640475,0.5924063460022208,1.0818710166565737,1.0264492806393883,0.8088787436067653,1.3200931168006609,0.16907993088111348,1.887176949767011,0.5595998325932094,1.0310300757446844,0.9197404712924612,0.47171656066675627,-0.755900687662261,0.14770722514044574,-0.06592272472889907,-0.031706424511912086,0.29614529590454036,0.46548565245157353,-0.9510334671295776,-0.32890872090493134,0.36895732248725965,-0.621450879874087,-0.7408399348102285,-0.7227909347573173,0.31482295426698004,-0.6542740485717423,0.033106242071923794,-0.5972547652852362,0.024362311101642695,-0.7736794739810892,1.4193720478207736,-0.8475672758087005,-0.16563020136895218,-0.3679951546209255,-0.014843685782390781,-0.6181760622274408,0.2489138666737005,24.4,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.16402129844586688,Low-risk,48.80251583654434
49_ipiPD1_PRE,0.18174980753485043,-0.6499155086471375,-0.3386706610214441,0.27769663460684096,0.03923397521651904,-0.12920494550926112,-0.1490330407836189,1.0627972182767311,0.013018102467074176,-0.19984515098000502,-0.821294491194201,-0.4284386155546083,-0.4350800797637424,0.14154013103386973,-0.04259565352150062,0.5437919088440101,0.5601983883441589,0.00475106287092825,-1.040525607268363,-0.30707460901266787,0.06894497783977734,-0.12392770837043633,0.17205184926984973,-0.43952050872633047,-0.27485511447564964,0.7369095357811234,-0.9305249456447872,0.3828328577701564,0.2794958144551207,-0.7249052242095476,1.402055310417966,0.10007993754411272,-0.5313779801643151,-0.4687887962791977,-0.7414649559513505,-0.9953080861917207,-0.12102941270046057,-0.015391575769935256,-1.0642234645886492,0.8182426186626135,0.3589623733516647,0.248377119199362,0.5068656445520123,25.83333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.26787010528820854,Low-risk,48.80251583654434
50_ipiPD1_PRE,0.3157865987194638,1.7149763025469833,0.2500088782140636,0.36726381272785363,0.7174499155667929,0.755032671766439,0.9447707192780183,0.5120026109059093,0.6440612333254923,0.1768539468952569,0.9420870044682812,1.1004398334297563,0.40056957589438325,0.22333422279805204,0.22660986334726688,0.6723003257167053,0.3764282124435943,0.2106852321212815,-0.4872589547090703,0.33998890969011253,-0.20623094751088458,-0.1673232220952687,0.018754524537100848,0.20350422469558105,0.25134288412082284,0.519561866105307,-1.3231183738071968,0.5106614852776284,-0.06457338844683728,-1.2572963358829088,1.2380574365392332,0.17232264820131313,-0.08665761739518534,-0.12840048012997765,-0.3109901811253648,-1.0158326104705095,0.7518131563296666,0.5392209367606378,-0.09806159863094904,0.9648364736197934,0.22798697152360525,0.8649383943222558,0.25207426977124925,30.133333333333333,False,Gide,CTLA4+PD1,Ipilimumab + Pembrolizumab,SKCM,R,,0.28841125573669885,Low-risk,48.80251583654434
2_PD1_PRE,-0.3038197804062346,-0.4758434029343113,0.10779822137549852,-1.1379245684935297,1.1868655915682436,0.4631052864949669,1.1908238565783094,0.20420035553679217,0.6041459481034266,0.020939813557582104,0.9044365766552072,0.1711751348101042,0.5600395327877415,0.7443232358506243,0.6067366041072697,1.1421094687998004,0.94387251306359,1.674727920670247,0.9213919461945894,1.7311819719980672,0.8631768116011274,1.0745433711423567,0.020080281261539438,0.2123579318649346,0.9772590412750951,1.593065983787833,0.2049534743273614,1.300138228626725,1.4745800398451916,-0.7797618487216309,1.415766413402822,0.42295484765263086,-0.3735098343222837,0.41637881239311697,-0.596847619400378,-0.444641310753779,0.1986456739302814,0.997371108929136,0.3499440035587502,-1.1415055518819073,-0.04166697393985238,-1.4246262914496866,-0.40672550094971777,2.1666666666666665,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.3648976111520183,Low-risk,48.80251583654434
3_PD1_PRE,-0.8577251103609969,-1.0455490814513995,-0.6828514001545205,-1.6017085336877401,-0.08338269946586688,-1.198071159739387,-0.0768334881605739,-1.0164931987330204,-1.2481202661553017,-1.4804373837358777,-1.4218220391881229,-1.2580996161620994,-1.0739850269225553,-1.192855531613535,-0.3234917335849791,-0.3030922118471785,-0.8171956996279464,-0.881130634705891,-0.728224100592556,-0.7222522619676864,0.1179434525734331,0.3737926822012425,-1.1106772151085484,0.001223244874218409,-0.522856582477844,0.3052058707533961,0.4648164873128119,0.16995658881676273,-0.8751294516494541,-0.502904187148616,0.05833219095818641,-1.146536584284725,-0.49779440902742206,-0.29931615135599327,-0.25141383747707324,-0.9597430153103739,-1.124452007221854,-0.4145121316325396,-1.2457781876009504,-0.9843394901379946,-0.6482566571034637,-0.5439699396882743,-0.3679236519152495,1.9666666666666663,True,Gide,PD1,Nivolumab,SKCM,NR,,0.5459831788951969,High-risk,48.80251583654434
4_PD1_PRE,0.04279545826245852,0.01586653056167297,0.1715947554627518,0.7610911842943298,1.485547795003723,1.2465167655777831,1.1076066673136986,0.43446621569883404,1.1870167693592966,1.2387609185434314,0.9842278777650081,0.8979487337616904,0.08736221843439489,0.7275846116970732,1.1517352180512852,0.7159311883969195,0.8848742838198557,1.1920100987787638,-0.10822938756498202,0.9455423021408934,1.1751719150002478,1.2992800641994078,-0.0858081542696904,-0.31103918835104855,1.6049758187927643,0.7640332020162408,0.05850356907408813,0.5694168493476578,0.6938487562143132,-0.12795357511362337,1.2410881255164194,1.6647526743673988,-0.1629916805420411,1.439489212472817,-0.5444701565737076,-0.4512215567285501,1.2733119843054483,0.364088729349628,-0.06196533925410027,0.43216721284806786,0.8654338486856163,-0.5006625212509614,0.44132673870196915,0.7333333333333333,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.2615442131896675,Low-risk,48.80251583654434
5_PD1_PRE,-0.5092059974152118,-1.0510409000580407,-0.608458584069654,-0.8797821840549918,-0.17900299738598097,-0.7547638746436895,-0.5264498616224039,0.5408519997752641,-0.8257245388914006,-0.9456663481485336,-1.4915212494261254,-0.9271955935373069,-0.9612591557398967,-0.752798921207758,-1.0940159897532133,-0.515012526345116,-0.019840032010398845,-1.057154748150227,-1.1377503892743686,-0.6100008476781562,-0.5682971246009391,-0.20267757209100995,-1.0382123365220535,-0.772814792239094,-0.4760652251922263,0.22421855524547296,-1.6775598978060409,-0.21490959673427723,-0.5528038153464393,-0.9898677212521111,1.0354754320237212,-0.679703422265792,-0.29244675100006096,-1.0090498727380957,-0.8445505124630589,-0.7405701782265705,-0.6587039604641794,-0.6794075246380578,-1.6327783871197847,0.2988878353435257,-0.9609914367696866,0.08687488278542423,0.3697099131415932,5.166666666666667,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.42190967462987894,High-risk,48.80251583654434
6_PD1_PRE,2.817134116624495,2.245662188476153,2.5664833293626534,1.1083951517208133,2.42949484982045,1.0225207882558376,1.85808853738478,2.4097122188620514,1.5967131602574538,0.8075980137648778,0.825369748479538,0.8470796722551845,1.5866315113225147,1.0069091262527954,1.113149155755453,1.2688597334933034,1.402873276021162,-0.12540959600765214,-1.129363543581362,-0.06182886668196632,-0.9380607785372562,-0.7260270644862983,0.7095332317535531,-0.740172091414755,-0.5671634188556115,-0.7444384960696664,-1.2057935634094905,-1.1827698020276858,-0.5389867528939767,-0.7524460708890051,0.27952751812681753,0.5270492288282095,-0.06783186684821,-1.0768462330384752,-0.37101854640525794,-0.8363403877827896,0.8576822799362068,-0.7244087212220585,-0.5246146011832381,0.342333944197999,2.2235659395917535,-0.33048550406412075,0.3019563547466912,3.1333333333333333,True,Gide,PD1,Nivolumab,SKCM,NR,,0.13901991695785193,Low-risk,48.80251583654434
7_PD1_PRE,-0.2480484027605718,1.9376996762875582,0.49554283550639894,0.1392558441233985,0.5600243110206218,1.334565768549734,0.8854730455253313,-0.6401001467954421,0.799090546626801,0.6193900932536125,1.0605855484275053,1.428707083125666,0.7329244283395971,0.3673940885578724,0.24188981645807003,0.8630007638581118,-0.4401778064459647,0.7528763258779776,0.3056952562727353,1.2167890605386165,-0.02423648391321628,0.1283078358590006,-0.09614292762629431,0.49400427061835206,0.659142080770107,0.033939301025027305,-1.6280763455982428,-0.2173517092356002,-0.06986389682266995,-0.9431524018573797,0.09909777266681709,-0.7682905640130758,-0.30749593983487933,-1.211549120628196,-0.26121741542582444,-0.41122122856238014,1.2556858102155521,0.6957795623981186,0.18917492920918133,0.7842493023804527,-0.5153219292684743,0.3563538244588727,0.589117686552977,2.6666666666666665,True,Gide,PD1,Nivolumab,SKCM,NR,,0.3986112221935973,High-risk,48.80251583654434
8_PD1_PRE,-0.99912858971148,-1.492077595875664,-1.1457919652524668,-1.6331312631040373,-0.980713513543009,-1.323735119592948,-1.2802488840417343,-0.010855302016170866,-1.2801119019178622,-1.3598780142425757,-1.6827244606721672,-1.6572702683734801,-1.2694318754162497,-1.7207106694873964,-1.6339667961460813,-1.2353625370740262,-1.0498063576674432,-1.834072621536267,-1.525523261950534,-1.4691409241208948,-0.9469838704070758,-0.5630946885658723,-0.576470144391941,0.38506154257535863,0.10267070161950932,-0.3442668465109417,0.07305059185538161,-0.9392816421177568,-0.825909790375663,-0.16213336410347878,-0.4507117007804443,-0.5331330446050623,-0.2514943842622798,0.16346601334937647,-0.5611162784008404,-0.9329714389461057,-1.5391379756906913,-0.6736512859382268,-1.8680708940994524,1.0855067265916245,-1.7266217416735719,0.5664546101163868,0.2090209883114386,1.9333333333333331,True,Gide,PD1,Nivolumab,SKCM,NR,,0.6885135707592799,High-risk,48.80251583654434
9_PD1_PRE,1.9339763672913302,1.1373003637916281,2.149095190324418,0.9049595316287906,0.7839394798770958,0.18539833086618981,0.648853361847757,0.6871430581529935,0.33447742121936447,0.10643417482899142,0.34720395428106515,-0.3546240817746826,0.0718852349677801,0.4366373695334812,0.5426586540024899,0.5437627765843418,-0.21083496326401444,0.6970340335651904,-0.5194110059111462,0.5749802679849071,-0.18412850546644266,1.2777840044284183,0.46438157736454444,0.6294222497072095,1.3678169379281477,1.1876866552090592,0.33866792657235656,0.7297294514211433,1.1067865026442354,-0.948282205581963,2.0277244699782404,1.506807184470386,0.5288804260986445,1.2949794824394802,-0.38933366675282816,-0.441925188337181,0.03157230111878746,0.6103889654400309,-0.883950055517289,-0.9639087125088772,-0.21477339017267294,-1.1077556938550075,-0.01685275766118089,3.3,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.4487423980087439,High-risk,48.80251583654434
10_PD1_PRE,-0.6257821218420853,-0.877196243476887,-0.7379658496818206,-1.1791877486065654,0.03507938041180471,-0.7811978124674559,0.6798040901796387,-0.2670968403524866,-0.4772925059736579,-0.8981788607499063,-0.9960586988950606,-0.6671542354160107,-0.34405752664101263,-0.5732706577674805,-0.7005082385279336,0.11620153815982533,0.7950342913017695,-0.30057189242562876,-0.9993532854987341,-0.24383814351824531,-0.3475481895294725,0.33123338021661664,-1.4033192466500966,-0.7807034779982999,-0.7050121948649717,0.12892887668558264,-1.47861216196944,-0.4326081408598103,-0.5799388582517087,-0.44062303843134004,-0.016352494456962956,-0.3900333645591494,-0.45830230217788237,0.06442000915301056,-0.39265113163403115,-1.5912166656496622,-0.5199736853887986,-0.6899478918577305,-1.5683328227401723,1.2277456900772161,-0.7798093654277792,0.9539968533359103,0.2468304290221818,18.366666666666667,False,Gide,PD1,Pembrolizumab,SKCM,NR,,0.39054742328692105,High-risk,48.80251583654434
11_PD1_PRE,-0.6896370583861812,-0.719889385449311,-0.9769306416899604,0.038191194142896144,0.5106689851967562,-0.47668326070813666,1.0634757224655071,-0.29265240768333767,-0.23524837195153322,-0.6319120328549999,-0.9687482854938191,-0.8344618231110077,-0.494489198329138,-0.9599762492537204,0.31552594691090585,1.0978469676207057,-0.07087858300592292,0.44473150922453214,0.613463802898121,-0.04221794135289133,1.8209780165636955,2.6507176773632386,0.380836000085757,0.5397568176445277,0.8160696270439649,0.6564272583307351,-0.27616355002702053,0.9954295085961151,0.3325446437097663,0.2824028602759889,1.0607843318839691,0.9653417960849068,-0.4928535169427793,1.381294934449224,-0.17735555481683174,-1.692842842881515,-0.4768663534757073,0.6636365101518485,-0.3917349956760501,-1.1148241494020603,0.2722008456022355,-0.7847473142180893,-0.015091440235341435,5.533333333333333,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.41435480985298345,High-risk,48.80251583654434
12_PD1_PRE,-0.963862234227876,-1.1443829648306452,-0.6903105543871689,-1.0607814276677998,-0.42954795005233193,-1.0666523323163353,-0.05973237742659785,-0.8460961769974354,-0.9519057801854757,-1.3212674594508955,-0.7472674735507798,-1.3424289046581015,-0.13395363386657602,-0.6465036355316939,-0.41646328167771307,-1.0184895433757393,-0.49752662899535377,-0.8777411245126233,-0.9747690212895139,-0.6638102397008898,-0.7469685840843348,-0.12848450939391817,0.9881335836954411,0.5195969047057897,0.1549691115877975,0.7668097452395666,0.8009150437892545,0.45372330506317277,0.7396764995835713,-0.8456761079293382,-0.15278681284126774,-1.7447065633703294,-0.5070216426025074,0.0854591780491458,0.4456017230152892,-1.266595271349431,-0.9845420748599275,0.27626526469761625,-1.2482070213126992,-0.7621979134126383,-1.1249879613871852,-1.0370692518029652,0.06798352370618468,6.633333333333334,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.5282534132763589,High-risk,48.80251583654434
13_PD1_PRE,-0.5413990249729211,-0.8414718542602532,-0.886099032025029,-0.33148464055080634,0.02591569831726576,-0.8763326160075536,-0.1307436408644906,-0.3948984013362357,-0.8052089432264987,-1.1165612556592923,-1.189513308218135,-1.18040119989118,-1.0177356078007322,-1.038325416254436,-0.6963371737648222,-1.0270752049944403,-0.9084247624514739,-1.0785760789658048,-1.2566671080393252,-1.2003822500837755,-0.003658452457493549,0.6133187518323621,-0.45855965477668476,-0.5432261640477655,-1.0940983937100877,-0.14297424396171726,-0.5077407728246073,-0.6267541106898382,-0.861791335421449,-0.5904845389808828,-0.09604661303965863,-1.2806940228082986,-0.4572813220352831,-0.4689408896694278,-0.473719081319322,-1.1119178223625978,-0.8502650858010882,-0.7568214713663446,-1.4829265934259104,0.36197898225495767,-0.881138343772425,0.18658882290387338,0.23767942081162166,3.2,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.44484838702243423,High-risk,48.80251583654434
14_PD1_PRE,-0.6124914118254938,-0.796114512928871,-0.8033918692443832,-0.5125330722830633,-1.2196354995576886,-1.0236319564818843,0.0620302843736444,-0.5630955453170411,-1.4105942672238698,-1.2583932980344952,-0.8582057898217401,-1.2300185431350334,-0.5476177444778513,-1.590398615762686,-0.8121306307484855,-0.8709103448310698,-0.7134395993508753,-0.5081288186709237,-0.29199781857583057,-0.2043225116413179,0.6689648983203789,1.0418788228685254,-0.3555034020337089,0.7941549290628728,-0.14323642510372925,-0.09064400034353148,0.4399111864909419,-0.37664229942181887,0.47699771564004206,-0.6153104399814265,-0.597882457598735,-0.23630781895602762,-0.4841046091791121,-0.8706732937910605,-0.15398745174212541,-0.7091075597731038,-1.1763292900734938,-0.31689891668123304,-1.317888431086886,0.4445129055707613,-0.8033618023210664,0.6856778971869211,0.44863183742548485,33.1,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.5371122520865371,High-risk,48.80251583654434
15_PD1_PRE,-0.35283086377897177,-0.8583749849017753,-0.39488802992284305,-1.191750804746468,0.35797757014020026,-0.8341216052353546,0.4403088650728539,-0.14376644125175841,-0.3945320789535598,-0.815161834427863,-0.8381122881334527,-0.7162213467089272,-1.2412275354774294,-0.6723544228113357,-0.2901247544565481,-0.04216923694015365,-0.4299766024046979,-0.7316173745479247,-1.2883437984686255,-0.5905814906746519,0.08355264203652715,0.2142720726061128,1.1279933770351798,0.12115421995757654,0.5536559422812541,0.00867601979989624,-0.03889768981229146,-0.29620576670576093,0.6163463248928018,0.1679579046367501,0.8333852944971981,1.0585591259572638,0.5536829994564706,1.0225284979279061,-0.20694589431590624,-1.352667862256114,-0.6006054655374284,-0.008091294760154907,-1.1707381156942511,-1.8301979856040478,-0.7356198071827944,-1.1409968815280542,-0.2420401658287665,10.0,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.49553333032002045,High-risk,48.80251583654434
16_PD1_PRE,-0.9318333925322247,-0.12360109123902618,-0.7053885950967962,-1.3842580055199134,-0.5754198350705849,-0.7193077750537608,0.013943308868314469,-0.3351077189795619,-1.016728681863833,-1.2907525907404835,-0.6289494444951684,-1.0132578094517144,-0.1625959968394414,-0.8665378137060096,-1.1830818619051926,-0.9932935859994287,-1.5343319675968496,-0.6587310563828521,-1.0724838539755084,-0.32470215876703745,-0.46809253467989365,-0.37241923332993704,0.9775487358613426,0.06414404421827796,-0.9366947693935572,1.267594714125905,-0.11386606456732848,1.2494052896239833,-0.47368790816247763,-0.9926410479127922,1.695554527036166,-0.4998723555342997,-0.3310390407274572,0.01693483211902821,-0.3127826459302076,-1.3489633228662896,-1.255749916340257,0.3962623751721429,-0.8927804583444475,-0.07977390863597848,-1.217399386182243,-0.5614272972053765,0.2146132066407724,5.633333333333334,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.5162893996118773,High-risk,48.80251583654434
17_PD1_PRE,-0.5989993105166346,0.32239779243783623,-0.3168388808290757,0.04174218860787834,0.049579767126682654,0.3789914228670517,0.6853196837084201,-0.5055153766725761,0.00436149029324708,-0.21741914258958753,0.026529419884349037,0.2699445744877283,-0.13845677648446636,-0.03210603162508507,-0.1670708835689064,0.45396045746887326,0.16783644377550994,0.7053499725684214,0.4760941238158809,0.7815897278047765,0.9897856412835047,1.2365449379922715,0.09271784746542315,1.0166864120723573,0.24817508950403794,1.1946779081673136,0.7211564573640785,1.085526011450358,1.2810472791320155,-0.7719443558417052,1.6485664612418627,0.5065669122182459,-0.25118628760122236,0.26105443792895017,-0.6925548952015134,-1.0021902181260185,0.16145729232843423,0.6759432963389975,-0.08005018164778424,0.9050571843203771,-0.2668742824777786,0.5924873435331781,0.3021875896723205,8.6,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.3347734161991419,Low-risk,48.80251583654434
18_PD1_PRE,-0.670704029830088,0.26425142942933794,-0.4799217650150516,-0.5949841514901216,-0.15237386690084517,-0.22406926379240757,0.32225923008214685,0.47209590376363336,-0.5694776991372821,-0.6189514411158188,0.06133849626320339,-0.052250470476162485,0.06955055698932755,-0.4936524841791563,-0.40617630545649963,-0.658914259816643,-0.618417974144769,-0.23029169541584096,-0.2492290909288096,0.4514950577347971,-0.5542620849646697,-0.4493722187416621,0.3842951638748446,0.37041637815695144,-0.09079689610309968,0.5917314117449487,-1.1508268019048975,0.20183279241498236,-0.3974501838331457,-1.0826008668321898,0.5448957891354987,-0.3488974972144957,-0.6654023004825289,-0.4446087199373019,-0.196117780600556,-1.5392817288374951,-0.4255341566804478,0.5597360769650819,-0.5669312694146178,0.24969428968443477,-0.8978544050178514,-0.5652190884662374,0.22613604181682834,7.6,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.4651525496571453,High-risk,48.80251583654434
19_PD1_PRE,-0.7343075194287298,0.4200136955867437,-0.7123000242881404,-1.2400493342705532,-0.2619051907696762,-0.8867913732096033,-0.5493162382284182,-0.6795041275419466,-1.0839162605119725,-1.2888611963714085,-0.9683642234343796,-0.8604462336228201,-0.6530609547686156,-0.681243579696977,-0.31477017687935854,-0.8657710482248633,-0.7205380521218699,-1.0752312666667032,0.4266603182726122,-0.39900424251405847,-0.468131825516464,-0.24484513185849155,-1.1299977708377626,0.5695732636836451,0.6396738496294025,-0.2196795363270027,-1.3906237014562086,-0.040837966350346075,-0.2904106425259401,-0.8158847369714086,-0.6800849480213265,-0.767275353311869,-0.5966756684405143,-0.5430899262648304,-0.7184259050289974,-1.2099552317450457,-0.9124704675656178,-0.36741351962676744,-0.9298388213926494,1.0937212041960471,-0.9543469309379825,1.199307042030953,0.9363855145281714,12.833333333333334,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.5712380482271608,High-risk,48.80251583654434
21_PD1_PRE,-0.9453949081842392,-0.42128040273411166,-0.5131319355990613,-0.9406201126176389,0.3223305692670661,-0.6101664292807504,0.09400743322809707,-0.3501892896113943,-0.6678407300759828,-0.9449240730087157,0.13097903903316852,-0.30492886746873427,-0.17744576531668663,-0.060999427111715236,-0.640942847335381,-0.7702501995703138,-0.3415861254748349,-0.32341584661561146,1.4708406137619807,0.710281911923782,0.8756638828162402,-0.5872968027311732,1.196514550902253,0.7426514531820023,0.04872048740378261,-0.16515648824953644,-0.7578306076851394,-0.048088122492245484,-0.5743262136809826,-1.371274915836546,0.15463860162565432,-0.9031857668842405,-0.2018255688876627,-0.5069987456636528,-0.2637259410651265,-0.7977672483808287,-0.6940607271438844,-0.14474050879374972,-0.3200013262903298,-0.4146923439742296,-0.7813416157497851,-0.5974073878297368,-0.02732595258453192,18.366666666666667,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.5316776005718281,High-risk,48.80251583654434
23_PD1_PRE,-0.19979010487970608,-0.230383161238837,-0.687960710405512,-0.9010910012554959,0.05028601967794017,0.08737487495016265,1.0314638901196715,0.06662574058113208,-0.1735288788111188,-0.6138651994235677,-0.25688331174308526,-0.12903610215944947,-0.012268745515062426,-0.21042778345855576,-0.368392355025158,0.022828916800505757,-0.8665722906732867,0.053687534988424886,0.13171381997988274,0.0692738281236472,-0.3460041991004182,0.7500741194019972,0.5255512485344567,0.2105845103668895,0.017214534192855898,1.0815651581614316,0.7803523991562077,1.0311727109252216,0.4680149233748586,-1.0257116224764993,1.394573255154493,-0.3781170007541457,-0.5145489961597067,-0.1197161781387075,0.12281438740822416,-0.9439936521057757,-0.46773340012866854,0.4512191824109752,-0.2906891068339695,-0.581598096484955,-0.8019010339321597,-0.4375374783194461,0.5229662739667696,6.366666666666666,True,Gide,PD1,Nivolumab,SKCM,NR,,0.4211460007679928,High-risk,48.80251583654434
25_PD1_PRE,-0.6955921476013874,-0.373571137203427,-0.48069735732649377,-1.045412042056936,0.7498675568555225,0.3690815841882257,1.0186518103169242,0.8027696994486938,0.43477105576924285,0.1333838833930715,-0.07563394318476946,0.09780195841340698,0.060256751759077874,-0.1639431409097412,0.36008967536264386,0.42317531151421356,-0.12021140656977078,0.34942664995483186,-0.5633533561536462,0.22503818949018936,-0.2296074675016879,0.334642182677497,-0.026683243106337993,-0.17493124427150333,-0.6568754923387153,0.7659306426051358,-0.36116171295742294,0.502918461738836,0.05215738892711002,-0.7346087044251082,1.5442789250023743,-0.7820788039075145,-0.3797317132692488,-0.01125457426499456,-0.3485445265947033,-0.7564667734762317,0.37428754528804964,0.3544887022742366,-0.613872356357841,0.4383247708221787,-0.013535071424225708,0.224248546756345,0.07546807110316901,29.9,True,Gide,PD1,Nivolumab,SKCM,R,,0.3289179448003885,Low-risk,48.80251583654434
27_PD1_PRE,-0.06514941270879837,-0.9221566728853267,-1.1232764154967418,-1.1103292794970496,-1.022121789191486,-1.382866496095859,-1.529101830804759,-0.7488713613516551,-1.7000803506471334,-1.278656578937301,-2.14957196014773,-1.4550593509481808,-1.4057023022120734,-0.9779550672925171,-1.399356426650739,-1.2677680555791684,0.6548106068801354,-2.4028046404367793,-2.2164746616209263,-1.9508527585547584,-1.1391969207431056,-0.8457324952826739,-1.7324104876785535,-0.6712390845963288,0.3838935634304981,-0.22825612110314084,-0.8804057640909819,-0.9827646270226876,-0.7913914381123083,-0.31910755356799647,0.28104205446889086,0.56311738210196,-0.48010135626965855,0.4253742140433349,0.27385583715437034,-1.7947397659184812,-1.304638439957052,-0.9329047034022029,-1.8949801809498532,0.8256992281527596,-1.594223810308496,0.7417219188536585,-0.10110141843068919,35.56666666666667,True,Gide,PD1,Pembrolizumab,SKCM,R,,0.5340872618073362,High-risk,48.80251583654434
29_PD1_PRE,-0.6028644213483557,-1.06790627842879,-0.8816249483791001,-1.3442540228877569,-1.4644625634631707,-1.7816578369730183,-1.386529607372567,-1.1517227076320469,-1.6514751447483524,-1.6373530647963952,-1.975918742835445,-1.6017088265887436,-1.2413315185949616,-1.3258889877283626,-1.1019395709262525,-1.7890300978750762,-0.7959246777651326,-2.1475839128855214,-1.434228225610515,-1.4746912616873555,-1.2666391565936996,-1.458731734999454,0.34749783160966247,-0.018545776386004218,-0.29293288037823095,-0.5454551214048846,-0.11072295012337778,-0.5073528653330274,-0.20394366879147888,-0.6343186869040296,-0.1783537121512044,-1.5655256642591395,-0.46882697208681473,-0.8892600502524198,0.21397292774883628,-0.6178279945855009,-1.4311221277711275,-0.3793390192418154,-1.9917427630013114,-0.336282439477808,-1.3541934538672147,0.05096074983280367,0.052496434461023075,27.5,True,Gide,PD1,Pembrolizumab,SKCM,NR,,0.6277013932030664,High-risk,48.80251583654434
30_PD1_PRE,-0.8917069201067918,1.0200539614960848,-0.5231903008101187,-1.2709933277313763,-0.4570242056430817,-0.4534166755342564,-0.5405753977273018,0.626437842130219,-0.7320360112154237,-0.971683557347334,-0.44454899383308416,0.3123962516474398,-0.37288446863837843,-0.601672964363428,-0.4459095500568646,-0.8443589459111986,-0.19584929687256172,-0.5674499776699917,-0.5596278480002261,-0.27528459676046074,-0.4434130817504902,-0.24534220906082327,-0.9078176302349846,-0.6135944708726783,0.7965190872858083,0.7181380456220161,-1.2489421104267433,0.7101435960732798,-0.17621985747263058,-0.8798764230509736,1.1639218677190917,0.33872321625830815,-0.0014726987354405081,0.07289612528564775,-0.033570964893031845,-0.482875349648455,-0.7944024321466516,0.8883948915024591,-0.6491234600431431,0.7438722834378809,-1.1903020311123447,0.20246397473628927,0.36740949130584294,19.366666666666667,False,Gide,PD1,Pembrolizumab,SKCM,NR,,0.4858566832871741,High-risk,48.80251583654434
34_PD1_PRE,1.5511775852542806,1.3876457234920012,0.8794135094278135,1.6097299734450545,0.9444388008921799,0.43836622840335554,0.8986393648529412,0.6943093732740566,0.5273380742173692,0.08378033230081106,0.7316965902887924,0.3600475361277372,0.6604811628642765,1.0609511443550819,0.4337041300615861,0.3035788239726699,0.5910097618092467,0.07038213308706709,-0.5120021145802583,0.2061151091811582,-0.6103497827535233,-1.2363962118258864,0.2038346496388643,0.4432115433792668,-0.05412399198179299,0.20633844649473004,-0.35040626231267874,0.17364906028516633,0.10580561216200327,-0.9281368854288655,-0.17252030729021245,-0.35906978126687145,-0.4874382518853014,-0.6371265331825274,-0.6447440766138375,-0.7763029496186163,0.413817776468694,-0.11764265818456075,-0.3915736161400588,0.08261756710016398,0.9951846706109407,-0.14329344833597987,0.10729492411200425,29.266666666666666,True,Gide,PD1,Pembrolizumab,SKCM,R,,0.3073219280327478,Low-risk,48.80251583654434
35_PD1_PRE,0.8633961415563184,1.0260301718639446,0.45398483888845087,0.4050585312102631,1.8256313813488747,0.943383002642339,2.00608993777893,1.479367892332903,1.1022850926519245,0.7385817434066528,0.2524365880776993,0.7410903322862837,0.7914329941004821,0.831211915463264,1.4011255388569015,1.913241942423393,1.5679254427879759,0.6737752119596522,0.7456144126582352,0.6332451700900283,0.7016794251486846,1.0402935587084676,1.1959470720258332,0.6379793639380168,-1.0301989034804042,0.3028126958211161,-1.373223168469473,0.3370338178413586,-0.3300842689278206,0.048270123137524386,1.119957698417354,0.6061495760291984,0.12281599736516705,0.759279093571341,0.07174621546185732,-0.5326577323584334,1.1809731916712733,0.06515840439360904,0.08533575068641568,-1.208188752979942,0.6256139630624131,-0.9673567586931011,-0.21527295939641844,36.36666666666667,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.2442631681343162,Low-risk,48.80251583654434
36_PD1_PRE,0.4918920588755707,0.6879776344562671,0.13512226481917544,-0.124135361988805,0.7634731128113811,-0.13004941656777674,0.6912647424934442,0.37088851201838174,0.2196322101829695,-0.09497956982811173,0.5882121261843869,0.27524676856051505,-0.009939493483883335,-0.15810730364496264,0.48882514802124105,0.19667953875715594,0.7688919175169299,-0.33705063262196744,-0.33399029624200044,0.28817911386361295,0.028439904545350874,-0.36340691049951107,0.30866721915381584,0.759847377402375,0.02501262806792464,-0.2967022193590256,-1.0966321661830647,-0.502002472761606,-0.7775763708788338,-1.069380160825667,0.8698420220687333,-0.22565528514852104,-0.38498029585693166,-0.6260796352442509,-0.0642915598103196,-0.7022353499859563,0.038658844640972446,-0.2761623524991266,-0.5407910447189652,0.013368545652478773,0.048379447793300175,0.11847470121562641,0.005527887161662794,20.23333333333333,True,Gide,PD1,Nivolumab,SKCM,R,,0.357344979440121,Low-risk,48.80251583654434
38_PD1_PRE,-0.4743192582005858,1.6143574469248627,0.41460454793495544,0.8961137215542977,1.148688279911031,1.4666741617143408,0.9304731577130542,0.40714672360918763,1.328527637720909,0.918927875942617,1.2094423469994033,1.9826514922551253,0.9411744164039448,1.225056563358518,0.8814704175436093,0.8731694453310062,0.6630701351157643,0.8831903106269546,-0.17816985327103368,0.9270150712452405,0.10343299046625003,-0.04655942115906669,1.4585593952900806,0.7132967355524142,0.30970202900705657,0.8810518241787816,-1.1790331742873281,0.5993406193867923,-0.03809337087082,-1.1866632639803738,0.49378936677852037,-0.44092237579337606,-0.6576339719940505,-0.4050189590622073,-0.20998367875529708,-0.7072864934812895,1.5344276442520994,0.7996262502914763,0.3938618718166933,0.11328306252470159,0.19692415054806267,-0.014714998717651947,-0.08509609798463935,51.56666666666667,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.24817090345872372,Low-risk,48.80251583654434
40_PD1_PRE,1.6186197278151435,2.075712694605645,1.2482374284094797,1.202561463858521,1.2943409232095309,1.0569192409213526,1.4398138440905117,1.5019580384563311,1.2820008126598628,0.8439424897682025,1.0051214635013475,0.9200525155440373,0.8991309817990367,1.0104171368678783,0.7437954243843131,1.048568334892462,0.6986770399336331,0.566788277617701,-0.05015528990878791,1.1314526775426887,-0.24236471723494907,-0.3642895919635379,0.9511523937975818,0.8971330396227318,0.06743508095563247,0.711884818054992,-2.062172028672933,0.3479672742114943,0.4568316481798057,-1.2338935406445017,1.4350376565970742,0.4601653507920157,-0.6714455498986408,-0.017670778700208088,-0.32807759339396486,-0.5700178324091275,0.9567119049701678,0.31876020506637676,-0.1180795644010229,-0.1522546180730129,1.005779416680929,-0.5101080514283399,0.19905761426801175,28.166666666666668,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.2435979823931584,Low-risk,48.80251583654434
41_PD1_PRE,-0.5008055810383096,0.1521812294888024,-0.3556129832764085,-0.64952262279862,-0.03417227720964546,-0.14401161438857218,0.4256120532459606,-0.6019382409740126,-0.12598406552740488,-0.46589536505247164,-0.034713035262755196,-0.004757328156686732,-0.12938401666685734,-0.28284143337505724,0.3316758179492623,0.005085526875363983,-0.030725954174314316,-0.13728622146741348,-0.14164749284491368,0.18346995659152984,-0.13281403462904387,-0.25322499576781443,0.25470776087975955,0.2825100946621139,-0.2523751651305585,0.2481653103877598,-0.6197495021543935,-0.38131159211346505,0.22588554627344462,-0.9171205995653028,0.7460905358927042,-0.8543523196658035,-0.45706487418966574,0.040703461130695964,0.16634438571445923,-0.6305868114456373,-0.07699660546337375,-0.07928836440740479,-0.5332843055036602,0.9055425421317032,-1.0126668104067393,0.8387001744402546,0.5005093133806744,29.53333333333333,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.4262222402485551,High-risk,48.80251583654434
42_PD1_PRE,0.1666273438995672,-0.3513585372882653,-0.35196917470964306,-0.06350436722055727,-0.13141795550498708,-0.49934946278732567,0.6595231066220475,-0.25806391149899094,-0.34811134873155625,-0.6623214158066336,-0.2515239890520596,-1.0504178162149203,-0.8994922913847447,-0.058966234750479046,-0.4797832369887602,0.18187991262964584,-0.13013885730422634,-0.6502002632642971,-1.0332868559352588,-0.6096165558863603,-0.2599854381922523,0.5789114714082471,1.4353127938322277,1.1031818385841314,0.8599550622823723,1.127796268618038,0.6311412017702478,0.5586343390431515,1.1886951179703147,-0.7975685462507552,1.8124956480492533,0.3508359653441349,-0.490414860004232,0.8107943477624886,0.533864493438416,-1.0826126258025244,-0.5267325100129014,0.4795698888556698,-0.7732516249083455,-0.561114282256031,-0.2711497562937541,-0.8403371161150033,0.03472023865572822,29.7,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.42138497989745827,High-risk,48.80251583654434
44_PD1_PRE,2.5759933477997685,2.060475443243424,2.2484733983294434,1.4018502586511683,2.1479439711020363,1.5933290498644246,1.9719226409785942,1.9453260774931544,1.9115319379850544,1.3862014810286905,1.92590413459396,1.3222427576871487,1.468548297661115,1.45053348247874,1.4765553738036328,1.3948191669220151,1.7242789956333748,0.1691417375784229,0.0871735904037064,0.7409293295282918,-0.5115615744051025,-0.30260091794712657,0.7287679237604932,0.5908411698019754,-0.7427480874725828,0.40944361272826507,0.031371403170527494,-0.0019280629849149195,0.005885184499934689,-0.7556483616495582,0.24592776793206952,0.09637794474340627,-0.4886045657533894,-0.3501736386090561,-0.31375287068261065,-0.38875709228460287,1.2465361817914806,0.1392036684912002,-0.11108014811688612,-0.29873727633259645,1.5824107691975056,-0.6796952009459222,0.2898917717509616,35.833333333333336,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.18662857517718517,Low-risk,48.80251583654434
45_PD1_PRE,0.34879351049416724,0.6116429366778635,0.36033955415559404,0.13963762973172902,1.4435119995233354,1.462912045182517,1.301978096942569,0.9617167905317635,1.795741407390429,1.2793227708653543,1.4152498722942233,1.380500264976955,0.6646121929561662,1.4948375953136488,1.4884072936510266,0.6797708573671289,1.5379282588073355,0.21546184322189937,-1.0716265108425729,0.3617999217445368,-0.014673243400385583,-0.2583575294667603,-1.082953708810461,-0.6239108287893794,-1.1641212425918173,-0.09404259631058043,-1.4936180841485518,-0.6347779428733176,-0.378056460858511,-0.8292231731804709,0.16283361914530597,-0.10704751837755722,0.004729871823839132,-0.3538258745847736,-0.1262133491435448,-0.6031087754435334,1.2342401061644772,-0.3007472431688034,-0.9548681920273785,-1.2544392933534,0.31159122217811486,-1.3006330454367092,-0.16952204084347658,36.16666666666666,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.149729998567512,Low-risk,48.80251583654434
46_PD1_PRE,-0.10084613469571195,0.450116421108236,-0.1905844979621168,-0.4422561320661655,0.8323256783804278,0.5069475220231151,0.8587742104999845,0.341714753346981,0.4726374329338223,0.1842278365419213,0.10957951159391088,0.44703972236226996,-0.02687767431509412,-0.00024922976597606833,0.3176750670116254,0.9878852084393709,0.6487370215995807,0.05694989997902486,-0.35570347135663455,0.38625114247298015,0.7125551663571953,0.5700296113959935,0.0015995479916102464,0.7551392844049302,-0.6414273127475535,0.06811225994395897,-0.5520310791828851,0.0006593053255270434,-0.3825062047987666,-0.6590450772606952,0.49163930836298064,-0.2502299180256079,-0.3297711272887298,-0.35906578837822395,-0.5024910090323014,-1.0391677157845947,0.53393476715874,-0.21731785557298897,-0.5862658448106239,0.771360543549244,0.23440136006729542,0.48437779551404997,0.4780059267079734,36.6,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.2681292684327697,Low-risk,48.80251583654434
47_PD1_PRE,-0.2605432765049622,0.255706630089502,-0.05947021160801158,0.05976054595390512,1.078098984776328,0.9212808899354473,1.1471112385272033,0.3184578418578532,0.9198019108107351,0.6179943738530557,0.08372944611442036,1.1231661095547552,0.3759857037232323,0.9868656585009143,1.1439980422481353,1.0252055358923013,0.886839368536428,1.6359675517063665,0.18307368603614074,1.1731583142097954,1.2091875359578363,1.940449621516902,-0.8921533205417003,-0.31558723939957717,1.5346133784982967,1.0252176615485784,-0.16090484515803288,0.10815453394939023,0.8848840419561737,-0.20647250413265467,1.539085208838996,0.29092075811914253,-0.5615456783716511,0.5798634013805898,-0.32716680984444274,-1.0580934614273896,0.9099479600175086,0.32113660639072145,-0.16119192342710678,-0.7026758016470708,0.23527058600518408,-1.0770588345560879,0.11415393143626565,39.13333333333333,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.17717642146918744,Low-risk,48.80251583654434
48_PD1_PRE,1.8680161146314413,1.5236457030757642,1.53836431340975,1.2578888018421588,1.6910407158193492,1.947992110379589,1.4844916719706598,1.255831869044879,1.7992108350194373,1.7417349498270458,1.9956850631222478,1.9836139010268607,1.4409438394523721,1.9496784873470643,1.8867495850409675,1.3586619357489063,1.2213892734651224,0.029514077029834204,0.3067488634944921,0.4545298976552733,-0.7618159230371695,-0.5326277098135432,-0.2638995941001977,0.16738166193632475,-0.9690742397700782,-0.16958713144506354,-1.2378716050832879,-0.4490495800809644,-0.6500398687766273,-0.8957529379647617,0.793286928924528,0.22801034153912336,-0.076311311110468,-0.7148890055232844,-0.32575612975691226,0.0917211749746177,1.6954041195223923,-0.20254470181020082,0.7352467750534908,0.12375714889766694,1.157517060555113,0.43875259628475977,0.33852870745135566,39.63333333333333,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.1976759742460667,Low-risk,48.80251583654434
49_PD1_PRE,-0.524012902916454,-0.09028969457346163,-0.47244646526923517,-0.29681831498939787,0.09164117799292928,-0.28423751802092645,0.6150773921148309,-0.22350147284060828,-0.17607959690039987,-0.32303231578576297,-0.6659810084878052,-0.3069452670792323,-0.3937798684705931,-0.1800119794561479,0.2063367148802797,0.16347564074504267,-0.17940747354313047,-0.11723307931135137,0.4732000914575297,-0.09079640523826302,0.07443230895556686,0.37384410185415207,-0.6015551946775157,0.2051276175014323,-0.6248260401771544,0.41701504903548153,-0.6826013412100345,0.06303434255849512,0.07852741282104127,-0.6966652624666418,1.0693490534000307,-0.2911246161688608,-0.2877530001806129,-0.7290288457897185,-0.675716819656362,-0.9444344257389418,-0.058817444578041916,-0.0681866672997097,-0.6871446783630575,0.47007147747779426,-0.8565893386246028,0.573217853312095,0.49307008186723844,44.266666666666666,False,Gide,PD1,Nivolumab,SKCM,R,,0.4148855283422693,High-risk,48.80251583654434
50_PD1_PRE,-0.5181369821943528,1.5048134555985402,-0.4646327171422019,0.5878430821766548,-0.165110882213257,0.280660130824764,0.2985432727321209,0.40303898475098404,0.08341450524857469,-0.019035856219797382,0.27479247561028636,0.5471751878225691,-0.2694317947705175,0.266516318308083,0.4170299478526071,-0.021065950082481168,-0.8735111982486623,-0.3291446863847131,-0.13584984421609067,-0.013092813917259267,-0.2390111431977921,-0.11465226393585297,0.5229371038919157,0.3961101429971934,0.30704646417460685,0.704213688348993,-1.799875365085551,0.8646525708636847,-0.34190645369382866,-0.8517437884626906,0.7335281480341742,0.05867282196841741,0.00579391985527587,-0.6864030098063318,-0.2598420167593948,-0.9513177612897221,0.3609228327554507,0.8365187690483336,0.19208144759396026,0.5790705165441479,-0.2719041156068439,0.3467141447381859,0.4120870201924908,44.73333333333333,False,Gide,PD1,Nivolumab,SKCM,R,,0.42656026472244474,High-risk,48.80251583654434
52_PD1_PRE,0.08362655029110865,0.11936930830037604,0.10204454455592094,0.4072358117588515,0.6620169402221618,0.22528367773603236,0.5871081815042318,0.13290989346216947,0.3722038218007563,-0.036823690112194364,0.37697839905288366,0.21915723050523322,0.003929244566838424,0.6083298950833518,0.3230635138516445,0.5901634415534747,0.5751032342735239,-0.21202810536308545,2.6380849340868555,1.1935646188254234,0.4852670480337697,-0.3530188189200222,-0.5179594346763404,-0.09882173233930289,-0.35909946134323983,-0.22027850279462688,-1.7344880209083025,-0.02395469988568207,-0.36884246165725587,-0.831678343402506,1.4025000595691581,-0.48714609428145167,-0.46131089762206356,-0.1930202319194786,-0.5442507987546942,-0.4312139197441241,0.3584650879924412,-0.23421531362743409,-0.2641941610234893,0.1837854999178127,0.11745810542277804,0.1593621931082236,0.2093831664572056,51.766666666666666,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.40637931851130704,High-risk,48.80251583654434
53_PD1_PRE,1.9462908916077,1.7453911339826247,1.2679685235987737,1.694002547870018,1.51523135591995,1.7255409072227232,1.896040402098359,1.0079293807570762,2.0017970780009438,1.3838393036333505,1.924641590748815,1.7636220803814018,1.5613652662669153,2.3443976242815388,1.4082717060805827,0.8845598757043219,1.3949326358093466,-0.33668918042013524,-0.5212570746098194,0.4362602237150002,-1.008021606737348,-0.26533918257160727,0.5953810465267886,-0.12122530758516267,-0.22536333467809444,0.7556642967172833,-0.5916168442285281,0.4480525702254962,0.03805252405915003,-1.2484386966906318,1.1016307081026386,0.9661002747331305,1.7339631924390198,1.3038798267079648,-0.026369034367088876,0.11073933213857558,1.1508849365019347,0.26383757994719303,-0.2047405926779894,-1.229524694009436,1.105103762792408,-0.70862853257546,-0.3186656327835483,52.96666666666667,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.23379630062746964,Low-risk,48.80251583654434
54_PD1_PRE,0.13817817767897903,0.656374057820144,-0.1486647553217101,0.9630555987430189,0.5422513393861358,0.4363851653406894,0.4502096970982992,0.9023668828223205,0.6486636418775619,0.24625933378143997,0.6931254150579268,0.8417022554228641,0.3753563187969624,0.1143485616350613,-0.029607090927895815,0.5918759713870263,0.402292441236108,-0.504839735686287,-0.5889067890162979,-0.16278697636855377,-0.7859726867111136,-0.9625136290408077,0.07019829542654882,-0.6838329185244503,-1.0527803023155058,-0.13920309890781082,-1.099655239398506,-0.4350060130863307,-0.9701417633740029,-1.1789568174876601,-0.21454512241697948,-0.43776407268063433,-0.5117018385522563,-0.07944799763553637,-0.49524908543335827,-0.8264030361380164,0.7627954212027398,-0.6980881654480097,-0.3214727075853319,1.7107007792608542,-0.3812338117372169,1.4945729001432795,0.7733123151389064,53.43333333333333,False,Gide,PD1,Pembrolizumab,SKCM,R,,0.3091489190365729,Low-risk,48.80251583654434
Patient166_T,-0.915584781286125,-1.4882039779911427,-0.8989945300777593,-1.4862729151028151,-1.3256468222681028,-1.4109175861116925,-1.0126618746829774,-0.5374279002392394,-1.416395180729234,-1.5992561334358473,-1.7262751777660794,-1.504018103526647,-1.798077385280032,-2.2117979044876916,-1.207204257882667,-1.5599093390683154,-1.2298986879518574,-2.3126166493307516,-1.333805719921337,-1.7535843089070047,-1.401001008817365,-1.3924561230977308,-1.3098151405106162,0.09614920287748016,0.06488238435592097,-0.3352624636122112,0.5842874945019306,-0.6853175123673603,-1.0838056282535227,-0.680030778819867,-0.4020583449903614,-1.168746473102068,-0.2108838054034262,-0.9426240550040769,-0.40862258044901556,-0.6315614716060659,-1.541435786089712,-1.042015943682222,-1.3936673213932977,0.5011248948431071,-1.4909676569105093,0.3724247504811434,0.7807097186160519,6.833333333333333,True,Liu,PD1,Nivolumab,SKCM,R,10.00000000000001,0.6874924663242573,High-risk,48.80251583654434
Patient99_T_P,-0.5899200231372891,-0.22536160524797055,-0.0816970706151053,0.4277127469205424,0.2769386733046776,0.252744337629465,0.22114477607648952,0.38710440235549665,0.20125369687925318,-0.09820192772970267,0.6004027871821752,0.845444348021017,0.14002825910048516,-0.366420819088866,0.01202787615298548,-0.241037046268707,0.12747692429356566,0.536099974127894,0.38946045726436435,0.9933319753846338,-0.8157514554500538,-0.5378626310801339,-1.092260987437577,0.42560967731252664,-0.16796322158372307,0.37161254914717085,-0.5922234630096833,0.042788452630307464,-0.3149300977581615,-0.8881659611298249,-0.7490703906231064,-0.7061675131612293,-0.5028935998930214,-0.37643405680875275,-0.7892649946521794,-0.5578312690280385,-0.03863170157709505,0.16952283020603767,-0.4702649182711481,0.6114976275959219,0.01552737750203008,0.40970255152899254,0.6397020479716964,30.7,False,Liu,PD1,Nivolumab,SKCM,R,908.9999999999982,0.42360824627049115,High-risk,48.80251583654434
Patient100_T_P,0.21764058171940862,0.7088678419063528,0.8204831839588818,1.0809179148774035,1.6512078146923526,3.000497540598376,1.633925004073246,1.0540480203582498,2.8771387960370443,2.9925149748498634,2.899690881197097,3.3632942265663073,1.9593486317190332,2.3475493087319217,2.6730933843251483,0.6693657441015888,0.7081892330005446,1.111943412776267,1.4104252959637327,1.5377824733580894,0.33694680008086086,-0.33575574146563275,0.6406248779075311,0.6061399835280912,-0.3856787337784435,1.1351577306173928,-0.5579294916854199,0.8549382306474601,0.5411651400206268,-1.2623936026954965,0.5722405261390111,0.958193996288254,-0.46367919961597664,-0.583532942891307,-0.5614250608090509,0.6870230480838765,2.4993200066624865,0.32603969073335665,0.869220360530415,-0.1215955218375015,0.7293271880519635,0.03613911319566609,0.32403416107611277,31.266666666666666,True,Liu,PD1,Nivolumab,SKCM,R,125.99999999999976,0.23489863230454908,Low-risk,48.80251583654434
Patient112_T_P,0.06567656023048046,0.380558265204127,0.017300386453587276,-0.17381386044264374,0.3193788037412539,0.30542370387481776,0.935104768302111,0.17300044243849708,0.5765844623127506,0.25461741411279526,0.10734523449565797,0.6326570410559598,0.21047058833343507,-0.1387683162310404,0.0998117332548391,0.6362672067252415,-0.8172114849786463,-1.167705112492783,-0.13894773615155723,-0.8592684720666801,-0.4132902117467013,0.2939200825199826,0.29158370588945376,-1.0915545655662349,-1.2005048340838067,0.263640149885114,0.04437037367446958,-0.04986501412459711,-0.7420114122945408,-0.5641213926037442,0.5399718247699025,0.33283498048473437,-0.046921516258749754,-0.2966842311546011,-0.3523715079628423,-0.5989594040282874,0.45097428570002135,-0.35017677883927745,-0.8081886913693532,-0.20679301692579288,0.02754368887374408,0.45948970245002124,0.0399951671612657,17.366666666666667,True,Liu,PD1,Nivolumab,SKCM,NR,240.99999999999875,0.4057150951369134,High-risk,48.80251583654434
Patient116_T_P,-0.8433396054974206,-0.9992298390874832,-0.8191181019512274,-1.3942371824950066,-0.573869482080008,-1.0542697608573641,-0.4510515368406234,-0.7155928039255856,-1.1971463787945154,-1.1009760832462603,-1.1487482134178288,-0.7780208024567753,-1.1304088340798992,-1.5646412532968133,-0.7269477265153992,-0.6071464317087661,-0.7283665409620327,-1.2813604132339427,-0.9768875618404771,-0.8896017225536424,-0.3356362952837017,0.007226288183918129,0.3934318249089092,0.060338741933874854,1.3725915765723213,0.47090851308064086,0.6811175865127068,0.06735593971039401,0.47482899397713635,-0.31026320513452726,0.20975835544489005,-0.5077464847664989,-0.6314579291658801,-0.35058871006601766,-0.4823616494995124,-1.0763874848677482,-0.8774304365631714,-0.3999262901569845,-1.2088387958034512,0.4983856618797477,-0.8392733357579685,0.11164452836061436,0.543001690626339,3.933333333333333,True,Liu,PD1,Nivolumab,SKCM,NR,229.9999999999998,0.5393979921524747,High-risk,48.80251583654434
Patient125_T_P,1.6209127048259568,1.8844594616887,2.256843764458546,1.986084680399266,2.3000871914651544,3.468004139215123,2.1108498524454533,2.2901477116071183,3.214982357254188,3.2462587427811234,3.2455664939986115,3.466122710319468,1.698889365128362,3.324551508337501,2.904666004484021,1.2680447862724702,1.2507107179138621,0.6667939372474396,-0.4158605762003458,0.7408967032109308,-0.8583271087700745,-1.211925241390329,-1.6942199555718171,-0.5640929603857436,-0.43735411576775557,0.22140712109663926,-0.9968913510210309,-0.5437714677414789,-0.4698570635135741,-1.1154848928453946,0.36436218750782107,0.37650564705127426,-0.616079093958066,-1.1443481283399242,-0.42226289024216207,0.7042968424873717,2.68876392204992,-0.6305036309131764,0.6796670563958576,0.5743396867118385,1.8251281378984077,0.34839031557851835,0.610773813714066,32.6,False,Liu,PD1,Nivolumab,SKCM,R,56.99999999999997,0.06488370926724235,Low-risk,48.80251583654434
Patient126_T_P,-0.21290615451461525,1.7520660175488687,0.1996410084826094,0.21615872407401052,0.3713522915495599,0.5250856704858071,0.45886596678633695,0.14399366393252103,0.46730058786747836,0.4228429014162287,0.16231747419341994,0.8298882220034183,0.002318737441708631,-0.10325034034928261,0.14613263771165289,0.3378873822120672,0.19615084122103796,0.14934037483191312,-0.35817697440905466,0.26610922632374445,-0.5112481605675638,-0.4906892217096755,-1.2142647582973818,0.18172775442798544,-0.8421935586132355,0.21308753174212758,-0.2986444483474605,-0.41549041893331556,-0.9783890681387699,-0.8244828104773709,0.2415380950707829,-0.1804734736599289,-0.4284898804160553,-0.5869905794196085,-0.6169152448551747,-0.6028776661904961,0.7840270912886131,-0.5730108578043572,-0.2792900472971693,-0.5250745042582687,-0.34411074920377804,-0.4428069455398581,0.4173943067313079,33.06666666666667,False,Liu,PD1,Nivolumab,SKCM,R,656.0,0.31402210193519553,Low-risk,48.80251583654434
Patient141_T,-1.0940543543210428,0.21306207675544336,-0.9692748067384297,-1.5086595663012032,-1.026036954588964,-1.4963707089765104,-1.48221799842333,-0.19256178942541077,-1.5116877276795393,-1.6697140406089015,-0.8565027974681887,-1.0921107027348516,-1.2580896590973198,-1.7449474842331538,-0.5274876586446694,-1.6936433035067595,-1.3645522964527899,-2.9765456603696268,-1.6204618740048577,-2.294858732807671,-0.6547464126464158,-0.8026452242617812,-1.2310191185876012,-0.017284950600924526,-1.6460659146654548,0.23920491909328873,-0.22195552205083707,-0.036150084754314374,-0.6558794996328134,-1.023218065541268,-0.11316393283700799,-0.5228550789701016,-0.5425845897265184,-0.011990042672249518,-0.5256458098147541,-0.47013428898788706,-1.6323072654554382,-0.5631769474943715,-1.192850417747768,-0.3877132329650902,-2.317538504014366,-0.5239176920410717,0.30105048923506245,29.166666666666668,False,Liu,PD1,Nivolumab,SKCM,R,59.99999999999998,0.5917535499862863,High-risk,48.80251583654434
Patient147_T,-0.7461544242568164,-0.9680074083030944,-1.0043501061519617,-1.3402148424761913,-0.9322144133381309,-1.1514761420169977,-1.3268155770971461,-0.43371097294225486,-0.989536554898506,-1.2989441478820212,-1.0411584034446848,-1.1037300309037563,-1.4235720521822077,-1.571466313815212,-0.814867508600271,-1.2525445199431884,-0.5714648557988449,-1.7566598752046068,-1.1540095943451654,-1.4768620966747656,-0.19851889586588353,-0.5490471945104727,0.8301393673743032,0.5370564224515871,-1.0108495262943693,-0.46471548412480457,-0.3474979349620823,-0.2234579068543845,-1.3048324115176968,-1.0913899579030675,1.0312270767610394,-0.8862659554925734,-0.33113266557361415,-0.6662897836734679,-0.4161205253870925,-0.9037201854499838,-0.9802086831120611,-1.0375830874172889,-1.2010963056107034,0.44940421285851073,-0.7651423290295022,0.41653790462125967,0.4206418261556346,32.0,False,Liu,PD1,Nivolumab,SKCM,R,541.999999999997,0.4597526050311404,High-risk,48.80251583654434
Patient18_T_M,-0.3674391445480371,-0.30515692425919805,-0.5330227717535662,-0.3882000838452077,-0.815081583294806,-0.7340481385676689,-0.4983542215477748,-0.5988664279804519,-0.6844024637465002,-0.6313592037185676,-1.0440788379982124,-0.33311922735673805,-1.122509593526714,-0.8197086838617633,-0.8169477504964439,-0.6485567374872094,-0.22904446255219937,-1.9475782850461756,-0.6071320512566042,-1.0276682972219473,-0.3986812555036752,-0.8651213871469228,-0.6618185944599551,-0.1881363979119663,-1.3517128612574345,-0.9145667864021928,-0.8711890928919368,-1.5773778055004706,-1.2561956391423628,-0.8050735369688414,-0.7636730195133336,-1.4879091335746992,-0.6459643229075762,-1.1509296824647375,-0.9551596822112568,-0.7013727029687947,-0.20342087374744702,-1.7855906947801434,-1.3398806502535447,0.7798464475193897,-1.0025472082744789,1.1513724049554181,0.864539078094687,4.333333333333333,True,Liu,PD1,Nivolumab,SKCM,NR,341.9999999999991,0.42702637729634296,High-risk,48.80251583654434
Patient181_T,-0.3608562685660922,-0.2391101448022266,-0.3228584155618292,-1.3783935911457574,1.2204037682230577,0.4119794732826942,1.3242464604091557,1.4864348610620657,0.6053561375240495,0.514803457369497,-0.0945335542101101,0.4131561614108272,0.3794294296576417,0.33567187829772344,0.5886202110476539,0.7057487537143152,-0.15301290470561954,0.16474655886003078,0.23151976527521534,0.12790977196411119,0.33218572764396875,0.848902740034663,-0.19863353988551458,0.08474117632740666,0.48197942716632214,0.5482612467396036,0.4678963279271006,0.20177190704144324,0.021666652940005523,-0.4213628304954127,1.3631629426990217,0.3749423639007469,-0.3943939203904046,0.6280936833575298,-0.5953721407268953,-0.7552390934371437,0.7539162735434306,-0.05297578372259839,-0.024496193553288914,0.026047872135087472,-0.28821893685011757,-0.05990804917981749,0.12519178246049475,15.866666666666667,False,Liu,PD1,Nivolumab,SKCM,R,274.99999999999847,0.375544014873043,High-risk,48.80251583654434
Patient185_T,-0.4224014049981631,0.15813615892497992,0.01155038624558761,-1.4336065975206493,0.08497860289929095,-0.06856246409437323,0.4042628334001293,0.8911125838625963,-0.12066624025398776,-0.27897558813296797,-0.1801297577283093,0.10485571741820993,-0.1066154218607627,-0.795335348871157,0.016469600071480777,-0.042976832355680034,-0.287853280073398,0.008071830180137173,-0.4428577792638611,-0.22189645855088358,0.1262889478773362,0.8106662209422778,0.025244651269115532,-0.23356795490610427,-0.2215457842810028,0.41233152109946103,-0.059189683025889644,0.14034060531842457,-0.8530999753984515,-0.2506539938225577,0.29018894520594796,0.7090215873974298,0.12035337039580972,0.39648065112891134,-0.7164818775591982,-0.8185551091394847,0.024093873656008857,-0.3919272045741441,-0.8766280465860213,0.4090613635949126,-0.31084148089906954,0.48978084749569506,0.2334228906867864,6.766666666666667,False,Liu,PD1,Nivolumab,SKCM,NR,156.9999999999997,0.44832038038860234,High-risk,48.80251583654434
Patient191_T,-0.010650070404166299,-0.266157214657639,0.01198744883329118,-0.41847170296650416,-0.11768338182302689,0.05400735815279565,0.37766553767728034,0.6237673759595223,-0.26078456365427694,-0.24348508590704085,-0.02385814898424172,0.35842754416086936,0.01153040721698544,0.38939798079739796,-0.04460197332788486,0.40385374797299206,0.3446219645938889,0.0714466088730429,0.20135748298794892,0.5767926772780155,-0.10392892199175575,-0.2788845677836238,0.7758160786721789,-0.5238522631590405,-1.400975440203007,-0.2738245868033566,-1.0719831686551446,-0.16049440527609948,-0.6949001665089983,-1.1899851635351992,-0.46682052330334073,-0.8317159735752381,-0.4052415274761908,-0.18556336105335172,-0.20537413570731522,-0.9860101899715579,0.12490093842875645,-0.6659319891797021,-0.28480774602518694,1.2305081709212073,-0.4989858406886236,1.3252912801830596,0.8395858941681753,21.933333333333334,False,Liu,PD1,Nivolumab,SKCM,R,4233.999999999985,0.3325653631161167,Low-risk,48.80251583654434
Patient195_T,1.5110365259338663,0.3565084923040291,0.7520012867158797,0.6667657894153893,0.22235647666153863,-0.014228268228792331,-0.14245261133000744,1.4694283931636245,0.33945041018397637,0.24440867913584938,-0.24068666382990972,-0.5717631130944903,-0.3204896684389928,-0.18362001194559419,0.47455688975633814,0.5576186704615476,0.9497857404767414,-0.8646033894578673,-0.7107191726037072,-0.558549985999034,-0.24153475809974592,-0.004696096230997108,-0.24187729909387987,-1.1721838004996294,-0.5664877658475208,0.3825234424920408,-0.5408479531065498,-0.28372296395110164,0.7265084442363939,-1.1331403194710454,0.19796878433730744,-0.2363835353102074,0.12523045051079537,-0.08582629561907686,-0.5651501863493711,-0.9072334488180113,-0.00578788506954651,0.10779124042044484,-0.6786340018935613,1.2041003919353135,0.937004250012718,1.0182289927455408,0.37604041154875967,29.83333333333333,False,Liu,PD1,Nivolumab,SKCM,R,1962.9999999999905,0.2820219317726807,Low-risk,48.80251583654434
Patient20_T_M,-0.0008522911298203805,1.1134997969336085,-0.23512634871730953,-1.0780482108081548,0.08944701673917906,0.8426587765203355,1.0434961868543327,-0.6234739267216866,0.4270402504172209,0.4682012482367868,0.41902172342645,1.9144273463335617,1.1159820640214082,-0.05880813845995973,0.6569346376246138,0.4433855374637852,-0.32502781983987367,0.8755524128527672,1.447040609984467,1.0170745963103451,-0.3769302944262158,-0.42517406947268027,-0.6930353494793913,0.5377631254876093,-1.0591369569375724,0.34201515545811806,-1.2096565112449424,-0.2685543020624914,0.21382216869637988,-0.6261050290094242,-0.4860569384041074,-0.251956968861342,-0.48518291566149174,-0.6045035211691919,-0.6103741682384007,1.020057699282926,0.6705434000938744,0.8777726755142178,1.48743030341865,0.8512575378670061,-0.5153436977995615,0.5830151027735344,0.649741738453935,8.066666666666666,True,Liu,PD1,Nivolumab,SKCM,NR,393.9999999999993,0.47974561627794143,High-risk,48.80251583654434
Patient22_T_M,-0.972561909781397,-1.2937462154598147,-1.0819964963886082,-1.6023049627551091,-1.1004681249465795,-1.6587631872960664,-1.8465857295643935,-0.3475600506318188,-1.4747650960646412,-1.2594938872076273,-1.704573289711747,-1.381969465925738,-1.4225212936579206,-0.9300400057150021,-1.4038638366459806,-1.4878636662315987,-0.18284638961126068,-1.2638505443640118,-1.4588978141764386,-1.0007542009884403,-0.5873561032153437,-0.725708714990954,-1.9403925735937657,-1.4248566631324664,0.678776501341595,0.06255625612515196,-0.20835057655531758,-0.906447112979407,-0.6160890726015937,-0.5623305956353344,-0.6430606820334668,-0.6389869265716198,-0.4258259464563782,-0.2875439742134489,-0.10711418680235794,-1.0359016659218794,-1.4575247521447456,-0.8527416579897348,-1.7362313112851024,-0.22010762308094542,-1.191530521289369,0.036903364933085055,0.5167322859305857,8.433333333333334,True,Liu,PD1,Nivolumab,SKCM,NR,57.99999999999999,0.5239639145478797,High-risk,48.80251583654434
Patient23_T_M,-0.8761883573166311,-0.621677709163591,-0.7792123583951135,-0.5258070941323453,-0.8756668485202758,-0.7987015620923117,-0.507532828933402,-0.23281931101578504,-0.8631971074788638,-1.0365544731134435,-1.1757542982804894,-0.7454143745756147,-1.0221915015706173,-1.243987108577788,-0.8420362604877687,-1.4139761898694168,-0.7594361640694725,-1.4726870661543998,-0.7797943325218566,-0.8639730037769666,-0.8077200763075523,-0.4736736941552351,-1.2826230760295727,0.18640052726249473,-1.0949404429866376,0.4244949862856237,0.2786192222612283,0.09496351325821388,-1.0361286122796214,-0.9108465657341062,-0.23889818064834986,-0.6730774719710411,-0.4232935511422649,-0.6533082091391462,-0.4709773522408967,-0.7869950655493781,-1.241674048495047,-0.2709798537821784,-1.5844141062627748,-0.009152316519298067,-1.248248223409,0.1487658235766562,0.697619112287449,32.5,False,Liu,PD1,Nivolumab,SKCM,NR,131.99999999999915,0.5482498019553513,High-risk,48.80251583654434
Patient24_T_M,-0.33364990959982915,-0.7856683549891719,-1.033279498364157,0.2881132087592387,-0.9409089208655402,-0.4627587910450921,-1.185420488669086,-0.0861220698144939,-0.8552202583873569,-0.6576816203449465,-0.5912609961799151,-0.9751633946403437,-0.9820955909716944,-0.7494544828193362,-1.3037060581667408,-1.234857179354055,-0.19517188870265492,-1.3123315463814749,-0.025626071839214098,-1.0089789172661565,-0.6546616295403888,-0.27455690267076505,0.9195395405530432,0.3937327848184688,-2.8715405274846675,-0.4094383744691265,0.7510596021852891,0.5493712926000537,-1.3404236753944387,-1.0447940861761118,-0.44466800244545607,-0.39366660392673014,-0.649587869684403,-1.3129310118840134,-0.4478337021239536,-0.6951620486383957,-0.7689982240023092,-0.2450969020544285,-0.9540869989026087,-0.16517767513200396,-0.9239400513350707,0.10802344081665204,0.5245393228249162,4.566666666666666,True,Liu,PD1,Nivolumab,SKCM,NR,275.99999999999903,0.45452950718225765,High-risk,48.80251583654434
Patient35_T_M,-0.6800141219476665,-0.8129790639828329,-0.385184419171695,-0.9129529999834501,-0.17435525717279882,-0.3795015320451643,-0.4844389705508358,-0.1595611798027038,-0.03702060288239544,0.028228584665079492,-0.8003077342767201,-0.30572191859936887,-0.8356884908448339,0.08057622120428848,-0.6012590694216158,-0.6267828979127279,0.34075425480805893,-1.1101944710152805,-1.7982088807194467,-1.0951807997674956,-1.0580225473687088,-1.4613446283050089,-2.2310540479615004,-1.3238014314717204,-1.7707637257612858,-1.6677698606692404,1.3625294947300006,-1.6069479991594813,-1.1510647134744816,-0.7833026707422935,-1.8540757212452477,-1.3827333564708768,-0.3027124929781249,-0.89449199845452,-0.5371516320022849,0.34732237957849327,-0.13660852618438446,-0.8711300464673837,-1.4776250493874186,-1.5575325305397598,-0.389952903128578,-1.1323104610010568,-0.15085475893507932,32.266666666666666,True,Liu,PD1,Nivolumab,SKCM,NR,38.99999999999999,0.39517730730483563,High-risk,48.80251583654434
Patient42_T_M,0.055076881002363395,-0.4488443762615972,-0.031046738582598203,-0.4098488476564027,-0.4633884783058694,-0.42471274266109627,-0.11793617084943339,0.8099472952104567,-0.40920265358697816,-0.36862992354934937,-0.6301485118085934,-0.4130186269906738,-0.5766773247450293,-0.3109024292751965,-0.6733320647465924,-0.32237841124080446,-0.3900397893464107,-1.2081332331624859,-0.6899965354932263,-0.6088601456873789,-1.010018217532017,-1.517382912691293,-1.0888062436291663,-0.087786137970645,-1.3635726045089018,-0.23370204846716208,0.04408925398882364,-0.4717935198605271,-0.7659428331444492,-0.8891108712353405,-0.320755023898936,-1.0770540164320477,-0.5627941025961728,-0.7913052086550136,-0.22005777788602776,-1.0500603835071523,0.0002596010510369387,-1.1565975563010975,-0.8517003896001532,0.8781611699359976,-0.29331302299297796,1.0776923521425112,0.6792760145464256,34.233333333333334,False,Liu,PD1,Nivolumab,SKCM,R,506.9999999999977,0.4250024524345508,High-risk,48.80251583654434
Patient45_T_M,0.22710604879737892,-0.2989361444885989,1.1596510194456273,1.0069718166622228,0.4183068729444813,0.5609694427988424,0.3862044528623934,1.3106450313992835,0.3113758843114346,0.4840769872137234,0.1189792053112058,0.5061478834568676,0.1868774599988818,0.4067135260637359,0.330902485944108,-0.36798953742658774,1.4018054841043464,-0.14585024858109497,-0.029355571570273995,0.32714250109664134,-0.39672831025316935,-0.8365344174457426,-1.7431803964324297,-1.024285753206939,-1.2482247044582109,0.1946499553528989,-0.4373628565781638,0.1317072522563525,-0.8055380051580048,-0.9628031544622904,-0.5814520495021887,-1.0562286087273172,-0.670650725163578,-1.0119877282960874,-0.6647408450838447,-0.69240485420134,0.4918649820563595,-0.4969793678362957,-0.44735487148267966,1.0150170142777861,-0.4101523494452354,2.0073448413407724,0.06181282932618688,55.53333333333333,False,Liu,PD1,Nivolumab,SKCM,R,292.99999999999915,0.37966703080599273,High-risk,48.80251583654434
Patient47_T_M,-0.6889352036223009,-1.3549364610122705,-0.7873805259913695,-1.240866765416142,-0.9087607481105607,-1.3342345028044817,-0.7015739888494029,-0.19979860503879873,-1.010010689291595,-1.0435684018273517,-1.3599471727933607,-1.1715116856527175,-1.5645030795283945,-1.7574924439767319,-1.8420399639637617,-1.1018330402531809,-0.7662730774345812,-1.7958246638223252,-1.5201731646327716,-1.4512276595786593,-1.2797524316758677,-1.2970197442580151,-0.7820782042368863,-0.6032590005323445,-0.7650140086522748,-0.5740079312060532,0.41161098937928586,-0.9438075805439858,-0.8798333174741081,-0.9706691597278858,0.4571228753758209,-0.1253455898663848,-0.19771071543197158,1.1701899485030702,-0.7271330466683282,-0.4415621524362359,-1.2834031358677642,-1.7481777672260717,-2.08286613161566,0.22857260923357461,-1.632959383783393,-0.401023624537316,-0.3680551025070587,31.23333333333333,False,Liu,PD1,Nivolumab,SKCM,NR,755.9999999999955,0.5975956942796772,High-risk,48.80251583654434
Patient56_T_M,-0.7926880107300146,-0.740747324449095,-0.45085428273541694,-1.1625910395816885,0.6632389381069262,-0.09436174421991392,1.624279072607106,0.4147330236072848,0.15321454013825875,-0.23273838769182342,-0.538952567854283,-0.01213706225545693,0.11059417850975091,-1.0408374309495714,0.8944754463910723,1.492280227850828,-0.031108662171295855,0.4226016531034695,1.166760021349171,0.6142463786399992,1.6783910406357871,2.660666254008112,-1.1096686427956777,0.11534351483270289,0.589920715593435,0.9544924611636999,-0.08698470570630615,0.3213930497088747,0.6170215506173651,-0.5081119075935676,0.23931083029981678,-0.37774298409210366,-0.05267038900104926,0.1877495211870203,-0.5396974074840377,-0.8120818125763297,-0.05767023810670599,0.29975828020970874,0.41893667673171764,-0.11615247392451093,0.5792430017150415,-0.019699811760336795,0.26517067501286257,4.066666666666666,True,Liu,PD1,Nivolumab,SKCM,NR,17.000000000000053,0.3812288899652382,High-risk,48.80251583654434
Patient62_T_P,-0.4610122453996966,-0.07620573205091073,-0.5212768678854282,-0.17751934107980202,-0.4122523462327078,0.03716660654406928,0.29693345166439855,-0.1236556150473334,-0.2565116333557229,-0.3707465924609626,-0.3389396780868267,0.8592397370959726,0.5159106846396679,-0.2370015233127506,0.050755215907221665,-0.34884482195079997,-0.06545510230151075,0.09674056694216118,-0.19030130528199826,0.3503487654197578,-0.29612179387756865,-0.19053358367842202,-0.8822051315629807,-0.43501026532091247,0.22013756636740545,1.184861742413871,-1.0997575434097588,0.3976961177342025,0.06437145668957613,-0.8654919250434224,0.6237537638617502,-0.835286410188454,-0.6613396406086133,-0.6059097793888045,-0.5672843301504,-0.7993008968330052,-0.11434433942412592,0.9259388550188257,0.3512443931722324,1.2273236027444576,-1.026631058715906,1.0941881327021874,0.42672692793639344,33.36666666666667,False,Liu,PD1,Nivolumab,SKCM,R,6248.999999999961,0.43520994237400606,High-risk,48.80251583654434
Patient63_T_P,-0.65316051663453,-0.3371952736489574,-0.22726651196186937,-1.159564471112561,-0.40318857721857626,-0.6289128891208674,0.14979014736224053,-0.206445218588985,-0.6395380123515534,0.15828678120146636,-1.5918189576696227,-0.451257670278137,-0.49590949668615936,0.14883128242420848,0.03220026791399904,-0.9467278577869301,-0.4519112719526677,-1.3498956181663577,-1.2447494540809487,-1.0971171493162868,-1.2521244681499248,-0.8833034313995766,-0.08876675196019287,0.04490872282055678,0.5850178141709054,-1.8797771549449656,-0.7155128013993782,-2.440496963313294,-1.0141196381485704,-0.8702726095443764,-1.4341394325663241,-0.3439595066056117,0.4151969191341012,-1.4444055402548963,-0.5377014206478928,-1.3213377422702441,-0.017759324563741782,-1.9872466373085265,-1.157860869332571,0.632688822268906,-1.544504936237046,0.17931324532373757,-0.38556450460265396,5.933333333333334,True,Liu,PD1,Nivolumab,SKCM,NR,83.99999999999963,0.5539378305336018,High-risk,48.80251583654434
Patient67_T_P,-0.73628220578144,-0.6766833876139737,-0.6771177900045854,-0.6404174184645925,-1.1911696948503991,-1.1586741847367206,-1.086476376260444,-0.8985943905238135,-0.7364571739503726,-0.698050903995412,-1.904953394085332,-0.9641452938992814,-0.9343201615976717,-0.6294230233097403,-0.7129653730576335,-1.728506997708895,-0.23043752472835943,-1.3068715565131284,-1.2974339479051278,-1.201318622112369,-1.0836251593947799,-0.17177866676972045,-0.6774686199021741,-1.5756146260949313,-1.1652143849337935,-0.7769943334929984,-1.1754774517603692,-1.2724519890775705,-0.8844337117607001,-0.5451165700759557,0.686692037697304,1.2908402294111563,-0.0430811703354247,0.04877429985208917,-0.7508616655956886,-0.5457439552808897,-0.9922361731498335,-1.1709266776895935,-1.7231702747914657,1.4547891139719067,-1.7530141989213934,1.0567228291244208,-0.4907900653015816,4.533333333333333,True,Liu,PD1,Nivolumab,SKCM,NR,73.9999999999997,0.5453387980829838,High-risk,48.80251583654434
Patient72_T_P,-0.4876771942441823,-0.245944347198858,-0.36130395868632964,-1.444716601723162,0.4311006259401621,-0.020538457162934863,0.44359952929252766,1.146214423655672,0.4001301057481983,0.3163679109249642,-0.7863405962249589,-0.45295616394919963,-1.0166950987235517,-0.2935647158000926,0.27442694368168286,-0.2089960187678357,-0.7690102493450155,-0.7686126094110551,-0.6013760050770336,-0.8486440373675552,-1.030591914343259,-1.1620810508789012,0.22031936731502383,-0.10423094345246384,0.04235308440560242,0.19283319549946087,-0.1850733237262411,-0.07822905906066985,-0.5973207392523128,-0.818673139690726,0.4607672275900519,-0.42785202066306544,-0.5693231624586469,-0.6093855961134884,-0.36874374890555317,-0.6807722032030415,0.19814185469845152,-0.7544464385922742,-0.7321372350677358,-0.734669759738903,0.06459022351682553,-1.152154143421768,0.24283726389763977,13.166666666666666,False,Liu,PD1,Nivolumab,SKCM,NR,120.99999999999994,0.45623910157316344,High-risk,48.80251583654434
Patient73_T_P,-0.8092435800667993,-0.7781155775841535,-0.6509103842607065,-0.8222129657094913,-1.1439587286772734,-0.6881805458304512,-0.6676149396947252,-0.7647616714427247,-1.1085739094974865,-0.8558153348270966,-1.4503929158089244,-0.8877885595159335,-1.0692950125995595,-1.312263874386429,-1.3847151701097167,-0.9510421151944833,-0.5465978635661084,-1.144187754288606,-1.3976573877448424,-1.0262838419749276,-1.0760924038121438,-0.6026901954626129,-1.9355885534772241,-0.14847272090267055,-0.9479478918661356,-0.31061936590706973,-0.9458057653630398,-0.3093006668447164,-1.4434607279865241,-0.9065196365588534,-1.2591837370591366,-0.9943865749767743,-0.39973711078664403,-0.4896032941012475,-0.1735279913501928,-1.3091574545424949,-0.6186050424515537,-1.078599141909283,-1.4837187670375342,0.6939640500338716,-0.8056802337728641,0.6651138791831742,0.748650790952856,28.2,True,Liu,PD1,Nivolumab,SKCM,NR,89.99999999999994,0.5155871920342542,High-risk,48.80251583654434
Patient83_T_P,-0.9037255819765748,-1.4272773921983453,-0.9584935572043817,-1.5943312118871935,-0.5044561292373831,-1.098924215405151,-1.198921144408105,-0.20836642474672226,-1.3505770987153323,-1.147185869916678,-1.4328630477904067,-1.219730998497619,-1.4975273444867894,-1.3375575207454706,-0.992206804949491,-1.5209927796607652,-0.5401756057214213,-1.4281143951047492,-1.9028799215336274,-1.3817509155439998,-0.19896551166066348,-0.47150710628741155,-0.947595650539223,0.13532520538176832,-0.7721831438605855,-0.5409755945740641,-0.37201713618010823,-1.0603350022987104,-1.2024244738784968,-0.7717815377369588,0.2812851937695007,-1.1595594579523467,-0.07124768267776771,-1.581508880197069,0.09188679800053692,-0.6948261641824077,-1.431878640060516,-1.2844381389733084,-1.8870896112981392,-0.3204741934008146,-1.2196145926249462,-0.48970973551634756,0.29785954628717365,2.3666666666666667,True,Liu,PD1,Nivolumab,SKCM,NR,193.9999999999995,0.4715475483048657,High-risk,48.80251583654434
Patient9_T_M,-0.5433606252289571,-1.197127876436404,-0.8274008096186407,-0.7178759210793598,-0.5092679091460808,-0.9482536062490283,-0.6336025883342461,0.056273262770702916,-0.7004500253380841,-0.8835694016086004,-1.1311665058712215,-0.8962526146764404,-0.8197060771693594,-1.4742289987608426,-0.7361833492182658,-0.331729247289605,-0.37142919811935143,-1.2504314157768117,-1.4145216991120806,-0.735984985507898,0.3297599119953037,1.099451997525101,-1.3553195593304683,-1.279756502362765,-0.19501336962658458,0.06398882095826783,0.14153047426466675,-0.5186851584649113,-0.4902913787293883,-0.5542553018739017,0.2900165051383745,0.019972609967586156,-0.26832113148614667,0.1177241933790977,-0.1821444999121269,-0.5643725918333761,-0.8760957577920429,-0.5622823003317882,-1.1210385198203485,0.6610511648368271,-0.9437890707566675,0.785002420374128,0.37783535378964506,32.1,False,Liu,PD1,Nivolumab,SKCM,NR,650.9999999999993,0.46110225498001994,High-risk,48.80251583654434
Patient163_T,0.4586110355958191,-0.47759496265869517,0.20186636445652273,-0.03514996491033138,-0.5945494979167449,-0.5182472805853892,-0.3561083625004877,0.7788889911398353,-0.6390134407033247,-0.1639822693958635,-0.5669639937350859,-1.247097386588519,-1.4813339938707777,-0.6600457461779047,-1.5820632463203577,-0.4448880965708016,-1.187030912352355,-1.336596660909075,-1.5991115669971874,-1.1517983672678882,-1.1261191848975962,-0.9074430972448198,-0.11179583023582723,-1.0307637709920672,-0.03151989889110201,0.3117193554694402,0.008184986904261336,-0.5671376270891253,-0.9165023155503167,-1.2252371748905262,1.3621746785516278,0.7101326509899254,-0.10948396250333302,1.3090255764561838,-0.03511059380665675,-1.914762907013787,-0.6844793560907201,-1.3460978878728314,-1.2849681132268107,1.0540270024561922,-0.24794389826039773,0.5067876549627994,0.20496252540219112,5.766666666666667,True,Liu,PD1,Nivolumab,SKCM,NR,200.9999999999993,0.4663558785141181,High-risk,48.80251583654434
Patient168_T,-0.9045291569237144,-1.2116671782305761,-0.9888746444405637,-1.5377304447748943,-0.7533446093503494,-1.054349506336277,-0.4184242496473999,0.1301732897221048,-0.8660166264737444,-1.0263551319584658,-1.1635897597971574,-0.6779786646406627,-0.6193952346584538,-1.096774169890266,-0.6971542820290282,-1.5808700476895219,-0.38187640301349635,-0.7289042632420787,-1.1932798924510646,-1.1516956954324533,-1.0316391050362204,-1.165399398163327,-0.38472508589150084,0.5953342470009838,-1.176864536548279,-0.483092338468156,0.2713609083940114,-0.9441930058821012,-0.1165944556429571,-0.6572107603148751,-1.2244656413305965,-1.1276473652981802,-0.47341030343032253,-0.12631681741049783,-0.7983424692712762,-0.8148121414395086,-1.196425576318791,-0.6406561602522979,-1.4339240008422516,1.162508302170709,-0.5771893637853056,1.0300497700703286,0.5429696532451863,20.766666666666666,False,Liu,PD1,Nivolumab,SKCM,R,31.00000000000001,0.49007682062406915,High-risk,48.80251583654434
Patient17_T_M,0.6793434624915109,0.5582317621102492,0.6461370728945869,1.1208554352841338,0.5447842009275289,0.6906035193983028,0.883152176386958,0.38569710254423795,0.34728558804522314,-0.005322052902775985,1.0989334831631923,1.0400530342484642,0.6372573140889587,0.38676646601549675,0.30318536211189234,0.6603978273937723,-0.2987138112603131,0.5632724641048543,-0.33212794889728325,0.8012906914082447,-0.6683645916766179,-0.5421458629779892,-0.5983467329936248,0.3154267793201319,0.061545962558846486,-0.04723079390566037,1.059684513402336,-0.37247742789391713,-0.18369585191978383,-0.83182349472354,-0.7012679374438185,-0.9073570217234889,-0.48333043377625035,-0.7743087934414552,-0.09261617433849706,-0.5703990469404585,0.4354858418448234,0.42947769412527265,-0.15795227379022192,0.24142346690582112,0.7494100728607411,0.20438273788644157,1.0426626342310035,22.866666666666667,True,Liu,PD1,Nivolumab,SKCM,NR,364.9999999999985,0.32317613288231195,Low-risk,48.80251583654434
Patient37_T_M,1.8999822170587968,1.1165325176129541,1.1223589855467273,1.5405875496908035,1.3793631927777457,0.9919481900061687,0.9977100993825824,1.151245844977613,1.2292935258977884,1.2766571129403768,1.2580493986318908,1.6952646802237086,0.5912317407062394,1.2233012860863977,1.0437201993931362,1.0924846718935355,-0.29489535048498366,0.14242538888622924,-0.6788055749263454,0.4703185370442188,-1.1130411099401372,-0.8145469817793899,0.2411634783510921,-0.38376007609797197,0.8139638286209078,1.1189668626283769,-0.4647602877093405,0.7488031933870359,0.47092430477059866,-0.9451068011516004,0.41336606626360584,-0.7924579740744163,-0.4487834035865357,0.009571357796115478,-0.5793008612283173,0.28107996001118163,0.7503871836843385,1.4467169765270105,1.0994335652365586,-0.3166590395037361,1.4883758800752285,-1.0102059330253965,-0.523087938724945,9.166666666666666,True,Liu,PD1,Nivolumab,SKCM,NR,39.99999999999999,0.34745720006322145,Low-risk,48.80251583654434
Patient36_T_M,-0.35814925843333634,-0.9650475519460565,-0.9696650822462165,-1.2421433403153816,-0.45105772227504587,-1.1678289449417738,-0.43311153780190026,0.09316553694494926,-0.7723514093869395,-0.6517355516473852,-0.7457217904159485,-1.3106809477871955,-1.6829400053728805,-0.9280806045789405,-1.057875150005211,-1.0139577517976475,-1.2419159034948875,-0.9636819676239171,0.17106151465032374,-0.6860433265003939,-0.2532423041360474,0.04285157228572989,0.6939219236025699,-0.16199017587755213,1.3077480379547763,-0.295900062268554,0.5264902021196985,-0.6950781178950972,-0.43307397828860456,-0.019675903962543234,-0.19597544342597426,-0.4202315603160028,0.38257046484526724,0.09456892217533136,0.9873124553458438,-0.980876612687153,-0.8098079358506913,-0.8194720232061341,-1.3536716945507612,-1.2364255624515952,-0.8115635253705297,-1.444873910074088,-0.4096084898682868,15.033333333333331,True,Liu,PD1,Nivolumab,SKCM,NR,179.9999999999999,0.646258935348043,High-risk,48.80251583654434
Patient98_T_P,-0.19278192657307966,1.3547118965400635,0.007228324255691911,0.4573335748165262,0.9426041025409928,0.787142860049792,1.2430656650488987,0.6394081625696455,1.1794913543236953,0.9046672827260841,1.1577606777697165,0.8395943478399154,0.2690519181744734,0.44830231632792833,0.5921261678767747,0.3943339495940263,0.007986701837710912,-0.20361415052991713,-0.15836751392383244,-0.02183677477937889,-0.2980007324859377,-0.5445034409569552,0.851300486431383,0.6015566551606677,0.49821473129860283,-0.29504120636494724,-1.2384558608451584,-1.1079783609640717,-0.45404406596717684,0.29502506061716993,-0.07515059690857623,-0.5539380953631031,-0.598141264800586,0.06128102232705483,1.3572204737028528,-0.1265673353042283,1.3302243790339927,-0.6014421283404621,-0.0678479120370208,-0.20848522895268867,0.2876077216955149,-0.32385418691117146,0.3369936685291667,22.766666666666666,True,Liu,PD1,Nivolumab,SKCM,NR,300.99999999999824,0.3887524513232495,High-risk,48.80251583654434
Patient127_T_P,-1.1724045967836905,-1.5982117189135097,-1.3003595345671504,-0.9962429005601152,-0.20755517686888966,-0.7514690652780294,-0.46612672595161597,-0.3605595600573896,-0.7954205460441794,-0.6851314285317444,-0.8887877627861687,-0.9248966301916073,-1.016425185695209,-1.133542772502496,-0.1756716385688521,-1.6737936784992977,-1.2767238712675737,-1.7529646982735387,-0.7500723552112087,-1.4234694266574246,0.10253748807356622,1.3231734346215467,1.4359275178029116,-0.1325803379211244,-2.2750178222734716,-0.9660795674828045,0.9208538583107747,0.008179722704291572,-0.8263281962804736,1.1646670963399814,-1.229324761481878,0.2881806133267448,-0.2267639275495537,-0.3529904741134583,1.1257184522496857,-0.6948252289834413,-0.8717601193224147,0.22970147775274186,-0.5200343395124154,-0.4922891496835716,-1.168568810874879,-0.2809473350495308,0.03653307831578675,28.866666666666667,False,Liu,PD1,Nivolumab,SKCM,R,413.9999999999997,0.5971067075452845,High-risk,48.80251583654434
Patient162_T,-0.1839689050363891,0.3944836172055979,0.2214407545771922,0.6692456540980034,0.3092160892223478,0.19074253879391267,-0.5359427280016139,0.6759878061157011,-0.2625348965689101,0.09883718780164769,0.2810580251815804,0.858549948063031,-0.49105069158041437,0.5278474600218984,-0.5534211646531995,-0.08997093990896302,-0.1770010288198572,-0.8030829300976046,-1.252165055299612,-0.41035360075319643,-0.7490526568067872,-1.397808505245581,-1.5262336436276105,-0.9270296841709238,-1.1585591372920572,-1.536384379619982,-0.529475525354336,-1.6353894243694092,-1.051372789837646,-0.6597862871216665,-1.3896790242913903,-0.9021915390490437,0.9932945115003533,-1.0521163112669085,-0.5484310931614276,-0.24843937642888667,0.2559261948732649,-1.49769928264253,-1.1315588987224106,-0.4500342194321453,-0.511716944256408,-1.010038609515438,0.4230520342986319,6.7,True,Liu,PD1,Nivolumab,SKCM,NR,1565.9999999999927,0.3137107555805615,Low-risk,48.80251583654434
Patient38_T_M,-0.8961203363145139,-0.961961242150291,-0.6704803220892651,-0.6695908534506132,-0.7993597448269585,-0.7330007594759751,-0.4884258180968019,-0.571697042610526,-0.3594826109647159,-0.3989695840074935,-0.5543891255458878,-0.44490781426965936,-0.735880865715267,-1.0970689095451682,-0.7285936438980543,-0.7946416852906247,-0.7693639389576283,-0.5757387907025568,-1.2563417948591165,-0.5178116047455824,-0.9761470339642749,-0.9323296213260845,-0.9127121595481575,-0.5428466483834474,-0.07223894131448234,0.35818318722063014,-1.1130321033508461,-0.23737913257710835,-1.0753836988982879,-0.8139472912854683,-0.11206796839759108,-0.6518382066097765,-0.45330665679868914,-0.7915560836359866,-0.2468620173937157,-1.034439299491253,-0.33773456060117013,-0.8687846925190567,-1.1460476402149096,-0.06283692520306114,-1.0416966211413092,-0.27466803038051835,-0.030490395326180652,11.433333333333334,True,Liu,PD1,Nivolumab,SKCM,NR,38.99999999999999,0.5414511702814515,High-risk,48.80251583654434
Patient40_T_M,-0.17580793301202727,-0.24772016605922664,-0.7173446534061079,0.14914961265346263,-0.4156047682807348,-0.6607534065814649,-0.8913155076825293,-0.31517085759137575,-0.45769195700026805,-0.2034266347562049,-1.3197175139151311,-0.8833690939481516,-1.370657416496733,-0.8798142032968761,-0.9595949137029314,-1.117326722335526,-0.6380698569157057,-1.764961108213679,-0.695361912584154,-0.9202603917838238,-0.564104716419923,-1.3597857698314175,-0.7713158185497082,0.8097580457292713,-0.9320086391270962,-0.6013696632857127,0.38111241349796215,-0.448179299957817,-1.0672889455643941,-0.764957444348027,-0.6393547169226147,-1.1591985743469877,-0.2781086889837459,-0.7848178743374107,-0.31295620793257106,-0.6931357009972451,-0.4128940698002231,-0.7077516370121862,-0.9688256854385084,1.687591926791483,-1.2099969839880904,1.303780676183864,0.5857893125308665,15.6,True,Liu,PD1,Nivolumab,SKCM,NR,6102.999999999973,0.5788182046014922,High-risk,48.80251583654434
Patient96_T_P,-0.24536012503934487,-0.854407546802723,-0.514015159104513,-0.9786091595241689,-0.23954236423430453,-0.8304855635984072,-1.1604583268113842,0.13120957711066486,-0.9503275990030486,-0.8530362425444526,-1.2768510976785208,-0.7293833402342129,-1.2168644969620113,-0.02935497100147812,-1.4934725772868795,-1.3449612236945323,-0.1731645785596398,-1.1739323258089847,0.208221185898158,-0.6895574379973368,-0.9408321427702042,-1.4034559403689537,0.5539119180007132,1.8339050593216173,-1.2610086080602354,-1.344029062741635,0.9870167354364093,-1.3253131073811846,-1.2552658926033495,-0.7813293782042945,-0.8309506989330878,-1.2400468807867833,-0.3466018354763872,-1.1997349512229862,0.002009350956984492,-1.0136684284419026,-1.080995811680679,-0.9616656907653666,-1.7916937306077219,-1.223393859656874,-0.5605713829953013,-0.6203778827371071,0.373169976672443,30.433333333333334,False,Liu,PD1,Nivolumab,SKCM,R,648.9999999999978,0.484188468314806,High-risk,48.80251583654434
Patient130_T_P,-0.3396592232793944,-0.34993310463403515,0.193167346092329,0.6670205706947807,0.1694106317128721,0.41649682714559283,0.10966448405156426,0.7578954913927558,0.34699966542878796,0.38282530173711843,0.8094217394697822,0.2848471862755091,-0.4042107890796355,-0.3864854584902109,-0.1553033471907225,0.18376026504727616,-0.9255817792919497,0.40669025377161844,-0.3143743550103338,0.16332398069600743,-0.7415782109660387,-1.2372422302109074,0.27615788394556307,-0.3449346757623947,-1.7341884783496513,-1.3801586917110789,-0.5435222702622152,-0.8186317150337438,-1.1966774420740776,-0.6742742461458302,-0.9248378142888775,-1.2277225748180172,1.1320971589796787,-0.043863684014891165,-0.5752188955769176,0.045314907960467624,0.7545099582539899,-0.910242043592188,-1.0435662720284213,0.49267363279963167,-0.620895250228843,0.21277968717097454,0.3340103432760276,6.4,True,Liu,PD1,Nivolumab,SKCM,NR,280.99999999999966,0.47485901890386006,High-risk,48.80251583654434
Patient167_T,-0.912535658796515,-0.5498251555268937,-0.23361545654919744,-1.020742014149941,-0.08773444205046446,-0.049647092480024635,0.63380133915043,0.052487433585045304,-0.14139119806927974,0.04385358458229178,0.07025682729475709,0.9697188135130217,0.16063574138689368,-0.5473874058566665,0.04960172369765568,-0.32203865430939793,0.11344467235670912,0.23540745590687176,-0.5551351212270145,0.5314657400316384,-0.12466044283459013,-1.2570488190066158,-0.6708404396598376,-0.1381582942899878,-1.0166523621039802,-1.589460421218729,-0.021149035778466566,-0.8367641613032026,-0.5235541916115399,-0.16718090991606213,-1.840597287631449,-1.4896318788488292,-0.3782216966231143,-0.7768201727466439,-0.7918505896725629,-0.669630541074323,0.26717772531513945,-0.7665096419953953,-0.9524376414705117,-0.14876372485940528,-0.7549633538828326,-0.15722557329102824,0.0812627924337616,9.4,True,Liu,PD1,Nivolumab,SKCM,NR,41.99999999999999,0.4166776949385711,High-risk,48.80251583654434
Patient196_T,-0.777783170478675,-0.26498970953410284,-0.8369528729371729,-0.6803401552851119,-1.2103149086773863,-1.135673856100467,-0.7248831582195507,0.4235026994799624,-1.0166930785111838,-1.321567903059522,-0.9630509036642765,-0.37230866765691395,-1.356199747702301,-0.9947122026891521,-1.2786630517284396,-1.4556895237233332,0.5247556788087473,-1.6113908349049457,-0.7878209596617542,-1.0295943494993085,-0.7284250379899779,-1.2550150474137087,-0.6101573769461143,0.7022488782347757,-1.812425673801011,-2.664768276595952,-0.8463340070130079,-1.6255454526760582,-1.3035121999280714,-0.7570414857830766,-1.6380374896103753,-1.3163643736149457,-0.6888494950946187,-0.5703926399403945,-0.2612120208750302,-1.043938209051144,-1.2460295551376295,-1.409618584118549,-1.7170575468827263,0.7045980209508553,-0.7647542190063198,0.7132169166230115,0.7540687325499599,2.7,True,Liu,PD1,Nivolumab,SKCM,NR,1733.9999999999984,0.3857732742889526,High-risk,48.80251583654434
Patient197_T,-0.6718748958969185,-1.1170435638976395,-0.4887512660322777,-1.3844603816667358,-1.0406227688096055,-1.3684623827375841,-0.5280983439599304,-0.5107438443991601,-1.3883639243627701,-1.2238576907817214,-1.3496995505511191,-1.174866153775198,-1.2264951468329268,-1.089783372753434,-1.096111532841795,-1.6380997827667043,0.1685576877041477,-1.8314398000670224,0.1424151244779465,-1.334965044655374,-0.4420777600796546,-1.2878940993900034,0.32545173438690417,2.1691311775074325,-1.5230652810661256,-2.1010081630531925,-0.30841849006950944,-1.9184127923611696,-0.9852695768148383,-0.7894074700820134,-1.0122910921451824,-1.27452238971143,-0.36484241603955947,-1.5131390071989212,-0.37350636098898204,0.1795696572613016,-1.4467911847721195,-1.289263759712616,-1.7284129330815754,1.4799458367229943,-1.9481153198117345,1.7693408176758179,0.8869701319009791,32.0,False,Liu,PD1,Nivolumab,SKCM,R,58.99999999999999,0.6457106918466945,High-risk,48.80251583654434
Patient117_T_P,-0.8363154575755398,-0.5913067890843913,-0.41727090591984617,0.12848658052300638,-0.11459423198765215,-0.015558579107949737,0.17264186425349287,-0.08442296137927768,-0.060656329316244616,-0.23027154953989293,-0.22235110246373588,0.318353948964502,-0.24578855023250124,-0.49211314315604754,0.008694006862662546,-0.20586793394784664,1.4132499461530939,1.15671096824151,0.07902417373007274,1.2289780194103803,0.6745077116352592,0.130161370297994,-0.06425792266222692,-0.011651382812554564,0.2167103000594243,1.2107702850092221,0.6418624490963788,0.9641406641481872,0.24887042822459815,-0.8897496589847484,0.48678465745900945,0.6347093703278714,-0.09605073041705589,0.5439471929750136,-0.6020940453679325,-0.6360133629853897,-0.19538365088314277,0.6673614850843058,-0.30868193946621814,-1.6154304269180908,-1.2142211864861971,-1.2548256468893464,-0.10859396351792726,9.833333333333334,True,Liu,PD1,Pembrolizumab,SKCM,NR,34.0,0.4117838662946871,High-risk,48.80251583654434
Patient165_T,-0.11451555661255367,-0.358766460387749,-0.3150663886060133,-0.9438049968805873,-0.392749976098224,-0.2649201989124741,-0.404768143610768,-0.0788327212197345,-0.34894228723947646,-0.18792676202224326,-0.14755176792761432,0.051122604658315016,-0.10939132822066773,-0.7720059220098411,-0.04159875564647052,-0.538201153145383,-0.019091476379440885,-0.260679568916924,-0.008211474748675417,-0.12419195415051508,-0.23100465131030648,-0.4042884838512808,-0.6423536567888068,0.34324727381755693,0.27261965560545826,0.5475802928597718,-0.6359727550722227,-0.37468127957303693,0.1550503330100739,-0.797865051891966,0.019666994733891725,-0.5684687002131343,-0.33222685607430125,-0.7506381755499356,-0.7470437225388112,-0.7169216260022621,-0.40536318228605217,-0.682451283394398,-0.5998524448392853,1.3348325449746121,-0.5272657536160883,0.7154369621617671,0.9128423593705348,2.5,False,Liu,PD1,Pembrolizumab,SKCM,NR,640.9999999999968,0.4381407431279718,High-risk,48.80251583654434
Patient1_T_M,-0.0876677251396323,-0.4871313841784941,-0.8538291342026438,-0.3593130754164026,-0.5218938688854132,-0.6708541902222034,-0.4946887805978409,0.546551402991333,-0.757218782091125,-0.1840204013883968,-1.575915980250414,-0.32697529583851537,-1.0157328192445423,-0.824180067647896,-1.0527060739946372,-0.5788754895214755,-0.4487932868602629,-1.2412568294876705,-1.9171570769263266,-1.2909325593189478,-1.684584251098344,-1.3937450569552237,-1.502656989222157,-1.3552413600175344,-0.022460077942821854,-1.7448958005176534,-0.8469026731291486,-1.628055936178945,-0.6103469103179142,-0.8020316331245919,-0.7525917073310829,0.5549958951427694,0.19918582849000435,-1.1826744321807523,-0.9286658817684953,-1.0070974744320524,-0.31899574118649754,-1.83352301951722,-1.7269198369358945,-0.6633574297703801,-1.3492265006337496,-1.0990250193006834,-0.2055931550622698,9.433333333333334,True,Liu,PD1,Pembrolizumab,SKCM,NR,22.00000000000001,0.45412644400687685,High-risk,48.80251583654434
Patient10_T_M,-0.20420394230122932,-0.7246892555645972,-0.44684601314677125,0.13292803779212511,-0.3146859946181387,-0.08121101530400761,-0.5956896820505247,-0.21141677640778872,-0.19750739451935448,-0.21278132601607908,-0.9682900364188681,-0.11439656039500198,-0.31646645460852857,-0.2498539879235988,-0.9117260416254048,-0.566785728337049,-0.2589652516698409,-0.044825228792658225,-0.5102555655479798,-0.42301509677662447,-0.1973637913056778,-0.11452798089745432,-1.8134581985722034,0.07892302590643305,0.9893545402254779,-0.2190605544013665,-0.07318017570680858,-0.6506663050524383,0.3604534223665226,-1.0211414566789299,0.2514142098298188,1.2232903237832962,0.20045468467961863,-0.49595186807357083,-0.6838493169071221,-0.5273413546924035,-0.18534599302835494,-0.7862973785634418,-0.7846407182587563,1.759965107679607,-0.5848335388294857,1.6925078833575884,0.6747761105140984,37.96666666666667,True,Liu,PD1,Pembrolizumab,SKCM,R,71.0,0.47398934823245115,High-risk,48.80251583654434
Patient105_T_P,-0.8337766395426792,0.15395330608844682,-0.6674792822429615,-0.6206924148283756,-0.6554956297271609,-0.7257843006704651,-0.6413851464465944,0.17301394248307736,-0.6011265367245697,-0.14331418454354466,-0.7254194201474597,-0.5943584832035284,-1.2915112956430452,-1.0405238561371473,-0.6773310565768523,-1.61033921554578,-0.9407750193088162,-2.19632584029889,-1.3467205828169815,-1.629555004264806,-0.8850848814884735,-1.800574649893296,-0.15865179383050673,-0.3440190453201971,-0.36316982564838585,-1.652805835015427,-1.084875179124783,-2.0486165364144067,-0.683680029102317,-0.6964402433763863,-0.23056507082607153,-1.4143435048832296,0.5631062684250172,0.09452659368526295,-0.837650855838762,-0.8445543934066113,-0.47136925177839656,-1.8261501091701366,-1.604642806376902,0.6028080944427247,-1.2137390048048915,0.15264317144893638,-0.19857220685013288,17.366666666666667,True,Liu,PD1,Pembrolizumab,SKCM,R,124.99999999999972,0.5086242136323812,High-risk,48.80251583654434
Patient106_T_P,-0.2981330790101913,-1.1048573031618503,-0.18506092019855813,0.401433089591839,-0.1938761929332876,0.05012409411223785,0.15709742972047286,-0.4550119784745976,-0.20377402297791872,-0.11986708556914845,-0.16482881228005744,0.5666541606285042,-0.5605759400391006,-0.3235185031029565,-0.39404946427022614,0.1294130000432748,-0.2426228995994301,0.07073759427525422,-0.15716067246701362,0.3161450460653213,-0.5177003596634351,-0.7450255662227087,-1.4388206567914845,-0.7373206199666275,-0.23861782422752234,-0.39936889767254047,-0.6177520218254314,-0.7755697922011152,-0.10969340093348956,-0.5202135181508718,-0.32241472928340853,0.2080694574445649,-0.36547502797613457,-0.42863082886844134,-0.8729299105630958,-0.5347801283387796,0.30735020931506674,-1.1287542832975381,-0.6972167242452546,1.1517766044746405,-0.33244610972273947,0.9283770985838394,0.40177651788604346,26.0,False,Liu,PD1,Pembrolizumab,SKCM,R,244.9999999999989,0.43118903848010215,High-risk,48.80251583654434
Patient11_T_M,-0.7966452393050428,-0.1181399755168955,-0.5057460684456898,-1.3304069130693652,-0.5261462003911157,-0.4312833121489683,-0.3418370273217973,-0.3328683967439674,-0.6680971641573871,-0.47778555685020363,-0.5432131439551462,-0.06817923770515677,-0.6675197599339018,-0.6281339572667791,0.10957758693575373,-0.5224198227899517,-0.23145459086181497,-0.6397297898978375,-0.3062730964020991,-0.3432330422305532,-0.47638528527908475,-0.5090454857935379,-0.6903825592265105,0.2570304696001662,-0.44787578007602413,-0.5558675955043568,0.528456890742378,-1.0864917889310421,-0.3904782925820797,-0.8739970437968846,-1.1475958283947265,-1.1405213956333207,-0.5863780690327047,-1.0171959290486838,-0.6528424698389473,-0.28941424269969057,-0.30507913017494437,-0.9119888678735855,-0.7099482825400153,0.09392967898452803,-1.5018744921610976,0.9024931767140729,0.639591019161166,5.333333333333333,True,Liu,PD1,Pembrolizumab,SKCM,NR,171.99999999999957,0.4913943816316018,High-risk,48.80251583654434
Patient121_T_P,-0.33055475635668474,-0.626438547603678,-0.1836000877704936,0.12136262437726918,0.2751304967966358,0.17665061661907133,0.16488121251395438,0.6446926487828757,0.37351884208477626,0.4834779686075721,-0.21617435484879272,0.2947212433689201,-0.3937071426893365,-0.12313358298582507,0.33913589667718314,-0.5939115717500199,-0.2967652089561932,-0.029625770664475946,-0.5620282144345571,-0.030922900279265707,-0.5946312217251462,-0.6258929335315676,0.12491044851532598,-0.24607439789890204,-0.7162161280985968,-0.28172790251616414,0.34243874823096765,-0.29132347059690505,-0.5621884396084298,-0.6702776055433802,0.8475863366253245,0.39848664426905717,0.3022486744308795,-0.44685671064118865,-0.3797792579012128,-0.5994927738735395,0.4952990892666606,-0.44592773274414294,-0.9724959692683095,-0.03698226771580552,-0.5929740170666029,0.11699237769144105,0.29193629907225555,43.53333333333333,False,Liu,PD1,Pembrolizumab,SKCM,R,767.0000000000005,0.4074101353036289,High-risk,48.80251583654434
Patient13_T_M,-0.6335885890398602,-0.9395610377499835,-0.7367000129733065,-0.6505957711585971,-1.0297428701888682,-0.941953801715326,-0.38527835931912924,0.6873251516157615,-1.0719039029659776,-1.1631460137630345,-0.8279224934373068,-0.6124258597512308,-0.8833547928469343,-1.3802181530120778,-1.4778763116825753,-1.5157988361130545,-0.6310442482720677,-1.7721972100455705,-0.002310011243471548,-0.9465631963399644,-1.266923371015194,-1.3673684016434444,-0.08532880059894074,-0.5311212009873089,-0.3258475240552546,0.04400894823572098,-1.1034314210932203,-0.22749992574479755,-1.1747053762314275,-0.9695637179354594,-0.6885305433332765,0.45486047838937693,-0.08927869661257473,1.039616672951388,-0.40549368610182795,-0.8003709314338135,-1.0120591838405935,-0.6467022012818213,-1.0328480157213802,2.2175158850628773,-0.9983399435182211,1.9475544168517167,0.5999597044031018,1.9333333333333331,True,Liu,PD1,Pembrolizumab,SKCM,NR,591.9999999999977,0.6804594309188227,High-risk,48.80251583654434
Patient133_T,0.04777724874081444,0.09016426882976927,-0.4582013224810912,0.6921654508206825,-0.14665086482817793,0.031130628455949726,0.21659553364124767,0.7269232652408937,-0.2301975990379258,-0.03888422991503088,-0.13292032057727016,0.2784608118402032,-0.20431080812974825,-0.09153395156715956,0.47436335611453123,0.13750563865168536,0.3989480085139846,-0.27259044680433336,0.829091879530071,-0.10350742431454028,0.38972833896447384,-0.36697746344620036,-0.5391244678892603,-0.22528306817285698,-0.7954272766663009,0.046684182777384294,-1.3755595439762767,-0.715922078022809,-1.0345662912008546,-0.8103328788923682,-1.2451631028313113,-0.9570698903884379,-0.5792354803756278,-0.7161103217652921,-0.8375926321534929,-0.7094138751159975,0.38812491516790365,-1.0013478955691388,-0.30430131420231793,0.6704633654903275,0.045168233501042536,0.5488223572779826,0.4298127886996295,12.333333333333334,True,Liu,PD1,Pembrolizumab,SKCM,NR,340.99999999999795,0.3771623848043271,High-risk,48.80251583654434
Patient134_T,0.9174696219634941,0.3319783390156724,-0.1132375595678738,1.1697694190885506,1.1268205850430761,0.49385127548278873,1.0259856298364334,1.6297921881032822,0.7137796517327146,0.516717236387414,0.2590406197688942,0.08882327773414164,0.6570433134040894,0.48281621946770475,0.824089704186404,0.5106864984003043,-0.5492836199059254,-0.5072508530162478,1.056401143831507,-0.13282910204357176,1.0363245843869762,0.9937857155366185,0.4953319362288601,-0.024529551573707113,-0.3489568041145087,0.3833495136803828,-0.5111371799286017,0.1649996866274156,-0.3242691412202555,-0.7544906016081637,-0.1922558384727761,-0.42516847287574033,-0.37892053587074404,0.4641822764848803,-0.8472291903865585,-0.45724258360315007,0.7903450568659225,-0.4096486172380774,0.15018265538046163,-0.5879692948117757,0.8155189176132853,-0.8130257017885947,0.06066965392292208,19.666666666666668,True,Liu,PD1,Pembrolizumab,SKCM,NR,328.0,0.35824700862034775,Low-risk,48.80251583654434
Patient135_T,0.333537944272518,0.18893763446920395,0.25906041756991477,-0.15898124743294675,0.055587118142526815,-0.21851213405547507,0.2965924757741462,0.49709483739166876,-0.08737350424883339,-0.16583127616034696,-0.2602938637899007,0.15011573657321903,0.09187690426788829,-0.6839826315910613,-0.5859749641125447,-0.3486576111752528,-0.7234372148420675,-0.8575486953046411,-1.1781654662482666,-0.07407907541549819,-0.8049505157227759,-0.4162964987936099,-2.072858184056642,-1.269819977871981,-0.2241949526620175,0.6455539170799001,-0.22274117860308498,-0.569921065165196,-0.7181602499490165,-1.185107623986788,-0.18399568559358034,-0.6896326619937376,-0.6227625348760192,-0.4018020267759861,-0.47708093135068497,-1.103958777397698,-0.1130627616657296,-1.633911629003777,-0.7139707476409157,1.1251545024577578,-0.2687917940031767,0.9378668256735883,0.4442511459071076,20.933333333333334,False,Liu,PD1,Pembrolizumab,SKCM,R,387.999999999999,0.3905809467262947,High-risk,48.80251583654434
Patient14_T_M,-0.40344756321718317,0.4535842740759195,-0.32084811482794773,-0.7430939707722185,0.21537619530867597,-0.03811035352910263,0.20522926881695253,0.15500764839039677,-0.11385017256471625,0.020550533480708587,-0.05041469797391657,-0.29973692074511143,-0.1302745235432941,-0.39657650088183827,0.15199839204972918,0.01577128801959192,0.3995527583937194,0.2756009263017111,0.6465424126516467,0.47955306268342385,-0.08836536827078711,-0.5415375392707515,-0.05521422032385655,0.6196426209599111,1.0665524494698302,-0.25225975201416145,0.08512492831763334,-0.7022910093897701,0.10019091303645584,-0.8720216373544964,0.450743590126275,1.1690597953931285,0.12632184808562108,-0.43799565378652844,-0.5609649970402363,-0.06798185491191187,0.12481146882978612,-0.46659245182978615,-0.43753595607821505,0.24203112544027933,-0.7661121260475127,-0.5565029643052573,0.026596837623166343,6.2,True,Liu,PD1,Pembrolizumab,SKCM,NR,30.00000000000001,0.525040330490017,High-risk,48.80251583654434
Patient140_T,-0.7059916672667007,-0.8497794263906389,-0.6105514500433042,-1.3271008419081216,-0.6999143823905828,-0.9634776613344584,-0.5102751902363373,0.04024549845866456,-1.0826109919315947,-1.1909374983203633,-0.9164173397650546,-0.6093626505871986,-1.4932505222988242,-0.6371290883274385,-1.174566820003548,-1.6808669935273957,0.22513605536969772,-1.7705331565501674,-0.7231092704211869,-0.992751994502268,-1.0747475448078607,-1.1319328025334245,-1.289655817502748,-0.0015830866907513678,-1.2847950969699913,-1.7880949890980957,-1.0350391951566915,-1.9446867754578518,-1.7814506431192196,-0.9243239612709766,-1.4647613488830982,-1.526929711019233,-0.27015224332557525,-1.0123227732781488,-0.5208259596896716,-1.1602917051034862,-1.0269925677170455,-1.4295405463930964,-1.791096292190162,0.9817296996364132,-1.5637387893547956,0.6816066391308006,0.11793502320752136,11.7,True,Liu,PD1,Pembrolizumab,SKCM,NR,2076.999999999994,0.5152787132156936,High-risk,48.80251583654434
Patient143_T,-0.8535455063329834,-0.927668434677657,-0.612542489862965,-1.5598035552549487,0.803046734348245,0.3472923330320985,1.4230859257798074,0.7934917639939904,0.294458594225515,0.04849459719271859,0.021655986455428464,-0.040289353150464266,0.30430495441372674,0.2709524748051145,1.0221085332705528,1.1999121131602082,0.5252758014823665,0.9464001153856432,1.0698581508040854,0.922273813578652,1.8187135686165743,2.0656580651301675,-0.06222440641191056,0.3412941853342588,-0.40545675794169345,1.227709498496527,0.638184986163657,0.9199130621864039,0.2857351931077988,-0.6088753676066414,1.5901316800634617,-0.2551684018455571,-0.6222710121831352,0.7363081076552848,-0.781310483298496,-0.5962671266822522,0.08525860374670603,0.0749188549028912,0.5041014212804372,0.7620387555633734,0.13655698621611312,0.4876351360184431,0.3334509415317555,21.0,False,Liu,PD1,Pembrolizumab,SKCM,NR,333.9999999999981,0.2891680363671518,Low-risk,48.80251583654434
Patient145_T,-0.8052434600793289,-0.12444386349532424,-0.3272727394731997,-0.9037046691172087,0.04106312097104231,0.023426547834409416,-0.4788300316622813,0.4162974654498145,-0.10153563329758399,0.06232182267157977,-0.1114969021071337,0.6815400345922665,0.490583515848815,0.08187505260954266,0.1165092044904862,0.22090122035371124,0.05493844764818207,0.502244017671005,-0.17825702271454902,0.7071808076025723,0.23591580842451784,0.19061867985822908,-0.16758133539645276,-0.6309740379833779,0.3106661624664057,0.7138429211742341,0.045109516400575235,0.08708036480339912,0.28356817691003977,-1.022766315272417,1.6667147878957245,0.1546727413714445,-0.235347951325334,-0.954319819706889,-0.7400749671062367,-0.6873722154223348,0.04909851825785846,-0.4067579065305248,-0.41542525828975896,0.7853875304565245,-0.661388097512771,0.6251378424993498,0.7088052060250398,27.766666666666666,False,Liu,PD1,Pembrolizumab,SKCM,R,287.99999999999835,0.28341477047260294,Low-risk,48.80251583654434
Patient146_T,-0.6020454603106087,-0.41109822110887817,-0.3276480235050902,-0.9482752569460394,-0.478094514676319,-0.5646330138807434,-0.08734504671210143,-0.3929205314170324,-0.6892820173924048,-0.6964243631807008,-0.839505014432619,-0.5927951249178157,-1.0725312449975015,-0.16270641698706786,-0.7657962475769451,-0.5526135997436313,-0.3795117689052587,-1.0818731111702378,-1.2548080448572805,-0.6773759136884974,-1.1141987556294646,-0.9089971438427973,0.47286032382079013,0.3631329527876215,-1.2531424825146378,0.1944906200153005,1.3243552128934508,-0.18873782680812623,-0.7254410089578505,-0.7902070726382916,0.7917409491109961,0.011656758182533183,-0.36298265094353366,-0.6348468294408405,-0.05703490432272113,-0.40307610455066356,-0.68830210969629,-0.32064289353987846,-1.0370676326244133,0.5823944639913046,-1.1116123550797137,0.34937115170676225,0.500819668948704,20.4,False,Liu,PD1,Pembrolizumab,SKCM,R,374.9999999999976,0.4813433864651979,High-risk,48.80251583654434
Patient148_T,-0.5018873972208062,-0.38181872450253124,-0.24168181184903914,-0.6296048978541714,-0.35625622969985427,-0.5731954369165553,-0.2524337043702357,-0.40397584416698273,-0.8202307865717439,-0.8470198226547964,-1.2517243009240757,-0.40102150075271187,-0.9183499717313347,-1.1341906942897868,-0.8883856598957497,-0.5432701529550706,-0.13698604018175103,-0.03926578956545231,-0.5070292728532657,0.16806870148683214,-0.5805222351081524,-0.11396012354966233,-1.5980122815096276,-1.0406401724430319,0.19233843009756862,-0.6758462546413554,-1.2503206684652146,-1.2017842365042992,-1.0337810235059508,-0.6296536721653773,-0.14400380694157802,0.009744820369636005,-0.4398872684361984,-0.9942524372829334,-0.6971328859369793,-0.9216110446714143,-0.7277314746724743,-0.8524679322561013,-1.4925116663289992,0.5932758324371152,-1.3923175013472038,0.19841385349391658,0.20229476767107918,26.4,False,Liu,PD1,Pembrolizumab,SKCM,R,319.9999999999981,0.5141625095311858,High-risk,48.80251583654434
Patient15_T_M,-0.05654312362392665,0.17124066799514615,0.36615953327042966,-0.8000035214990809,0.37585788640419,0.7167995594562967,1.280161428368515,0.8334553541108473,0.8605744840269036,1.0188846281356385,0.10511906420682643,0.6573135855033441,0.012181133234055746,0.2435048725230728,0.4316819529710019,0.1816586159892945,-0.17453067985446666,0.09194456099778546,-0.5811812544092041,0.2425588292994579,-0.25720341734762314,-0.07796165916649182,-0.12321909567221453,-0.13068469280556314,0.4555631558853491,-0.3652516769278355,-1.4769363072521224,-1.1735609384317716,-0.9425356106086097,-0.8680921665337128,-0.7166690657787789,-0.4355735820084963,-0.33803787814586167,-0.45208908380337787,-0.7009276130289923,-0.2727438370657403,1.0607849378504874,-1.085023846466239,-0.5182259363469502,0.1852899961163935,-0.611228910237961,0.14531593226064868,-0.5031279789606384,4.966666666666667,True,Liu,PD1,Pembrolizumab,SKCM,R,181.9999999999997,0.4843837224526214,High-risk,48.80251583654434
Patient154_T,-0.14235158528156527,-0.7986982768590162,-0.4319330231027908,-0.09881162150169251,-0.39836061464934913,-1.0933788927688532,0.16430631349752664,-0.7048649692234826,-1.1490416550300668,-1.3947004557054299,-0.9932950524223985,-0.9113603032881443,-0.959420043156657,-1.8189855817371112,-0.6992054066380646,-0.8504578691237815,-1.1965325461662697,-0.42430710416841605,-1.1611148063138264,-0.5237343048360164,1.7808347193103153,2.6700997974969614,0.5254418434030866,0.4698981303507118,1.7229616594206805,1.1625606904588721,0.6824492580242059,0.599848377222451,1.3921991735131916,-0.4355241254874796,0.758060650136964,0.7164292821538549,-0.11846589918308761,0.986750899154906,-0.5894516317557746,-1.1078724709209151,-1.3204121343348996,0.14210194907315019,-1.124904511394737,-1.6883391631839721,-0.826847097117082,-1.8078575676668165,-0.11179175150748547,21.166666666666668,False,Liu,PD1,Pembrolizumab,SKCM,NR,71.99999999999959,0.48900122997369183,High-risk,48.80251583654434
Patient155_T,-0.9500805441129271,-0.8370963642358796,-0.9464577105986063,-1.4433871222304764,-0.4507017261150321,-0.4751194488892704,0.29024381779240255,0.5802937967715318,-1.0030866376959449,-0.9512474029693736,-0.7278050399918775,-0.346826186729578,-0.5739152719639599,-1.143331634920239,-0.29973088851011453,-0.7277658376600957,-0.7791085751063148,-0.7205183760861704,0.3779751183229722,-0.7222104798404008,-0.7183930207330983,-0.0007259810302677542,-0.08959108780806595,0.4420422871479169,-1.3380387744469884,0.062121548183860016,1.3106878989013078,-0.32273073603001223,-0.5085331724978694,-0.48422110863003365,0.10782395492243024,-1.0697327247490533,-0.31500657430426926,-0.4957320006670365,-0.8295094230664282,-0.6217786067994854,-0.7144669764132779,-0.4673951073546155,-0.4576996750963343,0.142789417326264,-0.019260614761445558,0.5450533490864983,0.38584959286851994,15.833333333333334,False,Liu,PD1,Pembrolizumab,SKCM,NR,254.9999999999993,0.4462252251147453,High-risk,48.80251583654434
Patient156_T,-0.7127871790808153,-0.7902124691928596,-0.9557396669831427,-1.6593285877678343,-0.981605325855508,-0.8582144985478188,-0.22499609742481397,-0.7823909587327385,-0.9798810816238779,-1.262519119739264,-0.810035019189701,-0.20617977039682928,-0.8095181607880223,-1.0823507943227368,-0.6015304631806534,-0.7759845035967404,-0.42427600557180634,0.3650012580149426,-0.006215116257431988,0.017648605041062748,-0.367785823326663,-0.07029587988262294,-0.28163571514295493,-0.4276225128377743,-0.05618208214480346,1.1734154282720897,0.18220430115876474,0.6846387658511734,0.6021227972530676,-0.6949843815227571,1.7049365504876817,-0.4761362138669459,-0.5290349487247936,-0.5945440375222172,-0.7689778322427836,-1.0255399184296907,-1.297674401990721,0.28053208406304514,-0.9049718651251154,-0.1275654578958118,-0.7805201334919836,-0.12755741116161906,0.43364825536005513,2.9,True,Liu,PD1,Pembrolizumab,SKCM,NR,201.99999999999983,0.41272872592349524,High-risk,48.80251583654434
Patient169_T,-0.5690571960390985,-0.22801910816690654,-0.09243322847608552,-1.1731160614340612,0.3695120980877402,0.18924504200487952,0.5860802834738593,1.0849198385151013,0.0784472925694791,0.24576779519643088,-0.8145908919329294,0.17797164532530493,0.2559402386666005,-0.12477471156016334,0.10100981824979022,1.071447005182793,-0.14998158135642778,0.10974056685634885,-0.36009401119055506,0.28769055726727777,0.75806697774205,1.014622960422903,-0.6164325912820527,-0.7998156381972511,-0.4684296704225186,-0.35562915321883704,-0.4305761641855285,-0.842540537196662,-0.5251305159850098,-0.6754338213828617,0.17611637311108908,-0.4241104898420849,-0.5678256233183602,-0.47882517664362745,-0.25921627650629453,-0.5045517594935854,0.5650008598738517,-1.0759401214329678,-0.05428906767903477,1.064449052999354,0.1400315888598068,0.936673965155503,0.5059328639230775,18.1,False,Liu,PD1,Pembrolizumab,SKCM,R,1381.9999999999952,0.29567795734746816,Low-risk,48.80251583654434
Patient170_T,-0.41068163111278727,-0.5721305346296939,-0.7480886995673378,-1.5784614877999845,0.3756996621718727,-0.4387414049281989,0.3518986443566928,0.21672184484257473,-0.33495570876818764,-0.46555583957982655,0.017958035239284627,-0.474990411869912,-0.45138453630370245,-0.8311433509287336,0.19088489235167722,0.34175293102647547,-0.17285588510756714,-0.678670004725038,0.21013668307054972,-0.5578482499151844,-0.3089883152283017,0.9219904805590026,-0.31733707478362,-0.5829405225127791,0.11253797066093787,0.406912285148809,-0.6783539820618427,-0.08307527880938477,-1.126530544794162,-0.8672732146265626,-0.38623205180022,-1.144994213191071,-0.6620600176719222,-0.3227784258397047,-0.8781332121553027,-0.5610697484224755,-0.11412600348296059,-0.30909953730114,-0.1727240414208871,0.5873609100727127,0.20787920897859913,0.18176544274896123,0.23843406600764405,11.566666666666666,False,Liu,PD1,Pembrolizumab,SKCM,NR,55.99999999999999,0.4531437081280855,High-risk,48.80251583654434
Patient172_T,-0.247620326451186,-1.016785388605308,0.01593435452716684,-1.570907229398371,2.236497931216121,0.5163257778905351,2.302402121639811,1.49549249236187,1.233819758643406,0.7813747537318367,-0.15714103584332031,0.22405061534814427,1.1414453944627263,-0.2778128455636199,1.5045250832851835,2.5124778985539002,0.005463578206532709,1.1747091373280247,0.008758567532894989,0.7441160428613943,1.676994234714558,2.8503389631682614,-0.8630630186987391,0.6210081741621498,0.6507368871469233,0.7190457959793736,0.15897256238122132,0.4913031424431406,0.8877664558859728,-0.6848087025292824,0.5682407878242801,-0.42066761348360643,-0.6110863429317129,0.6933895030428582,-0.6373978145115429,-0.41967352223129245,0.6796254172804784,0.1467215707707308,0.6337487614503019,-1.0156864170753794,0.8657354966371824,-1.1367264109251047,-0.0009272207286820134,9.066666666666666,False,Liu,PD1,Pembrolizumab,SKCM,NR,678.0,0.2832599618446245,Low-risk,48.80251583654434
Patient187_T,0.1828972578163376,-0.3074134051002118,-0.1639339560791229,-0.34460921838094793,0.06556094128955024,-0.24997619014455,0.45147214851708867,0.20733074774886964,-0.3679102924316753,-0.3170490867187927,-0.2886575087740006,-0.37882830100637704,-0.5812712219727313,-0.13569076127854077,-0.7692598613327636,0.0024037183109531022,-0.46521609725609137,0.011060438191979683,-0.8277483004552861,-0.0055743788603516455,0.4763501436935387,0.34555998906246216,-0.5896438291515148,0.1406551191591687,-0.22794218577091876,0.15445286917809078,0.445234827044322,-0.43301091681413156,-0.4316040113287431,-0.8994383343693528,1.3714798564856494,-0.6147486491470816,-0.4247358135481069,-0.7065614370198059,-0.7680971635051157,-0.7304020509564353,-0.21661950560139584,-1.0693303906871652,-0.8181261155978657,0.052305394532364484,-0.24838829104236362,-0.5160073753326057,0.3059590771973005,20.566666666666663,False,Liu,PD1,Pembrolizumab,SKCM,R,132.9999999999995,0.31600652082512043,Low-risk,48.80251583654434
Patient188_T,-0.522201363188652,-1.2881917763709623,-0.831491706500481,-1.3269515038669957,-1.519976274668782,-0.9865191970530538,-1.451139942284819,-0.9169960071423144,-1.0025164760222824,-1.0239544354767043,-1.3779652538003206,-1.1626355072339942,-1.207141250107396,-1.4571295792506018,-1.888759072069898,-1.2691155018147156,-1.0652453690605634,-1.1574539074428123,-1.2429847208473415,-1.2062934819346747,-0.705661096386096,-0.6013963547746914,-1.2722532649652873,-0.10393107246566409,-0.03152179221459661,0.3888567783584526,-0.5530831180607957,-0.46345590792006847,-0.7238158958625011,-1.0088444090073432,0.6982141464204918,0.35356145463905925,-0.30067022444483604,0.12775216647045856,-0.6409088943558415,-0.8503442964542609,-0.9751648780934824,-1.1895049027541267,-1.743284141040479,1.3970738835775656,-0.7366007346776179,1.2815839457520855,0.46472958293327193,2.466666666666667,True,Liu,PD1,Pembrolizumab,SKCM,NR,22.00000000000001,0.5698183546060345,High-risk,48.80251583654434
Patient189_T,-0.9268778564654423,-1.3467994923044115,-1.0032137927555684,-1.965662886018893,0.4086559086812305,0.10549167818084339,1.3663961591144698,0.6018961392253062,0.30077985540774566,-0.09405763442882463,0.04638841022104583,0.10683492576121516,-0.3077634305241743,-1.058048194639915,0.5140076157490189,1.8674377590084197,-0.2605859347995189,0.06350215222793809,0.4212510727891209,-0.006040918265501541,1.102841546442591,2.2744464801515867,-0.0660423730406748,0.34877745917587444,1.1406270059943646,1.0984475342299305,1.855639187191649,0.43921985468942165,0.590484408634638,-0.381729296894766,0.34466300649658205,-1.1159305708622722,-0.5178525244447223,0.06840241903891567,-0.7243461873748989,-0.7548553968896715,0.09237924728091138,0.4784405070969416,0.9372939319623126,-1.386093127359599,-0.08872245084639532,-0.9663817976791587,-0.09058480564519092,23.933333333333334,False,Liu,PD1,Pembrolizumab,SKCM,R,49.99999999999997,0.402910637014385,High-risk,48.80251583654434
Patient193_T,-0.3242329426511669,-0.3085324755133503,-0.388040014708247,-1.4280364795333806,0.6082747820796637,0.09648021229345635,0.47822738308922114,0.8129222372413916,-0.29129210196501826,0.07821770800690901,0.16865376887157243,0.09697040188328578,-0.5328544177245093,-0.10461576704490766,0.42938439988009114,0.35476485217518744,-0.14045858179438206,0.13917152078231945,-0.42439123026917924,-0.03136265179662766,-0.058308852403770275,0.4974057131884969,-1.5353516487693954,0.4188846119055816,-0.6235357384982434,-0.3600697365219786,0.41769748428857645,-0.4955344017240278,-1.1054231932747995,-0.8783883133551693,0.23779307754614984,-1.2541754231727442,-0.6953111138883551,-0.9570325424259175,-0.28351025071199426,-0.46847236792803426,0.3881135411017543,-1.0574119270158433,-0.21244405127220004,-1.159440711885984,0.2504118019952077,-0.7749979779085805,0.4918207915229982,21.966666666666665,False,Liu,PD1,Pembrolizumab,SKCM,NR,570.9999999999966,0.27297550768815027,Low-risk,48.80251583654434
Patient203_T,-0.38745799795504554,-0.8876489844049109,-0.6438800733411061,-0.12311595183114371,0.3786387766388859,-0.1211531794185167,0.9684210137065288,0.31126213238699135,0.2755126983122768,-0.08410496853218757,-0.4051557508363819,-0.4922141191801942,-0.479432261569286,-0.6835504489576254,0.34574224165803613,0.4945046014621423,-0.30740046464558135,-0.2884767908355216,0.1000750727398891,0.02339533538994073,0.09218227432894568,0.8621027424514215,-1.6198615384986956,-0.3604598399230855,-0.2212892967968481,0.9765213905661828,-0.06704963541062663,0.38900524934194824,0.12027633692384616,-0.276471151025214,0.8072445293766369,-0.6999767336427767,-0.5605007201473167,0.10443855570316402,-0.23641681033080952,-0.8610374872815498,0.02184753256044264,0.37112786655634145,-0.2439381815379283,0.54201871177103,0.0392822488869734,0.9744617314985979,0.4773853071811505,20.866666666666667,True,Liu,PD1,Pembrolizumab,SKCM,NR,71.99999999999959,0.4323264909829195,High-risk,48.80251583654434
Patient204_T,-0.8369123627516726,-0.9653667125165862,-0.621204323760798,-1.3808852519752564,-0.2712817359346364,-0.14472022219437436,-0.03435716404437753,0.17736068476639394,-0.5534028972640351,-0.18081405400535586,-0.5612851954723133,-0.05206454329683516,-0.22005337838210295,-0.2531634424138955,-0.4154922037519629,-0.07949529929202324,-0.0928912900941423,-0.751954335385809,0.6611993232992149,-0.40854209811123976,-0.3164229682186888,-0.17087196993879059,0.13668092621828148,-0.11630334364575058,-1.6774294399705403,-0.4520039706756939,-0.005676505251032345,-0.5521398164166789,-1.2716546011010224,-0.8946016825313144,-0.3528418170135659,-0.8882364169099448,-0.6559427256181258,-0.3996493894369429,-0.41934596726516954,-0.6285065434586052,-0.006672984208125119,-0.9556067112410686,-0.5796283625090652,0.4337664257480284,-0.2218915088915996,0.7119125264235234,0.6478397867551556,27.3,False,Liu,PD1,Pembrolizumab,SKCM,R,1771.9999999999943,0.4039474205435751,High-risk,48.80251583654434
Patient205_T,-0.9461490067000414,0.06360747365760215,-0.4348220256812947,-1.4066294737490372,-0.7403064581264599,-0.22459819910653683,-0.7323765325635418,-0.8201198132595289,-0.7431659829520743,-0.6251744664088762,-0.18287849255551375,0.11129880634649991,-0.28102260397272566,-0.2634956570095259,0.03146031819337654,-1.1614210645711325,-0.642141145880553,0.03291137472908289,-0.004704773583564957,0.21867873596949267,-0.7970796687662438,-0.6751998672491039,-1.7041218255119683,-0.16251548131623875,-1.2951691807086592,0.5820929802829222,-0.14141294928609977,0.34789875522552066,-0.9840717259181181,-1.166806101026211,-0.9825628382703008,-1.2635792777067736,-0.5067640950757851,-0.5309882910398351,-0.5295219038312491,-0.48954438940655104,-0.47912153970802607,-0.24669624487256794,-0.7551969303402599,0.5443840048349202,-1.4466880275893008,1.0131866103136362,0.40678123775146235,13.066666666666666,True,Liu,PD1,Pembrolizumab,SKCM,NR,570.9999999999966,0.5330502740872047,High-risk,48.80251583654434
Patient206_T,-0.7731980052468571,-0.5010537283363625,-0.4852196948252768,-0.585271366005576,-0.2715916752616163,0.041751207919040356,0.09591264086006177,0.45887650943781594,0.19279878958351915,0.09476868360468468,-0.2321206154975052,-0.38846488312394023,-0.3522260345066921,-0.483999403746525,-0.4434385805455782,0.32228721791671366,-0.613425717584208,-0.20777689573733704,-0.27338634296927944,0.3565387654658562,-0.19452345864969697,-0.16623148868793977,0.2339491170532672,-0.5757941102465088,0.6380840489711086,1.522931124624376,-0.2875655478943741,1.4134043109497911,0.11065857163119508,-1.196342514770697,1.4306285526370148,0.5845717010297493,-0.20047931717672274,0.34794360475733455,-0.3794544760272743,-0.9453203061544502,-0.17832236869220858,0.7778717370722598,-0.662742591213459,0.0247310456385681,-0.13738737439782497,-0.08946619190171409,-0.027163691265989758,3.0,True,Liu,PD1,Pembrolizumab,SKCM,NR,5425.99999999999,0.5033955509923044,High-risk,48.80251583654434
Patient21_T_M,-0.716988771844531,-0.6216765296751872,-0.9709904963565545,-0.9399415744216201,-0.9236912910747596,-0.706551726772982,-1.25666845771857,-0.6053908611672896,-1.2419897319711861,-0.921995895323657,-0.9243946825779414,0.27099887083593627,-0.78508884807766,-1.3318190521769915,-0.7112330437569955,-1.4557837525380353,1.0593916002919626,-1.1815395087152398,-1.032284666859175,-1.0121326465097047,-0.7097240916778277,-1.2510263563460042,-1.5005481114500465,-0.3629539900971432,-1.2934065697311194,-1.408184288727883,-0.9402209244651211,-1.9767240676640312,-0.9238290543956514,-0.8763930607947419,-1.1052263509383873,-0.5253161229027605,-0.37759517294404255,-1.2391623564013723,-0.6520940245535817,-0.26873487480577324,-0.9688423055347036,-1.4804762492791688,-1.6006920885467686,0.873964894905261,-1.3040597506708256,0.8528152805575,0.4753865828501279,30.2,False,Liu,PD1,Pembrolizumab,SKCM,R,104.9999999999994,0.395292281165434,High-risk,48.80251583654434
Patient25_T_M,-0.34459416285194505,-1.03985191786474,-0.3968216424454434,-1.5067494790731448,0.09265838456967006,-0.3844402076938416,0.29641299942740706,0.2279492411132168,-0.41859833238820665,-0.3068766752936486,-0.7635383564517163,-0.17290090551618162,-0.5354696227931008,-0.44866751221916906,0.04172889213957303,0.2683427098837753,0.4297339713365003,0.34342959749860985,-0.11981021898732827,0.4172442306334255,0.22845999975347625,1.0687517631356667,-1.2872394684223343,-0.5582624015846105,1.275915747194254,0.6833149809281743,0.41493984036986253,-0.01757830485194709,0.2805564716467411,-0.48577470114715143,0.961381437206735,-0.3286348657768662,-0.33898688998138976,-0.4296389499931064,0.06396547231266124,-1.0487588131850152,-0.23210207849431058,0.384241447837199,-0.8542121759111992,-0.3038157652203261,-0.21662858776165358,-0.06681994575146503,0.11341805805693109,36.53333333333333,False,Liu,PD1,Pembrolizumab,SKCM,R,328.0,0.39620363171987705,High-risk,48.80251583654434
Patient30_T_M,-0.46311360128567647,1.081121996712649,0.20968946582057815,-0.5321579571430722,0.3564998341707276,1.0235245662315893,0.8660173793274527,0.7158071757325797,0.8555589110190773,1.4832772240363552,0.5164443427974401,0.8616100478637564,0.6566347527553837,0.5068273790756949,0.9853829603974784,-0.19578464281450708,0.7700987030836166,-0.3757326047554561,-0.4060280893278508,0.34531798927252844,-0.534142960844686,-1.0082709148708608,1.4578030307609855,0.7777916594889818,-1.5953021194762966,-1.059021751800226,-1.572663995313228,-1.5624200726879318,-1.3444146416704343,-0.7332316777347271,-0.7777159513463617,-1.142776696166818,-0.22941242858384422,-0.9932751171289251,-0.09435411864263765,0.5692198458839253,1.404202810893663,-1.182581380429009,-0.24020322400477825,-0.09871812555064165,-1.3262367615482462,-0.48073139802603615,-0.25769356287663486,7.1,True,Liu,PD1,Pembrolizumab,SKCM,NR,157.99999999999903,0.42121121080308743,High-risk,48.80251583654434
Patient31_T_M,-0.5075989239858223,-0.758308376180676,-0.5366580380456772,-0.20826752975154544,-0.2640905029065873,-0.783375901897231,-0.8819986883259858,0.09229553126435154,-1.0500375567455011,-0.8485399585300641,-1.0731443427955558,-0.49154304604860255,-0.5645878426015489,-0.6982126132159288,-0.7703213025245936,-0.9474638376646528,-0.15575831171670418,-0.881454985189837,-1.7573987601385674,-0.7257793243627408,-0.8126478785701414,-1.101882755037456,-2.439417527091986,-1.1626376705373285,-0.9183760938663027,-1.3269701780761596,-0.4797646099116581,-1.4163259716490577,-1.3525731049962422,-0.5873743625283308,-1.243977847641974,-1.3347471478292119,-0.2588319640468708,-1.7165706670624017,-0.3367816352728615,-0.456450051103875,-0.688771337300881,-0.9677445822990868,-1.4602461362620465,-0.5169306209182404,-1.1224736008590055,-0.303985827913459,0.354758087415843,14.2,True,Liu,PD1,Pembrolizumab,SKCM,NR,166.99999999999906,0.44054200925458686,High-risk,48.80251583654434
Patient32_T_M,-0.9379892849847121,-0.5430056481479744,-0.7790832056759173,-0.9626692781063476,-0.16966427372521029,-1.1026750555512528,-0.9405586734222033,1.0997640905361656,-1.026215987666608,-1.1852195207034923,-0.9756346277072492,-0.9420033710492344,-0.6144378124186369,-1.115276221088254,-0.4488249689633319,-0.7140880793879892,-0.10769477558761124,-1.3812920215012487,-0.17723886461049088,-0.42537960619835186,-0.06494195190734088,-1.224051727456015,-0.10789717177201347,0.09991512715437341,-1.3520322017478565,0.2230410557859929,-0.15874336698079336,-0.7266696090842651,-0.6879238533221006,-0.8620638181438922,-0.20405839630260042,-0.8765052712544579,-0.09294486413960407,-1.0527182804908801,-0.826259439217349,-0.6960665437221649,-1.1896109298794135,-0.8374906808532626,-0.9543961483925965,0.08031519940275726,-1.7905891454463627,-0.0422581332974724,-0.24622196954326936,1.7666666666666666,True,Liu,PD1,Pembrolizumab,SKCM,NR,269.9999999999987,0.5496075792995863,High-risk,48.80251583654434
Patient33_T_M,1.544878822483167,1.562473745785651,0.8576710276353299,1.7673534776799384,1.249558782725524,0.9196831208128552,1.3326087096528487,1.0524337654910139,1.3211017600432897,0.9202634984758024,0.5137081798166794,0.5655855088011388,0.3551418099507093,0.843956523635891,0.866104053520135,1.0442426949277086,0.48585834133105177,1.5717656636479815,2.2243987625486046,1.8027348366889988,1.2552434313435177,1.6530998435162196,0.1698969630854367,-0.252416424881982,2.199122396420015,1.0524301681435468,-0.38462101348443706,0.44858720672886315,0.9866499217513859,-1.2486444464663666,1.8860740225887107,1.6773120858612267,-0.01137906456515827,0.8225547062843819,-0.5039900221628032,-0.2843520745421247,0.7039283122820276,-0.04692871621740221,0.1687845219149341,-2.181458243861236,0.5808723814780691,-1.885982289267507,-0.4021955762746487,55.96666666666667,False,Liu,PD1,Pembrolizumab,SKCM,R,10.00000000000001,0.3305903844422515,Low-risk,48.80251583654434
Patient34_T_M,-0.35299684822537564,-0.7907185597818959,-0.6492059074824403,0.020357139147461054,-0.5877464552380904,-0.8401610690179528,-0.18276673578179925,-1.351116419202785,-0.8255018311376062,-0.6902333166014201,-1.0506291396694096,-0.6543647143242496,-1.342448065238205,-1.1955577051831752,-0.7376777518432539,-0.16232133592413914,0.8870481811357229,-0.32154309494113353,-1.4049461560088388,-0.6912196438876748,1.1103741321982532,1.7561272861732256,-0.5402317454153551,-0.25630951973723043,2.067551893702043,0.8768022550278586,0.8010555799420379,0.27006116818668147,1.7875423634098666,-1.3603665199823654,0.6826950516186768,1.4052808842008673,0.04347691315772572,1.0630040112966785,0.5867740371632106,-1.5092781578297483,-0.927199256999465,-0.10057543589369401,-1.0260748708637089,-2.2929190556267076,0.18493313789110105,-2.095718414110603,-0.32749582189213494,56.36666666666667,False,Liu,PD1,Pembrolizumab,SKCM,R,18.000000000000007,0.3018461045319499,Low-risk,48.80251583654434
Patient4_T_M,-0.7791238681938517,-0.2594089633619387,-0.7226651681504277,-0.8108972862245415,-0.15983761845957575,-0.2627296151993499,0.011579533591293637,0.17106750225177522,-0.537132487846495,-0.5079141574978452,-0.5601331192162903,-0.7514014192889322,-0.5607433943420015,-0.3178717428596463,-0.3398858056855826,0.03157880332843119,-0.6784578565067827,-0.8792124356700363,-0.802006441512811,-0.4368016692032941,0.3110524267545944,0.7041038790614348,1.1712328582261116,0.7036416802997606,-0.7581894619622196,0.07828882819527011,0.6279899465434359,-0.38347184249872157,-0.3929667593409493,-1.2190001994604351,-0.21135427897235995,-0.3343537376899574,0.28558864536756184,-0.4582800325311861,-0.20458534284552005,-0.8255994256087181,-0.48660793445486283,-0.8726256932091492,-0.44851210755521087,-0.2553183463441619,-0.7891674725519721,-1.024293814108632,-0.45021691374466,20.0,True,Liu,PD1,Pembrolizumab,SKCM,R,383.9999999999994,0.4399078480012686,High-risk,48.80251583654434
Patient48_T_M,-0.49326542573126236,-0.3277823943527462,-0.35529920066455684,-0.29859364740044575,-0.9189703113788023,-0.4495701982441419,-0.24561698077297345,-0.9233193922329458,-0.8688818226707284,-0.24313632947853414,-1.185291318113304,-0.5550532527652347,-1.1721347984947434,-0.5862623633487073,-0.9593514295813571,-1.1197102013629496,0.1585083333815928,-1.5682815121848954,-1.919494021670766,-1.3966917256588314,-1.500107753624996,-1.3381798538759881,-1.152110235640551,-0.624283275164089,-0.2518228803874064,-2.8511857824902447,0.3977439155604441,-2.238018426048269,-0.30893649584426824,-0.5426880778619423,-1.7683418911004065,-0.7815287814336699,-0.13745333588431533,-1.6437077545096652,-0.31534095080364866,-0.5918656434156891,-0.33573304420348893,-1.641879943779127,-1.4689970150273193,-0.2756530082710238,-1.3493876718895614,-0.22240170408981302,-0.17707258995548514,1.7666666666666666,True,Liu,PD1,Pembrolizumab,SKCM,NR,28.00000000000001,0.4755263576765269,High-risk,48.80251583654434
Patient6_T_M,-0.5169338968638257,1.1516666389304124,-0.5977913112763096,-1.4721739308753798,0.26113265868964264,-0.23874507438047254,0.9812962881236179,0.5654825619171203,-0.014621830751010473,-0.18046796625504652,-1.2177483897373211,-0.5371572171784961,0.41790675490362633,-0.4673338005996792,-0.24051250589465364,0.1244002181703844,-0.434812829983433,-0.5982592037441056,0.14251364256086377,-0.4972013665437492,0.6286206133352096,1.0762261974628384,0.3024965866600514,0.520634023406783,-0.8019167355413321,-0.17124938206034257,-1.4607716377786286,-0.12243615409886953,-0.9848464138881416,-0.5349733333391565,-1.0188908443597242,-0.8607544454513592,-0.6106690136199232,-0.03372469615801287,-0.5686864504067249,-0.7381224669913404,-0.1495650773392072,-0.311853261656467,-0.4922171063223944,0.6215361212382681,-0.30887774640048776,0.358662538862314,0.06219958166322165,22.9,True,Liu,PD1,Pembrolizumab,SKCM,NR,934.9999999999968,0.48039423322156494,High-risk,48.80251583654434
Patient7_T_M,-0.7237015719807133,-0.4350598847500858,-0.5201238137576217,-0.44991339982581235,-0.22879156121500263,-0.36905542029883875,-0.5807315836377748,0.220484075668447,-0.47289124173236846,-0.23499551897257584,-0.34623228081557833,-0.13647765382904148,-0.6504443675682727,-0.5108802142593815,-0.8981627359511445,-0.9790663214384178,-0.16030199973207662,-0.8166123591133704,-0.7422840696131707,-0.6279974450485621,-0.6874948414693196,-1.2727153203889816,0.68357594797934,-0.21908718209498923,-0.49682083752948014,-1.8543361365205149,-1.191913029754816,-1.7364495369044313,-1.3624385408827575,-0.9723544293961658,0.1200279358280322,0.21472543964040017,0.1679480142345072,0.054695988230942856,-0.21338636070583275,-0.9831846146679497,-0.06205585109635378,-1.0561493076604893,-1.5621083257745545,0.9156127066543968,-0.8324624918406219,1.2927575008023053,0.014480386402362067,8.966666666666667,True,Liu,PD1,Pembrolizumab,SKCM,NR,78.99999999999952,0.47177414413544316,High-risk,48.80251583654434
Patient78_T_P,-0.6259293871740819,0.9562598188320359,-0.08242626536183274,-1.1879730305393184,0.4340217790428937,0.5200493029845674,0.743596427150998,0.8056250740789473,0.08403937489255932,-0.14924153278279959,0.5331072323770225,0.4749947374240203,0.40887269602395127,-0.09294088830991885,0.36823584056305897,0.656928559442352,0.13697651932420182,0.23925922156451304,0.43758515715177415,0.5899605959096466,0.01855458250827984,0.22679995157797603,0.15513679248852685,0.4515685866846139,-0.2811816890184511,1.112751792299529,-0.3726152188854291,1.0816791846644145,0.6324513197957238,-0.5234105225140125,0.4385191116146137,-0.729882766160845,-0.6971966978821138,0.00854108833877543,-0.5911257149821451,-0.3798959482342413,0.26268746871016263,1.3836091506040262,0.20578288960556362,0.871048349253839,-0.4131726495938325,0.7751348243161202,0.509728676513269,11.866666666666667,True,Liu,PD1,Pembrolizumab,SKCM,NR,41.99999999999999,0.4212638022919861,High-risk,48.80251583654434
Patient8_T_M,-0.3396076412113653,-0.9017708833899519,-0.5600915835370948,-0.721338855791714,-0.44242095481244403,-0.8920084128639959,0.045033377611692356,-0.036532098180713735,-0.5917659690757203,-0.6576812759683276,-0.8265813471588666,-0.9447454136732658,-0.8507064244247968,-0.39621006031284106,-0.7492953393826718,-0.7262744191789207,0.061024498449067606,-1.2600855224270062,-0.962360810075317,-0.6174420138021905,-0.4381566411739972,-1.0026572942390004,0.6315863939104122,0.16273501523143244,0.8111684802244443,-0.06304050032966285,-0.22274826879027035,-0.8169096954527012,-0.6270208067010905,-0.8200295879685539,0.010103209118401606,-1.1259881790027846,-0.4785972811584425,-1.2250838514417777,-0.23395340778109966,-0.9221723085895005,-0.72375360758006,-1.070009972916067,-1.3115750780884734,-0.8148341669725371,-0.7664658619871171,-1.2132802439215296,-0.061707597720670804,33.5,True,Liu,PD1,Pembrolizumab,SKCM,NR,193.9999999999995,0.49676241106688146,High-risk,48.80251583654434
Patient87_T_P,1.5853417554202887,0.3241307955323893,1.583478671260168,1.33893994919051,1.4072045224796974,1.316670945543524,1.452016477332644,2.2709267885690574,1.4520101870239055,1.160146077212945,0.14014037751294464,1.1709339230225673,1.045970237262151,0.9508643269293972,0.8245233141148083,0.23544926858618642,0.8400986789784975,-0.2514701872852765,-1.1358476495463161,0.06276917096385905,-0.6670855741317055,-0.9583893782577355,-0.7399881783466437,-0.986299158844422,-0.3954765811029081,-0.9615518447097199,-0.8830842060343674,-0.7457102784568399,-0.9546778499573578,-1.0621847476003448,0.01136548409747172,0.5766159543049842,-0.597326184377628,-0.2436375777428256,-0.4022769684308853,-0.22994510906643253,1.1206190109977416,-1.015220950572762,-0.5117808503496664,1.1821472102561175,0.714364744256289,1.2474647864053097,0.03329069399759323,42.1,False,Liu,PD1,Pembrolizumab,SKCM,R,86.99999999999973,0.30919859574514996,Low-risk,48.80251583654434
Patient94_T_P,-0.5847992841500238,-0.519257501006474,-0.38225183076103847,-0.8724767775364419,-0.057619887775583425,0.34953088091938583,-0.05400233920218659,-0.15271093680717396,-0.057691962031148396,0.4293471955040053,-0.1595727617892929,0.506987012626283,0.42707032349579216,-0.23489127010680022,-0.04046003590825898,0.04359119133141474,0.2688547083610944,-0.5612222658174428,0.4421949901332055,-0.27732727896155696,-0.0559689887596044,-0.1431893655800768,-0.29103575251021097,0.4207941148681622,-1.1911906026310535,-0.9386242056092048,-0.621691259696674,-0.3898666910069408,-0.059509091198419906,-0.6042266649386863,-1.4576704626300325,-0.3772241959903848,-0.5261919250247681,-1.1388118567979049,-0.6187604750713985,-0.37985561604066803,0.6969516619465925,-0.7855957506132125,-0.17750840442755186,1.5959296399503968,-0.4539559194792117,1.1235898330271137,0.4274924362394383,1.3333333333333333,True,Liu,PD1,Pembrolizumab,SKCM,NR,267.9999999999984,0.4336079528991501,High-risk,48.80251583654434
Patient137_T,1.339234668156433,1.813104016572759,0.9255040255539002,1.2950935342857257,2.0176944952854248,2.2036516955089773,2.1361863132387873,1.7361732042309905,1.8286567272343148,2.1129932382020735,1.7608970105809445,2.00150430744725,1.4462001793880035,1.6424862884547613,1.4927871319287183,1.182939006848471,-0.43912403782870385,0.46433558960721655,0.24316258212431024,0.9259696546261998,-0.10880580073714675,-1.4943528410605178,-0.31394556113596495,0.24842966490414514,-0.7596122777645957,-0.11609452547302537,-0.087782361026129,-0.20981770799310587,-0.05620894075126037,-1.359957489493096,-0.8540032483255191,-0.8359251964933788,-0.6761151452171367,-0.6729548581924876,-0.7589156274590685,0.2777332737248686,2.0588421955164837,-0.019126457509972054,0.9048779997591748,0.5128864328525891,1.3954796458283882,0.6604201123303901,0.1903678138293124,25.73333333333333,False,Liu,PD1,Pembrolizumab,SKCM,R,859.999999999996,0.28385269337533836,Low-risk,48.80251583654434
Patient27_T_M,1.9309131210004915,1.0637954008318038,1.449788777079051,1.3188195275182941,0.8733326805831276,0.4171694056826164,0.22365718480428834,1.964641089403184,0.541648453780187,0.7265281061927426,0.33724657090699817,0.24868921942615882,0.45566140879256867,-0.1091849013651772,0.08216859691811744,0.31666529221551454,-0.17763845260660438,-0.8702137147119466,-1.3836529769624597,-0.5354384364214924,-0.74713237549745,-1.398385148712542,-0.07974946803681593,-0.27115666580671677,-0.05305877509818151,-1.0646150869637228,-0.3727743001205938,-1.2492498658748301,-0.9063788934012917,-1.1113571568662521,-0.5770161449129425,-0.2188981545480352,-0.30797738910672906,-0.8105253972360823,-0.8391601740969421,-0.1985405060813062,0.7860657282155157,-1.732256723279701,-0.6264742051023942,1.2479485572754205,1.0575942922425317,0.3202549844297134,-0.13104740609003632,14.366666666666667,True,Liu,PD1,Pembrolizumab,SKCM,NR,216.9999999999992,0.36663213407199075,Low-risk,48.80251583654434
Patient86_T_P,1.818615937862085,1.1898250507476889,1.0651200327192647,2.0269602586591438,1.735541423368318,2.091879767182551,1.5913304222015654,1.8874065367300787,2.3613985376007194,1.9553436392425803,1.7370925045255836,1.9070950128868451,1.3469994317044858,1.501395686186714,1.5685950812140317,1.4813521008375528,-0.10835154620446946,0.8424621801857619,-0.3453274290995972,0.6288750100134787,-0.41068060764273717,-0.5830165879481629,-0.7627481584296311,0.2869949362174899,0.23269296066407638,1.074550385143624,-0.13484797023685313,0.754005735536987,-0.2741552190270907,-1.2085723329981608,1.5459153216630124,0.8222626713662132,-0.16416616859078217,-0.6619916130935216,-0.5713723469057167,0.5130581552347537,2.0131508352391396,0.03373888362742843,0.5507835229485583,-1.1451924751033191,1.8704913234141534,-1.0834421017462266,0.12379963167474341,44.23333333333333,False,Liu,PD1,Pembrolizumab,SKCM,NR,278.9999999999993,0.22287913559264438,Low-risk,48.80251583654434
Patient132_T,2.4214581647559035,1.1883049438888764,1.469345181221855,1.2621222798745224,1.7040233932005913,1.1665608317846519,1.701843779490761,2.135276178640161,1.209224240735177,0.8110235509595767,1.2794331735222693,0.7073339135905898,1.0545663714923155,0.5231115665556644,0.8830511055328314,1.4411735351993924,-0.340243517572136,0.9657493399926592,0.5837044032435487,0.8848410488300867,-0.2530913766506289,0.5216063281122778,0.5190120282797114,-0.186359979006768,-0.6916455946042399,0.2448334122609818,-0.12146964626443167,-0.29701049258735684,0.07294701065440218,0.24138427636219892,0.4429091245893054,0.10078178014466471,-0.5324061445543748,0.038308495522304746,2.2416838000088286,-0.6650585006519824,1.125236072477898,-0.29275065502745,0.36652233330048667,-0.1936861607525403,1.7695695460922831,-0.50326350578072,0.2660526312102856,24.633333333333333,False,Liu,PD1,Pembrolizumab,SKCM,R,629.9999999999981,0.2802496954311554,Low-risk,48.80251583654434
Patient149_T,1.3320532281930346,1.0468864569344287,1.6323410257441082,0.36637891358808167,1.375029353078163,1.3627499580912714,2.0121658194250838,1.4086280668287288,1.13284920193381,0.8898773877245604,0.7222191878324962,1.969419342731815,1.057766496627397,0.7087064550019849,0.805887789637742,0.8219555467359646,0.4811503588589418,1.632538616666416,1.954558315701573,1.7300715149421748,0.8532881770971599,0.16111406458361485,-0.19848616920619563,-0.2889445938050558,0.15498784789130815,0.1497789084206786,-0.9279623164993378,0.11515162272876084,-0.21719874046955567,-0.924469181564838,2.1111630636825143,0.7657471754296541,-0.21414803166137822,0.09362174474486133,-0.3901216739234673,-0.08110908432680591,1.2140094680702211,0.4159832535716287,1.0735537210282233,1.0917351604508052,0.8340183776310021,0.6968173144745274,0.3202581080963208,16.566666666666666,True,Liu,PD1,Pembrolizumab,SKCM,NR,218.99999999999855,0.30610615124424584,Low-risk,48.80251583654434
Patient173_T,-0.43671923648367533,0.2418473832693346,-0.5456044423133352,-1.3193718007443294,-0.4569815626732264,-0.8554484103163635,0.03264696419121319,0.059639600585348014,-0.9583507749176163,-1.1842992557855139,-0.7365277748479411,-0.3438121994283967,-0.3618399231242501,-1.1775101693895247,-0.528253864410319,-0.9701178394717167,-0.8513647950261785,-0.7161295563674166,0.027492728665868896,-0.23649017624193538,-0.9106618285148289,-1.1453750042252628,1.134833836236357,0.4717369686399641,0.21547488903415676,-0.5631838165449441,-1.2433804910685027,-0.9884322139368054,-1.1378229244634814,-1.2883631037499146,0.6669407654329529,-1.1862324968873856,-0.32039517060556166,-0.23632478597897738,-0.34503445786528825,-0.9211336332738638,-1.034351879507658,-0.9914436817598934,-1.2068786679282462,1.1105836668590285,-1.5702157402895915,0.7753806896919119,0.23811004751900788,1.4,True,Liu,PD1,Pembrolizumab,SKCM,NR,71.99999999999959,0.5716806272395879,High-risk,48.80251583654434
Patient77_T_P,-0.6457087952069102,0.16363330552173358,0.06874332833201699,-0.39399307977760184,0.17557353529639122,0.6245178633723465,0.07583187260905909,0.3571069549333377,0.2560945701529157,0.6089447957305602,1.2954888956659978,0.9672048756275926,0.09614280796749387,0.07971430573332022,0.21177788363887964,-0.28425073922703004,0.03170209497316176,0.03522676222066385,-0.47785173883181226,0.4153250854531051,-0.6845772965599007,-1.2762294957979483,-0.4392590435782868,-0.008553631474722264,-0.4030621099427378,-0.7004069575301122,-0.24170813161353594,-1.4713660244900155,-0.749054543395663,-0.7467173633118653,-0.16216743230595995,-1.1991384070193263,-0.6219919310346411,-0.5266155623018249,-0.5881336707629581,-0.2849534271163997,0.7776348992849597,-0.6793301413769015,-0.19620169418465472,0.202964330432554,-0.7052481451261451,-0.18293663224679743,0.2604327851900849,14.8,True,Liu,PD1,Pembrolizumab,SKCM,NR,91.99999999999945,0.36766043284034766,Low-risk,48.80251583654434
Patient150_T,-0.5676602138203032,-1.0249930630487993,-0.6780118117016456,0.3847569762091636,-0.4329335210547712,-0.5621894690817769,-0.523343765873546,-0.09795660740888941,-0.5111922119824043,-0.558556874156669,-0.42439081836587556,-0.5369174387127293,-0.47658403329327687,-0.7980027050827938,-0.5366356971920117,-0.8514863975513806,-0.28777001523562606,-0.07619190955939839,-1.0927011580931798,-0.23127427127099998,-1.0544582169502212,-1.0671092253108505,-0.43214506504723177,0.2797428110081576,-0.8687320899576657,-0.23727801155888129,1.6820165783483878,-0.9895635881860562,-0.7427674122175092,-0.5158068117803882,-0.5477029473305574,-1.1646423254271165,0.13971370082155293,0.2925958569615477,0.03791519116085318,-1.047203619033388,-0.5384096212615104,-0.959954427912975,-0.9705176691011677,-0.29787042670793595,-0.27987846940574973,-0.6456939201157607,0.4793823072991343,22.83333333333333,False,Liu,PD1,Pembrolizumab,SKCM,R,23.0,0.4023907104505302,High-risk,48.80251583654434
Patient158_T,-0.07871192403051311,-0.5286954207086673,0.05016736353672056,-0.15516374804947983,-0.48506992115633946,0.07926212510773327,-0.7088217882279706,-0.08836739071704383,-0.25065122942618373,0.18105621273024933,-0.4429728787814006,0.2112666010926028,-0.10976314264657347,-0.3327492445459843,-1.2118710860087676,-0.5930453220520318,-0.500451478895372,-1.0898265034363388,-0.881814191997156,-0.4979329167257468,-0.9006627001992811,-1.3446280259807657,-1.1778739421973274,-0.1549720484423791,-1.150510591657491,-0.08154223779347379,-0.2598517770231581,-0.8664571845493723,-0.8498384265954982,-1.1385846880966493,-0.7742987934493368,0.14259507144786082,-0.48036074624358716,-0.24987892669523296,-0.5717206987608949,-0.683047738514688,0.18466007656539837,-1.5080953917809587,-1.5105875099166164,1.7445415090476752,-0.8464095127253372,1.7612655012782736,1.080056869877748,6.466666666666667,False,Liu,PD1,Pembrolizumab,SKCM,R,2295.999999999994,0.4680078711008873,High-risk,48.80251583654434
Patient102_T_P,-0.5045791676141488,-0.125404498569093,-0.707806725045417,-0.6801988148037008,-0.3786502093034807,-1.0186746547592136,0.019811708777084953,-0.2860652675170053,-0.9650508143315281,-1.0137885698084348,-0.32889651760903427,-0.8092295525818536,-0.24669574664866176,-0.9165604963433006,-0.33190652151648514,-1.8375417848260829,-0.4535367764523747,-0.44346618729753323,0.008996697310064661,-0.2431074904140886,-1.1021294517823965,-0.068487143954155,0.924813667501664,0.827721529424959,-0.8128427054765616,-1.284827801287424,0.14824220032462568,-0.39362745910064134,-1.1145960286338956,-0.7323896453612392,-1.2538676843259735,-0.923296849957146,-0.15333557650606006,-0.7245303741433538,-0.00783257267354634,0.04237965425460675,-1.1059188483882094,-0.2542732630771431,-1.2845043556139097,-1.018517875820382,-0.6875764878233422,-1.0724538315961312,0.4134440822944841,26.166666666666668,False,Liu,PD1,Pembrolizumab,SKCM,R,245.99999999999892,0.5546669123863992,High-risk,48.80251583654434
Patient200_T,-1.002634560239438,-0.5100092227233887,-0.4766976121302034,-1.5036735738644296,-0.049834525087990106,0.5825030812432499,0.24625076033251372,0.45785806336114404,0.20222573129060054,0.5094567490675976,0.7466190915366013,0.7850004716623736,-0.3831249181519085,-0.9439112610628632,-0.756248054137648,-0.7826642407606037,0.3171045623080075,0.34779649194507456,-0.9451525019370641,0.14386896321874296,-0.45379595916721044,-1.1241447813031449,-0.6397034185330648,-1.2314398979626375,-1.7953258204177611,-0.7914773685268258,0.11943615459220394,-1.0150983194363283,-1.4756110816078887,-0.743641914647046,-1.2505216749568087,-1.3242580590782658,-0.5902977189218451,0.6452147041978702,0.013541443912077924,-1.055400967514544,0.6062263115316326,-1.2906369378128395,-1.072199431354913,-0.04382020107219613,-0.5529611812512155,-0.053713115158939714,0.12715569649051303,17.066666666666666,True,Liu,PD1,Pembrolizumab,SKCM,NR,734.9999999999984,0.3268450247997886,Low-risk,48.80251583654434
Patient79_T_P,-0.7149128114290031,-0.2961425708622775,-0.049630863059384106,-0.9958249393859127,0.3130077682391742,0.44909964149447273,0.4159229634105189,0.07843848850207336,0.24745222562652636,0.24385424416181598,0.4104219087365861,0.7094728568163375,0.13461869052820008,-0.043284689987374454,-0.25309301875533335,-0.18083206932872717,-0.33005703880206644,0.5708185630843865,0.22965619866090078,0.6607210600993134,-0.18591386282535155,-0.47541506254534965,-0.6790289040322643,-0.8534873482801638,-0.19315482483214533,0.20939625009806764,0.6157079817819056,0.1413119986836578,-0.06314588502348661,-0.6057059955290242,-0.4144002022256662,-1.183552522578964,-0.24825677665377877,-1.2221351496920119,-0.5868946080428413,-0.26647567492262064,0.42656585886275683,-0.18102552311281173,-0.5117748468752038,-1.1135560570488143,-0.3133364949994901,-0.9425174621776101,0.08799137002972457,28.3,False,Liu,PD1,Pembrolizumab,SKCM,NR,204.9999999999997,0.40819872253364226,High-risk,48.80251583654434
Patient82_T_P,-0.4913127505229766,-1.363494159279072,-1.2196691515244371,-0.11625440237473182,-1.09541843837613,-1.213240187349525,-0.9280260214707559,0.3881007837045132,-1.4677895505472744,-1.438132045588087,-0.8658399020341584,-1.007113574535668,-1.8693856571056193,-0.6185933341838745,-0.8202025651846815,-1.8652702695084218,-0.46297502523384576,-1.8494915040590856,-0.8877761478117712,-1.2673358181870564,-0.5415178076858426,-0.5373706082104032,0.24814540077002145,0.45911839810826494,-1.3726266361527666,-1.8093383834020618,-0.16658762827007467,-1.531495524622819,-1.0469773117542027,-0.9068222158039091,-0.6872730926906404,-1.286235349809942,0.155910324689559,0.08294162568997422,-1.1143037597816954,-0.505003180860738,-1.5210609511836757,-1.4448979756965714,-1.348492265867481,-0.3280086448523673,-1.2228515730523393,-0.6870021542949782,0.1375805430031874,4.366666666666666,True,Liu,PD1,Pembrolizumab,SKCM,NR,1476.9999999999948,0.4534279327551495,High-risk,48.80251583654434
Patient159_T,-0.6580814141836225,-1.0468706451442535,-0.6152456451460746,-0.1387935271386394,-0.39466158393261525,-0.09204290832875175,-0.3057627792323009,-0.05322404350655378,-0.10667093417028982,-0.09572454297165672,0.47577067159702774,-0.272962392619435,-0.36955396637113413,-0.49157646665531374,-0.2796870673994905,-0.1797026611773939,-0.7787592685572456,-0.40170749151566837,0.9536535029968748,-0.03893835690181877,-0.6009878230503202,-0.9255827495715628,-0.29112426784789247,0.543548714692033,-0.5951362159295588,0.3701546395879653,-0.13828442756717438,-0.49292643797064073,-0.2737507318481456,-0.4197793373745249,-1.306740827838209,-1.506157440448257,-0.5886664516249988,-0.20743920500801125,-0.5195105684987082,-1.0348141292006228,-0.2123891413963693,-0.34081737461223766,-0.4639018265731618,0.694776541189562,-1.0990563197193017,0.9710394648229709,0.37825905772616336,9.6,False,Liu,PD1,Pembrolizumab,SKCM,NR,45.999999999999964,0.6015584183611113,High-risk,48.80251583654434
Pt1_Pre_AD101148,0.3247178201386866,0.536026544192344,1.1797668613510581,0.17528942171339476,1.224192876193029,1.3819494247535735,0.361558855677487,0.5025967437444591,0.7671888047939684,1.5195949983370478,0.7831170053176789,1.8010650104304997,0.8581901007547985,1.2532487153893914,1.0118801662574206,0.9256739781823818,1.2878945944054274,1.2278165148557003,0.8096649861903121,1.4590666234977052,0.45738045502487085,-0.698071439450313,-1.1606999754370906,-0.9105026959279013,-0.2873300025475809,-0.45164683625745955,-0.00902174976057207,-0.30808731701022934,-0.7127272185494539,-1.0691735006319376,-1.2017268418056608,-0.053073910992103394,0.023870006427728876,-1.08417049293364,-0.6271799057771615,1.764667926397715,1.4176859338665513,-0.980867196889512,1.3976663535217557,1.110876938360742,1.6346466549075391,0.5374512386809244,-0.40594918613333514,5.333333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,,0.32336859156036657,Low-risk,48.80251583654434
Pt2_Pre_AD101150,-0.4899644409442593,1.044206891153943,0.41443461628655326,-0.9005147754837499,0.7121707383788216,1.2243821092185936,0.6702832219450313,-0.3092681412969154,0.4270215827235668,1.0154434053894843,0.7107660376356818,1.4011554512766813,0.2320789042963133,0.8649635669899122,0.11788423522808968,0.8174292308891296,-0.8385396515363346,1.0612803071508545,1.6167091676035394,1.7758920018593016,0.5330049550048117,-0.3349410706291626,0.7630438238408327,-0.1781069453142187,0.8930064032080746,0.49376328331910047,0.99898954235122,0.647484289564207,0.5862851092604628,-1.2040376250786435,-0.8133619577651654,-0.6965635269745118,0.07874621648692623,-0.7176804034999862,-0.44533237230631817,1.751325033593478,1.3471040212983774,-0.5264435236511322,1.170044532440024,0.9266021888843092,0.5988322106193663,0.42338263481062177,0.3988767999975278,9.166666666666666,True,Riaz,PD1,Nivolumab,SKCM,NR,,0.4740416736834894,High-risk,48.80251583654434
Pt3_Pre_E9024733,-0.8265309762380251,-0.9474075466186598,-0.6078841819393647,-1.1572809442278662,-1.0289276244595857,-0.5890502951748283,-1.1433135544400232,-0.6657445843487964,-0.8220406536975694,-1.004257854057351,-0.9537860244739934,-0.9693557085982921,-1.0385952977540367,-0.7217790305034284,-0.537230356482658,-0.45974041704463064,-0.6990343265374276,-0.34860614598789275,0.9975887060878806,-0.24959113578765102,-0.45105547994602235,-1.3713458978454323,-1.0967596603620646,-0.38208051516699565,0.5075515628443986,-0.18668162860090837,0.49620343529712774,0.321593252709955,0.8018425932312679,-1.1676689196019163,-1.5758487726404242,-0.5674536426267507,0.7268369863301906,-0.8625476838361555,-0.9553466177664321,0.7499336987166102,-0.929839428070853,-0.6219855354800538,1.018360805948285,1.5749973418330436,0.08637177032994985,1.1310891386898723,-0.0078043729813857396,38.13333333333333,False,Riaz,PD1,Nivolumab,SKCM,R,178.99999999999966,0.6773455367468482,High-risk,48.80251583654434
Pt4_Pre_E9021023,-0.007660316794857596,-0.24142082583040328,0.277407111152167,-0.35943797528360205,-0.5990797338713436,0.34158693747564806,-1.4537169881823242,-1.2868147910121739,-0.09678973036962181,0.3910591718801881,0.2923190985850765,-0.1684940493141189,-0.8673107827290251,0.647053992705794,-0.7709665321570626,-0.9830171609611519,0.009395538430093806,-0.6228576028764189,1.1686806719208487,0.14093964083312244,0.49119394163082536,-1.105326733296149,0.20957433957830982,0.775842161734888,0.3357577184816659,-2.1279412355967358,-0.12678739328178196,-0.42665807348553714,-0.5543317870164162,-0.9192340920664871,-1.5738043432422766,-0.4765042266632867,-0.07497569249223165,-0.9222458359191391,-0.8084065883432316,1.0209591008446284,0.10410719544851404,-1.240292626111919,-0.3595335889808472,0.19557378790317217,-0.220841924794344,0.19357758976617523,-0.42204955528882576,21.1,True,Riaz,PD1,Nivolumab,SKCM,NR,279.9999999999995,0.6160638670891145,High-risk,48.80251583654434
Pt5_Pre_E9021022,0.12010919345951894,0.5318033903507505,1.115215490675113,0.11521277735885224,0.42689222000331345,1.41914573444735,-0.35633462121783266,-0.10679507113913139,0.620746983483613,1.7275586552956879,1.1067983861177781,1.0133583679816403,0.2419577721961957,1.052858373253638,0.337540041369718,0.2039559399380571,0.05558726860668167,0.6428117374984719,1.5405749981156556,1.5097626218097062,1.3147001194533656,-0.8782336393158133,1.347266754665499,-0.34057924245035087,-1.1392191481388725,-2.026702666719613,-1.617582281744305,-1.5929143111563715,-1.0396530344836123,0.39397884382512127,-1.5645490822886594,0.4689487820099066,0.6788706797117794,-0.8510012444015121,-0.4707204742653822,1.2969631591028088,1.3204533385364166,-1.2438583344297551,0.22025188713589508,0.6665577752349384,-0.09078856558269556,0.8608373115625219,-0.09100720590355402,7.4,True,Riaz,PD1,Nivolumab,SKCM,NR,50.99999999999998,0.5341631175274897,High-risk,48.80251583654434
Pt8_Pre_AD153354,0.04090896257235674,0.6262459437434872,-0.19682607205757938,1.0180940855782208,-0.30086939387635264,0.311736224278079,-0.5191176560838655,-0.6548698767123984,-0.18376500372221408,0.4259165549871307,0.35035355478456204,-0.21494571977543037,-0.7318002961695496,0.1406439508604276,-0.3151889421203969,0.08817292962106973,-0.8917203576934721,0.8674121699069506,0.08653084344057463,0.668489757211902,0.011547399390982625,0.08100792706266906,0.6943890502368514,-0.18227509371655146,1.9715404395321523,1.0703260646089985,1.6710619933919262,1.2064945568472865,0.9326388409858012,-0.9636245915256432,0.9290991813299514,0.929148788773612,0.27457722592293754,0.07317537307957236,-0.48856851566538473,0.9159969750504636,0.3813333096734717,0.19021255083997216,1.0007499681580647,0.1868415542125949,-0.15656001570510505,0.18819845837977203,-0.425783749677838,8.633333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,86.99999999999973,0.5573428854163179,High-risk,48.80251583654434
Pt9_Pre_E9021024,-0.8861254871679893,-0.7449525433363379,-0.89138602625208,-1.1309763598818772,-1.121194624978496,-0.5439467218483026,-0.8422700848805779,-0.49290548868532474,-1.0072302610010115,-1.2118746073098263,-0.09544374442243324,-1.0752075715210476,-1.6145178285889545,-1.1042692663200284,-2.0606257297636614,-1.1795052319232406,-1.3513769291075275,0.37637212864178315,0.30772128445938735,0.23264222778415994,-1.054677911848116,-0.6859864952798593,0.5992745186164731,0.038842241016296575,0.7491353831769626,0.4205842424468892,0.8647745632350226,0.9436836338076979,0.9656518218709185,-0.9789139398800294,0.6018798084810589,1.4604135902015742,1.9368651119039295,0.0906672838644746,-0.3603253530000058,0.46552502438415433,-1.253803324841931,0.10711681971117142,-0.10603601534881399,0.3945340515087472,-1.031428774132156,-0.27992124036480975,-0.030094554195634938,3.066666666666667,True,Riaz,PD1,Nivolumab,SKCM,NR,406.9999999999992,0.7139800223329713,High-risk,48.80251583654434
Pt10_Pre_E9047565,0.19103750251447488,-0.08558580935119449,0.019082657848144845,0.527980779762441,-1.0933460894383422,-0.5992958749120265,-1.5137233592492245,-1.5785921543612618,-1.262976163307129,-0.8270384211635957,-1.2866553157880531,-0.7743997209940516,-1.1501677092072073,-0.8875483859523384,-1.933437061054016,-0.47009635997796495,-0.34602215281568954,-0.23922328900075301,-1.4371703550460477,-0.27763813516833064,-0.8515527517298384,-0.9553505760996269,-1.6014093006441044,-1.230478898744553,1.4608943404617056,-0.8987190425661888,-0.25429052171526595,-1.10765795489855,-0.34367156437471985,-1.270199394005072,-1.1610490482813949,-0.24503889915754884,-0.33771268789001424,-0.9185866020546148,-0.8688358686932479,0.8881010052014557,-0.6534885679521822,-1.5248204617678744,-0.7520216349253317,0.8662279028247796,-0.3825861456130048,0.4038581968032255,-0.19560565175968903,8.533333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,72.99999999999983,0.5702560557460947,High-risk,48.80251583654434
Pt11_Pre_AD153352,-0.8563092685448587,1.545757665480794,0.46441705042941817,-0.5673959873382464,0.7833977916174938,1.02282079458897,0.2868732408862382,-0.8608947732156986,-0.07110842491197429,1.0615549696632947,0.6556427796407716,0.7472003431720604,-0.5458999957861923,0.28079913218533936,0.44475959110117863,1.9218029940707706,-0.37745949366372933,1.7454205443162614,0.8813234640725107,1.5123057589426492,0.6446094247736894,0.011975279490661826,0.20683877182322374,1.6289652146766853,0.5827329680946552,-0.22261616431725112,1.166727459788145,0.3010011257787241,-0.1414773594717174,0.15305375852837122,-0.11507337254896036,1.5918128660428528,0.08055769856992523,-0.5708053182377156,-0.8945445174086221,1.0487999465109017,1.2477700408657015,-0.385515574644329,1.3492915731268118,0.06356737728702315,0.03857210322305181,-0.5022374839465005,-0.1231128020690453,27.9,True,Riaz,PD1,Nivolumab,SKCM,NR,103.99999999999942,0.5184351818207146,High-risk,48.80251583654434
Pt17_Pre_E9047563,-0.8650147185701828,-1.3052428420682487,-0.658842838652965,-1.4772540486490071,-1.750804004420628,-1.048836325547299,-1.8275299492135102,-1.9663038738113523,-1.7255247840812287,-1.1782073287239556,-2.0905924470275963,-1.0686866672994164,-1.9603631641735968,-1.0691446298312608,-2.043669481961383,-1.4958959406890433,0.09553778631026118,-0.8681836093960006,-2.295712573266722,-1.2002784059538583,-1.2996721137075358,-1.0130236824026895,-1.650069137497695,-1.3415365818263567,0.5963136788268666,-1.3895784358052248,0.2605409694326198,-0.8477326254014155,-0.2754183997129992,-0.8183576068040426,-1.2381969204747607,0.47762673568963304,0.47356155967353714,-1.1761128229638669,-0.9885469036274354,1.1949575937340555,-1.4052727610385007,-1.223315667825696,-1.3997768583513688,-0.01767017831396914,-0.8662018237079471,-0.39525135462059274,-0.2037268478257338,1.9,True,Riaz,PD1,Nivolumab,SKCM,NR,19.000000000000004,0.6009797007123239,High-risk,48.80251583654434
Pt18_Pre_E9024732,3.5187550390310203,1.6619313465457717,3.9390161439887494,1.9316248631997481,1.680768098680456,1.939187901984607,1.5472793468873456,1.6118465083861624,0.9894187317715425,1.7093668573027305,1.1953580746312549,1.063547247916619,0.7704450601347391,1.1952916990250633,1.0000279303678792,1.8918809903730407,1.3842817356382138,0.5109089574854264,0.09938402803956879,1.098482056081326,1.317864516158932,-0.695084557969387,-1.5825914334013955,-0.1848165343360923,0.3503161466604121,-0.8397131140721801,1.103855248233631,-0.6824844887015965,0.286774676413317,-1.2137566848348917,-0.6978104628708436,1.2768297693127222,-0.08746920750043856,-0.3954784213812828,-0.6879020565766081,1.9639365829149387,1.7685829565894802,-1.0535415095795875,1.7639874036128567,0.6386215378924653,2.9239431972595566,0.7032749006167538,0.40869238561902316,35.766666666666666,False,Riaz,PD1,Nivolumab,SKCM,R,214.99999999999903,0.29454690336183625,Low-risk,48.80251583654434
Pt23_Pre_AD313075,-0.6133870707984137,-0.45287997670520597,0.28966062376836044,0.16874655625571605,0.5549546460952224,1.1226708964090455,0.5445352560047125,0.09401368310877732,0.12439042998119823,0.6624459450886265,0.5200624587668996,0.6279427026261377,-0.36129900683478683,0.7677477756577452,0.0047633234173078175,0.27687378478392655,-0.9514056404088861,1.6654732263779108,1.5884413475103039,1.663354669273919,1.2016017713454077,-0.5394252781894511,0.5488105089572948,0.8594387984465962,1.6137562459031674,0.835634230052408,1.2025336225556043,1.371337089747216,1.5389371404597914,-0.3824397627355809,-0.01867181814958733,1.1305429562334335,-0.2780202521203511,-0.8898728064565976,-0.2103791320845484,1.4171544490124517,0.8857542567178884,0.9195982072992318,1.8429992154747092,0.43570669959491176,0.7058475034800111,-0.09343851553515878,0.08055649641863967,1.7333333333333334,True,Riaz,PD1,Nivolumab,SKCM,NR,631.9999999999959,0.5995231181404033,High-risk,48.80251583654434
Pt24_Pre_AD436687,1.2842465212666803,1.1651312042737196,1.463895924050018,1.0830291562550824,0.6796030757990199,1.2597131517181153,0.4218601539389805,-0.4874514811481954,0.7010342826916824,1.1471402720357375,1.4935133703784758,1.3088396715876707,-0.03583295910619841,0.8069480696133331,-0.2785413558926341,1.5461314359988678,2.167066313822264,2.2338356074327828,2.7037603854035814,2.69698834085906,1.549502454036301,1.7079054834104754,0.5690288305623787,0.1015008929851509,1.813872230025622,0.5950688575569812,0.5186903375478156,1.5255361391097184,1.179776078021819,-0.7763878927282224,0.403538785624865,3.3957101579384505,0.40146288188474555,0.9315543290347026,-0.8926356550328379,1.5240895812580422,0.7825391443736449,0.19631819739422954,2.3750284660866767,-0.4218675802151877,1.8138939355114059,-0.8975338150023005,-0.3641395127493136,4.966666666666667,False,Riaz,PD1,Nivolumab,SKCM,NR,1.0000000000000029,0.36512760176219006,Low-risk,48.80251583654434
Pt26_Pre_AD467789,-0.0009885516380182943,-0.2263517943639761,0.38608253074181703,-0.5517922506363497,-0.49899356416849294,-0.5172640251820629,-1.5821163568530845,-0.253874648064914,-0.7715402793301018,-0.29044063307235946,-0.9108143481222432,-0.47759192366333403,-1.4259172841991845,0.0981247029336125,-0.8023385850487592,-0.40063466077857157,0.42987821755089695,-0.7666424605222434,-1.683308521148805,-0.6270697681796802,-1.1239613023202655,-1.1869318104917639,-0.9817146934245143,-1.6504976019130908,0.14128674562901658,-1.6510334157801791,-0.8602853907423684,-1.7271531518625964,-1.238511625946091,-0.7708612473741162,-0.9948138952814726,0.8147484850036287,-0.21582653195568696,-1.2143420658420312,-0.18451324922875767,1.1868251619010572,-0.17580482189672952,-1.550112305101515,-0.3005818212794559,-0.3487076237096084,-0.5848099039597235,-0.34102800963085994,-0.5947894231580328,31.73333333333333,False,Riaz,PD1,Nivolumab,SKCM,NR,118.9999999999992,0.5246877636924092,High-risk,48.80251583654434
Pt27_Pre_AD453873,0.16661716820951517,0.24793948175241096,0.8792720148403937,0.7095981893590074,0.26364111339987123,0.6814648501313247,-0.7089964160713208,0.26335436197118994,-0.1266681759611966,0.3336015375837849,-0.0338564594000814,0.5418438781434811,-0.1969137537451722,0.8645105571393121,-0.4818253010464319,-0.44798253802956456,-0.4032932288697088,-0.03850288419313112,2.5867269840869413,0.8976419703480155,8.212142885620201,-0.7703724645856541,5.5721875316342855,1.670136088378469,-0.4592356617324517,-1.3938691788415705,-1.023144520696184,-0.5352583413752207,-0.30411387903255394,-0.5524776173611838,-1.7857231462977814,0.761198734459227,0.35471583942225743,-0.678065357851731,-0.37876122947464075,1.3960679646521537,-0.14288056216739764,-1.1829741315521272,-0.0589972602639893,1.0630960743579811,-0.37521970102730956,1.009661093783702,-0.4021669027957584,15.833333333333334,True,Riaz,PD1,Nivolumab,SKCM,NR,178.99999999999966,0.6222169225172149,High-risk,48.80251583654434
Pt28_Pre_AD297619,0.37219676414960284,0.1905802321003533,0.04891139719929557,0.9877135784908341,-0.52138598426475,0.36157566568108485,-0.8906354796081609,-0.26425827815053826,-0.23481490333759136,0.40306437780255255,-0.8160357710353865,-0.4274307386502814,-1.0878627248782178,0.10097827707290302,-0.6238266442942598,0.3406919843277466,-1.0945080603137265,0.6188475580649087,-0.6481286617504032,0.0011742028000791642,-0.6519372474635442,-0.835547018255052,-1.4003298976628462,-1.8102033918467937,1.5738169881198985,-0.029686848652088066,-1.09436827550983,-0.19453256970675611,-0.24003867202074516,-1.0865853681530726,-0.1864425854001452,1.2684384689170864,0.18807263261727955,-0.5345116164437452,-0.7838400450006884,0.21608508576962726,0.42419142930398845,-1.050011644944533,-0.07862182277799029,0.9951843177742336,-0.11320420490660257,0.7905681034702059,-0.255022870197019,24.666666666666668,True,Riaz,PD1,Nivolumab,SKCM,NR,38.99999999999999,0.5664863469093006,High-risk,48.80251583654434
Pt29_Pre_AD497504,0.05822696363366495,0.2241240885757435,0.08861522636264899,1.4934025824442145,-0.15486315502003875,0.245733307756684,-0.11770569457935925,-0.33865448817910615,-0.6982269980046142,-0.26714164811957297,-0.2478772111089067,-0.27150439983781893,-0.7737733301129988,-0.8553154622944495,-0.6519156427323924,-0.08029426011607414,-0.022262071557744328,0.9708327730036803,0.16513805302623558,0.8430924382644758,-0.2804337147770219,-0.09256191844674438,-1.5654145137985795,-0.10979307007064,0.8313749921771282,-0.6257145986750604,0.6732047961357368,-0.736726859762397,0.07936540173880245,0.3179380748052593,-1.1831274927414475,-0.7426764806765263,-0.14143034209447314,-0.16718324178730992,1.6939223424180876,1.0410752836790398,-0.091624230489043,-1.145272195623836,0.22487417222112321,1.4980079763750052,0.07702006057714511,0.9903591120021008,0.5352531358308203,9.1,True,Riaz,PD1,Nivolumab,SKCM,NR,401.9999999999986,0.5321923076238745,High-risk,48.80251583654434
Pt30_Pre_AD497503,-0.35062552017242404,-0.5191095148895637,-0.2940831261879234,-0.3521322126496016,-1.0127805047308511,-0.4537707938671879,-2.046971484231798,-0.49505711873416386,-1.6067806040942998,-0.5539579112619343,-1.5831860719621114,-0.6181090661951957,-1.1937128460178275,-0.4947615239138986,-1.2073886644957177,-0.7157055763857153,-0.6754233059022392,-0.7947688349431921,-1.6673533990856624,-1.028879655830894,-0.9502325415346795,-1.1978757714384807,-2.0335363886097575,-1.5519274218257986,-1.0930936665697735,-1.9421351341033386,-1.3838298658831263,-1.6012008772311142,-1.1366083060000847,-1.0306141612970114,-1.5482024713176803,0.08782173579885813,0.05818046564624621,-0.47290924911178783,-0.65114939115286,-0.4657240532308326,-0.41995967560581127,-1.8433832905947838,-1.2689423879622006,1.9481275236267275,-0.9884179625181392,1.8899738713595504,1.010845255871877,35.1,False,Riaz,PD1,Nivolumab,SKCM,R,64.0,0.4525368508385619,High-risk,48.80251583654434
Pt31_Pre_AD453872,0.29362890930165764,0.2760817489458449,0.29730359739610834,1.6861015892724658,0.7839311938792332,0.4442293286278771,-0.6040706952589056,0.05998128605767421,-0.050548038025210226,0.4088351956157889,0.1394103426139727,0.35544923424273633,-0.6120199140523247,0.007041609282307519,-0.5815900606558805,1.0877594811185782,-0.1035314513634857,0.9630594888709892,-0.6512473368849441,0.7537342595200713,-0.5851540819168591,-0.7781838064700449,-0.39197342749580105,-1.0004180872189872,0.9677367697930043,-1.1581897843892985,0.3835090409319642,-0.8678650716398812,0.1622302218448235,-0.8518405700872252,-0.0679197703783989,1.447637148950905,-0.25511782369534136,-0.4107591904314673,-0.6381321223028369,0.932898952105378,0.7484652366898397,-1.0054624448801686,0.5415549194520545,-1.074747743344544,0.6807700290318613,-1.2059321659958109,-0.32980594752223324,32.03333333333333,False,Riaz,PD1,Nivolumab,SKCM,NR,443.9999999999994,0.37382353677027835,High-risk,48.80251583654434
Pt34_Pre_AD466985,-0.1904792050472357,1.8762866880050602,0.8660979246600157,0.4549774942645652,1.139446711616717,1.9092908737559204,0.7121522522784574,0.6877370810788217,1.6825861485855613,2.0751603710128523,1.7491825974781474,2.3503180949358735,0.7039569711099112,1.5756563014393643,1.1928543821591955,1.2584765544676997,1.6397300115972104,2.345257229061399,1.6563336512190574,2.658691446437205,2.009937112612957,0.9947690366235918,0.5299502061136572,-0.7934691735095711,1.208239926177665,0.6836583915713235,-0.2229506137179863,1.1109473038087798,0.06806643147598518,-1.1474023822207111,0.19745072862968527,0.2675556211087414,-0.4567681996884475,-0.04236368630593348,-0.9962899241176737,2.059577816560242,1.9649308428007526,-0.0019800729390098315,1.6876323877919954,-0.3317479130068398,0.984499659988286,-0.47791722624826005,-0.04034964786258005,27.8,False,Riaz,PD1,Nivolumab,SKCM,R,207.99999999999883,0.2275950448583867,Low-risk,48.80251583654434
Pt36_Pre_AD467095,-0.7751991698242112,-0.0584723661906589,0.13255798030976404,-1.2739945796057615,-0.35543425240870297,-0.010312562293959045,-0.45142590302462304,-2.1320336551848054,-0.8220798149829589,-0.5318826923627995,0.3534872456850416,0.06494289154733612,-0.9236133706789244,0.4326040691829216,-0.8513810181364944,0.9583986637889972,0.03567396153245937,2.151554028174159,1.5112353948563841,2.4566251821063774,2.5004820452814083,2.2673889390675632,-0.38249984898988293,0.6336637657156271,2.905959038296396,1.5698504497514003,1.4120515539170937,1.1121218327833038,2.5714646370791243,-0.9806342884847039,2.3576585220194444,4.061790877073669,0.7244736223199384,1.3038807833313897,-0.9613255976929692,0.9082110657488625,-0.8861277853111864,0.8020886837859517,1.0995494281760043,-1.4196304320169029,0.010667063041385452,-1.8299764595021972,-0.8536904835017253,36.03333333333333,False,Riaz,PD1,Nivolumab,SKCM,NR,2.0000000000000053,0.5022454520756461,High-risk,48.80251583654434
Pt37_Pre_AD502452,-0.8521107449898319,-0.15323731388354223,-0.4366015570847641,-0.32197958823898076,-0.48995909324115283,-0.35143410299247446,-0.6188926968494949,0.30859048102243547,-0.8312539412125798,-0.33712069728094435,-0.4783985297357902,-0.8597820190000449,-1.524282080624277,-0.878990458692127,-1.06475425712459,0.621719881354294,-0.5586567921218207,-0.15097134491816974,0.29404956244338104,-0.41173410469610167,0.19776563690470322,0.35671307883752984,-0.6043249431374308,0.606967643789817,0.34757069785431094,0.10535032089815202,1.779281354292214,0.5210019836228045,-0.19318274704507854,-0.4152428435451564,-0.6914217260294827,-0.13767132249359107,-0.49627471737909845,-0.9160064090248441,-0.7153794336118574,0.8952854318585939,-0.41641397730046564,-0.6700863534785756,0.5483889046234443,-0.3623687359274698,0.6429984617580784,-0.05315648287545367,-0.6039736035439488,21.53333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,28.00000000000001,0.5556163443266254,High-risk,48.80251583654434
Pt38_Pre_E9200719,-0.7745453636171566,-0.2223079749536551,-0.5476927488281423,-0.6510885957571328,-1.368727687316307,-0.9004967799856493,-1.6123830354218958,-0.646646195833781,-1.5998989973513604,-0.9201392912342615,-0.6679956236081867,-0.994179473087047,-1.8038572050581962,-0.13082355388380212,-1.0487625003069085,-1.5956697596088645,-0.917806119604039,-0.9706941153153331,-1.4829505182586835,-0.9657117549883831,-0.7479261758469373,-0.49271180512025314,-1.611812481612023,-0.28198600682574176,-0.7777226351784897,-1.8868839845394516,0.8474296389035453,-0.8134670470629926,-0.456635955487822,-0.9799411104454601,-1.0216395072644069,0.4133273515887334,-0.024699171838098017,-0.04813504509640759,-0.736501000735459,0.65768226343872,-1.0955661279408058,-0.845219976306393,-1.1345705940644812,0.5767686248566535,-1.2019474233288607,0.5434407550621899,-0.02729378706875529,5.566666666666666,True,Riaz,PD1,Nivolumab,SKCM,NR,441.99999999999767,0.5514943526719676,High-risk,48.80251583654434
Pt39_Pre_AD485899,-1.1125511410759332,-1.9118111928714725,-0.9018077958962577,-1.4043128921124148,-1.7648932303462312,-1.1730193582299095,-2.6128382207360814,-1.9769687904998339,-1.93445143886852,-1.408428040848014,-1.9214258255718266,-1.8431529646026883,-2.3195832059529677,-1.5505252431444463,-2.2778336803336248,-1.7224334733982096,-1.0680271729832842,-1.4482134288295803,-1.390567193665908,-1.1861500722521061,-1.2647348156777414,-1.436645442397365,-1.2463221205816093,-1.3140137134849637,0.7342321257123194,-0.9294161112707935,-0.1435946774410752,-1.3704821071124136,0.1709941761703264,-1.1949547265161842,-0.8545010217105153,-0.9674118876778622,-0.15022208230913914,0.005780088542350388,-0.8733711804309906,0.6672466109920789,-1.5633599761174712,-1.7582921554243245,-1.7717756820827084,1.5371014365530171,-0.798374745507555,1.1635293703925877,-0.2305446910547397,5.533333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,,0.6806033019323972,High-risk,48.80251583654434
Pt44_Pre_AD467790,-0.23864149695802347,0.10089627589666042,0.4465797841317011,-0.13958641363114663,0.2006583261886413,1.2840453974631543,-0.4193203451377612,0.05860785316801138,0.424483402632977,1.1751833926674027,0.8640726377614976,1.1875252728429664,-0.27834240380353575,0.2927376858157329,-0.48655959497006435,0.1316981712579905,-1.1961935797273346,1.4868202135459294,0.8761597347405754,1.3308031177554824,0.23160388719247932,-0.5808949045931856,-0.47425338328499655,-1.17008021050069,1.4676369213876301,1.0533221804543005,-0.5449772930130652,0.7355597258905294,-0.1593021960813827,-0.8902798388442157,1.5420815178938752,1.253798896808246,0.10544594611255795,1.3418950751768648,-1.2046084497996201,1.1156401388334403,1.5315648718007637,-0.033342602174577,1.0745761326984318,1.358444221657897,-0.25278844539633466,0.9667422570939772,0.15067978668141602,36.43333333333333,False,Riaz,PD1,Nivolumab,SKCM,R,358.9999999999981,0.5577003612317764,High-risk,48.80251583654434
Pt46_Pre_AD467096,0.0017896974129532216,1.2735875153511294,0.9061356682140539,0.12067779581733327,0.9443847462661978,1.4594227331830123,0.7085685138053766,-0.13443466070626756,1.1987614746944055,1.416188706544259,1.0262709100997478,1.224478563551807,0.1843064411979307,1.143225330237046,0.24892764446207036,1.357551549165703,1.9631017012706715,2.4271118412381325,1.5264244116766381,2.7033708060859247,3.137139393445429,2.88931236468482,-1.1541479674042348,-0.4784540912732795,2.0000085555390767,1.1518971648100433,0.4261731413298226,1.7945571481585918,1.0092085532089898,-0.9031636183181043,0.7908985275963697,1.7377725869664795,0.25494807547716064,1.0324089297948529,-0.8317643214262916,1.5808458111068426,1.2594611566012703,0.2745505163929789,1.6109897132957631,-1.375900408249473,1.2554384350551353,-1.6997943758288148,-0.30374891526840336,7.566666666666666,True,Riaz,PD1,Nivolumab,SKCM,NR,176.99999999999957,0.24020925716389274,Low-risk,48.80251583654434
Pt47_Pre_AD506073,-0.6878498835451828,0.4127026590784079,-0.4409083912392475,-0.5279474822015774,0.6184856176966387,0.15991302947725083,0.5204603338540985,-0.2606776516764115,-0.3231893800495128,-0.230540800661854,0.37093045740194336,-0.05284755151174867,-0.2666246480420179,0.5437579431962448,-0.15573672515079828,0.9261545541963239,-0.8195975139054695,0.9455069366669766,1.4574022680299101,1.3386199165772201,0.9782175607426525,-0.00789412523960699,0.8804370787996847,0.026725270180177587,1.3963514507962453,0.8722334516652575,1.1525309339332683,1.2412432316391997,0.09570591502513741,-0.3960945002069416,0.442165092078537,-0.3032823649327729,-0.1581149773925109,-0.6562299733149523,-0.6587800792798194,1.5188599661530187,-0.008157346034446178,0.5380695775473351,1.3304981674314105,-0.5254518737909589,-0.3174316348549422,-0.6807316810165327,-0.2595725457101506,23.933333333333334,True,Riaz,PD1,Nivolumab,SKCM,NR,991.9999999999992,0.6102383999385184,High-risk,48.80251583654434
Pt48_Pre_E9047561,-0.02650980895064971,-0.3187528313897754,0.14859294141744636,1.6023596005147978,0.17236254770832637,0.2528609215295359,0.3720931525597731,-1.7109256267205455,-0.05211596749662648,0.2304895637948642,0.03791498974333263,0.005808283024426344,-1.100815947025552,0.1879680574568929,0.12236253241511172,1.1201060558784282,-0.8252069023785368,2.1099998362319434,0.18452887405690097,1.0780210634352088,1.5532563885476454,-0.2023511568654256,-0.6363316905831626,-1.316195998668548,3.474815855935261,-0.07261228299976867,-0.3667193312123659,0.2170142775185319,1.6757533995064036,0.04574905841322426,1.1361765221484856,-0.21314259603837074,6.81406453950607,3.126953819273866,-0.9448368967152629,0.5728096385000677,0.40825071514910066,-0.17384670642703062,1.280990439409016,-1.9966846736568806,1.6745955390949085,-2.4658143641459813,-0.5454896558985421,34.86666666666667,False,Riaz,PD1,Nivolumab,SKCM,R,96.99999999999974,0.4723166953510264,High-risk,48.80251583654434
Pt49_Pre_AD667851,0.9577117055666504,0.8557707703156225,1.1737814899321355,2.0854947828984374,1.3709847460301963,1.7712120173815216,0.8226703437420965,0.35146106607855215,1.3315313580893966,1.9373339433489003,1.5454495910848078,1.365952083123675,0.17184129785776428,1.3656497290008192,0.15305559654029613,1.8121593220280312,-0.05469498621035871,1.9964049813897016,0.36965117524203656,1.5185723774006432,0.922346644130747,0.44351714719674784,-0.010223634835823421,-0.7925628811378048,1.6561276885201763,0.8347112579961541,1.505998004880594,1.0872644228989843,1.655982705675098,-1.1821323584960948,1.8079546222974348,3.8275569542746024,0.5200438734150409,0.5855335212785674,-0.9950124535195831,1.5962264649940556,1.9736168640711982,-0.04688253815306527,1.6274263818415122,-1.2058662624946803,1.4559451792469653,-1.2822221093861876,-0.4379859005675062,27.566666666666663,False,Riaz,PD1,Nivolumab,SKCM,R,839.9999999999949,0.31449167103498277,Low-risk,48.80251583654434
Pt52_Pre_AD506075,-0.5719012321676737,1.1931724601057851,-0.17039987470234394,-0.6033967882878591,-0.17415027600619554,0.015920158006026284,-0.5456463237305655,-0.6086891571052054,-1.0041197137935807,-0.2889736167739153,-0.49786549207727304,-0.9128992525395883,-1.427216796697807,0.36659147846934387,-0.6233086855260718,0.5353629300925267,-0.466190028116152,0.8560029274621075,0.09026857379230603,0.33665871358148697,-0.12962247555363846,-0.1637139730220293,0.0935294098606655,0.06591664848918766,2.5489927199803346,-0.05268371751746112,1.973192638396579,0.6517491857761809,0.2872876936402769,0.517559620040325,0.9343381128594155,-0.6055463064556397,6.733348896269357,3.025628062608857,-0.17029545979217312,0.6491752774116103,-0.46481380004907924,-0.6698664692492728,0.7129945295134682,-1.008305722958578,0.7609709510990758,-1.8027214832124252,0.18257810248378878,15.866666666666667,True,Riaz,PD1,Nivolumab,SKCM,NR,350.9999999999983,0.5296556163912255,High-risk,48.80251583654434
Pt59_Pre_AD823915,-0.022046274348696618,1.1282102839017496,0.6268655063747253,0.7808776239950196,0.5162649750328755,1.5585914853377572,0.09123734044369833,-0.5445226900159105,0.4874512269045721,1.5162552170989367,0.5252987259889607,1.6232948896023818,0.15583003369087772,0.502737416950288,0.16817824491271507,0.7175002647241714,0.590133943250374,1.5354647253712725,0.736765052703845,1.6685889729955212,1.0085743989302705,0.5735655311072531,-0.7391382395839095,0.022383226816712887,1.1231189345480603,0.2597002847144418,0.2149411318872784,0.8755377594777105,0.7279295251504521,-1.4590930484460793,-0.04994844693551388,1.1738181034983204,-0.2994466504124092,-1.0790171408668408,-1.033523467719096,1.3908777842972353,1.5079735330194,-0.5820655830776458,1.255011636941326,0.8534445414581008,0.515737011719042,0.7381663553155613,0.022210051836313402,23.6,True,Riaz,PD1,Nivolumab,SKCM,NR,418.9999999999978,0.3489044166289279,Low-risk,48.80251583654434
Pt62_Pre_AD608303,-0.6522083782249858,-0.4075729820035763,-0.3165213800776907,-0.3937458593236601,-1.3975894525106987,-0.5406234885060932,-2.005579475745062,-0.784223317554558,-0.9585073741167306,-0.34512787620141483,-1.0887250156867767,-0.4459575872313595,-1.128174716536829,-0.45504173474735204,-1.9676265411746146,-0.877090945253603,-0.19969238209259546,-0.5834760326998967,-0.717899480870646,-0.579972696798911,-0.44303658082825464,-1.4433884807478148,-0.5029391530223155,0.2017017344102256,-0.5599621656943649,-2.9865429467333717,0.23911687299452844,-1.399126920226947,-1.146994216749383,-0.7640721047185646,-1.997719028326598,-0.9883402580451227,-0.0480659830617707,-1.4886440153478795,-0.38192842110034225,0.8688833980599177,-0.5955377379840547,-1.305314226317613,-0.8241746953609144,0.2324431878146902,-1.2983789497891136,0.03603471754529711,-0.6910954141194866,15.733333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,,0.6084869152598802,High-risk,48.80251583654434
Pt65_Pre_AD793919,0.6524759497443757,0.7412269400261444,0.3858953200949369,1.2354845472428224,0.18687769745820437,0.6102860952239804,-0.26895288064218964,1.115754638684353,0.14414058707049213,0.47750364100862375,0.46477015977108316,0.36192024312131865,-0.3774338253909852,0.5998359138344178,-0.3506868832630138,1.037814120194912,0.4410338099296785,0.6851016993532473,-0.8639085782859304,0.23204199703886852,-0.5011331715970103,-0.1526289569144542,-1.646824266802163,-1.4104149442292357,0.38830422433540207,0.3634216946797435,0.49427835952281396,0.6966932236974835,0.3093222752847072,-1.0536876852373191,-1.061200976587939,-0.865148844116013,0.031753085897946134,-0.5815095001076187,-0.4610925693080565,1.092653361194245,0.9823294213312674,-0.24345771390262677,0.6087627699580604,0.7260306679937562,1.1235097717472322,0.36244153990280137,-0.2920379792793757,23.066666666666663,False,Riaz,PD1,Nivolumab,SKCM,NR,2505.999999999989,0.3301540388912284,Low-risk,48.80251583654434
Pt66_Pre_AD667850,-0.7150996647959122,-0.36354741297654136,-0.4275086020588215,-0.4902918206081243,-1.3111657812934643,-0.7411253826398205,-2.1608939846550648,-1.3456633970245715,-1.4241252940568871,-0.5745194708486684,-0.9766477482699208,-0.9514327342798761,-1.8174354686302088,0.5655710007753948,-1.775620548374686,-1.2284281107784747,-0.4377890174147957,-0.4823885131564122,-0.7150605568293132,-0.6974406669392934,-0.9484373336169906,-0.9843775544022001,-1.0929141483674758,-0.16509517591117953,0.8409739019385819,-2.251827668321658,0.9838494356407672,-2.0019062200910263,0.1929042426014597,-0.7927201875165028,-0.3702869372275761,-0.7764346598907746,-0.06372625140218209,-0.5255036200388323,-0.833987342134617,1.24331570258184,-0.724990537572947,-1.2458295413841516,-0.1903759229302589,0.06411000443643328,-1.3985554367865245,-0.06873611901017068,-0.6847355650261718,18.066666666666663,True,Riaz,PD1,Nivolumab,SKCM,NR,147.99999999999943,0.5615977662706484,High-risk,48.80251583654434
Pt67_Pre_AD506074,0.3986646164881067,-0.3140639352006082,-0.06967521016910273,1.2279912000773716,-0.0885988083845519,0.13192156448138403,-0.9033473483852156,-0.5737725889471915,-0.5226784460288989,0.31622051990203226,-0.8678903660973608,-1.0967581178599208,-1.9003935201054558,-1.1411232301823266,-1.0476117887460175,-0.5694262673386855,-0.9359415078223927,-0.13818049670265933,-1.3177044165368776,-1.1693205024827495,1.2307138926000614,1.812511515970755,-0.14102600542319232,-1.752059878048831,-0.3932584840985397,-1.2579182159596065,-0.4258080851607314,-0.7980358922810724,-0.5528801585575962,1.6886755362276695,-2.0392751794070048,0.17643375462381075,2.045772203976191,1.5046647352363414,0.3512120437587141,0.7162037970028049,-0.0005815974396684611,-0.9552230487313649,-0.07817424862008866,-1.1356493300684105,-0.11102313489799222,-1.574164874130247,-0.43410850963636116,34.4,False,Riaz,PD1,Nivolumab,SKCM,NR,16.000000000000043,0.565257551529535,High-risk,48.80251583654434
Pt72_Pre_AD793922,-0.48665029577157703,-0.3206288486509629,-0.8725127680835616,-0.9373454659506751,-0.7754766203141168,-0.8640030319136277,-1.1274456269511934,-1.0931175136466833,-1.3609250722968367,-1.1546838350577224,-0.4341615615099493,-0.9219220896870912,-1.5882229297692194,-0.1541777660547635,-1.6924561454123013,-1.219343305302703,-0.16790557165892306,-0.5971192241237363,0.015009619106787667,-0.366830458700114,-0.8480290006834439,-0.9450997105838266,-0.044998560461223226,0.2189613219661137,-0.44074349849818867,-1.7487416975857413,0.9497975761505703,-0.4256880173746812,-0.05011447459577211,-1.091178791167528,0.07670390914508814,-0.5746249363973969,-0.3099875293437916,-0.7297673303987928,-1.0587775323271995,1.139111968453169,-0.9934113264084345,-1.3908979736188378,-0.530497174548808,0.8410202450670953,-1.65204546329604,0.26982165668520336,0.14688772307690445,25.666666666666668,True,Riaz,PD1,Nivolumab,SKCM,R,431.9999999999986,0.5353254872738981,High-risk,48.80251583654434
Pt76_Pre_AD667852,-0.9226937221886116,1.8886467360634178,-0.8537519796138229,-0.8527734749523885,-1.332118662448305,-0.6267278045691039,-1.2253601018066904,-1.1554647839825256,-0.838153134936925,-0.7637870863383872,-0.891752672756197,-0.11750503665029682,-1.7176778031210902,-0.6335520231828463,-1.4114109567936608,-1.121754512214971,-1.528310004181979,-1.4990740239311064,1.6072820363691969,-0.9527171112885069,-0.5624827462246232,-1.059675328518925,0.7579225728889215,-0.3404640776635472,-0.3530710830367552,0.012195077993560791,0.7589740731961929,0.4599356634804798,-0.1936345974236501,-0.6668567345696735,-1.0374995284809279,0.42721136361556156,-0.2896383517462515,0.7960804091843572,-0.8308923092082076,1.8030709932379037,-1.0018391245736415,0.5679225696920729,0.5609360622693028,-0.04602655268165603,-0.1408939075894674,-0.46672020877258197,-0.39072232129916007,0.3333333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,219.99999999999915,0.7284254844859608,High-risk,48.80251583654434
Pt77_Pre_AD733591,3.2906615566532653,3.139607770388591,3.46067566439951,2.2317984751690383,2.03092046445354,2.2183972309348587,1.7989304181625652,2.1252854439492634,1.6845104548714895,2.0882005044714442,1.5953339679833076,1.7760900542316371,1.5001686069093507,2.3366698409493583,1.4659073574015078,2.0058112266406876,2.0355013798390327,0.9725095121536561,0.04592974349171259,1.111005776576617,0.32024127270376224,0.07499931794320631,0.6580291488494984,-0.012083022790328921,0.03406928794781634,0.06603757514323323,1.8250705841425958,0.6211188208502131,1.244362075165222,-0.8611461611101775,0.15585149522965652,1.2327935059483048,-0.2730937654047921,-0.8445073227318707,-0.5177795382792835,1.5129654714939271,1.9070871035242005,-0.07016704705421592,1.601268661518426,-0.322972978392416,2.736491251272169,-0.6010121308368634,-0.3775600396630181,15.7,True,Riaz,PD1,Nivolumab,SKCM,NR,48.99999999999999,0.12694187464843248,Low-risk,48.80251583654434
Pt78_Pre_AD467018,-0.8537159632081323,-1.0248228164686257,-1.0524855398282118,-0.9315698868308842,-0.9847371411638469,-0.9796859278336298,-2.1039070442354384,-0.31562897478321955,-1.7733589194758295,-1.339644659185921,-1.3727086304306526,-1.6043757440297448,-2.159599228575522,-2.074248273448565,-2.3816678370897013,-1.547113430773379,-1.4604400147800587,-1.6826680790253985,-1.8604250728417437,-1.8032889407962467,-1.7631231277317587,-0.9725753547589235,-1.2885835588750305,-1.4132760139789229,-0.5365292017025475,-0.9200818145725306,0.5200451413797905,-1.0592632458993283,1.0744334865722986,-1.1544681114197957,-0.7141863700543456,0.6712575038020091,-0.3418976635192799,0.15983833960696225,-0.8403061919493814,0.5399791690602156,-1.4754330961015671,-1.6490412860771069,-1.4796269486898441,1.5195814860656527,-0.08496008465735014,1.3048216946238742,-0.03616476716886655,2.6,True,Riaz,PD1,Nivolumab,SKCM,NR,,0.5475186953634567,High-risk,48.80251583654434
Pt79_Pre_AD733587,-0.9222050448898262,-0.3557425394149488,-0.41507103556452124,-0.7886837872009794,-0.728954861917037,0.04837489196856254,-1.5908113704989408,0.163141182834166,-0.7567094080838782,-0.18309352343904145,-0.3614239310877875,-0.502163548555964,-1.325799899204448,0.47132419439830137,-1.2721654801833842,-0.5364623795689193,-0.38072499232711804,-0.43213975435732055,-1.5858789926132821,-0.6743975963348069,-1.2200219919693673,-1.1124862205173607,-1.9263710064605,-1.0343936908772666,-0.49806367281110914,-1.1630753866630772,0.0089664196430713,-0.9008573607436351,-0.8151556407765378,-0.8924172966164112,-1.8284635726010658,-0.4189969678477865,-0.3041889900343285,-0.9258427911816389,-0.9693636100237336,0.9306618839669534,-0.08336664925259271,-1.3045084960230755,-0.8356323061840751,0.7763474619907943,-0.8181849962440569,0.07734341335616636,0.04237748156310407,7.266666666666667,True,Riaz,PD1,Nivolumab,SKCM,NR,535.9999999999968,0.4959930790355619,High-risk,48.80251583654434
Pt82_Pre_AD823914,-0.4302824570673336,-0.2972973821629451,-0.2279440459118923,0.2985299716926419,-0.44068051979587625,0.4217832475088707,-0.724309985037789,-1.4184132894455288,-0.33234894800594933,0.020552742431515295,-0.10704016431939542,0.1601061756690063,-0.931763860867305,0.008848952602425394,-1.0827669658735157,0.3244648816595553,0.014890231469424297,1.2793764915353334,-0.037558542814330936,0.7249748407994989,0.8130279928621603,-0.47976961827970444,-0.8579861715256188,-1.6672398130611255,1.1930681031701456,-0.20015943467811997,-0.22830461980730737,0.12561876513029127,-0.23766178481853112,-0.19613126959808244,-0.7367540258831896,-0.23086099636838486,5.772639941368667,1.983175281281609,-0.7795826922400196,0.9940774506166614,0.4030864913848448,-0.7060962145065255,0.22626790021448165,0.6738934902354823,0.34668864964454865,0.4185471754161232,-0.3990205199954597,14.3,True,Riaz,PD1,Nivolumab,SKCM,NR,33.000000000000014,0.5674291684154836,High-risk,48.80251583654434
Pt84_Pre_AD486532,-0.8641094754541514,-1.5518665560929317,-0.7560792452982488,-1.3861556383189984,-1.604246149002542,-1.5330941144888703,-1.6996794125073604,-0.22136723119232027,-1.9053478345219943,-1.4182741295480294,-1.3178921846311864,-1.6170190388327412,-1.9950216793828364,-1.5826576053502894,-2.3320608659579105,-1.4209437589590281,0.19324661874113747,-1.0130213898800922,-2.154866383673745,-1.2618841742226858,-1.01881911194864,-0.6429959372400225,-1.271485758961861,-1.9029619560505813,0.22324302212424957,-0.5690610573316185,0.7300564362568611,-0.4224389044937016,-0.43727865679627476,-0.6965040370752453,-0.23829806171264742,2.283176592079445,0.5375069924522357,-0.04403519434276097,-0.42729907239338416,1.1952139192444347,-1.7940926163882698,-1.1193610733538717,-1.4587638063073185,0.0044822536090580465,-1.1496079982495244,0.019834187253205543,-0.5093738857403926,5.033333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,11.000000000000052,0.6547992305278953,High-risk,48.80251583654434
Pt85_Pre_AD486329,-0.6182190624496865,-0.18615661820690013,-0.7722743357046943,-1.3107037312094283,-1.6241513300529484,-1.254417927425305,-2.2078454879688914,-1.9870566023415952,-1.445226656500299,-1.3640702841183323,-0.9475992328954262,-0.9358588254199861,-1.6918880266221972,-0.7960172294993751,-2.1692961345303097,-1.2149477079913003,-0.5708352183532467,-1.299957251883952,-0.7724489547649861,-0.6852715524215461,-0.7343194827948173,-0.7676893621995204,-0.1318203890898974,0.03855930257559366,-0.5177206287533714,-1.9499382008055268,-0.3768698631253647,-1.041071025852495,-0.889224931255933,-1.1254570071202188,-1.4831807800465784,-0.9610322716041362,-0.6278295425620475,-0.48378288705259087,-0.5793438829455578,1.462463915021737,-1.159057424237814,-1.766011252129187,-0.7701100667821239,-0.1710285505997995,-1.327495785291504,-0.4806231502154865,-1.0146393709558121,30.133333333333333,False,Riaz,PD1,Nivolumab,SKCM,NR,126.99999999999984,0.6413112984434501,High-risk,48.80251583654434
Pt89_Pre_AE070951,-0.7365766118382306,1.7013861613031422,-0.9197356926399142,-1.1591444259152346,-0.4431693525226693,-0.3901099421471084,0.4076951310597996,-0.585476667157936,-1.1682948596233933,-0.7259810181727254,-0.2708692249172198,-1.2702089572106992,-0.7862999409747159,-0.28351721864996193,-0.31170513100549396,0.45143364919478796,-0.9240858889165048,-0.21779099104365982,0.2385935049851787,-0.546937040531282,1.4173281634295292,1.9048063999218199,0.6652489209052274,1.1863483747051142,1.1162853106371367,0.5775373047899888,2.1408972150719268,1.4324783818243676,0.947894767487778,0.12135642389495456,-0.8258908360064106,0.18936262699461479,-0.3712913801263901,-0.1312485236846963,-1.0377097296425666,1.4494223756018834,-0.6693802359691203,0.9719209183418072,0.9052270458982046,-0.44855773349638556,0.695226605477417,-0.41140031078224415,-0.2416193426900559,28.133333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,210.99999999999983,0.5750392329142758,High-risk,48.80251583654434
Pt90_Pre_AD467873,-0.2536156720514458,0.12359171784668198,-0.4006508527283982,1.4795194811186034,0.29014373292333473,1.0711548641602797,0.9656814821600729,-0.25614436865468526,0.7110652384130239,1.3956658713587842,1.6574851683374099,0.6131771975526199,0.1648291565924673,0.5376906845536747,-0.17641352736963214,0.02567790858251723,-0.5657648277948903,1.341911963397165,2.8484200738606407,1.715258974974103,1.6106784951442032,0.09949930941310012,0.10362517901505615,1.431646906683071,-0.4311456637404943,-0.8295000991904475,-0.46714497627763396,-0.11338427441732164,-0.5303788328933876,-0.2268915530588032,-1.3194070497619363,-0.774252869780461,-0.7305606395689669,-0.735709760315334,-0.7623783107068606,1.3643104130823138,1.073905453410687,-0.38129339423212183,2.7444492410121795,0.9817538026677349,-0.12180272111810843,0.7584191636742545,-0.5267754964571425,5.8,True,Riaz,PD1,Nivolumab,SKCM,NR,271.999999999999,0.6055401621561826,High-risk,48.80251583654434
Pt92_Pre_AE134060,0.08729313636107991,0.6633399063780221,1.0166644033297103,0.4964893523914697,0.7752612743055298,1.736220287024129,0.00565026661603355,-0.1920549884552118,0.8465485658134466,1.8261560345006236,0.707486167279054,1.5849474286003744,0.11715778802132555,0.9973980171032072,0.05132634413186239,1.0565432940865813,0.09506190591715567,0.643270033861497,0.37076575068992335,1.2701649227284868,0.22318295363720214,-0.6023377205953475,-2.88650985532044,-0.1761855772756789,1.1521580217366327,0.046815560937319,0.21045141369854284,0.08136496291651009,0.7890612572151301,-0.9189626877452539,0.626350302144882,0.2887116462154519,-0.4548405755596258,-1.1870372416516197,-0.31525427535360173,1.3983093172968208,1.9048203130828698,-0.8417260175755553,1.0072905810945807,0.755837414002253,0.9309502896867032,1.0133969685963895,-0.2479944692083951,11.1,True,Riaz,PD1,Nivolumab,SKCM,NR,626.9999999999981,0.3740224193633274,High-risk,48.80251583654434
Pt94_Pre_AD732850,0.5298178159865974,0.4430774236099231,0.29598132875816036,0.5987834692044909,0.45554975074680715,0.43928549380985255,-0.25810532935390823,0.18816930476889007,0.13310004955996174,0.4489509323986481,-0.09538661857106845,0.3717223957335984,0.28448022083003466,0.7735344485384967,-0.2727945821154259,0.9131013952212159,-0.10190515055110327,0.7209589330661257,0.10671633773727386,0.7067407285982281,0.6731089351070556,-0.39536519659197666,0.3411086045667112,0.05755066423247027,1.2367362608038903,-0.04043527237814434,0.6364141624486509,0.29334040086088725,1.596278858953933,-1.0701712994231143,-0.2604214451470463,1.147166299367133,0.7643223054733603,-0.3547132935726707,-0.8256393548527164,0.5985977816125142,0.05320049432362592,-0.04345483736490702,0.565597207506162,0.4504625379791725,1.3099944785608446,0.2231411402317601,-0.002296767813545912,32.7,False,Riaz,PD1,Nivolumab,SKCM,R,396.9999999999989,0.3912377470022039,High-risk,48.80251583654434
Pt98_Pre_AD733586,-0.4841975285146693,-0.6761341110088039,0.23910634354842508,-1.0971336821032731,-0.7824546187223088,-0.42560537001462406,-1.3315418131344632,-0.35817210971358543,-1.220752935892197,-0.7013290125957004,-0.7869485046650065,-0.5144864737034855,-1.534148557507563,-0.5336727064862126,-1.6074347341790647,-0.6196259199360217,0.872368205521309,-0.006305113287884548,-1.4054040503604421,-0.3159096570780317,-1.1018054630376959,-1.1187475229674253,-1.134882092270735,-0.9559167472579233,0.07807463512444593,-1.4957103682766932,0.392249175644638,-1.0995198072396568,-1.0035419152611185,-0.7862941824173956,-2.169967869615037,0.591119205915575,0.10126756522160156,-1.269203831819363,-0.48291216260306724,1.0472922925181116,-0.6629311875746154,-1.3100475120543136,-1.1775042657115122,-0.3447935998636096,-0.3623816720682903,-0.28559735765863353,-0.9316832475280578,24.9,True,Riaz,PD1,Nivolumab,SKCM,NR,19.000000000000004,0.5784032660770216,High-risk,48.80251583654434
Pt101_Pre_AD486328,4.847689298619383,4.646224112324891,5.492459037041934,2.7201969854623522,3.2964795624689622,2.8564228748848715,2.853530218064295,3.534127632331746,2.5933277237767163,2.7387260742508017,1.9925761151501904,2.079824623470552,3.205502407276466,2.4688103408757334,2.590220691578057,3.0328883363658115,3.991995306056538,0.3431408027734264,0.7841376112834113,1.4164457044556935,0.47449808514974484,-0.4064384597015742,0.3253976808470199,0.17659356573339013,0.43306469087786104,-1.4509004661037028,-0.22301214597385563,-0.5800570460439574,0.4457190391094213,-0.98453746558087,-1.9025985706249586,0.7799325573716145,-0.3231217397114187,-0.8420616386191492,-0.38993407685530085,2.599723214915208,2.266726510008675,-1.1205386302163431,2.102312170964163,0.2384250426919729,3.5993729112700725,0.035491924395386544,-0.4719055963375831,27.8,False,Riaz,PD1,Nivolumab,SKCM,R,10.00000000000001,0.17455808530067995,Low-risk,48.80251583654434
Pt103_Pre_AE134058,1.268416153056725,1.1858092377751301,1.2477715277818728,2.448556318179676,0.8327199841033578,1.9512677741885203,0.4633338970886709,-0.0643261763725813,1.562063453805878,2.565630626872763,1.6121020294664608,1.3900510204069292,1.117113873900035,2.4782602224742485,0.6669546205095499,2.9631926996768145,2.229937004716729,2.472004380016672,1.3402064943207128,2.263899424430771,2.599535295204882,2.066183968354226,0.6391179888370051,0.617962840221048,1.0111675212704294,0.6062394676854005,1.9990229245422315,1.63091389478552,0.4356174500128392,0.31125361122482303,0.4909220107529989,0.8076812627265769,-0.4623827694992389,0.32411174648880425,-0.5509017847029226,1.4266489804427533,1.7526022012579556,-0.2426594532821123,2.1975079834172906,-0.42811333331557777,1.8719459566720196,-0.5689286268625288,-1.2160093425010732,16.133333333333333,False,Riaz,PD1,Nivolumab,SKCM,NR,20.00000000000001,0.210552123941823,Low-risk,48.80251583654434
Pt106_Pre_AD502250,-0.5333790003199856,-0.06874452505697405,0.22630246216289582,-0.9723223899432815,-0.3428182930167042,0.553673769852532,-0.6659065774379733,-1.0158539125520742,-0.06798210049495847,0.38859740366900813,-0.6629162795655933,0.15103724846390587,-0.6500607775222516,0.3505372965995137,-1.4169203962327936,0.16968369863006688,-0.25627564824672416,0.6231725433293711,-0.5378676549954367,0.5791942996382085,-0.25311229227352494,-0.3868500396924,-0.7287761796075787,0.4122946599460289,1.8902235651127437,0.6907377160661502,1.7018981892970602,0.5410036899206018,0.5377115386793618,-0.9294498298850775,-0.6061865584214606,0.8026841415272133,-0.36045254023350487,-1.0407935808249398,-0.6982023269116795,0.7901549782105848,0.5146435366365606,-0.6385089291935678,0.1726636411230581,1.27229093952784,-0.022543975880081692,1.648521998975651,-0.17484195190108046,3.033333333333333,True,Riaz,PD1,Nivolumab,SKCM,NR,690.9999999999976,0.5825423653763447,High-risk,48.80251583654434
MEL-IPI_Pat03-Tumor-SM-4DJZY,-1.0619315374619995,-0.8571688739493561,-0.9047870376501103,-1.7559066262422995,0.17257711402020323,-0.9226399006969647,0.42672424941911385,-1.2213028318650687,-1.0856496049496414,-1.360560586941599,-0.448603839708506,-0.8359183955647135,-0.6889325811053634,-0.7206544157703606,0.39255356397978025,0.5626706435391385,-1.1890157229556322,0.11852169835856323,0.4946898574392069,-0.152922948303142,1.4554700951543966,1.7553689634642848,0.18568632841402308,1.3904664052157936,0.7159810387654315,0.9960209919141312,1.2473431709749152,1.011131580541797,0.6029547241927579,-0.3823896658043226,1.1054822181811743,-0.6779772643837485,-0.667093218868206,0.6722389698177748,-0.39289294951031073,-1.1474074222824624,-1.0152482331711963,0.532079947994791,-0.05357716083786596,-1.6587559695625456,-0.694803833164498,-0.928763966692931,-0.0029817481918169423,3.333333333333333,True,Allen,CTLA4,ipilimumab,SKCM,NR,361.9999999999996,0.4981047671548701,High-risk,48.80251583654434
MEL-IPI_Pat06-Tumor-SM-4DK12,1.568660489316076,0.5672292904066111,1.5713429010999098,1.4706291544684846,1.8053712921296612,1.2950252955244586,1.6717801548772149,2.080938411570945,1.4416570967357107,0.929637897399509,1.0173522924036233,1.332781915704073,1.4955962229923228,1.2796584506571558,1.6965016295051514,1.3168411474084694,3.4797599573031253,0.6568012676320367,1.364975040534175,1.4761201658521903,2.4028910496202722,0.38162172568411573,0.2404770904142256,0.2809242196619542,-0.7687052735048046,0.4188420886383514,0.27376141908742746,0.272884685753148,0.40815405323751724,-0.9815982864845741,1.0675043950877947,-0.3285058205631887,-0.5612396331967867,-0.5175430782545237,-0.2704798408826165,-0.14759044978836358,0.9644701609444346,0.5650827048677922,0.49411951641162427,-1.6139060995653418,1.6862569178086448,-0.2579655630553356,0.2838497912519458,5.366666666666666,True,Allen,CTLA4,ipilimumab,SKCM,NR,145.99999999999966,0.05641339794884059,Low-risk,48.80251583654434
MEL-IPI_Pat08-Tumor-SM-4DK14,-0.29283021062087006,0.5790721600547643,-0.15502376433758172,-0.391372339464411,0.28050683458086084,0.3043423990230691,0.8566499856675253,0.4334157745950306,0.12200803695648019,0.047152662158111834,0.030025050066861937,0.3769768919103841,-0.1312343291557692,0.6114578357026386,-0.425978376421524,0.4710162818115463,0.6836587990605657,-0.19103018991634496,-0.4477026226345966,-0.08327091881600553,-0.8951287777416851,-0.7336490287009784,0.2919275632162758,0.14513405847424546,-0.5619975593522254,-0.77689608027754,1.1591537653342532,-0.4360427217408131,-0.33615830405564673,-0.8794613822395745,0.3354783612732747,-0.2733909748684186,-0.20099356737684407,-0.9222860139861465,-0.5675360598996501,-0.7734307664082023,0.4882841907343393,-0.8575590349066332,-0.6354210597126652,-0.405886334278296,0.20003326642271804,0.24718692557383679,0.5895046090531297,4.666666666666667,True,Allen,CTLA4,ipilimumab,SKCM,NR,243.9999999999996,0.24870606755452426,Low-risk,48.80251583654434
MEL-IPI_Pat14-Tumor-SM-53U3C,-0.17470606397869645,-0.6744872883809846,-0.0745057196122249,0.5788688725027065,0.40433348113898404,0.007379517899784486,1.1717716907078546,-0.2215374691246903,0.4167648006474068,-0.26221912610154086,-0.016330006938379996,0.6715909601151508,0.7534661666831651,-0.34071523746776267,-0.06816195889197531,0.5282280088833916,0.2976030284945211,-0.21456948456963768,-0.43176330564848503,-0.08274056293293533,-0.31348867067241054,-0.04125384550116848,-0.2131027056088332,-0.3693101163653701,-0.5031546711542181,0.8306326599790158,1.3762101659487769,0.09295434169362675,4.356910712491255,-1.124307510947614,0.414304584370755,1.1894850282208413,-0.4364104601482836,0.13055449728516166,0.14634392646152936,-0.31585252214235426,-0.3733285657318699,1.189384174610328,-0.5286382911321481,0.7771978875337393,0.32180716388992786,0.9243009081583938,0.4649213367124405,5.433333333333334,True,Allen,CTLA4,ipilimumab,SKCM,NR,49.99999999999997,0.29153605031436924,Low-risk,48.80251583654434
MEL-IPI_Pat15-Tumor-SM-4DK1B,-0.8243262574532847,-1.4221116604181354,-0.799532799263439,-0.8985779024360494,-0.9971986729093425,-1.539048394518829,-1.6568265018500348,-1.2501716832423686,-1.645907301771787,-1.6923457720579453,-1.3874170847512937,-1.4240234192649117,-2.1006703924175576,-1.4605011692748988,-1.412949979244927,-1.7022852452607653,-0.9929775275728676,-2.58144097949514,-1.9593769193785702,-2.1341345922917094,-1.2773499559706525,-1.4811387738645188,-0.9755096196851569,0.15340717708817106,-1.1591350768253996,-0.9210248082625204,0.7730861980069034,-0.46757749222728673,-0.7573616118700417,-0.9048737928323014,-0.7902340827612252,-1.1018381983142134,-0.1999103411068823,-1.0087433391686198,-0.39497233729039977,-0.1961263522062229,-1.7732898274521813,-0.8210523748109347,-1.6135034103240564,0.45965942940843507,-0.4719476855454226,0.9285196163648545,0.8656380996266889,1.6666666666666667,True,Allen,CTLA4,ipilimumab,SKCM,NR,236.99999999999915,0.5591941748321906,High-risk,48.80251583654434
MEL-IPI_Pat16-Tumor-SM-53U3E,0.17706573407582699,0.6749960950269018,0.2960533973392885,0.3091006227694972,0.37610562363383704,-0.017810854070665176,-0.38370574694262793,0.7962033856209122,0.27048008708654886,0.12388862659323784,-0.37781659852328514,0.4071948168415038,-0.00978476113831233,0.2794149988335391,-0.24497597730887255,0.08817069179925371,0.31014645302796984,-1.1125536522958777,-1.316052757444538,-0.6880501888310852,-1.12117692087756,-1.1827858471514354,-1.8040572410934963,-0.028275613702291043,-0.7195250728626125,-1.722099954979018,-1.6801502452497288,-1.8756186337884575,-1.4446462972325205,-0.9804337362963158,-1.1466573720796958,-0.7640425663395691,-0.5075492398525789,-0.5507788711453375,-0.38237456984427265,-0.7577567349870434,0.31936647793827416,-1.935979564965185,-1.0141523435248894,-0.10930488147144847,-0.7803239354011984,0.08307135683994818,-0.12757696975835545,27.03333333333333,True,Allen,CTLA4,ipilimumab,SKCM,NR,1896.9999999999973,0.37220512470112127,High-risk,48.80251583654434
MEL-IPI_Pat19-Tumor-SM-4DK1F,0.41968442288648444,0.8036869727050948,0.4771739101086983,0.2322957176144844,0.8289258176025709,0.6848349137602994,0.9255646733218524,0.29012090375428706,0.7429539774837394,0.561808825113059,0.777518263307409,0.32354801103000386,-0.03236898966689706,0.2517041006489822,0.4284102955506235,0.6498713007345823,-0.1697800331829995,1.1852823186983052,0.4137142437602517,1.1312690074522191,-0.14102343419737295,0.02057569652939892,0.05403796923553195,0.41800363567712034,0.11412295781902587,1.094394316987811,1.206593497883299,1.0324070452385863,0.7532673404396175,-0.8421221975677234,2.073606785674825,2.182141434016075,2.191562089468767,1.0237160383643187,-0.4725762926593442,-0.8098753256813919,0.6152256693456961,0.6202051940112165,-0.09290725482439753,0.28842118503278347,-0.1277441686702124,0.6269531803189566,0.45529404980308674,5.833333333333333,True,Allen,CTLA4,ipilimumab,SKCM,NR,475.9999999999969,0.423624827239594,High-risk,48.80251583654434
MEL-IPI_Pat25-Tumor-SM-4DK1L,-0.25353606598241374,-0.3250023811632992,-0.5341555941834951,0.4278845187213205,-0.49497818152584194,-0.4773157763446238,-1.5587726937903978,-0.21111401387118245,-0.5820615135658836,-0.7241157012524405,-0.4802113521774056,-0.12028773391287984,-0.9823863887104384,-0.5097827754728659,-1.1455302881951555,-1.0860600310806396,-0.35167518625214905,-0.8506998861132737,-1.9158090686586617,-0.6877232411233586,-1.296315231967891,-1.0669955992055116,0.37979446988042437,-0.5626206379265979,-0.2904457409571143,-1.4732987598812153,0.0013200122283908498,-1.361538733448676,-0.7788124932459125,-0.6887730762297732,-0.8606502483203358,-0.9074484991333164,-0.5663057509639553,-0.5387568498300194,0.3047038864815927,-0.23860580497901518,-0.5101400223658712,-0.7706615468964569,-1.2941798361606798,-1.274250023749189,-0.4986080198921054,-0.422585270506815,0.064340994953547,10.833333333333334,True,Allen,CTLA4,ipilimumab,SKCM,NR,42.99999999999997,0.40610672564214484,High-risk,48.80251583654434
MEL-IPI_Pat27-Tumor-SM-4DK1N,-0.9860750424426475,-0.3435108544680421,-0.7476147977379655,-1.7246348401410652,-0.1736387116278039,-0.2936320402363869,0.008214104659114489,0.47403325845034466,-0.5268156970852844,-0.6891142624212926,-0.4878695445693329,0.29411440076370216,-0.4811156785043895,-0.19515596949450864,-0.03964228981669341,-0.4435472796707438,0.22831175077678634,0.596040444141003,-0.06377699348928695,0.63155731592736,-0.40337646409510425,0.0013312023451508524,-0.9378890616654773,0.07074716419529832,-0.6860892931543103,0.8967746237854317,0.19523361602556374,0.6711084979204598,-0.18727564651975984,-0.5659620166477335,0.8831270344065956,-1.2639871460709369,-0.7394054198475031,-0.3496422603719079,-0.3918678132779287,-0.8855481485943407,-0.4588214525579651,0.4469742032561577,-0.5959995645535828,-0.34134512371972603,-0.6881163364420209,0.21788494841667708,0.6080309347870938,45.96666666666667,False,Allen,CTLA4,ipilimumab,SKCM,NR,32.0,0.33883434361324394,Low-risk,48.80251583654434
MEL-IPI_Pat28-Tumor-SM-4DK1O,0.09220350057035587,0.7804619742669763,1.8104169726802997,0.0837477819159822,0.2204170647451532,1.1801500803578662,-0.2320951778441137,-0.978581640300758,0.44385244950969543,0.8372576012138004,1.1328102261720814,1.7096933319459535,0.19846774509994397,0.849731108525822,0.4918796016796039,0.29095739150667926,0.16871087463004936,-0.6047521650328923,-0.4527857395683831,-0.09717424811352796,-0.9910608989078938,-1.4793585171561365,-0.5297509672728957,-0.1564918670425911,-1.840674982115712,-2.813321079120296,-0.055460479354550514,-1.784412105465577,-1.6387127711218832,-0.8854530087755741,-1.1737960648362047,-1.4646162075242966,-0.710793686405768,-1.9667465355958604,-0.7763055326658418,-0.3866703580319883,1.511604420707543,-1.198495927215603,-0.1997919281766101,-0.15586845777377006,-0.4533284912101602,0.3217235073201196,0.5625440218920772,39.46666666666667,True,Allen,CTLA4,ipilimumab,SKCM,NR,632.9999999999967,0.2972290543770919,Low-risk,48.80251583654434
MEL-IPI_Pat33-Tumor-SM-4DK1T,-0.9775155499850202,-1.4760859760495162,-0.5075892486919594,-1.0537337270703155,-0.571360562765514,-0.8131533930411196,-1.3152071851795382,-0.7282907976039067,-1.0000546052392292,-1.3835041136339374,-0.7713168877231088,-0.5804077376398198,-0.7936005791479008,-1.3534885716237361,-0.714986769144512,-1.3993696658563706,0.07760944522695844,-1.5089254003633332,-0.8929522913412927,-1.1552301779104281,-1.2215186774686408,-1.0492977560873937,-0.9185372841826128,-1.3447060792137504,-1.1843735196365917,-1.0056528449193183,-1.310719248719163,-1.2256396809667767,-0.8353149669014656,-0.4659469535569508,-0.727473411081716,-0.9867156623792679,-0.3291370230344884,-0.6041490339453126,0.8306965734339073,-0.06875628200357846,-1.0981818752052082,-0.45608914412708645,-1.1756614299868509,0.35491880292643496,-1.0552680224472162,0.6858166576635472,0.423510114958247,7.033333333333333,True,Allen,CTLA4,ipilimumab,SKCM,NR,14.000000000000094,0.5468231060770123,High-risk,48.80251583654434
MEL-IPI_Pat36-Tumor-SM-53U3X,-0.8111807578330729,-0.7606093263553952,-0.627968878012323,-1.226072284613891,-0.9520037385460078,-0.7520885792772356,-1.3344814353221195,-1.4385598334122605,-1.284018465552937,-1.0515449499521679,-1.0031902986198986,-1.064054468548963,-1.5379396226024717,-1.0899568321735318,-1.3144252557445035,-1.4846627013950155,-1.220315763178058,-1.575659463581413,-1.3695497857199763,-1.6016196700284073,-0.9659233374903187,-1.2699188014537985,-0.9974346005416316,0.2553646724245323,-0.34675714550772646,-0.29376378700234573,0.79202259236645,-0.6192666631713751,-0.6774343100200934,-1.0164945728764525,0.3697891146493461,-1.202444245143013,0.01027343234863538,-0.08961831284282852,-0.7133316302961951,-0.38297118472475017,-0.9426331466561025,-1.0561048848420211,-1.1953576408613706,0.5770340714020459,-1.2244857854780304,0.408063150335768,0.6301080131474165,1.8,True,Allen,CTLA4,ipilimumab,SKCM,NR,6.999999999999999,0.5563580162380041,High-risk,48.80251583654434
MEL-IPI_Pat37-Tumor-SM-53U3Y,-0.5654731473498502,0.45206255197244105,-0.4099071095090419,-0.7395330154326535,0.1427588373717733,-0.10513918779488951,-0.7888382540398546,0.009457938836302008,-0.4648069222613922,-0.42076728461899027,-0.8512866641015274,-0.3096180167961854,-0.5018560432020341,-0.4378751111030338,-0.6194245637111975,-0.29861468927540297,-0.41337081315552676,-0.28673463032884106,-0.3652494107999682,-0.642439867084965,-0.7039125383892442,-0.9404364967255536,-1.0422031555785667,0.399312445564916,-0.7039606331222693,-0.6219782285836111,0.7005456635947778,-0.5439934997075568,-1.0805456657269807,-0.999870675896254,-1.2578740434953455,0.11924488780676769,-0.10169704891645052,-1.0636024853209238,-0.13816832623827185,-1.0855389962198052,-0.16674005932582775,-0.059458104290246054,-0.87148223824164,1.3748098537939422,-1.128696200163191,1.52333906665752,1.0044140035654192,2.333333333333333,True,Allen,CTLA4,ipilimumab,SKCM,NR,119.99999999999964,0.5209097936345485,High-risk,48.80251583654434
MEL-IPI_Pat40-Tumor-SM-4DK21,-0.7564686687321347,-0.5950713978045886,-0.8134344452318899,-1.5191279750872744,-0.08227522436548926,-0.6472036306446787,-0.24464125976064321,-0.34817084260218145,-0.8834027151647675,-0.7603055131098216,-0.10904185609976623,-0.5717591394687775,-0.7541349888160724,-0.3597505325764776,-0.3386940608950487,-0.696800003334767,-0.46258317227960183,-0.5088722970567516,-0.02668211559621439,-0.15785194342478295,0.6519387577111153,-0.2068757735015669,0.8420634348548478,0.40062968011006916,-0.32287309390466457,0.886389099769565,1.1503967408471787,0.7529117460170165,0.333541322758848,-0.5505120829116648,-0.812650754456917,-1.060829814902796,-0.1038784131996752,-1.170697540839094,-0.23454701338942266,-0.17967319101514215,-0.5843125771279299,0.616532464384333,-0.3676896922338321,-0.13649898816834102,-0.9900884646748273,-0.19965179443866904,0.4641806264930704,1.1333333333333333,True,Allen,CTLA4,ipilimumab,SKCM,NR,19.000000000000004,0.5437536833098187,High-risk,48.80251583654434
MEL-IPI_Pat43-Tumor-SM-4DK24,-0.19665096782719577,1.0426537349876552,0.1991061838630825,1.2746474846399416,1.6401400860143485,1.4745345152058111,1.540528664963681,1.0073273814574852,1.652609615912252,1.4699608837735396,1.6295025538503523,1.117938192849906,0.9779252110059541,0.9000198463747636,1.1691126987641476,0.6139316519091217,-0.6279377299875136,1.47662481502234,-0.19373191877733842,1.1531686671457937,1.6258140847749705,2.58745613148393,-0.06317670410570823,-0.4487174871949955,1.2235992119014985,1.7476180135323442,0.3397808842469191,1.4886121285240985,1.0382060813118328,-1.2411827790444776,1.2122990228299388,1.6487127432688808,1.3511169756975547,1.6523115343481745,-0.4203521959264301,-0.2829645500300238,1.3744175873970101,0.865831968050397,0.35404948265126873,-1.1748999145793777,-0.2241176808664707,-1.0938108323062943,-0.4042513803627061,1.2333333333333334,True,Allen,CTLA4,ipilimumab,SKCM,NR,176.99999999999957,0.3276644287479843,Low-risk,48.80251583654434
MEL-IPI_Pat44-Tumor-SM-4DK25,-0.7011448804625877,-1.5296465719535697,-0.5338495099211967,-1.3374687040569975,-1.1492697599195307,-1.5580537196564332,-1.7458203632477698,-0.2588911375143159,-1.644090735141569,-1.7549370364649899,-2.01765185786074,-1.3133829539529722,-1.975071742492899,-1.8737097649721735,-1.9482484300536564,-1.4630007187863778,-0.42132649646589915,-2.533933548397841,-2.366055856645016,-1.7457847177246568,-0.28061752524855854,-0.2713364214583091,0.13963257770727633,-1.5126276902879634,-1.363894863448852,-1.14299853503725,0.2995159830753044,-1.1539886664520909,-1.3395635183735324,-1.1499470078430667,-0.8948589077881699,-0.8243010286238084,-0.02237617955978472,0.21008129913306084,0.3792556842501654,-1.0843966418298272,-1.6877559508903424,-1.9470884883639668,-2.216695792472952,0.6699813663647255,-1.7492936085828232,1.0051398907988902,0.4092930752075034,9.033333333333331,True,Allen,CTLA4,ipilimumab,SKCM,NR,52.0,0.4942011939383275,High-risk,48.80251583654434
MEL-IPI_Pat45-Tumor-SM-4DK26,-0.6440871110945554,-1.5418133268153584,-1.1576324486674239,-1.1232931616347481,-1.4262997776617823,-1.6799970788151604,-1.4234886338637607,-1.0598351369474572,-1.846322263220712,-1.754362431197085,-1.2709267822821533,-1.7205811402713798,-1.6321126462872542,-1.6107420280377318,-1.6605654097582334,-1.7911264301232537,-1.3282980147742764,-2.758595390188893,-1.9599660686620182,-2.420767835267164,-1.349553234475521,-0.9318171575011058,-0.24932495521595366,0.2080469637920991,-1.6346881853311963,-1.0268674337642505,0.6188236190085993,-0.8372980173743877,-0.7046159301181065,-0.8852454077522426,-1.0039194510891138,-1.1342408231835717,-0.3299932409611271,-0.9563545610035622,-0.019334321966393123,-1.1685772820780025,-1.9097873490825945,-0.6990845439949426,-2.0883775159529048,0.05178521189206962,-0.7400295342111531,0.302027952634716,0.8812356102713592,2.966666666666667,True,Allen,CTLA4,ipilimumab,SKCM,NR,904.9999999999976,0.5321278177655733,High-risk,48.80251583654434
MEL-IPI_Pat46-Tumor-SM-53U48,-0.5072540251570743,1.6027162200726843,-0.7281988001092212,-1.0814574572957605,-0.32840590880575626,-0.24699883414031187,-0.3319285594859404,0.8495077976396509,-0.6672569124306535,-0.7223155397490492,0.5207792830538882,-0.27305232555385556,-0.4502332995528851,-0.3214840301723577,-1.380058190307119,-0.7059248234224068,-0.7784633617559488,-0.4188271828558917,0.36673251162121867,0.3943667487265499,-0.7906804307655423,-0.8106118819568091,-1.0640543226847001,0.46364732551179866,-0.5439556583665369,0.364294026002621,-0.6081064762230942,-0.015664035430339243,-0.6017104000219454,-1.1883495301911606,-0.33817327803047215,-0.3411689070634807,-0.04807014195722178,0.970708561359081,0.10928464923155996,-1.3349062522380828,-0.5989420254901799,0.5522992751990419,-1.1047749526424397,0.4332221578787677,-1.4666313731774656,0.7398677445785024,0.3106817578273021,5.333333333333333,True,Allen,CTLA4,ipilimumab,SKCM,NR,251.99999999999957,0.5486687794604241,High-risk,48.80251583654434
MEL-IPI_Pat50-Tumor-SM-53U69,-0.3745748033213969,-0.27287604891449063,-0.6333921504752088,0.028615143991190986,-0.47706916007880984,-0.6389323776177124,-1.2196736516707813,-0.3090594388315335,-0.9715882439015074,-0.5093053814244629,-1.2962879684021946,-0.7166157958590721,-0.8706056522407865,-0.34367930193077817,-0.852620460540693,-0.6767009826470023,0.8208718048749564,-0.9562825584063624,-0.8776802474407679,-0.7741589783652258,-0.37719165626087126,-1.2722402134949147,-0.3191116585719217,0.06103722731502147,-1.255462717635136,-0.4881687179236779,-0.6507181810288509,-0.8831005419935654,-0.9978334628165005,-0.7411454515411657,-0.837607161771493,-1.294213347283412,-0.4308472848096029,-1.2758767903911192,0.2381401797559872,-0.2960422211438708,-0.48498444568470295,-1.1081597052036212,-1.342506923060521,0.20542952141907997,-0.4878886633247604,0.16377909401551882,0.47121603960401615,2.1666666666666665,True,Allen,CTLA4,ipilimumab,SKCM,NR,412.9999999999997,0.3951452116870596,High-risk,48.80251583654434
MEL-IPI_Pat81-Tumor-SM-4DK37,-0.8957071332183021,-1.110857293302005,-0.5860782689980527,-1.3777282299445337,-0.6779092413559863,-1.2767150125771332,0.3463405932670862,-0.7942344805465369,-1.4921349174124057,-1.0180582035932566,0.056368782232210875,-0.9968191836337792,-1.3374705660058908,-0.005058185371386558,-0.9141148046429124,-1.5559272730983291,-0.8581120950067157,-1.0618218872379945,-0.6964222596129153,-0.6793168279368406,-0.8185976902323535,-0.6308043274798496,-1.60706186315961,0.26030246475436103,-1.511424756484181,0.1739339211292493,0.654323979410519,-0.27178106584408557,-0.39245458976045533,-0.8974626777787187,-0.5142135492016047,-1.4850220384747657,-0.5147509506413545,0.22746922846402193,-0.2847630728490647,-0.7039902252796634,-1.067170720431547,-0.04784567514434318,-1.310769094655874,-1.9528989223069388,-1.6965796913929139,-0.8538504022498942,0.34514295821197005,20.933333333333334,True,Allen,CTLA4,ipilimumab,SKCM,NR,95.99999999999986,0.5370768236622636,High-risk,48.80251583654434
MEL-IPI_Pat83-Tumor-SM-53U2W,0.17345592553653544,-0.18193381098358494,-0.06017186977771256,0.6704691805491256,0.8040312085496757,0.5258451336467145,0.5390409577724213,0.6340490132710455,0.983890649443123,1.0386472789457446,-0.49962880919021263,0.13085521002622358,-0.2645350862286645,0.9681144614239059,0.1390847081188064,0.21555724152053865,-0.14682105021125022,-0.4689923023562252,-1.4318387409132882,-0.5868399262201839,-1.4586901858549552,-1.593530666366039,-2.2622375948471394,-1.3714136336766776,-1.4831055753282962,-0.41289542816336494,0.8589710338908777,-0.7658763152208502,-1.0617671868413618,-0.8427268014909,-1.1798867060356901,-0.8339721956458306,-0.5709544118156987,-1.2027060395025253,-0.7274219146183212,0.09339858662688917,0.6932229518759719,-0.40757731934327623,-1.0320564955093243,-1.587917607088597,-0.07931587964855688,-1.2676314550097616,0.03198228125726365,34.233333333333334,False,Allen,CTLA4,ipilimumab,SKCM,NR,35.0,0.37653441181809166,High-risk,48.80251583654434
MEL-IPI_Pat85-Tumor-SM-53U2Y,0.2407925089960771,1.2962406383131464,1.2133058221286734,0.8147697397290369,1.7930569128491858,2.577980762620377,1.399283033469936,1.6338291891752472,2.3150062198381756,2.105444787351002,3.209511502131263,3.226994425813567,1.7172247493340809,1.5737387948765766,1.7068934820690016,1.0270533070391095,-0.004153534542125259,0.5556422821009576,1.0954955598371845,1.472372401654521,-0.009901174866636525,-0.5425367822738868,-0.45986311215072206,-0.5098192164358207,-0.7951757466448935,0.6303698927129688,-0.9209141221987444,0.7401322149395518,-0.3463137939305279,-1.299699402066301,-0.2147794945514565,-0.04727372564617209,-0.4875513161537812,-0.4912612562714638,-0.3539303433208941,0.18493172902827032,2.067944532112903,0.8112488018238426,0.8028861124098228,-0.025258886614131084,0.8418577628223513,0.6004536006410677,0.42011322134879003,15.266666666666667,True,Allen,CTLA4,ipilimumab,SKCM,NR,319.9999999999981,0.2738511993748821,Low-risk,48.80251583654434
MEL-IPI_Pat86-Tumor-SM-4DK3C,-0.6496661902488223,-0.8552017531260987,-0.41489609870469407,-0.7615567144282953,-0.47188096992018524,-0.41616741985045785,0.014923817811370465,-0.7868688234246313,-0.7317194390579004,-0.7410846071042004,-0.2802000388608974,-0.40238498847539234,-1.0921090806754545,-0.7571076327889967,-1.374923535816276,-1.0862627824113407,-1.1093541926225272,-0.1674776717598345,-1.2959819738323826,-0.1412676780497746,-0.391484401270173,-0.4387461710184748,-0.6394984922679434,0.4052925389485125,-0.6506730433342565,-1.177686019421105,1.181705110138863,-1.1206147672385247,0.2719170421240623,-0.9131770185256396,-1.0186490932009027,-0.8175199683292425,-0.3179768749953394,0.008916411398302918,-0.5575480497260352,-0.07571326326829261,-0.7207841708760465,-0.40861973211739866,-1.190864575236855,-0.16904968153427394,-0.5941578513714706,-0.36062337358006413,0.4476142488467901,9.766666666666667,True,Allen,CTLA4,ipilimumab,SKCM,NR,60.99999999999998,0.4721083569154348,High-risk,48.80251583654434
MEL-IPI_Pat98-Tumor-SM-4CU6L,-0.02377126167546292,-0.39454875768134673,-0.13732528869458818,-0.7683669880436285,0.15578461521942744,-0.2777081219927835,0.009508486958683015,-0.043719662807620505,-0.33360270802953895,-0.4043106535604077,-0.38171019406526935,0.16096317016624148,-0.4680535575194972,-0.2361986487067136,-0.32731774878291403,-0.7207025060732691,0.5854145826137973,-0.7128824803457237,-0.4886143042835647,-0.12637264256359335,-0.7098269823310456,-1.0124165874843567,-2.2629749029401447,0.30230935024852423,-0.82153272491161,-0.4660357336206746,-0.7082092130450298,-0.45127579661232925,-0.5804848639882924,-0.6871910722348744,-0.20473397971457233,-0.5293824546875499,-0.46431335606813473,-0.9833840108346207,0.14994321286019605,-0.3679624711731797,0.022319935546157132,-0.24956951379031203,-0.9911443409090128,0.06458686232663632,-0.7744193730026633,0.3326150497924243,0.6175221440388445,4.666666666666667,True,Allen,CTLA4,ipilimumab,SKCM,NR,32.0,0.4416419217666876,High-risk,48.80251583654434
MEL-IPI_Pat118-Tumor-SM-5X2QV,-0.178813894102593,-0.08183838168036318,0.06326931708537675,-0.45659211418498596,1.255951986682688,0.6098357141645502,0.8944413814004123,0.8661262168792097,0.9138578187529047,0.6629739502553909,-0.005327570023215348,0.3234673147075778,0.24378979068113393,0.3768441462258245,0.6585017197371026,1.181861131340478,0.12441311403534296,1.1461130520732512,0.14497243895223375,0.7341497182263963,0.7462359040822043,1.4410278023125078,-0.5107602487748863,0.0673160809020138,0.7891967601263243,1.2694905851237923,0.6427119861891522,0.8848508894334939,0.5583198958244948,-0.8852972945622236,2.035342629591589,2.143787190706594,0.08844369572151647,1.3050703504531032,-0.39158137752500005,-0.6153287231283372,0.7110203217471947,0.2660453255513328,0.09871630311031511,-1.0354213084929345,-0.26442343184567024,-0.8952205500394753,0.07819690000876289,10.433333333333334,True,Allen,CTLA4,ipilimumab,SKCM,NR,112.9999999999997,0.35196604328669157,Low-risk,48.80251583654434
MEL-IPI_Pat119-Tumor-SM-7459N,0.23516648212835567,-0.08232855300979308,0.003078172885066494,-1.3183282808221675,0.167903268536531,-0.5180339121293579,-0.5360889176998583,0.7783084244588492,-0.479530381559879,-0.19963139051100448,-1.3948535296062952,-0.49839451121448836,-0.9360715401828434,-0.15237369532598627,-0.7341182420554689,-0.2679765886165355,0.5462504011884179,-0.9346828790876557,-1.1978577815681752,-0.5219042814042709,-0.5739809969651334,-0.6426742225724824,-0.31880642419487853,0.1864375973640601,0.234261056925783,-1.2496979075791455,-0.5892749738419022,-1.7555259898253757,-1.0088365438746154,-0.8287145668587629,-0.01843175514938012,-0.11535143269614032,-0.45520971904427787,-1.0130452128254297,-0.3206483590449312,-0.6448894587832004,-0.15564331332257672,-1.3280908381427634,-1.2068045158811007,0.10637820257036922,-0.5284935871594951,-0.3730663664605463,0.24555580756821815,26.933333333333334,False,Allen,CTLA4,ipilimumab,SKCM,NR,289.9999999999999,0.3946310065447093,High-risk,48.80251583654434
MEL-IPI_Pat39-Tumor-SM-4DK1Z,1.983198262435198,0.715203628052127,1.2937966696707766,1.1597194477819366,1.6042188353423636,0.6178832624642873,0.8774511373913492,1.323659613509284,1.0535981733313753,0.43318938322142225,-0.17641504751090684,-0.1037835244388252,0.4740103964280353,0.7304584493532535,0.670960179597045,1.1570547464424348,1.2690256215401496,1.4695870581226567,0.24519796812287248,1.1394329656267723,1.3805421346921543,2.058700737259077,-0.26767574983749626,0.1779554895459822,1.0340516331534502,1.2094999530880832,0.9715833681782831,0.9003191868324175,1.437960056289042,-1.031584130995308,2.35729038716244,3.135629835343122,1.0070904212062617,1.9502399520418063,-0.34309548464380457,-1.0974826117258811,0.4252933363278374,0.8271164848469272,-0.47735845071783034,-1.424298987296534,0.8771232712242243,-1.2227771839751547,-0.5767982072522969,49.56666666666667,False,Allen,CTLA4,ipilimumab,SKCM,R,64.99999999999997,0.2667244606820509,Low-risk,48.80251583654434
MEL-IPI_Pat47-Tumor-SM-4DK28,-0.38431291353537544,-0.835053641887306,-0.2856100046515746,0.3643747467168283,-0.6311503562431258,-0.8708775002744911,-1.0130703068055484,-0.3758198711265098,-1.1968692769122031,-1.067937128139752,0.005519663008996536,-0.2769103084255989,-0.8706612798065202,-0.38247303982275993,-0.2755237159228517,-1.5285987361647018,-0.3642326698468463,-1.1900790324612907,-0.6159650500877802,-0.6519405685674936,-0.2524311714379579,-0.6813261155765602,-1.141304284831935,0.058632893551248295,-1.4698078961873706,-0.5693042196965901,-0.0905306643512279,-0.8881424576964011,-0.7480643829767786,-0.9755518336675713,-0.7512564830705192,-1.0066825573543168,-0.3574132923578079,-0.7211297655664397,-0.32537505412430007,-0.6705813496074244,-0.7207406793287557,-0.7384471926986399,-0.7093358758991166,-0.17729584695429443,-0.5689110224435733,0.4016213730645136,0.7501710722173254,36.86666666666667,False,Allen,CTLA4,ipilimumab,SKCM,R,134.99999999999935,0.403059102740564,High-risk,48.80251583654434
MEL-IPI_Pat04-Tumor-SM-4DJZZ,-0.6578573450137323,-0.4202069875362675,-0.1381644264170297,-1.1175035764273495,0.053904030358867455,0.095223764375428,-0.6867714034196338,-0.7564411019591136,-0.09262340703503488,0.0002582063298204456,-0.05435680226833189,0.8973176166075799,0.030172576392118507,-0.5789694502488838,0.0901136339033956,-1.3347803852517715,-0.14782007161905109,-0.38691536636343415,-0.5084727313264189,-0.28507492721181266,-0.7122023446601938,-0.7313185175280709,-0.39533196035986395,0.13742354641381835,-1.544539454073319,-0.4103000260249412,0.17095758518403667,-0.3817391640998491,-0.6419715106137402,-1.3071646914472208,-1.2855576021303912,-1.1738728931176232,-0.4863385791142472,-1.3861012868573752,0.6132065459117105,-0.6511625805541142,-0.002894415902735139,-0.7350435699566676,-0.8255556083840817,0.9132755618958887,-0.8131150992737195,1.0831840281331742,1.0563365845112471,32.9,False,Allen,CTLA4,ipilimumab,SKCM,R,325.9999999999992,0.3891663657324369,High-risk,48.80251583654434
MEL-IPI_Pat38-Tumor-SM-53U3Z,-0.034430695793854514,0.144750164167444,0.2405271463208417,-0.07005684849779342,1.0423039407266492,1.51546595807283,1.0739620353660504,0.7896897155179824,1.3628802129706168,1.4729267523478853,1.0279877521128067,2.0214822984392167,0.6870489756100927,0.6635971307442385,1.3367126174928143,0.8290142433623703,0.6085653490864351,0.9398953592586465,0.6115753605122873,0.9090009377763218,0.22218771150144528,-0.25641036329706807,-0.4862023221610637,0.3084195697380714,-1.059406841334696,0.3540014673166501,0.6274833820108352,0.2958383403635171,-0.18264673557055264,-0.9947122889011224,-0.6075048639024613,-0.7882612467344506,-0.6282994078332486,-1.3307521988356819,-0.5714427902138396,-0.18905312610567956,1.4889509911589287,0.5065477136262586,0.3582423465225582,0.720940758737435,0.39804413281849343,1.099048367911235,0.7920806374598808,51.3,False,Allen,CTLA4,ipilimumab,SKCM,R,2424.9999999999864,0.26830295399653237,Low-risk,48.80251583654434
MEL-IPI_Pat79-Tumor-SM-53U2S,-0.04837488073243977,-0.37630699420557495,-0.0549125880596321,-0.24025142152200957,-0.17878904926115843,-0.5404748094711161,-0.5096015128766149,-0.06446460615831907,-0.27665133781654194,-0.36903484347970156,-0.662772907475152,-0.5466719546282706,-0.7285442437651991,0.138081318295306,-0.7302889368501492,-0.471122996611264,0.2606532971261194,-1.5364486376069015,-1.1230674822795093,-1.0128175796153829,-1.007780637658846,-0.8260393073062745,-1.6884697280506025,-0.3143592388666287,-0.9714252269197035,-0.2124370601580413,-0.014636512128291595,-0.7662498627133851,-0.9940318355000088,-0.9369514721788309,-0.8613845581922579,-1.3182515462777413,-0.460900342049813,-0.9420055921478029,-0.0733610310689827,-0.8702604522345263,-0.251128340435541,-1.110558394655552,-1.284564953594308,-0.601764645199596,-0.3326741609178623,-0.10232855737110397,0.40650564686699703,26.7,True,Allen,CTLA4,ipilimumab,SKCM,R,306.9999999999988,0.3914614391913062,High-risk,48.80251583654434
MEL-IPI_Pat90-Tumor-SM-4DK3G,0.019610304290058236,-0.35458207859720153,-0.12534771992751034,0.23574022495279962,-0.1297420971599173,-0.332111366839707,-0.39971376430365185,0.34199657901892355,-0.2551432961267508,-0.3474547711627554,-1.2214390296694015,-0.48890624372033786,-0.6098931919600189,-0.4168835118422775,-0.49236286029673054,-0.2928608282673866,0.07823735399134003,-0.7226358091420102,-1.3220751430929227,-0.8987574705738035,-0.6907151328913899,-0.5214420032981539,-0.5858233308764028,-0.14209107122532985,-0.2973532286736396,-0.6163310567049264,-0.3486025303925277,-0.9713045999848235,-0.3582774105133991,-0.8375868961031747,0.14546310977615806,-0.5110476685867043,-0.48365219633921724,-0.7260558390408237,-0.1210771645083799,-0.8413470255121531,-0.14166714732125948,-0.5458558258434,-1.3203764289261668,0.27061591705616445,0.05247430631838231,0.4509121414070546,0.19354353210692152,33.5,False,Allen,CTLA4,ipilimumab,SKCM,R,201.99999999999983,0.37435828929714465,High-risk,48.80251583654434
MEL-IPI_Pat126-Tumor-SM-5X2R4,-0.22270022219679964,-0.35277896021883104,-0.405561206969551,-0.599905115212228,0.23287353903461996,-0.0032583818807608925,-0.5888000908818708,-0.2076607018240312,-0.19558002973637406,-0.23126173329120536,-0.39717825219058395,0.08384941172400183,-0.35545821408413547,-0.7223152534222171,0.0991961885684245,-0.1913991041308831,-0.048059002375167484,-0.36361671694008874,-0.6567644601492711,-0.22799229699728832,-0.36655491157965303,0.03791256185633995,-0.08294092159477262,-0.967430696774915,-0.32022023101704883,0.5104872565642041,-1.1856502095511694,0.017707196653649407,-0.3334491030531066,-0.3302477075244297,0.5073508632036892,0.3532796598620888,-0.19796129287608785,-0.0678881710425395,0.2664119931816797,-0.7851179748441948,0.11674695632521076,-0.2738947698518254,-0.32858885729476595,0.9063232093730111,-0.507245333656056,0.8926075019955984,0.4776997433884836,21.366666666666667,False,Allen,CTLA4,ipilimumab,SKCM,R,369.9999999999979,0.42545073819457185,High-risk,48.80251583654434
MEL-IPI_Pat02-Tumor-SM-4DJZX,-0.27445713772534114,-0.1716695382410775,0.48168981621483886,-0.7006030602431956,0.8646138081358504,0.786724775969746,1.0710684004331859,0.3073518783402865,1.1870962406581136,0.8579820833173781,1.8439845997219015,0.8689947707836702,0.4796376900071081,0.4018539916765523,0.6685722635757937,0.6446429760817636,0.2508065065064862,1.7929251857042692,1.6347535809220382,2.1503181834040315,2.0111864226879157,2.352967701592298,0.7808165314465125,0.9959579206412318,0.5969100547335452,1.5381499309328623,0.9477893629198852,2.2492066597264553,1.6980007817916893,-0.6885962461072173,1.112773729838111,0.643702325372534,-0.3614915795975993,1.0383631318662805,0.12998480954769995,-0.050688929299068056,0.4165522667247619,1.5134631210509422,0.7268861490458953,-1.8376617397558506,0.14129500960455543,-0.5146637338430766,0.13749046734140094,54.4,False,Allen,CTLA4,ipilimumab,SKCM,R,214.99999999999903,0.37785861292519607,High-risk,48.80251583654434
MEL-IPI_Pat49-Tumor-SM-4DK2A,0.9780953192220665,1.2653094995180794,1.2244295050894285,1.3652892137198747,1.6169493582596894,2.125579943360394,1.9420332703440335,1.1515056940869648,1.7340821400677577,1.9118005239581095,1.6001695255649377,2.2562888414141624,1.0618271731794209,1.8129056496747196,1.5406323128336985,1.0606974501567366,1.4632752047629103,0.23449537346002206,0.5653924176360262,0.5920296889545534,0.10448641290301271,-0.09188940542343996,0.08272385014431236,0.5147950281279609,-1.4213598418931115,-0.9543695934055748,-0.3513865541089727,-1.3070401683269024,-1.2727910487660574,0.32216621071909035,0.507294298052245,-0.8450905817170774,-0.6733167303220975,-0.7127772609805934,-0.20528719331525425,-0.10219595378057814,1.9376645020835168,-0.6616696075614906,0.27570171396864646,-0.9924373796801257,1.152829372001936,-0.332051024152208,0.0983009095670318,34.46666666666667,False,Allen,CTLA4,ipilimumab,SKCM,R,660.9999999999964,0.1317659060709867,Low-risk,48.80251583654434
MEL-IPI_Pat80-Tumor-SM-4DK36,-0.33361099871758754,0.22868678568696743,-0.08128148423020419,0.6186649428022426,0.09002521711761348,0.17903655008762578,-0.12938385590828502,0.5770014148253939,0.0842462489197036,0.050396786498013546,0.43320607218066404,0.4521079327892917,-0.24950933486659405,-0.07505933930392408,0.17543506019138666,0.0545332553208231,0.7142445069438857,-0.09534288071427201,-0.005208564543746175,0.19801609077646143,-0.44174075631360327,-0.8716455922647306,-0.5639882720010541,-0.0328429721390664,-1.208619466839793,0.3088337723565296,-0.2164929585769954,0.3565559522536681,-0.8209542772993055,-1.0994140562101216,0.704552203028536,-0.905137901487521,-0.4471125116562229,-0.39899177641134864,-0.8129488946189106,-0.19864909877712433,0.27730795292619637,-0.2157806558284768,-0.5965656714398351,0.9846963951379067,-0.8659400136441165,1.1211057903445063,0.8067102997561624,24.133333333333333,True,Allen,CTLA4,ipilimumab,SKCM,R,191.9999999999997,0.3528877664470643,Low-risk,48.80251583654434
MEL-IPI_Pat88-Tumor-SM-4DK3E,0.5727046663891944,2.0024419011475256,0.9670428873674188,0.8617165047013753,1.0113826593169108,1.6110970299242504,1.2381523087392654,0.7839210143541905,1.385763258438507,1.6990654977880097,1.5729549858432945,1.9698801039063047,0.5056208809412259,1.5638210910298764,1.3383919441420087,0.7748894429403402,0.6168341607617079,-0.15473855848853826,-0.528003548683913,0.11243359500601362,-0.5889739907892033,-1.608924180736429,-1.1071470831588806,-0.3638071362142271,-1.244356665477306,-2.496458821459658,-0.36189918287966544,-1.9312451300947866,-1.3596550630179194,-0.9711919270579822,-0.7812056283326578,-0.522837974594764,-0.39725798743943586,-1.8504786919226224,-0.26222076056566507,0.3313432086661942,1.856490342987843,-1.1304621842756089,-0.3204541466167356,0.6098151896516779,-0.15011117066442106,0.6206143293943143,0.6281322362303621,32.96666666666667,False,Allen,CTLA4,ipilimumab,SKCM,R,1076.9999999999973,0.2280433229565712,Low-risk,48.80251583654434
MEL-IPI_Pat123-Tumor-SM-5X2R1,-0.39076650625511816,-0.4020928927144297,-0.4196588163897688,-0.6388172509085145,-0.5211653573175712,-0.6760815146561465,-1.1358680147716878,-0.6872960189236446,-0.6683631143962108,-0.5956096063849764,-0.806042019131368,-0.26525848086650566,-0.6635109294913605,-0.879784868392726,-0.35944280684381785,-0.8393196542933843,-0.4193959216941504,-0.9039350480157545,-1.4720965878864254,-0.6452641136968523,-1.2659823765647549,-1.1522213057802708,0.9542830563256829,-0.47099844342748676,-0.7279918644185127,-2.1838844496683465,-0.21404496532177586,-2.252741196442657,-1.087463958195902,-0.8526814244968571,-1.0906606284281792,-0.9131246310775116,-0.2855096620243553,-0.6093722036699516,0.04552155753560082,-0.6925514416048071,-0.38407605074566203,-1.393952826976096,-1.4813221364978584,-0.6157780546257237,-1.6713639961632862,-0.14290906701456604,0.42195891764969423,28.433333333333334,True,Allen,CTLA4,ipilimumab,SKCM,R,495.9999999999995,0.46167628575854514,High-risk,48.80251583654434
MEL-IPI_Pat29-Tumor-SM-4DK1P,2.5415882588237158,1.2265383347869117,1.946935357906961,1.4546268362312234,1.416241785161078,0.39192687941046833,0.4935907235066994,1.4887693156477477,0.5272212454788239,0.16393519634307466,-0.13757788311054198,-0.24056112483491365,0.6457069919662153,0.8374127315341271,0.25019062382538804,1.0777695467780795,2.212312409680078,-0.7403278492085119,-0.9360938620499952,-0.49404200207882193,-0.6844544533278953,-0.611898921767675,-0.3511264271285708,-1.1427081499410747,-0.5846835266192525,-0.5717021976169068,0.805480652365424,-0.5947402844710742,0.6587739877740862,-1.0882045597808871,-0.5242434228821767,0.1055764579727512,-0.5801381013093161,-1.238905371727261,-0.2003952689171285,-0.4026916616562907,0.233960934461197,-0.3264074807183348,-0.23353413922336486,0.49442211240204487,1.6643641967560598,1.077269565979216,0.5471581294671851,44.2,False,Allen,CTLA4,ipilimumab,SKCM,R,40.99999999999998,0.18185299658111176,Low-risk,48.80251583654434
102T-Tumor-SM-BZ9XL,-0.7110585823740253,0.006338242357199204,-0.749075665230303,0.3998578594486923,-1.3223557256591567,-0.50277144410667,-1.5039528271348717,-0.050163566812846984,-1.0547464965239444,-0.9583017512512872,-0.9225557436094961,-0.9163188150588295,-0.9819022180796163,-0.5344246551059071,-1.3967191454126338,-0.5581479168084189,-1.0095147523926014,-0.6676759491114053,-0.31089659811931913,-0.6099450533686712,-0.773715838679131,-1.34755124113331,-1.4426806946896962,-0.20544181072472842,-2.037034824044895,-1.8155992701714427,-0.6761285646349253,-1.8022049763957473,-1.0587382023920682,-0.4792814345222878,-1.4176483707773722,-1.6087719520062942,0.7914138102694066,-0.8727092423648086,0.0028835845368710383,-0.7131744027072964,-0.7843700329733208,-0.9887671787564529,-0.7996415149938076,1.8238334854667568,-1.7456376444416462,1.8610378039193614,0.9715621036661599,26.2,False,MGH,CTLA4,unknow,SKCM,R,,0.5257256433551627,High-risk,48.80251583654434
107T-Tumor-SM-BZ9WD,0.2542470897224796,-0.19625706433042103,0.5227262445479129,0.2727250317430747,0.6730175176752818,0.36794605077153436,1.5495430517702131,0.6799869938942579,0.7146840037913931,0.37696957480718896,-0.5421132240197901,0.3276462933802518,-0.7907160693754235,-0.01818081419170161,0.14679291379117407,1.3088250463839357,-0.0009529588333349808,1.483077213163408,0.7895607848305349,0.9447454318127976,1.2925490820386394,-0.2538413359481639,-0.5228249720403866,1.0728374006896102,1.1979995250348525,-0.595774410222905,-0.41300676541951115,-0.42658282411325343,-0.11838215381664535,0.8457930476088609,0.17663978486597334,-0.31450731248967106,6.740467292518991,3.1901677070687167,0.014038436726993049,-0.43064220354067295,0.33557458354219927,-0.1418322454959319,-0.18180961335929827,-1.620378055565798,0.9717859219289413,-1.7582280607738114,0.2094082542200452,33.266666666666666,True,MGH,CTLA4,unknow,SKCM,NR,15.000000000000057,0.5197602679785313,High-risk,48.80251583654434
115T-Tumor-SM-BZ9WG,-0.22016845354507653,0.16398212218121938,-0.12050526179339363,-0.17533187675453896,-0.4358333856357597,0.7717376035791983,0.40557019662082566,-0.36615709305682537,0.22189472514719677,0.6864643408459772,-0.06032919504599033,0.0019128135064388051,-0.7997543983639269,0.3200636241730377,-0.5870269787257949,-0.29303339613327406,-0.29550941936320424,0.6574558862593997,-0.26297331797407203,0.23972390278232056,0.47672517358903665,0.18728225018014183,-1.0218209765726163,-0.8430783705404886,-0.7945162743393003,-2.053570172571474,1.055166236996047,-1.2875317719169235,-0.4699627486331668,-0.5363134810371494,-1.7548696314020285,-0.6497229017253295,0.30220554087244506,-0.6651120824803688,-0.5688268403217841,-0.37067345702893484,0.6570257599340692,-1.0572097693295033,-0.842717019763526,0.4460151430756955,0.3294822353435594,-0.38750621698997556,0.4873028333645086,36.4,False,MGH,CTLA4,unknow,SKCM,NR,3121.99999999999,0.3223465299604621,Low-risk,48.80251583654434
122T-Tumor-SM-BZ9WT,1.0054687309946486,1.7095656652437252,1.0202092212753222,1.190421933015196,0.7226800008833164,1.5194851213109626,1.2214551612562747,0.20778527962660678,1.0412236793059622,1.5669059773046126,1.0523359602624982,1.6765405306801344,0.4768283532493536,1.5276717856577473,0.17350545982681534,1.4359484747715092,0.6594407299447773,1.1415043229328052,2.124027861383433,1.6404601486923016,0.6266162886576959,0.08955570151637329,-0.10452553394533165,0.934234083801038,-0.6422183631830879,-0.46749852147154614,-0.2032047672486488,-0.47535135466349726,-0.46873988111282316,-1.209522243326581,-0.6149172731657322,0.22120090287262684,-0.202480729732838,-0.5791513025241714,-0.46742954778732504,0.8153293306768101,1.5797368260219524,-1.093645379383704,1.2552397606795498,0.15015078119774744,1.483656735105056,0.005975312000582199,0.73125448887732,35.36666666666667,False,MGH,CTLA4,unknow,SKCM,NR,978.0000000000005,0.25111586731203217,Low-risk,48.80251583654434
126T-Tumor-SM-CDZ2D,-0.11648645641231305,-0.3901468518983543,0.2324345099277706,-0.6947178372457345,0.8013188974873403,0.3890076818741215,0.402905756631192,1.6981214306821113,0.8699473487750161,1.213859437523794,0.6116234629467072,0.9943380252235559,0.3598727274263986,1.6553981528619135,0.8613899805436087,-1.2022269685756253,-0.2707857389316257,-2.532130891173334,-0.3551987869309922,-1.3502628465967341,0.13975217053855984,-1.7469924127566114,3.507453355670442,2.786802530843349,-2.8787474202441454,-3.0124643913938125,-0.43095360096882807,-2.796225522879281,-2.03325815143484,-0.6222234488011231,-1.6402904753086252,-1.3323406235970743,-0.5741788729452809,-1.1084993971710289,0.433678071207355,0.4969866900047468,0.5964852322672305,-1.9516812421269985,-1.6040407973211463,-1.1477366707433478,-0.21474978909890763,-0.2027762518541554,0.03155682088639955,25.73333333333333,True,MGH,CTLA4,unknow,SKCM,R,625.9999999999982,0.4053292426949429,High-risk,48.80251583654434
148T-Tumor-SM-BZ9XH,-0.9913141856007264,1.5612327309619063,-0.010889389714407807,-1.0319243138190877,0.009921677494416654,0.4037850548730278,6.362214258064142e-05,-0.12397738105936947,-0.6714248661824079,-0.613964147869443,-0.5786241271165177,0.4713703700889031,-0.20694621674374258,-0.5988308311627255,-0.7213058195133342,-0.47087260895214583,-1.1243857966280835,1.2341092363284532,-0.12787370390786112,1.091599093076662,0.12179980426694985,0.22228170722358498,-0.14498108926225078,0.05978757438825321,0.22405386487568835,0.056140456734711665,0.6150666444577899,0.12921947792537822,-0.08806335420125572,-0.974164734113078,0.41699091287255485,0.8743179593525446,-0.3522597650087965,-0.8089681641232447,-0.363438653644728,-0.673398604861405,-0.21271572934116825,-0.49006909346796196,-0.0695507194540441,-0.2749006971759551,-0.7816519064826375,-0.5481921801115841,0.4541229436340484,14.0,True,MGH,PD1+KIR,unknow,SKCM,R,1183.9999999999957,0.40212714869959887,High-risk,48.80251583654434
155T-Tumor-SM-BZ9WV,-0.9078059814877244,-1.0031202071077854,-0.522477123015883,-1.1239105883814804,-0.5330903062343606,-0.3955549241664281,0.3622443663596014,-1.362494865835163,-0.5538941481430812,-0.7218452026799566,-0.9154668883707301,-0.6224193490318484,-0.8952821718323645,-0.5987275008574144,-0.9383759098709069,-0.36675907772429317,-1.0418675912075865,-0.2533084263112577,-0.45212202097119225,-0.16881727157000012,-1.1442153723742547,-1.2956355781455715,-1.0790683453428362,-0.891148147417435,-1.0645838616676533,0.25959015837682353,0.37203861382935205,-0.4755874445100407,-0.5146549395889112,0.8564514299257172,-0.9196734523858411,-0.7210528932686457,1.939197579342633,1.8188746249045267,0.13221154103495017,-0.4166440286488692,-0.37174483617720605,-0.22038646604294138,-0.5130017081396026,-1.155908340388308,-0.5585376032568216,-1.1832014673134246,0.20682007532258254,9.266666666666667,True,MGH,CTLA4,unknow,SKCM,NR,15.000000000000057,0.6367755079266197,High-risk,48.80251583654434
166T-Tumor-SM-AZXO4,-0.9051054799971302,-1.2669732966773437,-0.41719846778737163,-1.2375130406574248,0.2865621524988367,-0.5024621844203937,1.4267684066045654,0.3557354964089952,-0.6441275455267139,-0.6794254488279503,0.012096101797125497,-0.27455487501255105,0.10753321064326633,-0.6534789870425135,-0.17292776785905128,-0.519818433336408,-1.0136216087657284,-0.20265826509229512,0.0499178723927226,-0.5999131887949972,-0.7017299076643576,0.36421347724487985,0.023789391205031384,0.012288055648127443,0.10092491158979186,-0.6254524964668948,1.4823217723734095,-0.1810316408243543,3.148672841609647,0.6330391792047358,-0.004203190977962323,1.466345269832698,-0.3918155575972715,1.7254403326707923,2.7039086243946966,-1.0361432472186192,-0.7496636165560299,0.5084922312441402,-0.5710492461546657,-1.9835607374952022,-0.19526237030521007,-2.2136993993868295,-0.4612542068316886,26.666666666666668,True,MGH,CTLA4,unknow,SKCM,R,1443.9999999999934,0.5031742091639221,High-risk,48.80251583654434
208T-Tumor-SM-AH3NE,-0.4489943635920532,-0.6685789485996727,-0.7885516156420469,-1.3920409149233806,-0.46218385054363775,-0.8302342025019982,0.3853907651020513,-0.243518139389405,-0.9249571073301279,-1.1487942213758173,-1.6347351613552354,-0.8895768501656275,-0.782265083048458,-1.1162459469708843,-1.1222811655633604,0.08398217519234658,0.004556909865259247,-0.48998485847180856,-0.04870791357457136,-0.4439811942008548,0.4367268187592583,0.7565457279045331,-1.6473138256524864,-0.18487649242185974,-1.3000441386175687,0.3425873236757843,0.11297125692565901,0.5315682754469838,-0.7119299561322617,-0.7345228255699136,-0.5902570162980114,-0.6337151397837308,-0.5996132644673033,-0.10121722576810843,-0.5481013900456423,-1.148440491938016,-1.1854413128173795,-0.25251923271920185,-0.6626711027241181,1.4018968094582396,-1.0141840436897354,2.0499507821391676,0.8137452039350783,23.433333333333334,True,MGH,CTLA4,unknow,SKCM,R,371.9999999999981,0.49278798694389225,High-risk,48.80251583654434
212T-Tumor-SM-BZ9X2,-0.6810987595118969,-0.7377401197941993,-0.5473388604097419,-1.3008067516050583,-0.9066466022539102,-0.5405292687291359,-1.2289331696401755,-0.40957856210279203,-1.0072316613410026,-1.0496461090828408,-1.1560233479923894,-0.5035425112293097,-1.5768390853829632,-1.14403085727573,-1.2341503262567493,-0.702565288026348,-0.7591984867773274,-1.1691350579694133,-0.8422558886112935,-0.8962649130593217,-0.5152194674367779,-0.3421798000341126,-7.996273671516258e-05,-0.6273367464319697,-0.8977309962903958,-0.033584091710777614,0.5360178182303398,0.21502651380660062,-1.0455475506499579,-0.5773642931204003,0.5520370119448311,-1.002432443669027,-0.611119432029348,-1.0460824851319543,0.0519086259833964,-0.9735346509621319,-0.7162254247301103,-0.6675427341823064,-1.2457700953165813,0.3135992614320528,-0.8684454384508771,0.30625776143983346,0.5089200005650258,30.666666666666668,False,MGH,CTLA4,unknow,SKCM,NR,291.9999999999993,0.4516789527661656,High-risk,48.80251583654434
255T-Tumor-SM-CO8YG,-0.9849604449343441,-1.3549421306420093,-1.1615406301803377,-1.7376405594352688,-0.4758691542756247,-1.2075326638011257,0.2066601714927119,-0.9209924839591318,-1.160071317372501,-1.477881196250744,-0.6157788757429123,-1.119589511673417,-1.3054441507744183,-1.455832815111433,-0.43562775012880683,-0.8715803968275809,-0.7640282283803853,-0.09773659195412325,0.46243975079229727,-0.6855765789717199,0.7214110235970866,1.6275108592303742,0.1670935234181455,0.27609223964887214,1.560912765756678,0.8384064388194842,0.01899333141617864,1.1681519231481707,0.331209252504884,0.22154041626389082,1.6669935577109913,1.802983411630787,0.5824670543885162,1.9288544939997485,-0.34243670034020474,-1.2022698501687128,-1.2728191195017755,0.5598052195088689,-0.7395484307272441,0.030827210773215753,-0.3828914251648555,-0.4538502022663952,0.1424574500431075,28.6,False,MGH,CTLA4,unknow,SKCM,NR,,0.6083097044299721,High-risk,48.80251583654434
272T-Tumor-SM-BZ9X7,-0.38748056647632956,1.1242911232738748,0.3784478955428585,-0.7007763728683062,1.6885806227250646,2.3338821933588516,1.7594898625005195,0.8091716986094842,1.3766865646527953,2.201432213868282,0.9716627541007596,1.6187594703969264,0.5237715184929271,2.010083038625768,1.2333980367242368,1.3348260027175374,0.36006089073794006,0.45736733770509386,1.1276973448148597,0.9740666597830834,0.40295055759213555,-0.6486130302974586,-0.3768454104334241,0.7005978956266703,-0.8056821151280145,0.2876794369354524,1.8934209220219618,0.7119978460730251,0.20111075603499673,-0.7192988840349577,0.7700454148465201,-0.18689333804926564,-0.5461931737342075,-1.2518587571265094,-0.9651339305571565,-0.0872991842704792,1.9780147138206692,-0.3597724483414904,0.5812014244948964,1.2413983359241583,0.7150895340075725,0.9822698297769656,0.8116718208864395,27.4,False,MGH,CTLA4,unknow,SKCM,R,250.9999999999986,0.2264201582793157,Low-risk,48.80251583654434
278T-Tumor-SM-CRSYW,-0.6450379498307929,0.6298931666643961,0.5039265433319721,-0.13624393148222044,1.5885583818385722,2.008410528019104,1.5220199667393328,1.3678614596968413,2.2341272137187325,1.766754622829768,1.7591130875469658,2.172156278033791,1.188722486875028,1.8745471388254662,1.4108947908081817,0.4475637292717781,1.0525765620605108,1.4418326098759535,1.1695002636207545,1.935331490816073,1.956515953177257,0.7365145452919093,1.8853472065251173,0.7938551014632376,0.1101226791560728,0.2306122150858866,-0.5605340887208005,0.2996341893773174,0.1571278424160345,-1.123715259998675,-0.3089928382100657,0.059508968004018,-0.45211428868500647,-1.0630135599779282,0.005253540699815071,0.4232178341476071,1.2592061139253015,0.2151202666558441,-0.15579402423315244,-1.642195321678121,0.8652947950241742,-1.43486170901523,-0.24157811256972778,24.666666666666668,False,MGH,CTLA4,unknow,SKCM,R,,0.23002973992983444,Low-risk,48.80251583654434
292T-Tumor-SM-CDZ2C,-0.8140730427081321,-1.0948220758092808,-0.513058051565127,-1.2133882294611849,-0.6090935809973899,-0.8729731789224338,-0.6483211952002903,-0.07997273809006294,-0.9025308057465437,-0.807304782860065,-0.1821819705400924,-1.6543177857103675,-1.3843368930570517,-0.6010870587323864,-0.6525478515152734,-1.6092437696136002,-0.7424848905148081,-1.053672162230972,0.1139315376572334,-0.9236324174726329,-0.9949887651001077,-1.1318175229394818,0.4730209794060668,2.783897071232734,-1.2953795478642607,-0.7288302080655016,0.3245907008680225,-0.400676225410337,-0.27648551783482117,-0.9627767661699871,0.087819611383552,-0.4269009688456041,0.03185274521457562,-0.30885813521867156,0.1269498526925767,0.1830520487813879,-1.2257332874214686,-0.5115072038504873,-0.7017472420582518,0.6320467235800771,-2.0643646221109875,0.7002890339562582,-0.21321540044470524,0.9,True,MGH,CTLA4+PD1,unknow,SKCM,NR,91.99999999999945,0.7462545080866092,High-risk,48.80251583654434
324T-Tumor-SM-BZ9XM,1.9439031197833931,1.8240381296691035,1.3832640480727265,0.4263773668149878,1.0463011739702879,1.2266791868317433,1.4183692122124076,2.1388693063061597,1.1708521861141237,0.9070206407464485,0.49534535755964554,0.5664482554010155,1.008919585233262,0.47492141401511834,-0.15644817447558537,0.8694380772844261,0.9950100889758111,-0.019464519926639123,-0.09454548375952236,0.21665978808898112,0.3124421995430199,-1.1273399605752088,-0.6378938923014172,0.033132845860420854,-0.08870361509424929,-1.1388470693117207,0.1470203048452514,-1.1179449581868002,-0.1327426017126913,-0.9948787442718721,-1.4141211462108294,-0.31552174627235163,-0.05835346386713608,-0.7275326253952201,-0.10555223739508159,-0.2357943539315079,1.002528094779892,-0.9984786729827655,-0.6028462052094988,0.9449581542292614,1.7110141179826168,0.7876961952017298,0.7145376434324443,14.533333333333331,True,MGH,PD1,unknow,SKCM,NR,,0.2770236716190386,Low-risk,48.80251583654434
333T-Tumor-SM-AZXNZ,0.36400260463565753,-0.4081962801096295,0.41265549316661954,-0.1723393778418226,0.08313946085686001,-0.2536278301742126,0.2681600152075543,0.43991134977086205,-0.09193641746238954,0.218781361979324,-0.03387142720338296,0.6693424833812547,-0.20366446570475297,-0.19035370425420042,0.10952811619190367,-0.5783582258713647,-0.3648393632802316,-1.0920084408544948,-0.09252296977012921,-0.43063302440451223,-0.99667042670711,-1.423584393916437,-1.2288615424145386,-1.403188467118327,-0.99648233413964,-1.3987598376999735,-0.4096554283924539,-0.9874176830268379,-0.3722449764237405,-1.036585739418933,-1.3864885130567484,-0.33046747475774224,0.03302236516192668,-1.2851599787136818,-0.4605891854905089,-0.3363417277535921,0.372203749166956,-0.6362147256248605,-0.4128407986361203,0.17426570852937295,-0.015214071070965172,0.16363656499210755,-0.15236854873611605,27.4,False,MGH,CTLA4,unknow,SKCM,NR,2230.99999999999,0.46482912204279364,High-risk,48.80251583654434
356T-Tumor-SM-AZXNY,-0.4888475997151018,-0.7489030003449773,-0.5917033668306124,0.5498238139400898,0.3674793812489519,-0.12054032674366526,0.7240359128022247,0.718823696981068,-0.12433986207362141,-0.5760547117609296,0.25113279433415525,-0.6604477515871255,-0.31758689658522965,-0.26483117218537877,-0.48209247171322966,-0.7427143008482313,-1.1231161954389326,-0.4386118596368069,-0.3869056407346882,-0.21152907555571157,-0.09502504493744919,0.9348109366361865,1.0711583665228017,-0.15348728171865839,-0.8734704075871623,0.38605365458054325,0.41524910135638965,0.14061296023154293,-0.13451237836853103,-0.13989273424260215,0.3580243524030287,-0.12238829929278014,-0.5050998142676194,0.10651608321011598,1.6086365669776417,-0.7902185559979716,-0.23728922440860833,-0.17163292405662336,-0.44926099822463705,-1.1518969895540154,-0.154939570921364,-1.5336816558647575,0.3116240783012498,21.4,False,MGH,PD1,unknow,SKCM,NR,147.99999999999943,0.4157972515833885,High-risk,48.80251583654434
35T-Tumor-SM-BZ9VQ,-0.0023776176718647126,-0.2168160365018328,0.6574904491133529,0.4717535273752257,0.21596499816703077,0.2750430108175192,-0.2067276436296458,0.264489375417409,0.04020436023833974,-0.0022128547873471343,-0.048835133302464605,0.8648770596510033,-0.048590422989706915,-0.5224656240816454,-0.9683017200471897,0.5247465100249945,0.9943343579207242,-0.06354063177329805,-0.5007959262834393,-0.03970592029032754,-0.3692612364739788,-0.967686468219672,-1.7902830863991208,-0.6456085985303525,-1.724467314764758,-0.5707918315466712,0.07456291264739077,-0.3605617483270987,0.2572128352043156,-1.3356740874136033,-1.4965846681920763,-0.7414299610017934,0.2298297756269677,-0.842754339027597,-0.08815151706374982,-0.7193061192723351,0.3022487553572284,-0.2834372916348155,-0.3715237374675979,0.1473065129889834,-0.037596712235916624,0.8888379953008505,0.6976472948993793,25.933333333333334,False,MGH,CTLA4,unknow,SKCM,NR,198.99999999999932,0.2935482373900906,Low-risk,48.80251583654434
379T-Tumor-SM-BZ9XI,-0.7974266216396023,-0.8492411680518133,-0.764464418819753,-0.44043181774858736,0.002942826385870362,-0.37051198165898064,0.5884648267939343,0.5387740358089553,-0.8469000851808118,-0.8393183894151539,-0.4517231909701217,-0.7181184522051047,-0.446362695251425,-0.5042834061594816,-0.4273826768736548,0.6815522267861704,-0.8038928285401123,0.3652513846144162,1.1904937425323563,0.036435991126338926,1.887903923135215,1.7450085198380882,-0.09539370627617563,0.5619036537419225,-0.6814349022156796,0.1047070171358327,1.728715446510143,0.04144457617628096,-0.302561435294285,-0.4647279310364904,0.146858819566403,0.23070350218786131,-0.5892079787574066,0.3721685144249778,-0.46541469297008525,-0.819843205113822,-0.7259509385390683,-0.443688470350359,0.47430723024741284,0.2817974502501466,0.36903479922066745,0.3801373865898027,0.573370217002235,4.833333333333333,True,MGH,PD1,unknow,SKCM,NR,48.99999999999999,0.3905231362049754,High-risk,48.80251583654434
383T-Tumor-SM-BZ9WI,-0.21830936449207367,-1.4402875176458014,-0.12289954122376895,-0.7130406852301163,-0.6579098332084286,-0.23749540210703676,-0.117069460958138,-0.1360341722640321,-0.720936056420501,-0.7112126756269315,-0.04498121227285585,-0.09123978048509512,-0.8779211001894234,-0.5055206269241019,-1.3838864531107005,-0.8138207378504296,-0.663466667472075,-0.3671530119705675,0.49684727465560224,-0.0076720696395072155,-0.32179075943333907,-1.230059700901097,-1.8688901305589034,0.20387253044088838,0.061611006988874166,-0.5449300412959779,1.0376354469390763,-0.799687814682828,0.5296851457643864,-0.9296448935753614,-1.3865790978080583,-0.4453274206291926,-0.20916048815155808,-0.029355169707891624,-0.5044793276930416,-0.7280414860212522,-0.6703705973547325,-0.8205705439075005,-0.5859751245301982,1.4826553769688893,0.07635208862272436,1.3987370441670708,0.6488471266149015,11.566666666666666,True,MGH,PD1,unknow,SKCM,NR,158.9999999999999,0.533457459791974,High-risk,48.80251583654434
391T-Tumor-SM-AZXNX,-0.9905102899516127,-0.9286273957467585,-0.7802532953205975,-1.426105598334427,-0.4195522930904536,-0.5254324500780474,0.01399001451276932,-0.14472051582272058,-0.6782303936264164,-1.040997380505292,0.42356627978095146,-0.5978729588768993,-0.47512607099804505,-0.19490895753344697,-0.7210424418192193,-1.3789956189480317,-1.1661138662859194,0.20356094281294337,0.3331212711255429,0.2965029300134647,-0.19855895773506613,-0.8316911043991013,1.0697541222669649,0.43631870365511466,-0.5610103682329535,0.2392879416945674,1.5144198406500122,0.5953752546413478,0.44696220899716055,-0.8519880552012965,-0.5140410164798642,-0.7055779247384619,-0.5513258782664663,-0.6145492777054671,-0.6003748637424012,-0.4981029525884646,-1.0365875324688447,0.6765473684010628,-0.44182564350330855,-1.4716665631490264,-0.9638406050674694,-1.320238543519772,0.5719785210595707,18.6,True,MGH,PD1,unknow,SKCM,NR,339.9999999999981,0.539483200854394,High-risk,48.80251583654434
39T-Tumor-SM-BZ9VS,-0.40627804771703396,-0.24439743302776026,-0.006444396670879007,-1.136924159530874,-0.27542835015663336,0.03639159123122287,-0.644355280240189,-0.2226349228997188,-0.8230977923965357,-0.4290778105120242,-0.3550669696078792,-0.03798781334633432,-0.3276511601964802,-0.6115285677511626,-0.6690793019176762,-1.094304810544327,0.41467989613815626,-0.3151539764204043,-0.3233575690210611,-0.20785071174029882,-0.9087304640500491,-0.9101664701308657,-2.1391088322307623,-1.0950155576317957,-0.24314094720694976,-1.6474615882396488,-0.40936644082673146,-1.7189612171553952,-0.5317982960210713,-0.8964730162911225,-1.4929632100013364,-0.08503748778048975,-0.5188392007665056,-0.5611089868366064,-0.6481535435860283,-0.771397761009376,-0.390148733033218,-1.2938996289679168,-0.9898031677703303,1.0193191742549383,-1.0494934581362938,0.8539507840691093,0.6870070209268297,6.933333333333334,True,MGH,PD1,unknow,SKCM,NR,196.9999999999997,0.44676322491315346,High-risk,48.80251583654434
422T-Tumor-SM-BZ9WK,0.3322537260021929,1.1364987077407256,0.5402733463843906,-0.6611998891864399,0.539869645482035,1.3759477913579785,0.5977734588832089,0.1467270438870104,0.49344194446326917,1.1453691059727689,0.8924981694130504,0.9313466638653741,0.31781393177527034,0.9723632542878436,0.7008703455668671,1.0192731056143187,0.610129798702183,0.6955879228992645,1.8483512415639536,1.1084852120867048,1.8902964231376076,0.08551049094810718,-0.2056795675885314,1.0096451570798441,-0.03962094901751135,-0.33143169340833634,1.009882956098758,-0.43141009887604975,0.008346103353579468,-0.6507389444934439,0.2226064135422783,0.9227704292410216,-0.5675222157891268,-0.4582271156144597,-0.698099500081351,0.3346417056366072,1.4173225695511802,-0.6396344619950433,1.4311771063994154,0.49918455871067097,1.110268100910432,0.6350454422909845,0.7062201571100757,17.966666666666665,False,MGH,CTLA4+PD1,unknow,SKCM,R,225.9999999999994,0.30343339078164744,Low-risk,48.80251583654434
42T-Tumor-SM-BZ9VZ,-0.5068794139000486,-0.18758969728745148,-0.5543535719875563,-0.11268831070173617,-0.4116674255472152,-0.35615806824842255,-0.8389147856489293,0.031201389262744756,-0.898115593335176,-0.5465415183340933,-1.2611770441357593,-0.8919753668760431,-0.768372031463018,-0.5436114737059232,-1.186180824293933,-0.1708024648570273,-0.26691818444654675,-0.16535025977909182,-0.5817842574611978,-0.5688066177596252,-0.6421240792636858,-0.7005664530723859,-1.8172438682477112,0.33006203726058503,-0.9616933360087605,-0.639339090110969,0.5014423971902482,-1.0230939977720563,-0.6160499345477144,-0.8872727693948439,-0.1695430541393507,0.8121012792523566,-0.5197333785934507,-0.456775822887346,-0.596180470138239,-0.30135899157374635,-0.4511796093557351,-1.44497015152615,-1.1087898760122419,0.6195807543021795,-0.7660205079472054,0.8406469780425811,0.40493661002213,5.433333333333334,True,MGH,PD1,unknow,SKCM,NR,161.99999999999994,0.465947109029176,High-risk,48.80251583654434
430T-Tumor-SM-AZXO1,-0.8969964028377944,-1.2349789005479181,-0.9131890783585868,-0.570555369950718,0.19812668232732042,-0.5325823534573698,1.0113589235846756,0.6939229189604316,-0.031201550428286907,-0.20581648348430417,-0.10742078537486664,-0.8844667795597292,-0.4025133162968933,-0.7148810772601233,-0.01584790127293245,-0.7996402921020108,-0.7277549671141702,-0.055372172726825764,0.1645147790016473,-0.27985736961121394,1.0106592767489593,1.9957632601892898,-0.043401291215212814,-0.23187186156643483,-0.04683247763898415,-0.18535686887555228,1.0410066702552376,-0.034532016503577935,1.7018725126286867,0.4167472221738053,0.6920550801615576,0.9337794154528849,-0.16011895442017013,1.68630936800503,2.449870988279546,-0.9417487429082086,-0.5538056023320846,0.3071915984671619,-0.7850879037747668,-1.922727664339376,-0.4905050666802697,-1.7797388848591371,0.1445302021564965,10.0,True,MGH,PD1,unknow,SKCM,NR,40.99999999999998,0.42845844544704315,High-risk,48.80251583654434
43T-Tumor-SM-CO8YI,0.012472258388275528,-0.16175438216196078,-0.10751782027598282,0.7263122201719054,0.4902413063009864,0.8694835229933342,0.8971530868125388,0.9432798370707289,0.9572186363782341,0.5104156080191916,1.2481317835016936,0.8329804647835699,0.021814674667873735,0.7614361427839562,0.5079637904091335,-0.36273081599729223,0.0847455305803838,1.2920657909329987,1.9023646403572647,1.8302889149607842,0.9070586082047318,-0.13336270688009177,1.572927606612183,1.6871196406995501,0.045675621676218935,0.7421686780464255,0.04609437781935715,0.9003997947932402,1.288088842826535,-0.8120466620561628,1.1377863082152593,-0.2007439590766991,-0.3698584826864058,-0.3240756745649391,-0.5383879443038503,0.1133359286265889,0.37470788513174763,0.7766512587676627,0.39750420446779167,-0.9488823496939933,0.3370881847749205,-1.1405720800418997,0.14622140051464655,33.6,False,MGH,CTLA4,unknow,SKCM,NR,130.99999999999943,0.3708035317324498,Low-risk,48.80251583654434
62T-Tumor-SM-BZ9W5,-0.700544265985598,-0.8271916215191044,-0.21778229411899255,-1.3731065582117081,-1.0126311408217412,-0.29122039370618746,-1.130774857782263,-0.5927762860067097,-0.7694935552724944,-0.31909547228400414,-1.1196523089075878,-0.2683304801104534,-0.6986362125168801,0.049941987672963394,-1.3735601117319785,-0.2878385957146726,-0.9320117858421455,0.6789322656230846,-1.4959989061075183,-0.20086501447061778,-1.138969014584002,-0.8491076430394082,-1.675244243724571,0.08481451612392436,-1.8716266205051804,-1.1246685822767077,2.0751011864208744,-1.4625745685653937,-0.8280860072724768,-0.8979133307396763,-1.5728026377890103,0.8610170141814733,-0.14308607472645965,-0.6010749939653727,-0.42767411616775364,-0.7001059433395496,-0.1836793189513374,-0.6632829543861991,-0.9599634673424638,-0.7878507582019549,-0.9456900049726675,-0.477897548722113,0.3816610832558902,20.866666666666667,True,MGH,CTLA4,unknow,SKCM,NR,24.00000000000001,0.4479552407034854,High-risk,48.80251583654434
77T-Tumor-SM-BZ9W8,-0.7629579077655226,-1.0796870636430898,-0.24770910754686856,-1.5091072713179707,0.0632971010121854,-0.157774115838405,1.240786907751644,-0.6686623978827552,-0.7335076671490828,-0.7897325566920167,-0.5561851490354224,0.6647774708261853,0.07019973378348741,-0.9296393868059374,0.16630038187818486,-0.22203969407352006,-0.6461864203274248,0.4283319897884195,1.1635476130054407,0.5250190069773891,-0.5800651180671972,-0.12887639464271397,-1.1148663232771958,0.4980108681365907,-0.8437432952866512,0.04687226270140258,0.728376403691909,0.3205331460192223,-0.39712071144515815,-0.5713575157978155,-0.11169611505946307,-0.6937670585125464,-0.2300590514273831,-0.20214817351115327,-0.7552455874908047,-0.6378581955996855,-0.45702615914348926,-0.15725080263187893,0.14783557629462804,-0.039988646532984784,-0.04890507492305715,0.5540209668235027,0.5884868644325467,3.1666666666666665,True,MGH,PD1,unknow,SKCM,NR,40.99999999999998,0.4934609983252118,High-risk,48.80251583654434
98T-Tumor-SM-BZ9WA,-1.0595109719353342,-1.0292799514633426,-0.8746408870523908,-1.5957027272171387,-0.37043697943937476,-0.6362549637034343,-0.08105837394668923,-0.9980364691018341,-1.22502303001587,-1.0519707387628023,-1.157209727525231,-0.7410047133711195,-1.5245147425762908,-1.1450673447211583,-0.7177595818437664,-0.8281089616027513,-1.402911507190015,-0.6547590409448383,0.3373030618368607,-0.832817131257031,-0.5833904685338357,-0.3812538660286537,-2.8393306964139158,1.1264122281304267,-0.8878029351540209,-0.0064351026141162134,1.3222457217700048,-0.13423926809869707,-0.08984314666009,-0.6453735726110013,-1.1048081857234018,-0.8408301594560987,-0.38532156499405606,-0.19527377857094208,-0.6194417079474188,-0.9903188062217518,-0.7244915187566302,-0.8567248256300157,-0.6760545431676914,0.7941306633980372,-0.8272591340437622,0.5303263413140805,0.6565538280113771,40.73333333333333,False,MGH,CTLA4,unknow,SKCM,NR,341.9999999999991,0.5836100304289004,High-risk,48.80251583654434
99T-Tumor-SM-AH3NB,0.32839803003267676,0.0742993049666584,-0.07602828526428536,1.0909766035580364,-0.3039772123078013,0.306211243979954,-0.16994677156816967,0.18947903852655879,-0.16413309745967974,0.05447840170288774,-1.2578820000734898,-0.3054156990150223,-0.33537541829794565,0.059619143468763035,-1.20711090442191,0.3149974272420767,-0.7915678846301412,-0.10355658134543946,-1.3524427861411417,-0.40617535565265295,-0.40976786309327007,-1.3422928199766178,-2.0601823876698484,-1.0768622595131847,-0.7147664661767086,-1.238331366663556,-0.22723130694649535,-1.043978092917346,0.39776520816333394,-0.6412610919807338,-2.0563764875158164,0.7652182166052469,-0.33871204518280545,-1.124256118871783,-0.3087963052558457,-1.8244710462475664,0.3510470731724607,-0.9730844812631673,-0.6654439811907725,0.7027908336312856,0.7737375906138657,1.1043132802837685,0.35707314161408815,16.4,True,MGH,PD1,unknow,SKCM,R,32.0,0.36027466179174783,Low-risk,48.80251583654434
Bl1AT-Tumor-SM-BZ9XO,-0.8394644991766353,-1.1829691270612614,-0.8929570419972479,-1.7671694513755156,-0.905734886850128,-0.7054779009315926,-1.1069189843035234,-0.6778101824825754,-1.241930279452302,-1.610986824145686,-0.6394072672230228,-0.950915545145314,-1.4349597563366738,-0.9399208774432919,-0.8097825827261295,-1.4985535199432904,-1.3637725521629505,-0.8904759642285106,1.648684407675929,-0.4682030833035346,-0.15055322971504825,-1.0253728208850512,-0.3583365116286342,1.7346147123766786,-1.04464961791049,-0.5000106165521311,1.821369431668186,0.09740605380157794,0.6150273776950944,-0.6177353278219899,-0.7672935673151046,-0.4110879706992975,-0.2721893853755404,-0.5508959589289779,-0.49073694176625804,-0.4510542194978058,-1.438829129084966,-0.00523056078967516,-0.6463594641993149,0.30546774651831565,-0.8704220728319747,0.3304318009524465,1.1102250520580508,41.833333333333336,True,MGH,PD1,unknow,SKCM,R,,0.6392242174454454,High-risk,48.80251583654434
PD004T-Tumor-SM-BZ9XG,-0.46877776612644717,-0.05301432240653617,-0.15481257754656946,-0.879252499100014,0.39094481782327034,0.7515250632484528,0.03347802485745823,0.012230576442001566,0.14369554396815382,0.6518642716520264,0.20872576304647808,0.5594559252322772,-0.84565230976722,1.5147182937441344,-0.12541557998304953,-0.26577725070046393,-0.8740739026073613,0.2645738309201387,-0.5220336605580832,-0.16391382792385784,-0.6210915758719653,-1.0952924434856373,-0.4901838725047353,0.4691347435904175,-1.2275394132762965,-1.58446240816168,1.710873302571402,-0.7740081847708898,0.12260803574212746,-1.006051050023987,-1.09836357177348,-0.8734265467576832,-0.47760766763510165,-1.614536886711845,-0.4004260880454058,-0.22853032523323075,0.7976566510383907,-0.9944120245703253,-0.364626876558965,0.2722636098044651,-0.10179433042703591,-0.31418063803963575,0.43606984714283836,53.6,False,MGH,PD1,unknow,SKCM,R,616.9999999999984,0.3062716293582254,Low-risk,48.80251583654434
PDL002T-Tumor-SM-BZ9WQ,2.6587552337175295,2.412583736492674,1.7473072840110533,1.869188469371033,0.907622617129758,1.6099016834491053,1.1225295829094775,0.6452945189235326,0.9745614618082042,1.2923588771565226,0.9526294739898357,1.1242793248888334,0.6947287992688218,1.0071703305789625,0.339928536244935,1.422556192596786,0.8736084663111725,1.1106784744432348,0.11336988106044175,1.2098956422128158,0.5060222589490896,0.43530845287148784,-0.8413010012472141,-0.2467929484990745,-1.1095229931152601,0.6311035013958526,0.09894322278759551,0.6871934821093192,-0.6217216469776199,-1.274362700858785,0.08919046936783787,0.3145905440893028,0.6359962703178997,0.07899814376080047,-0.7716514039935335,0.20049210692753747,1.5542465690152942,-0.8124100716045175,0.5522352675786463,0.4204235978622945,1.1014197902336,0.37064978316772185,0.6445715164557769,14.166666666666666,True,MGH,PD1+KIR,unknow,SKCM,R,,0.20108048857327437,Low-risk,48.80251583654434
QQQT-Tumor-SM-AZXO5,0.41941957089885484,0.4396367655208085,-0.19947641405071023,0.7692267146946744,0.654503954182219,0.15305165659781203,1.0937849882523456,0.658790741160481,0.27807561685694937,-0.2184066094536837,1.071154063044642,-0.08092319481791718,0.2880826902816105,-0.34289012603183205,0.0738110095725661,-0.30692628812037254,-1.354865702326373,0.28270007123984564,0.5407357405545277,0.6611932043329923,-0.11595504476203022,0.39560972307743336,1.1199666006309272,0.09635241143957318,-0.38404037690171966,0.9233233594461752,0.47913953980152474,0.6972152765605454,-0.05945198602589532,-0.19150166175631225,0.4876209988192307,0.6984014526573689,-0.47005942710258775,0.2549812988327282,1.669696767153715,-0.5884717345488617,0.0022139977112115195,0.612030883820426,0.2772853029149543,-0.3743214872525735,0.40122585996635646,-0.6996510554535664,0.19130655669226945,45.6,False,MGH,CTLA4,unknow,SKCM,NR,2529.999999999986,0.4973791621887807,High-risk,48.80251583654434
